Genworth Financial (GNW) 10-K 26 Feb 16 2015 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2015	Feb. 10, 2016	Jun. 30, 2015
Document Information [Line Items]
Document Type	10-K
Amendment Flag	false
Document Period End Date	Dec. 31, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	FY
Trading Symbol	GNW
Entity Registrant Name	GENWORTH FINANCIAL INC
Entity Central Index Key	1,276,520
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		497,828,731
Entity Public Float			$ 3,800,000,000

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Assets
Fixed maturity securities available-for-sale, at fair value		$ 58,197	$ 61,077
Equity securities available-for-sale, at fair value		310	275
Commercial mortgage loans		6,170	6,100
Restricted commercial mortgage loans related to securitization entities		161	201
Policy loans		1,568	1,501
Other invested assets		2,309	2,208
Restricted other invested assets related to securitization entities, at fair value		413	411
Total investments		69,128	71,773
Cash and cash equivalents		5,965	4,645	$ 3,657
Accrued investment income		653	660
Deferred acquisition costs		4,398	4,852	5,038
Intangible assets and goodwill		357	265
Reinsurance recoverable		17,245	17,291
Other assets		520	479
Deferred tax asset		155	0
Separate account assets		7,883	9,208
Assets held for sale		127	2,143
Total assets		106,431	111,316
Liabilities and equity
Future policy benefits		36,475	35,915
Policyholder account balances		26,209	26,032
Liability for policy and contract claims		8,095	7,881
Unearned premiums		3,308	3,485
Other liabilities ($46 and $45 of other liabilities are related to securitization entities)		3,004	3,234
Borrowings related to securitization entities ($81 and $85 are carried at fair value)		179	219
Non-recourse funding obligations		1,920	1,981
Long-term borrowings		4,570	4,612
Deferred tax liability		24	858
Separate account liabilities		7,883	9,208
Liabilities held for sale		127	1,094
Total liabilities		$ 91,794	$ 94,519
Commitments and contingencies
Equity:
Class A common stock, $0.001 par value; 1.5 billion shares authorized; 586 million and 585 million shares issued as of December 31, 2015 and 2014, respectively; 498 million and 497 million shares outstanding as of December 31, 2015 and 2014, respectively		$ 1	$ 1
Additional paid-in capital		11,949	11,997
Net unrealized investment gains (losses):
Net unrealized gains (losses) on securities not other-than-temporarily impaired		1,236	2,431
Net unrealized gains (losses) on other-than-temporarily impaired securities		18	22
Net unrealized investment gains (losses)	[1]	1,254	2,453	926	$ 2,638
Derivatives qualifying as hedges	[2]	2,045	2,070	1,319	1,909
Foreign currency translation and other adjustments		(289)	(77)	297	655
Total accumulated other comprehensive income (loss)		3,010	4,446	2,542	5,202
Retained earnings		564	1,179
Treasury stock, at cost (88 million shares as of December 31, 2015 and 2014)		(2,700)	(2,700)
Total Genworth Financial, Inc.'s stockholders' equity		12,824	14,923
Noncontrolling interests		1,813	1,874
Total equity		14,637	16,797	$ 15,620	$ 17,781
Total liabilities and equity		$ 106,431	$ 111,316
[1]	Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information.
[2]	See note 5 for additional information.

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Other liabilities, securitization entities		$ 46	$ 45
Borrowings related to securitization entities, fair value	[1]	$ 81	$ 85
Class A common stock, par value		$ 0.001	$ 0.001
Class A common stock, shares authorized		1,500,000,000	1,500,000,000
Class A common stock, shares issued		586,000,000	585,000,000
Class A common stock, shares outstanding		498,000,000	497,000,000
Treasury stock, shares		88,000,000	88,000,000
[1]	See note 17 for additional information related to consolidated securitization entities.

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) shares in Millions, $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Premiums		$ 4,579	$ 4,700	$ 4,516
Net investment income		3,138	3,142	3,155
Net investment gains (losses)		(75)	(22)	(64)
Policy fees and other income		906	909	1,018
Total revenues		8,548	8,729	8,625
Benefits and expenses:
Benefits and other changes in policy reserves		5,149	6,418	4,737
Interest credited		720	737	738
Acquisition and operating expenses, net of deferrals		1,309	1,138	1,244
Amortization of deferred acquisition costs and intangibles		966	453	463
Goodwill impairment		0	849	0
Interest expense		419	433	450
Total benefits and expenses		8,563	10,028	7,632
Income (loss) from continuing operations before income taxes		(15)	(1,299)	993
Provision (benefit) for income taxes		(9)	(94)	313
Income (loss) from continuing operations		(6)	(1,205)	680
Income (loss) from discontinued operations, net of taxes		(407)	157	34
Net income (loss)		(413)	(1,048)	714
Less: net income attributable to noncontrolling interests		202	196	154
Net income (loss) available to Genworth Financial, Inc.'s common stockholders		$ (615)	$ (1,244)	$ 560
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per common share:
Basic		$ (0.42)	$ (2.82)	$ 1.07
Diluted		(0.42)	(2.82)	1.05
Net income (loss) available to Genworth Financial, Inc.'s common stockholders per common share:
Basic		(1.24)	(2.51)	1.13
Diluted		$ (1.24)	$ (2.51)	$ 1.12
Weighted-average common shares outstanding:
Basic		497.4	496.4	493.6
Diluted	[1]	497.4	496.4	498.7
Supplemental disclosures:
Total other-than-temporary impairments		$ (28)	$ (9)	$ (16)
Portion of other-than-temporary impairments included in other comprehensive income (loss)		1	0	(9)
Net other-than-temporary impairments		(27)	(9)	(25)
Other investment gains (losses)		(48)	(13)	(39)
Net investment gains (losses)		$ (75)	$ (22)	$ (64)
[1]	Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the years ended December 31, 2015 and 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the years ended December 31, 2015 and 2014, as the inclusion of shares for stock options, restricted stock units ("RSUs") and stock appreciation rights ("SARs") of 1.6 million and 5.6 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the years ended December 31, 2015 and 2014, dilutive potential weighted-average common shares outstanding would have been 499.0 million and 502.0 million, respectively.

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions		3 Months Ended																12 Months Ended
		Dec. 31, 2015	[1],[2]	Sep. 30, 2015	[1],[2]	Jun. 30, 2015	[1],[2]	Mar. 31, 2015	[1],[2]	Dec. 31, 2014	[3]	Sep. 30, 2014	[3]	Jun. 30, 2014	[3]	Mar. 31, 2014	[3]	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Net income (loss)		$ (240)		$ (238)		$ (139)		$ 204		$ (708)		$ (787)		$ 228		$ 219		$ (413)	$ (1,048)	$ 714
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities not other-than-temporarily impaired																		(1,209)	1,573	(1,817)
Net unrealized gains (losses) on other-than-temporarily impaired securities																		(4)	10	66
Derivatives qualifying as hedges	[4]																	(25)	751	(590)
Foreign currency translation and other adjustments																		(530)	(537)	(442)
Total other comprehensive income (loss)																		(1,768)	1,797	(2,783)
Total comprehensive income (loss)																		(2,181)	749	(2,069)
Less: comprehensive income attributable to noncontrolling interests																		(106)	32	31
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders																		$ (2,075)	$ 717	$ (2,100)
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[2]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.
[3]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.
[4]	See note 5 for additional information.

Consolidated Statements of Chan

Consolidated Statements of Changes in Equity - USD ($) $ in Millions	Total	Common stock	Additional paid-in capital	Accumulated other comprehensive income (loss)	Retained earnings	Treasury stock, at cost	Total Genworth Financial, Inc.'s stockholders' equity	Noncontrolling interests
Balances at Dec. 31, 2012	$ 17,781	$ 1	$ 12,127	$ 5,202	$ 1,863	$ (2,700)	$ 16,493	$ 1,288
Repurchase of subsidiary shares	(43)	0	0	0	0	0	0	(43)
Comprehensive income (loss):
Net income (loss)	714	0	0	0	560	0	560	154
Other comprehensive income (loss), net of taxes	(2,783)	0	0	(2,660)	0	0	(2,660)	(123)
Total comprehensive income (loss)	(2,069)						(2,100)	31
Dividends to noncontrolling interests	(52)	0	0	0	0	0	0	(52)
Stock-based compensation expense and exercises and other	3	0	0	0	0	0	0	3
Balances at Dec. 31, 2013	15,620	1	12,127	2,542	2,423	(2,700)	14,393	1,227
Sale of subsidiary shares to noncontrolling interests	511	0	(145)	(57)	0	0	(202)	713
Repurchase of subsidiary shares	(28)	0	0	0	0	0	0	(28)
Comprehensive income (loss):
Net income (loss)	(1,048)	0	0	0	(1,244)	0	(1,244)	196
Other comprehensive income (loss), net of taxes	1,797	0	0	1,961	0	0	1,961	(164)
Total comprehensive income (loss)	749						717	32
Dividends to noncontrolling interests	(75)	0	0	0	0	0	0	(75)
Stock-based compensation expense and exercises and other	20	0	15	0	0	0	15	5
Balances at Dec. 31, 2014	16,797	1	11,997	4,446	1,179	(2,700)	14,923	1,874
Sale of subsidiary shares to noncontrolling interests	226	0	(65)	24	0	0	(41)	267
Repurchase of subsidiary shares	(68)	0	0	0	0	0	0	(68)
Comprehensive income (loss):
Net income (loss)	(413)	0	0	0	(615)	0	(615)	202
Other comprehensive income (loss), net of taxes	(1,768)	0	0	(1,460)	0	0	(1,460)	(308)
Total comprehensive income (loss)	(2,181)						(2,075)	(106)
Dividends to noncontrolling interests	(157)	0	0	0	0	0	0	(157)
Stock-based compensation expense and exercises and other	20	0	17	0	0	0	17	3
Balances at Dec. 31, 2015	$ 14,637	$ 1	$ 11,949	$ 3,010	$ 564	$ (2,700)	$ 12,824	$ 1,813

Consolidated Statements of Cash

Consolidated Statements of Cash Flows $ in Millions	12 Months Ended
	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Cash flows from operating activities:
Net income (loss)	$ (413)	$ (1,048)	$ 714
Less (income) loss from discontinued operations, net of taxes	407	(157)	(34)
Adjustments to reconcile net income (loss) to net cash from operating activities:
Loss on sale of subsidiary	141	0	0
Amortization of fixed maturity discounts and premiums and limited partnerships	(106)	(111)	(105)
Net investment (gains) losses	75	22	64
Charges assessed to policyholders	(788)	(777)	(812)
Acquisition costs deferred	(293)	(383)	(363)
Amortization of deferred acquisition costs and intangibles	966	453	463
Goodwill impairment	0	849	0
Deferred income taxes	(196)	(341)	(100)
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments	(239)	206	(59)
Stock-based compensation expense	16	28	39
Change in certain assets and liabilities:
Accrued investment income and other assets	(106)	(163)	(53)
Insurance reserves	1,847	2,497	1,644
Current tax liabilities	(15)	(196)	341
Other liabilities, policy and contract claims and other policy-related balances	293	1,517	(361)
Cash from operating activities-held for sale	2	42	21
Net cash from operating activities	1,591	2,438	1,399
Cash flows from investing activities:
Fixed maturity securities	4,541	5,198	4,891
Commercial mortgage loans	882	765	896
Restricted commercial mortgage loans related to securitization entities	41	32	60
Proceeds from sales of investments:
Fixed maturity and equity securities	4,391	2,386	4,147
Purchases and originations of investments:
Fixed maturity and equity securities	(9,750)	(9,188)	(10,458)
Commercial mortgage loans	(956)	(967)	(873)
Other invested assets, net	175	(35)	65
Policy loans, net	25	12	242
Proceeds from sale of a subsidiary, net of cash transferred	273	0	365
Cash from investing activities-held for sale	(26)	(39)	85
Net cash from investing activities	(404)	(1,836)	(580)
Cash flows from financing activities:
Deposits to universal life and investment contracts	2,257	2,993	2,999
Withdrawals from universal life and investment contracts	(2,144)	(2,588)	(3,269)
Redemption and repurchase of non-recourse funding obligations	(61)	(42)	(28)
Proceeds from issuance of long-term debt	150	144	793
Repayment and repurchase of long-term debt	(120)	(621)	(365)
Repayment of borrowings related to securitization entities	(36)	(32)	(108)
Repurchase of subsidiary shares	(68)	(28)	(43)
Dividends paid to noncontrolling interests	(157)	(75)	(52)
Proceeds from sale of subsidiary shares to noncontrolling interests	226	517	0
Other, net	(98)	(30)	(53)
Cash from financing activities-held for sale	9	(33)	(23)
Net cash from financing activities	(42)	205	(149)
Effect of exchange rate changes on cash and cash equivalents (includes $(35), $(39) and $-related to businesses held for sale	(70)	(103)	(109)
Net change in cash and cash equivalents	1,075	704	561
Cash and cash equivalents at beginning of period	4,918	4,214	3,653
Cash and cash equivalents at end of period	5,993	4,918	4,214
Less cash and cash equivalents held for sale at end of period	28	273	557
Cash and cash equivalents of continuing operations at end of period	$ 5,965	$ 4,645	$ 3,657

Consolidated Statements of Cas8

Consolidated Statements of Cash Flows (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Effect of exchange rate changes on cash and cash equivalents related to businesses held for sale	$ (35)	$ (39)	$ 0

Nature of Business and Formatio

Nature of Business and Formation of Genworth	12 Months Ended
	Dec. 31, 2015
Nature of Business and Formation of Genworth	Genworth Holdings, Inc. (“Genworth Holdings”) (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an initial public offering (“IPO”) of Genworth common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, under the name Sub XLVI, Inc., and was renamed Genworth Financial, Inc. (“Genworth Financial”) upon the completion of the reorganization. References to “Genworth,” the “Company,” “we” or “our” in the accompanying consolidated financial statements and these notes thereto have the following meanings, unless the context otherwise requires: • For periods prior to April 1, 2013: Genworth Holdings and its subsidiaries • For periods from and after April 1, 2013: Genworth Financial and its subsidiaries The accompanying financial statements include on a consolidated basis the accounts of Genworth and our affiliate companies in which we hold a majority voting interest or where we are the primary beneficiary of a variable interest entity (“VIE”). All intercompany accounts and transactions have been eliminated in consolidation. We operate our business through the following five operating segments: • U.S. Mortgage Insurance. • Canada Mortgage Insurance. • Australia Mortgage Insurance. • U.S. Life Insurance. • Runoff. In addition to our five operating business segments, we also have Corporate and Other activities which include debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are managed outside of our operating segments, including certain smaller international mortgage insurance businesses and discontinued operations. On December 1, 2015, we completed the sale of our lifestyle protection insurance business, which had previously been designated as a non-core business. Our lifestyle protection insurance business, previously the only business in the International Protection segment, has been reported as discontinued operations and its financial position, results of operations and cash flows are separately reported for all periods presented. All prior periods reflected herein have been re-presented on this basis. See note 24 for additional information related to discontinued operations. On October 27, 2015, we announced that Genworth Mortgage Insurance Company (“GMICO”), our wholly-owned indirect subsidiary, entered into an agreement to sell our European mortgage insurance business. As the held-for-sale criteria were satisfied during the fourth quarter of 2015, our European mortgage insurance business, included in Corporate and Other activities, has been reported as held for sale and its financial position is separately reported for all periods presented. All prior periods reflected herein have been re-presented on this basis. See note 24 for additional information.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2015
Summary of Significant Accounting Policies	(2) Summary of Significant Accounting Policies Our consolidated financial statements have been prepared on the basis of U.S. generally accepted accounting principles (“U.S. GAAP”). Preparing financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ from those estimates. Certain prior year amounts have been reclassified to conform to the current year presentation. a) Premiums For traditional long-duration insurance contracts, we report premiums as earned when due. For short-duration insurance contracts, we report premiums as revenue over the terms of the related insurance policies on a pro-rata basis or in proportion to expected claims. For single premium mortgage insurance contracts, we report premiums over the estimated policy life in accordance with the expected pattern of risk emergence as further described in our accounting policy for unearned premiums. In addition, we have a practice of refunding the post-delinquent premiums in our U.S. mortgage insurance business to the insured party if the delinquent loan goes to claim. We record a liability for premiums received on the delinquent loans where our practice is to refund post-delinquent premiums. Premiums received under annuity contracts without significant mortality risk and premiums received on investment and universal life insurance products are not reported as revenues but rather as deposits and are included in liabilities for policyholder account balances. b) Net Investment Income and Net Investment Gains and Losses Investment income is recognized when earned. Income or losses upon call or prepayment of available-for-sale fixed maturity securities is recognized in net investment income, except for hybrid securities where the income or loss upon call is recognized in net investment gains and losses. Investment gains and losses are calculated on the basis of specific identification on the trade date. Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method used for mortgage-backed and asset-backed securities of high credit quality (ratings equal to or greater than “AA” or that are backed by a U.S. agency) which cannot be contractually prepaid in such a manner that we would not recover a substantial portion of the initial investment, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage-backed and asset-backed securities, future cash flows are estimated and interest income is recognized going forward using the new internal rate of return. c) Policy Fees and Other Income Policy fees and other income consists primarily of insurance charges assessed on universal and term universal life insurance contracts and fees assessed against customer account values. For universal and term universal life insurance contracts, charges to policyholder accounts for cost of insurance are recognized as revenue when due. Variable product fees are charged to variable annuity contractholders and variable life insurance policyholders based upon the daily net assets of the contractholder’s and policyholder’s account values and are recognized as revenue when charged. Policy surrender fees are recognized as income when the policy is surrendered. d) Investment Securities At the time of purchase, we designate our investment securities as either available-for-sale or trading and report them in our consolidated balance sheets at fair value. Our portfolio of fixed maturity securities comprises primarily investment grade securities. Changes in the fair value of available-for-sale investments, net of the effect on deferred acquisition costs (“DAC”), present value of future profits (“PVFP”), benefit reserves and deferred income taxes, are reflected as unrealized investment gains or losses in a separate component of accumulated other comprehensive income (loss). Realized and unrealized gains and losses related to trading securities are reflected in net investment gains (losses). Trading securities are included in other invested assets in our consolidated balance sheets and primarily represent fixed maturity securities where we utilized the fair value option. Other-Than-Temporary Impairments On Available-For-Sale Securities As of each balance sheet date, we evaluate securities in an unrealized loss position for other-than-temporary impairments. For debt securities, we consider all available information relevant to the collectability of the security, including information about past events, current conditions, and reasonable and supportable forecasts, when developing the estimate of cash flows expected to be collected. More specifically for mortgage-backed and asset-backed securities, we also utilize performance indicators of the underlying assets including default or delinquency rates, loan to collateral value ratios, third-party credit enhancements, current levels of subordination, vintage and other relevant characteristics of the security or underlying assets to develop our estimate of cash flows. Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and judgments regarding the future performance of the underlying collateral. Where possible, this data is benchmarked against third-party sources. We recognize other-than-temporary impairments on debt securities in an unrealized loss position when one of the following circumstances exists: • we do not expect full recovery of our amortized cost basis, • the present value of cash flows expected to be collected is less than our amortized cost basis, • we intend to sell a security or • it is more likely than not that we will be required to sell a security prior to recovery. For other-than-temporary impairments recognized during the period, we present the total other-than-temporary impairments, the portion of other-than-temporary impairments included in other comprehensive income (loss) (“OCI”) and the net other-than-temporary impairments as supplemental disclosure presented on the face of our consolidated statements of income. Total other-than-temporary impairments that emerged in the current period are calculated as the difference between the amortized cost and fair value. For other-than-temporarily impaired securities where we do not intend to sell the security and it is not more likely than not that we will be required to sell the security prior to recovery, total other-than-temporary impairments are adjusted by the portion of other-than-temporary impairments recognized in OCI (“non-credit”). Net other-than-temporary impairments recorded in net income (loss) represent the credit loss on the other-than-temporarily impaired securities with the offset recognized as an adjustment to the amortized cost to determine the new amortized cost basis of the securities. For securities that were deemed to be other-than-temporarily impaired and a non-credit loss was recorded in OCI, the amount recorded as an unrealized gain (loss) represents the difference between the current fair value and the new amortized cost for each period presented. The unrealized gain (loss) on an other-than-temporarily impaired security is recorded as a separate component in OCI until the security is sold or until we record an other-than-temporary impairment where we intend to sell the security or will be required to sell the security prior to recovery. To estimate the amount of other-than-temporary impairment attributed to credit losses on debt securities where we do not intend to sell the security and it is not more likely than not that we will be required to sell the security prior to recovery, we determine our best estimate of the present value of the cash flows expected to be collected from a security using the effective yield on the security prior to recording any other-than-temporary impairment. If the present value of the discounted cash flows is lower than the amortized cost of the security, the difference between the present value and amortized cost represents the credit loss associated with the security with the remaining difference between fair value and amortized cost recorded as a non-credit other-than-temporary impairment in OCI. The evaluation of other-than-temporary impairments is subject to risks and uncertainties and is intended to determine the appropriate amount and timing for recognizing an impairment charge. The assessment of whether such impairment has occurred is based on management’s best estimate of the cash flows expected to be collected at the individual security level. We regularly monitor our investment portfolio to ensure that securities that may be other-than-temporarily impaired are identified in a timely manner and that any impairment charge is recognized in the proper period. While the other-than-temporary impairment model for debt securities generally includes fixed maturity securities, there are certain hybrid securities that are classified as fixed maturity securities where the application of a debt impairment model depends on whether there has been any evidence of deterioration in credit of the issuer, such as a downgrade to below investment grade. Under certain circumstances, evidence of deterioration in credit of the issuer may result in the application of the equity securities impairment model. For equity securities, we recognize an impairment charge in the period in which we determine that the security will not recover to book value within a reasonable period. We determine what constitutes a reasonable period on a security-by-security basis based upon consideration of all the evidence available to us, including the magnitude of an unrealized loss and its duration. In any event, this period does not exceed 18 months for common equity securities. We measure other-than-temporary impairments based upon the difference between the amortized cost of a security and its fair value. e) Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have fixed maturity, equity and trading securities, derivatives, embedded derivatives, securities held as collateral, separate account assets and certain other financial instruments, which are carried at fair value. Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: • Level 1—Quoted prices for identical instruments in active markets. • Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. • Level 3—Instruments whose significant value drivers are unobservable. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded derivatives and actively traded mutual fund investments. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable, information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed maturity and equity securities; government or agency securities; certain mortgage-backed and asset-backed securities; securities held as collateral; and certain non-exchange-traded derivatives such as interest rate or cross currency swaps. Level 3 comprises financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In certain instances, this category may also utilize non-binding broker quotes. This category primarily consists of certain less liquid fixed maturity, equity and trading securities and certain derivative instruments or embedded derivatives where we cannot corroborate the significant valuation inputs with market observable data. As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability, such as the relative impact on the fair value as a result of including a particular input. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. See note 16 for additional information related to fair value measurements. f) Commercial Mortgage Loans The carrying value of commercial mortgage loans is stated at original cost, net of principal payments, amortization and allowance for loan losses. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Commercial mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date. “Impaired” loans are defined by U.S. GAAP as loans for which it is probable that the lender will be unable to collect all amounts due according to original contractual terms of the loan agreement. In determining whether it is probable that we will be unable to collect all amounts due, we consider current payment status, debt service coverage ratios, occupancy levels and current loan-to-value. Impaired loans are carried on a non-accrual status. Loans are placed on non-accrual status when, in management’s opinion, the collection of principal or interest is unlikely, or when the collection of principal or interest is 90 days or more past due. Income on impaired loans is not recognized until the loan is sold or the cash received exceeds the carrying amount recorded. We evaluate the impairment of commercial mortgage loans first on an individual loan basis. If an individual loan is not deemed impaired, then we evaluate the remaining loans collectively to determine whether an impairment should be recorded. For individually impaired loans, we record an impairment charge when it is probable that a loss has been incurred. The impairment is recorded as an increase in the allowance for loan losses. All losses of principal are charged to the allowance for loan losses in the period in which the loan is deemed to be uncollectible. For loans that are not individually impaired where we evaluate the loans collectively, the allowance for loan losses is maintained at a level that we determine is adequate to absorb estimated probable incurred losses in the loan portfolio. Our process to determine the adequacy of the allowance utilizes an analytical model based on historical loss experience adjusted for current events, trends and economic conditions that would result in a loss in the loan portfolio over the next 12 months. Key inputs into our evaluation include debt service coverage ratios, loan-to-value, property-type, occupancy levels, geographic region, and probability weighting of the scenarios generated by the model. The actual amounts realized could differ in the near term from the amounts assumed in arriving at the allowance for loan losses reported in the consolidated financial statements. Additions and reductions to the allowance through periodic provisions or benefits are recorded in net investment gains (losses). For commercial mortgage loans classified as held-for-sale, each loan is carried at the lower of cost or market and is included in commercial mortgage loans in our consolidated balance sheets. See note 4 for additional disclosures related to commercial mortgage loans. g) Repurchase Agreements We have a repurchase program in which we sell an investment security at a specified price and agree to repurchase that security at another specified price at a later date. Repurchase agreements are treated as collateralized financing transactions and are carried at the amounts at which the securities will be subsequently reacquired, including accrued interest, as specified in the respective agreement. The fair value of securities to be repurchased is monitored and collateral levels are adjusted where appropriate to protect the counterparty against credit exposure. Cash received is invested in fixed maturity securities. See note 12 for additional information related to our repurchase agreements. h) Securities Lending Activity In the United States and Canada, we engage in certain securities lending transactions for the purpose of enhancing the yield on our investment securities portfolio. We maintain effective control over all loaned securities and, therefore, continue to report such securities as fixed maturity securities on the consolidated balance sheets. We are currently indemnified against counterparty credit risk by the intermediary. See note 12 for additional information related to our securities lending activity. i) Cash and Cash Equivalents Certificates of deposit, money market funds and other time deposits with original maturities of 90 days or less are considered cash equivalents in the consolidated balance sheets and consolidated statements of cash flows. Items with maturities greater than 90 days but less than one year at the time of acquisition are considered short-term investments. j) Deferred Acquisition Costs Acquisition costs include costs that are directly related to the successful acquisition of new or renewal insurance contracts. Acquisition costs are deferred and amortized to the extent they are recoverable from future profits. Long-Duration Contracts Amortization for deferred annuity and universal life insurance contracts is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for changes in underlying assumptions relating to future gross profits. Estimates of gross profits for DAC amortization are based on assumptions including interest rates, policyholder persistency or lapses, insured life expectancy or longevity and expenses. Short-Duration Contracts. We regularly review our assumptions and test DAC for recoverability at least annually. For deferred annuity and universal life insurance contracts, if the present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to income is recorded for additional DAC amortization. For traditional long-duration and short-duration contracts, if the benefit reserve plus anticipated future premiums and interest income for a line of business are less than the current estimate of future benefits and expenses (including any unamortized DAC), a charge to income is recorded for additional DAC amortization or for increased benefit reserves. See note 6 for additional information related to DAC including loss recognition and recoverability. k) Intangible Assets Present Value of Future Profits. We regularly review our PVFP assumptions and periodically test PVFP for recoverability similar to our treatment of DAC. See note 7 for additional information related to PVFP including loss recognition and recoverability. Deferred Sales Inducements to Contractholders. Other Intangible Assets l) Goodwill Goodwill is not amortized but is tested for impairment annually or between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying value. The determination of fair value requires the use of estimates and judgment, at the “reporting unit” level. A reporting unit is the operating segment, or a business, one level below that operating segment (the “component” level) if discrete financial information is prepared and regularly reviewed by management at the component level. If the reporting unit’s fair value is below its carrying value, we must determine the amount of implied goodwill that would be established if the reporting unit was hypothetically purchased on the impairment assessment date. We recognize an impairment charge for any amount by which the carrying amount of a reporting unit’s goodwill exceeds the amount of implied goodwill. See note 7 for additional information related to goodwill and impairments recorded. m) Reinsurance Premium revenue, benefits and acquisition and operating expenses, net of deferrals, are reported net of the amounts relating to reinsurance ceded to and assumed from other companies. Amounts due from reinsurers for incurred and estimated future claims are reflected in the reinsurance recoverable asset. Amounts received from reinsurers that represent recovery of acquisition costs are netted against DAC so that the net amount is capitalized. The cost of reinsurance is accounted for over the terms of the related treaties using assumptions consistent with those used to account for the underlying reinsured policies. Premium revenue, benefits and acquisition and operating expenses, net of deferrals, for reinsurance contracts that do not qualify for reinsurance accounting are accounted for under the deposit method of accounting. n) Derivatives Derivative instruments are used to manage risk through one of four principal risk management strategies including: (i) liabilities; (ii) invested assets; (iii) portfolios of assets or liabilities; and (iv) forecasted transactions. On the date we enter into a derivative contract, management designates the derivative as a hedge of the identified exposure (fair value, cash flow or foreign currency). If a derivative does not qualify for hedge accounting, the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in income. We formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. In this documentation, we specifically identify the asset, liability or forecasted transaction that has been designated as a hedged item, state how the hedging instrument is expected to hedge the risks related to the hedged item, and set forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure hedge ineffectiveness. We generally determine hedge effectiveness based on total changes in fair value of the hedged item attributable to the hedged risk and the total changes in fair value of the derivative instrument. We discontinue hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (ii) the derivative expires or is sold, terminated or exercised; (iii) the derivative is de-designated as a hedge instrument; or (iv) it is no longer probable that the forecasted transaction will occur. For all qualifying and highly effective cash flow hedges, the effective portion of changes in fair value of the derivative instrument is reported as a component of OCI. The ineffective portion of changes in fair value of the derivative instrument is reported as a component of income. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the derivative continues to be carried in the consolidated balance sheets at its fair value, and gains and losses that were accumulated in OCI are recognized immediately in income. When the hedged forecasted transaction is no longer probable, but is reasonably possible, the accumulated gain or loss remains in OCI and is recognized when the transaction affects income; however, prospective hedge accounting for the transaction is terminated. In all other situations in which hedge accounting is discontinued on a cash flow hedge, amounts previously deferred in OCI are reclassified into income when income is impacted by the variability of the cash flow of the hedged item. For all qualifying and highly effective fair value hedges, the changes in fair value of the derivative instrument are reported in income. In addition, changes in fair value attributable to the hedged portion of the underlying instrument are reported in income. When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair value hedge, the derivative continues to be carried in the consolidated balance sheets at its fair value, but the hedged asset or liability will no longer be adjusted for changes in fair value. In all other situations in which hedge accounting is discontinued, the derivative is carried at its fair value in the consolidated balance sheets, with changes in its fair value recognized in current period income. We may enter into contracts that are not themselves derivative instruments but contain embedded derivatives. For each contract, we assess whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract and determine whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated from the host contract and accounted for as a stand-alone derivative. Such embedded derivatives are recorded in the consolidated balance sheets at fair value and are classified consistent with their host contract. Changes in their fair value are recognized in current period income. If we are unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried in the consolidated balance sheets at fair value, with changes in fair value recognized in current period income. Changes in the fair value of non-qualifying derivatives, including embedded derivatives, changes in fair value of certain derivatives and related hedged items in fair value hedge relationships and hedge ineffectiveness on cash flow hedges are reported in net investment gains (losses). The majority of our derivative arrangements require the posting of collateral upon meeting certain net exposure thresholds. The amounts recognized for derivative counterparty collateral received by us was recorded in cash and cash equivalents with a corresponding amount recorded in other liabilities to represent our obligation to return the collateral retained by us. We also receive non-cash collateral that is not recognized in our balance sheet unless we exercise our right to sell or re-pledge the underlying asset. As of December 31, 2015 and 2014, the fair value of non-cash collateral received was $86 million and $287 million, respectively, and the underlying assets were not sold or re-pledged. Additionally, we have pledged $263 million and $49 million of fixed maturity securities as of December 31, 2015 and 2014, respectively. We have not pledged any cash as collateral to derivative counterparties. Fixed maturity securities that we pledge as collateral remain on our balance sheet within fixed maturity securities available-for-sale. Any cash collateral pledged to a derivative counterparty is derecognized with a receivable recorded in other assets for the right to receive our cash collateral back from the counterparty. o) Separate Accounts and Related Insurance Obligations Separate account assets represent funds for which the investment income and investment gains and losses accrue directly to the contractholders and are reflected in our consolidated balance sheets at fair value, reported as summary total separate account assets with an equivalent summary total reported for liabilities. Amounts assessed against the contractholders for mortality, administrative and other services are included in revenues. Changes in liabilities for minimum guarantees are included in benefits and other changes in policy reserves. Net investment income, net investment gains (losses) and the related liability changes associated with the separate account are offset within the same line item in the consolidated statements of income. There were no gains or losses on transfers of assets from the general account to the separate account. We offer certain minimum guarantees associated with our variable annuity contracts. Our variable annuity contracts usually contain a basic guaranteed minimum death benefit (“GMDB”) which provides a minimum benefit to be paid upon the annuitant’s death equal to the larger of account value and the return of net deposits. Some variable annuity contracts permit contractholders to purchase through riders, at an additional charge, enhanced death benefits such as the highest contract anniversary value (“ratchets”), accumulated net deposits at a stated rate (“rollups”), or combinations thereof. Additionally, some of our variable annuity contracts provide the contractholder with living benefits such as a guaranteed minimum withdrawal benefit (“GMWB”) or certain types of guaranteed annuitization benefits. The GMWB allows contractholders to withdraw a pre-defined percentage of account value or benefit base each year, either for a specified period of time or for life. The guaranteed annuitization benefit generally provides for a guaranteed minimum level of income upon annuitization accompanied by the potential for upside market participation. Most of our reserves for additional insurance and annuitization benefits are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future experience. The projections utilize stochastic scenarios of separate account returns incorporating reversion to the mean, as well as assumptions for mortality and lapses. Some of our minimum guarantees, mainly GMWBs, are accounted for as embedded derivatives; see notes 5 and 16 for additional information on these embedded derivatives and related fair value measurement disclosures. p) Insurance Reserves Future Policy Benefits The liability for future policy benefits is equal to the present value of expected benefits and expenses less the present value of expected future net premiums based on assumptions, including, investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy o

Earnings (Loss) Per Share

Earnings (Loss) Per Share	12 Months Ended
	Dec. 31, 2015
Earnings (Loss) Per Share	(3) Earnings (Loss) Per Share Basic and diluted earnings (loss) per share are calculated by dividing each income (loss) category presented below by the weighted-average basic and diluted common shares outstanding for the years ended December 31: (Amounts in millions, except per share amounts) 2015 2014 2013 Weighted-average common shares used in basic earnings (loss) per common share calculations 497.4 496.4 493.6 Potentially dilutive securities: Stock options, restricted stock units and stock appreciation rights — — 5.1 Weighted-average common shares used in diluted earnings (loss) per common share calculations (1) 497.4 496.4 498.7 Income (loss) from continuing operations: Income (loss) from continuing operations $ (6 ) $ (1,205 ) $ 680 Less: income from continuing operations attributable to noncontrolling interests 202 196 154 Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ (208 ) $ (1,401 ) $ 526 Basic per common share $ (0.42 ) $ (2.82 ) $ 1.07 Diluted per common share $ (0.42 ) $ (2.82 ) $ 1.05 Income (loss) from discontinued operations: Income (loss) from discontinued operations, net of taxes $ (407 ) $ 157 $ 34 Less: income from discontinued operations, net of taxes, attributable to noncontrolling interests — — — Income (loss) from discontinued operations, net of taxes, available to Genworth Financial, Inc.’s common stockholders $ (407 ) $ 157 $ 34 Basic per common share $ (0.82 ) $ 0.32 $ 0.07 Diluted per common share $ (0.82 ) $ 0.32 $ 0.07 Net income (loss): Income (loss) from continuing operations $ (6 ) $ (1,205 ) $ 680 Income (loss) from discontinued operations, net of taxes (407 ) 157 34 Net income (loss) (413 ) (1,048 ) 714 Less: net income attributable to noncontrolling interests 202 196 154 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (615 ) $ (1,244 ) $ 560 Basic per common share $ (1.24 ) $ (2.51 ) $ 1.13 Diluted per common share $ (1.24 ) $ (2.51 ) $ 1.12 (1) Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the years ended December 31, 2015 and 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the years ended December 31, 2015 and 2014, as the inclusion of shares for stock options, restricted stock units (“RSUs”) and stock appreciation rights (“SARs”) of 1.6 million and 5.6 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the years ended December 31, 2015 and 2014, dilutive potential weighted-average common shares outstanding would have been 499.0 million and 502.0 million, respectively.

Investments

Investments	12 Months Ended
	Dec. 31, 2015
Investments	(4) Investments (a) Net Investment Income Sources of net investment income were as follows for the years ended December 31: (Amounts in millions) 2015 2014 2013 Fixed maturity securities—taxable $ 2,558 $ 2,598 $ 2,603 Fixed maturity securities—non-taxable 12 12 9 Commercial mortgage loans 337 333 335 Restricted commercial mortgage loans related to securitization entities (1) 14 14 23 Equity securities 15 14 17 Other invested assets (2) 135 105 108 Restricted other invested assets related to securitization entities (1) 5 5 4 Policy loans 137 129 129 Cash, cash equivalents and short-term investments 13 24 19 Gross investment income before expenses and fees 3,226 3,234 3,247 Expenses and fees (88 ) (92 ) (92 ) Net investment income $ 3,138 $ 3,142 $ 3,155 (1) See note 17 for additional information related to consolidated securitization entities. (2) Included in other invested assets was $9 million, $8 million and $13 million of net investment income related to trading securities for the years ended December 31, 2015, 2014 and 2013, respectively. (b) Net Investment Gains (Losses) The following table sets forth net investment gains (losses) for the years ended December 31: (Amounts in millions) 2015 2014 2013 Available-for-sale securities: Realized gains $ 102 $ 72 $ 149 Realized losses (82 ) (46 ) (184 ) Net realized gains (losses) on available-for-sale securities 20 26 (35 ) Impairments: Total other-than-temporary impairments (28 ) (9 ) (16 ) Portion of other-than-temporary impairments included in other comprehensive income (loss) 1 — (9 ) Net other-than-temporary impairments (27 ) (9 ) (25 ) Trading securities (7 ) 39 (23 ) Commercial mortgage loans 7 11 4 Net gains (losses) related to securitization entities (1) 5 16 69 Derivative instruments (2) (76 ) (103 ) (49 ) Contingent consideration adjustment 2 (2 ) — Other 1 — (5 ) Net investment gains (losses) $ (75 ) $ (22 ) $ (64 ) (1) See note 17 for additional information related to consolidated securitization entities. (2) See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses). We generally intend to hold securities in unrealized loss positions until they recover. However, from time to time, our intent on an individual security may change, based upon market or other unforeseen developments. In such instances, we sell securities in the ordinary course of managing our portfolio to meet diversification, credit quality, yield and liquidity requirements. If a loss is recognized from a sale subsequent to a balance sheet date due to these unexpected developments, the loss is recognized in the period in which we determined that we have the intent to sell the securities or it is more likely than not that we will be required to sell the securities prior to recovery. The aggregate fair value of securities sold at a loss during the years ended December 31, 2015, 2014 and 2013 was $1,827 million, $857 million and $1,743 million, respectively, which was approximately 96%, 95% and 91%, respectively, of book value. The following represents the activity for credit losses recognized in net income (loss) on debt securities where an other-than-temporary impairment was identified and a portion of other-than-temporary impairments was included in OCI as of and for the years ended December 31: (Amounts in millions) 2015 2014 2013 Beginning balance $ 83 $ 101 $ 387 Additions: Other-than-temporary impairments not previously recognized — 1 4 Increases related to other-than-temporary impairments previously recognized — 1 11 Reductions: Securities sold, paid down or disposed (19 ) (20 ) (301 ) Ending balance $ 64 $ 83 $ 101 (c) Unrealized Investment Gains and Losses Net unrealized gains and losses on available-for-sale investment securities reflected as a separate component of accumulated other comprehensive income (loss) were as follows as of December 31: (Amounts in millions) 2015 2014 2013 Net unrealized gains (losses) on investment securities: Fixed maturity securities $ 3,140 $ 5,560 $ 2,346 Equity securities (10 ) 32 23 Other invested assets — (2 ) (4 ) Subtotal 3,130 5,590 2,365 Adjustments to DAC, PVFP, sales inducements and benefit reserves (1,070 ) (1,656 ) (869 ) Income taxes, net (711 ) (1,372 ) (517 ) Net unrealized investment gains (losses) 1,349 2,562 979 Less: net unrealized investment gains (losses) attributable to noncontrolling interests 95 109 53 Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. $ 1,254 $ 2,453 $ 926 The change in net unrealized gains (losses) on available-for-sale investment securities reported in accumulated other comprehensive income (loss) was as follows as of and for the years ended December 31: (Amounts in millions) 2015 2014 2013 Beginning balance $ 2,453 $ 926 $ 2,638 Unrealized gains (losses) arising during the period: Unrealized gains (losses) on investment securities (2,467 ) 3,244 (3,780 ) Adjustment to DAC 177 (172 ) 248 Adjustment to PVFP 89 (66 ) 95 Adjustment to sales inducements 30 (15 ) 40 Adjustment to benefit reserves 290 (534 ) 673 Provision for income taxes 663 (862 ) 952 Change in unrealized gains (losses) on investment securities (1,218 ) 1,595 (1,772 ) Reclassification adjustments to net investment (gains) losses, net of taxes of $(2), $7 and $(12) 5 (12 ) 21 Change in net unrealized investment gains (losses) (1,213 ) 1,583 (1,751 ) Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests (14 ) 56 (39 ) Ending balance $ 1,254 $ 2,453 $ 926 (d) Fixed Maturity and Equity Securities As of December 31, 2015, the amortized cost or cost, gross unrealized gains (losses) and fair value of our fixed maturity and equity securities classified as available-for-sale were as follows: Amortized Gross unrealized gains Gross unrealized losses Fair (Amounts in millions) Not other-than- Other-than- Not other-than- Other-than- Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 5,487 $ 732 $ — $ (16 ) $ — $ 6,203 State and political subdivisions 2,287 181 — (30 ) — 2,438 Non-U.S. government 1,910 110 — (5 ) — 2,015 U.S. corporate: Utilities 3,355 364 — (26 ) — 3,693 Energy 2,560 103 — (162 ) — 2,501 Finance and insurance 5,268 392 15 (43 ) — 5,632 Consumer—non-cyclical 3,755 371 — (30 ) — 4,096 Technology and communications 2,108 123 — (38 ) — 2,193 Industrial 1,164 53 — (44 ) — 1,173 Capital goods 1,774 188 — (12 ) — 1,950 Consumer—cyclical 1,602 95 — (22 ) — 1,675 Transportation 1,023 75 — (12 ) — 1,086 Other 385 22 — (5 ) — 402 Total U.S. corporate 22,994 1,786 15 (394 ) — 24,401 Non-U.S. corporate: Utilities 815 37 — (9 ) — 843 Energy 1,700 64 — (78 ) — 1,686 Finance and insurance 2,327 152 2 (8 ) — 2,473 Consumer—non-cyclical 746 24 — (18 ) — 752 Technology and communications 978 36 — (26 ) — 988 Industrial 1,063 19 — (96 ) — 986 Capital goods 602 19 — (17 ) — 604 Consumer—cyclical 522 8 — (4 ) — 526 Transportation 559 52 — (6 ) — 605 Other 2,574 187 — (25 ) — 2,736 Total non-U.S. corporate 11,886 598 2 (287 ) — 12,199 Residential mortgage-backed 4,777 330 11 (17 ) — 5,101 Commercial mortgage-backed 2,492 84 3 (20 ) — 2,559 Other asset-backed 3,328 11 1 (59 ) — 3,281 Total fixed maturity securities 55,161 3,832 32 (828 ) — 58,197 Equity securities 325 8 — (23 ) — 310 Total available-for-sale securities $ 55,486 $ 3,840 $ 32 $ (851 ) $ — $ 58,507 As of December 31, 2014, the amortized cost or cost, gross unrealized gains (losses) and fair value of our fixed maturity and equity securities classified as available-for-sale were as follows: Amortized Gross unrealized gains Gross unrealized losses Fair (Amounts in millions) Not other-than- Other-than- Not other-than- Other-than- Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 5,006 $ 995 $ — $ (1 ) $ — $ 6,000 State and political subdivisions 2,013 236 — (27 ) — 2,222 Non-U.S. government 1,761 143 — (2 ) — 1,902 U.S. corporate: Utilities 3,292 577 — (5 ) — 3,864 Energy 2,498 265 — (21 ) — 2,742 Finance and insurance 5,102 537 20 (13 ) — 5,646 Consumer—non-cyclical 3,483 538 — (8 ) — 4,013 Technology and communications 2,112 217 — (4 ) — 2,325 Industrial 1,195 100 — (8 ) — 1,287 Capital goods 1,748 263 — (5 ) — 2,006 Consumer—cyclical 1,750 158 — (8 ) — 1,900 Transportation 929 114 — (4 ) — 1,039 Other 370 31 — — — 401 Total U.S. corporate 22,479 2,800 20 (76 ) — 25,223 Non-U.S. corporate: Utilities 857 48 — (2 ) — 903 Energy 1,911 163 — (38 ) — 2,036 Finance and insurance 2,757 203 — (3 ) — 2,957 Consumer—non-cyclical 764 41 — (9 ) — 796 Technology and communications 986 71 — (4 ) — 1,053 Industrial 1,166 65 — (18 ) — 1,213 Capital goods 592 31 — (5 ) — 618 Consumer—cyclical 520 14 — — — 534 Transportation 521 70 — (1 ) — 590 Other 3,153 257 — (15 ) — 3,395 Total non-U.S. corporate 13,227 963 — (95 ) — 14,095 Residential mortgage-backed 4,871 362 13 (17 ) (1 ) 5,228 Commercial mortgage-backed 2,564 143 4 (9 ) — 2,702 Other asset-backed 3,735 23 1 (54 ) — 3,705 Total fixed maturity securities 55,656 5,665 38 (281 ) (1 ) 61,077 Equity securities 250 32 — (7 ) — 275 Total available-for-sale securities $ 55,906 $ 5,697 $ 38 $ (288 ) $ (1 ) $ 61,352 The following table presents the gross unrealized losses and fair values of our investment securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, as of December 31, 2015: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 883 $ (16 ) 32 $ — $ — — $ 883 $ (16 ) 32 State and political subdivisions 464 (15 ) 81 163 (15 ) 17 627 (30 ) 98 Non-U.S. government 366 (5 ) 49 — — — 366 (5 ) 49 U.S. corporate 5,836 (332 ) 817 466 (62 ) 83 6,302 (394 ) 900 Non-U.S. corporate 3,016 (170 ) 400 486 (117 ) 87 3,502 (287 ) 487 Residential mortgage-backed 756 (10 ) 88 103 (7 ) 38 859 (17 ) 126 Commercial mortgage-backed 780 (19 ) 116 39 (1 ) 13 819 (20 ) 129 Other asset-backed 1,944 (22 ) 349 336 (37 ) 55 2,280 (59 ) 404 Subtotal, fixed maturity securities 14,045 (589 ) 1,932 1,593 (239 ) 293 15,638 (828 ) 2,225 Equity securities 153 (23 ) 64 — — — 153 (23 ) 64 Total for securities in an unrealized loss position $ 14,198 $ (612 ) 1,996 $ 1,593 $ (239 ) 293 $ 15,791 $ (851 ) 2,289 % Below cost—fixed maturity securities: <20% Below cost $ 13,726 $ (472 ) 1,877 $ 1,259 $ (78 ) 238 $ 14,985 $ (550 ) 2,115 20%-50% Below cost 319 (116 ) 54 316 (139 ) 50 635 (255 ) 104 >50% Below cost — (1 ) 1 18 (22 ) 5 18 (23 ) 6 Total fixed maturity securities 14,045 (589 ) 1,932 1,593 (239 ) 293 15,638 (828 ) 2,225 % Below cost—equity securities: <20% Below cost 133 (18 ) 56 — — — 133 (18 ) 56 20%-50% Below cost 20 (5 ) 8 — — — 20 (5 ) 8 Total equity securities 153 (23 ) 64 — — — 153 (23 ) 64 Total for securities in an unrealized loss position $ 14,198 $ (612 ) 1,996 $ 1,593 $ (239 ) 293 $ 15,791 $ (851 ) 2,289 Investment grade $ 13,342 $ (524 ) 1,834 $ 1,245 $ (135 ) 225 $ 14,587 $ (659 ) 2,059 Below investment grade 856 (88 ) 162 348 (104 ) 68 1,204 (192 ) 230 Total for securities in an unrealized loss position $ 14,198 $ (612 ) 1,996 $ 1,593 $ (239 ) 293 $ 15,791 $ (851 ) 2,289 The following table presents the gross unrealized losses and fair values of our corporate securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2015: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities U.S. corporate: Utilities $ 485 $ (25 ) 74 $ 14 $ (1 ) 7 $ 499 $ (26 ) 81 Energy 1,162 (134 ) 163 131 (28 ) 22 1,293 (162 ) 185 Finance and insurance 1,142 (35 ) 160 94 (8 ) 15 1,236 (43 ) 175 Consumer—non-cyclical 836 (26 ) 107 51 (4 ) 10 887 (30 ) 117 Technology and communications 658 (36 ) 95 23 (2 ) 5 681 (38 ) 100 Industrial 476 (33 ) 64 44 (11 ) 9 520 (44 ) 73 Capital goods 293 (10 ) 48 26 (2 ) 4 319 (12 ) 52 Consumer—cyclical 427 (18 ) 60 63 (4 ) 10 490 (22 ) 70 Transportation 273 (10 ) 38 20 (2 ) 1 293 (12 ) 39 Other 84 (5 ) 8 — — — 84 (5 ) 8 Subtotal, U.S. corporate securities 5,836 (332 ) 817 466 (62 ) 83 6,302 (394 ) 900 Non-U.S. corporate: Utilities 130 (6 ) 20 32 (3 ) 6 162 (9 ) 26 Energy 589 (48 ) 71 127 (30 ) 20 716 (78 ) 91 Finance and insurance 478 (7 ) 77 30 (1 ) 8 508 (8 ) 85 Consumer—non-cyclical 261 (14 ) 27 37 (4 ) 4 298 (18 ) 31 Technology and communications 324 (15 ) 37 33 (11 ) 9 357 (26 ) 46 Industrial 495 (54 ) 67 110 (42 ) 18 605 (96 ) 85 Capital goods 154 (8 ) 22 41 (9 ) 9 195 (17 ) 31 Consumer—cyclical 155 (4 ) 20 — — — 155 (4 ) 20 Transportation 147 (6 ) 17 — — — 147 (6 ) 17 Other 283 (8 ) 42 76 (17 ) 13 359 (25 ) 55 Subtotal, non-U.S. corporate securities 3,016 (170 ) 400 486 (117 ) 87 3,502 (287 ) 487 Total for corporate securities in an unrealized loss position $ 8,852 $ (502 ) 1,217 $ 952 $ (179 ) 170 $ 9,804 $ (681 ) 1,387 As indicated in the tables above, the majority of the securities in a continuous unrealized loss position for less than 12 months were investment grade and less than 20% below cost. These unrealized losses were primarily attributable to the increase in interest rates, mostly concentrated in our corporate securities. For securities that have been in a continuous unrealized loss position for less than 12 months, the average fair value percentage below cost was approximately 4% as of December 31, 2015. Fixed Maturity Securities In A Continuous Unrealized Loss Position For 12 Months Or More Of the $78 million of unrealized losses on fixed maturity securities in a continuous unrealized loss for 12 months or more that were less than 20% below cost, the weighted-average rating was “BBB+” and approximately 75% of the unrealized losses were related to investment grade securities as of December 31, 2015. These unrealized losses were predominantly attributable to corporate securities and state and political subdivision securities including fixed rate securities purchased in a lower rate environment and variable rate securities purchased in a higher rate and lower spread environment. The average fair value percentage below cost for these securities was approximately 6% as of December 31, 2015. See below for additional discussion related to fixed maturity securities that have been in a continuous unrealized loss position for 12 months or more with a fair value that was more than 20% below cost. The following tables present the concentration of gross unrealized losses and fair values of fixed maturity securities that were more than 20% below cost and in a continuous unrealized loss position for 12 months or more by asset class as of December 31, 2015: Investment Grade 20% to 50% Greater than 50% (Dollar amounts in millions) Fair Gross % of total Number of Fair Gross % of total Number of Fixed maturity securities: State and political subdivisions $ 9 $ (3 ) — % 1 $ — $ — — % — U.S. corporate: Energy 23 (8 ) 1 4 — — — — Industrial 18 (9 ) 1 3 — — — — Total U.S. corporate 41 (17 ) 2 7 — — — — Non-U.S. corporate: Utilities 8 (2 ) — 1 — — — — Energy 21 (8 ) 1 2 — — — — Industrial 29 (14 ) 2 4 — — — — Capital goods 6 (5 ) 1 2 — — — — Other 5 (2 ) — 1 — — — — Total non-U.S. corporate 69 (31 ) 4 10 — — — — Structured securities: Other asset-backed 66 (25 ) 3 4 — — — — Total structured securities 66 (25 ) 3 4 — — — — Total $ 185 $ (76 ) 9 % 22 $ — $ — — % — Below Investment Grade 20% to 50% Greater than 50% (Dollar amounts in millions) Fair Gross % of total Number Fair Gross % of total Number Fixed maturity securities: U.S. corporate: Energy $ 21 $ (9 ) 1 % 6 $ — $ — — % — Finance and insurance 7 (3 ) 1 1 — — — — Technology and communications 5 (2 ) — 1 — — — — Industrial 4 (1 ) — 1 — — — — Total U.S. corporate 37 (15 ) 2 9 — — — — Non-U.S. corporate: Energy 44 (20 ) 2 8 — — — — Technology and communications 5 (4 ) 1 2 4 (5 ) 1 1 Industrial 10 (6 ) 1 2 14 (17 ) 2 4 Capital goods 3 (2 ) 1 1 — — — — Other 24 (10 ) — 5 — — — — Total non-U.S. corporate 86 (42 ) 5 18 18 (22 ) 3 5 Structured securities: Other asset-backed 8 (6 ) 1 1 — — — — Total structured securities 8 (6 ) 1 1 — — — — Total $ 131 $ (63 ) 8 % 28 $ 18 $ (22 ) 3 % 5 For all securities in an unrealized loss position, we expect to recover the amortized cost based on our estimate of the amount and timing of cash flows to be collected. We do not intend to sell nor do we expect that we will be required to sell these securities prior to recovering our amortized cost. See below for further discussion of gross unrealized losses by asset class. Non-U.S. corporate As indicated above, $95 million of gross unrealized losses were related to non-U.S. corporate fixed maturity securities that have been in an unrealized loss position for more than 12 months and were more than 20% below cost. Of the total unrealized losses for non-U.S. corporate fixed maturity securities, $37 million, or 39%, related to the industrial sector and $28 million, or 29%, related to the energy sector. Reduced overseas demand for metals, particularly copper and oil, has led to a decline in commodities pricing, adversely impacting the fair value of these securities. We expect that our investments in non-U.S. corporate securities will continue to perform in accordance with our expectations about the amount and timing of estimated cash flows. Although we do not anticipate such events, it is reasonably possible that issuers of our investments in non-U.S. corporate securities may perform worse than current expectations. Such events may lead us to recognize write-downs within our portfolio of non-U.S. corporate securities in the future. While we considered the length of time each security had been in an unrealized loss position, the extent of the unrealized loss position and any significant declines in fair value subsequent to the balance sheet date in our evaluation of impairment for each of these individual securities, the primary factor in our evaluation of impairment is the expected performance for each of these securities. Our evaluation of expected performance is based on the historical performance of the associated securitization trust as well as the historical performance of the underlying collateral. Our examination of the historical performance of the securitization trust included consideration of the following factors for each class of securities issued by the trust: i) the payment history, including failure to make scheduled payments; ii) current payment status; iii) current and historical outstanding balances; iv) current levels of subordination and losses incurred to date; and v) characteristics of the underlying collateral. Our examination of the historical performance of the underlying collateral included: i) historical default rates, delinquency rates, voluntary and involuntary prepayments and severity of losses, including recent trends in this information; ii) current payment status; iii) loan to collateral value ratios, as applicable; iv) vintage; and v) other underlying characteristics such as current financial condition. We used our assessment of the historical performance of both the securitization trust and the underlying collateral for each security, along with third-party sources, when available, to develop our best estimate of cash flows expected to be collected. These estimates reflect projections for future delinquencies, prepayments, defaults and losses for the assets that collateralize the securitization trust and are used to determine the expected cash flows for our security, based on the payment structure of the trust. Our projection of expected cash flows is primarily based on the expected performance of the underlying assets that collateralize the securitization trust and is not directly impacted by the rating of our security. While we consider the rating of the security as an indicator of the financial condition of the issuer, this factor does not have a significant impact on our expected cash flows for each security. In limited circumstances, our expected cash flows include expected payments from reliable financial guarantors where we believe the financial guarantor will have sufficient assets to pay claims under the financial guarantee when the cash flows from the securitization trust are not sufficient to make scheduled payments. We then discount the expected cash flows using the effective yield of each security to determine the present value of expected cash flows. Based on this evaluation, the present value of expected cash flows was greater than or equal to the amortized cost for each security. Accordingly, we determined that the unrealized losses on each of our structured securities represented temporary impairments as of December 31, 2015. Despite the considerable analysis and rigor employed on our structured securities, it is reasonably possible that the underlying collateral of these investments will perform worse than current market expectations. Such events may lead to adverse changes in cash flows on our holdings of structured securities and future write-downs within our portfolio of structured securities. The following table presents the gross unrealized losses and fair values of our investment securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, as of December 31, 2014: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross (1) Number of Fair Gross (1) Number of Description of Securities Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ — $ — — $ 75 $ (1 ) 10 $ 75 $ (1 ) 10 State and political subdivision 9 — 7 267 (27 ) 45 276 (27 ) 52 Non-U.S. government 64 (1 ) 15 22 (1 ) 4 86 (2 ) 19 U.S. corporate 1,639 (33 ) 231 1,201 (43 ) 174 2,840 (76 ) 405 Non-U.S. corporate 1,456 (67 ) 199 504 (28 ) 67 1,960 (95 ) 266 Residential mortgage-backed 180 (1 ) 24 249 (17 ) 87 429 (18 ) 111 Commercial mortgage-backed 163 — 21 362 (9 ) 49 525 (9 ) 70 Other asset-backed 1,551 (12 ) 215 487 (42 ) 55 2,038 (54 ) 270 Subtotal, fixed maturity securities 5,062 (114 ) 712 3,167 (168 ) 491 8,229 (282 ) 1,203 Equity securities 30 (3 ) 46 48 (4 ) 6 78 (7 ) 52 Total for securities in an unrealized loss position $ 5,092 $ (117 ) 758 $ 3,215 $ (172 ) 497 $ 8,307 $ (289 ) 1,255 % Below cost—fixed maturity securities: <20% Below cost $ 5,025 $ (103 ) 708 $ 3,036 $ (114 ) 470 $ 8,061 $ (217 ) 1,178 20%-50% Below cost 37 (11 ) 4 131 (53 ) 15 168 (64 ) 19 >50% Below cost — — — — (1 ) 6 — (1 ) 6 Total fixed maturity securities 5,062 (114 ) 712 3,167 (168 ) 491 8,229 (282 ) 1,203 % Below cost—equity securities: <20% Below cost 26 (2 ) 40 48 (4 ) 6 74 (6 ) 46 20%-50% Below cost 4 (1 ) 6 — — — 4 (1 ) 6 Total equity securities 30 (3 ) 46 48 (4 ) 6 78 (7 ) 52 Total for securities in an unrealized loss position $ 5,092 $ (117 ) 758 $ 3,215 $ (172 ) 497 $ 8,307 $ (289 ) 1,255 Investment grade $ 4,501 $ (75 ) 631 $ 2,918 $ (145 ) 424 $ 7,419 $ (220 ) 1,055 Below investment grade (2) 591 (42 ) 127 297 (27 ) 73 888 (69 ) 200 Total for securities in an unrealized loss position $ 5,092 $ (117 ) 758 $ 3,215 $ (172 ) 497 $ 8,307 $ (289 ) 1,255 (1) Amounts included $1 million of unrealized losses on other-than-temporarily impaired securities. (2) Amounts that have been in a continuous unrealized loss position for 12 months or more included $1 million of unrealized losses on other-than-temporarily impaired securities. The following table presents the gross unrealized losses and fair values of our corporate securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2014: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities U.S. corporate: Utilities $ 55 $ — 10 $ 164 $ (5 ) 23 $ 219 $ (5 ) 33 Energy 404 (16 ) 56 96 (5 ) 15 500 (21 ) 71 Finance and insurance 399 (3 ) 56 257 (10 ) 35 656 (13 ) 91 Consumer—non-cyclical 160 (3 ) 20 182 (5 ) 32 342 (8 ) 52 Technology and communications 181 (3 ) 27 97 (1 ) 15 278 (4 ) 42 Industrial 151 (4 ) 21 80 (4 ) 11 231 (8 ) 32 Capital goods 85 — 13 122 (5 ) 18 207 (5 ) 31 Consumer—cyclical 132 (2 ) 17 139 (6 ) 18 271 (8 ) 35 Transportation 52 (2 ) 9 57 (2 ) 6 109 (4 ) 15 Other 20 — 2 7 — 1 27 — 3 Subtotal, U.S. corporate securities 1,639 (33 ) 231 1,201 (43 ) 174 2,840 (76 ) 405 Non-U.S. corporate: Utilities 79 — 13 43 (2 ) 5 122 (2 ) 18 Energy 442 (33 ) 57 58 (5 ) 13 500 (38 ) 70 Finance and insurance 237 (2 ) 32 29 (1 ) 6 266 (3 ) 38 Consumer—non-cyclical 134 (6 ) 10 83 (3 ) 9 217 (9 ) 19 Technology and communications 77 (2 ) 13 81 (2 ) 8 158 (4 ) 21 Industrial 214 (9 ) 30 116 (9 ) 15 330 (18 ) 45 Capital goods 63 (2 ) 7 38 (3 ) 4 101 (5 ) 11 Consumer—cyclical 8 — 1 — — — 8 — 1 Transportation 30 — 6 14 (1 ) 1 44 (1 ) 7 Other 172 (13 ) 30 42 (2 ) 6 214 (15 ) 36 Subtotal, non-U.S. corporate securities 1,456 (67 ) 199 504 (28 ) 67 1,960 (95 ) 266 Total for corporate securities in an unrealized loss position $ 3,095 $ (100 ) 430 $ 1,705 $ (71 ) 241 $ 4,800 $ (171 ) 671 The scheduled maturity distribution of fixed maturity securities as of December 31, 2015 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties. (Amounts in millions) Amortized Fair Due one year or less $ 1,729 $ 1,744 Due after one year through five years 9,814 10,192 Due after five years through ten years 11,772 11,917 Due after ten years 21,249 23,403 Subtotal 44,564 47,256 Residential mortgage-backed 4,777 5,101 Commercial mortgage-backed 2,492 2,559 Other asset-backed 3,328 3,281 Total $ 55,161 $ 58,197 As of December 31, 2015, $7,730 million of our investments (excluding mortgage-backed and asset-backed securities) were subject to certain call provisions. As of December 31, 2015, securities issued by finance and insurance, consumer—non-cyclical , utilities and energy industry groups represented approximately 22%, 13%, 12% and 11%, respectively, of our domestic and foreign corporate fixed maturity securities portfolio. No other industry group comprised more than 10% of our investment portfolio. As of December 31, 2015, we did not hold any fixed maturity securities in any single issuer, other than securities issued or guaranteed by the U.S. government, which exceeded 10% of stockholders’ equity. As of December 31, 2015 and 2014, $44 million and $49 million, respectively, of securities were on deposit with various state or foreign government insurance departments in order to comply with relevant insurance regulations. (e) Commercial Mortgage Loans Our mortgage loans are collateralized by commercial properties, including multi-family residential buildings. The carrying value of commercial mortgage loans is stated at original cost net of principal payments, amortization and allowance for loan losses. We diversify our commercial mortgage loans by both property type and geographic region. The following tables set forth the distribution across property type and geographic region for commercial mortgage loans as of December 31: 2015 2014 (Amounts in millions) Carrying % of Carrying % of Property type: Retail $ 2,355 38 % $ 2,150 35 % Industrial 1,562 25 1,597 26 Office 1,516 24 1,643 27 Apartments 465 8 494 8 Mixed use/other 289 5 239 4 Subtotal 6,187 100 % 6,123 100 % Unamortized balance of loan origination fees and costs (2 ) (1 ) Allowance for losses (15 ) (22 ) Total $ 6,170 $ 6,100 2015 2014 (Amounts in millions) Carrying % of Carrying % of Geographic region: Pacific $ 1,581 26 % $ 1,636 27 % South Atlantic 1,574 25 1,673 27 Middle Atlantic 890 14 826 14 Mountain 585 10 536 9 West North Central 416 7 382 6 East North Central 386 6 397 7 West South Central 294 5 268 4 New England 268 4 264 4 East South Central 193 3 141 2 Subtotal 6,187 100 % 6,123 100 % Unamortized balance of loan origination fees and costs (2 ) (1 ) Allowance for losses (15 ) (22 ) Total $ 6,170 $ 6,100 The following tables set forth the aging of past due commercial mortgage loans by property type as of December 31: 2015 (Amounts in millions) 31 - 60 days 61 - 90 days Greater than Total Current Total Property type: Retail $ — $ — $ — $ — $ 2,355 $ 2,355 Industrial — — — — 1,562 1,562 Office 6 — 5 11 1,505 1,516 Apartments — — — — 465 465 Mixed use/other — — — — 289 289 Total recorded investment $ 6 $ — $ 5 $ 11 $ 6,176 $ 6,187 % of total commercial mortgage loans — % — % — % — % 100 % 100 % 2014 (Amounts in millions) 31 - 60 days 61 - 90 days Greater than Total Current Total Property type: Retail $ — $ — $ — $ — $ 2,150 $ 2,150 Industrial — — 2 2 1,595 1,597 Office — — 6 6 1,637 1,643 Apartments — — — — 494 494 Mixed use/other — — — — 239 239 Total recorded investment $ — $ — $ 8 $ 8 $ 6,115 $ 6,123 % of total commercial mortgage loans — % — % — % — % 100 % 100 % As of December 31, 2015 and 2014, we had no commercial mortgage loans that were past due for more than 90 days and still accruing interest. We also did not have any commercial mortgage loans that were past due for less than 90 days on non-accrual status as of December 31, 2015 and 2014. We evaluate the impairment of commercial mortgage loans on an individual loan basis. As of December 31, 2015 and 2014, our commercial mortgage loans greater than 90 days past due included loans with appraised values in excess of the recorded investment and the current recorded investment of these loans was expected to be recoverable. During the years ended December 31, 2015 and 2014, we modified or extended 21 and 28 commercial mortgage loans, respectively, with a total carrying value of $110 million and $254 million, respectively. All of these modifications or extensions were based on current market interest rates, did not result in any forgiveness in the outstanding principal amount owed by the borrower and were not considered troubled debt restructurings. The following table sets forth the allowance for credit losses and recorded investment in commercial mortgage loans as of or for the years ended December 31: (Amounts in millions) 2015 2014 2013 Allowance for credit losses: Beginning balance $ 22 $ 33 $ 42 Charge-offs (4 ) (1 ) (2 ) Recoveries — — — Provision (3 ) (10 ) (7 ) Ending balance $ 15 $ 22 $ 33 Ending allowance for individually impaired loans $ — $ — $ — Ending allowance for loans not individually impaired that were evaluated collectively for impairment $ 15 $ 22 $ 33 Recorded investment: Ending balance $ 6,187 $ 6,123 $ 5,932 Ending balance of individually impaired loans $ 19 $ 15 $ 2 Ending balance of loans not individually impaired that were evaluated collectively for impairment $ 6,168 $ 6,108 $ 5,930 As of December 31, 2015, we had an individually impaired commercial mortgage loan included within the office property type with a recorded investment of $5 million, an unpaid principal balance of $6 million and charge-offs of $1 million. As of December 31, 2014, we had an individually impaired commercial mortgage loan included within the industrial property type with a recorded investment of $15 million, an unpaid principal balance of $16 million and charge-offs of $1 million. As of December 31, 2015, this loan had a recorded investment of $14 million, an unpaid principal balance of $15 million and interest income of $1 million. In evaluating the credit quality of commercial mortgage loans, we assess the performance of the underlying loans using both quantitative and qualitative criteria. Certain risks associated with commercial mortgage loans can be evaluated by reviewing both the loan-to-value and debt service coverage ratio to understand both the probability of the borrower not being able to make the necessary loan payments as well as the ability to sell the underlying property for an amount that would enable us to recover our unpaid principal balance in the event of default by the borrower. The average loan-to-value ratio is based on our most recent estimate of the fair value for the underlying property which is evaluated at least annually and updated more frequently if necessary to better indicate risk associated with the loan. A lower loan-to-value indicates

Derivative Instruments

Derivative Instruments	12 Months Ended
	Dec. 31, 2015
Derivative Instruments	(5) Derivative Instruments Our business activities routinely deal with fluctuations in interest rates, equity prices, currency exchange rates and other asset and liability prices. We use derivative instruments to mitigate or reduce certain of these risks. We have established policies for managing each of these risks, including prohibitions on derivatives market-making and other speculative derivatives activities. These policies require the use of derivative instruments in concert with other techniques to reduce or mitigate these risks. While we use derivatives to mitigate or reduce risks, certain derivatives do not meet the accounting requirements to be designated as hedging instruments and are denoted as “derivatives not designated as hedges” in the following disclosures. For derivatives that meet the accounting requirements to be designated as hedges, the following disclosures for these derivatives are denoted as “derivatives designated as hedges,” which include both cash flow and fair value hedges. The following table sets forth our positions in derivative instruments as of December 31: Derivative assets Derivative liabilities Balance sheet Fair value Balance sheet Fair value (Amounts in millions) 2015 2014 2015 2014 Derivatives designated as hedges Cash flow hedges: Interest rate swaps Other invested assets $ 629 $ 639 Other liabilities $ 37 $ 27 Inflation indexed swaps Other invested assets — — Other liabilities 33 42 Foreign currency swaps Other invested assets 8 6 Other liabilities — — Total cash flow hedges 637 645 70 69 Total derivatives designated as hedges 637 645 70 69 Derivatives not designated as hedges Interest rate swaps Other invested assets 425 452 Other liabilities 183 177 Interest rate swaps related to securitization entities (1) Restricted other invested assets — — Other liabilities 30 26 Credit default swaps Other invested assets 1 4 Other liabilities — — Credit default swaps related to securitization entities (1) Restricted other invested assets — — Other liabilities 14 17 Foreign currency swaps Other invested assets — — Other liabilities 27 7 Equity index options Other invested assets 30 17 Other liabilities — — Financial futures Other invested assets — — Other liabilities — — Equity return swaps Other invested assets 2 — Other liabilities 1 1 Other foreign currency contracts Other invested assets 17 14 Other liabilities 34 13 GMWB embedded derivatives Reinsurance recoverable (2) 17 13 Policyholder account balances (3) 352 291 Fixed index annuity embedded derivatives Other assets — — Policyholder account balances (4) 342 276 Indexed universal life embedded derivatives Reinsurance recoverable — — Policyholder account balances (5) 10 7 Total derivatives not designated as hedges 492 500 993 815 Total derivatives $ 1,129 $ 1,145 $ 1,063 $ 884 (1) See note 17 for additional information related to consolidated securitization entities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. (3) Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. (4) Represents the embedded derivatives associated with our fixed index annuity liabilities. (5) Represents the embedded derivatives associated with our indexed universal life liabilities. The fair value of derivative positions presented above was not offset by the respective collateral amounts received or provided under these agreements. The activity associated with derivative instruments can generally be measured by the change in notional value over the periods presented. However, for GMWB, fixed index annuity embedded derivatives and indexed universal life embedded derivatives, the change between periods is best illustrated by the number of policies. The following tables represent activity associated with derivative instruments as of the dates indicated: (Notional in millions) Measurement December 31, Additions Maturities/ December 31, Derivatives designated as hedges Cash flow hedges: Interest rate swaps Notional $ 11,961 $ — $ (747 ) $ 11,214 Inflation indexed swaps Notional 571 13 (13 ) 571 Foreign currency swaps Notional 35 — — 35 Total cash flow hedges 12,567 13 (760 ) 11,820 Total derivatives designated as hedges 12,567 13 (760 ) 11,820 Derivatives not designated as hedges Interest rate swaps Notional 5,074 2,100 (2,242 ) 4,932 Interest rate swaps related to securitization entities (1) Notional 77 — (10 ) 67 Credit default swaps Notional 394 — (250 ) 144 Credit default swaps related to securitization entities (1) Notional 312 — — 312 Equity index options Notional 994 1,455 (1,369 ) 1,080 Financial futures Notional 1,331 5,700 (5,700 ) 1,331 Equity return swaps Notional 108 386 (360 ) 134 Foreign currency swaps Notional 104 58 — 162 Forward bond purchase commitments Notional — 1,140 (1,140 ) — Other foreign currency contracts Notional 425 2,516 (1,285 ) 1,656 Total derivatives not designated as hedges 8,819 13,355 (12,356 ) 9,818 Total derivatives $ 21,386 $ 13,368 $ (13,116 ) $ 21,638 (1) See note 17 for additional information related to consolidated securitization entities. (Number of policies) Measurement December 31, Additions Maturities/ December 31, Derivatives not designated as hedges GMWB embedded derivatives Policies 39,015 — (2,869 ) 36,146 Fixed index annuity embedded derivatives Policies 13,901 3,939 (358 ) 17,482 Indexed universal life embedded derivatives Policies 421 595 (34 ) 982 Cash Flow Hedges Certain derivative instruments are designated as cash flow hedges. The changes in fair value of these instruments are recorded as a component of OCI. We designate and account for the following as cash flow hedges when they have met the effectiveness requirements: (i) various types of interest rate swaps to convert floating rate investments to fixed rate investments; (ii) various types of interest rate swaps to convert floating rate liabilities into fixed rate liabilities; (iii) receive U.S. dollar fixed on foreign currency swaps to hedge the foreign currency cash flow exposure of foreign currency denominated investments; (iv) forward starting interest rate swaps to hedge against changes in interest rates associated with future fixed rate bond purchases and/or interest income; (v) forward bond purchase commitments to hedge against the variability in the anticipated cash flows required to purchase future fixed rate bonds; and (vi) other instruments to hedge the cash flows of various forecasted transactions. The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2015: (Amounts in millions) Gain (loss) Gain (loss) Classification of gain Gain (loss) (1) Classification of gain Interest rate swaps hedging assets $ 78 $ 85 Net investment $ — Net investment Interest rate swaps hedging liabilities (10 ) — Interest — Net investment Inflation indexed swaps 9 — Net investment — Net investment Foreign currency swaps 2 — Net investment — Net investment Forward bond purchase commitments — 1 Net investment — Net investment Forward bond purchase commitments — 32 Net investment — Net investment Total $ 79 $ 118 $ — (1) Represents ineffective portion of cash flow hedges as there were no amounts excluded from the measurement of effectiveness. The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2014: (Amounts in millions) Gain (loss) Gain (loss) Classification of gain Gain (loss) (1) Classification of gain Interest rate swaps hedging assets $ 1,229 $ 63 Net investment $ 15 Net investment Interest rate swaps hedging assets — 2 Net investment — Net investment Interest rate swaps hedging liabilities (69 ) 1 Interest expense — Net investment Inflation indexed swaps 17 (9 ) Net investment — Net investment Foreign currency swaps 4 — Interest expense — Net investment Forward bond purchase commitments 34 — Net investment — Net investment Total $ 1,215 $ 57 $ 15 (1) Represents ineffective portion of cash flow hedges, as there were no amounts excluded from the measurement of effectiveness. The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2013: (Amounts in millions) Gain (loss) Gain (loss) Classification of gain Gain (loss) (1) Classification of gain Interest rate swaps hedging assets $ (892 ) $ 47 Net investment $ (14 ) Net investment Interest rate swaps hedging assets — 1 Net investment — Net investment Interest rate swaps hedging liabilities 42 2 Interest expense — Net investment Inflation indexed swaps 45 (5 ) Net investment — Net investment Foreign currency swaps (1 ) — Interest expense — Net investment Forward bond purchase commitments (60 ) — Net investment — Net investment Total $ (866 ) $ 45 $ (14 ) (1) Represents ineffective portion of cash flow hedges, as there were no amounts excluded from the measurement of effectiveness. The following table provides a reconciliation of current period changes, net of applicable income taxes, for these designated derivatives presented in the separate component of stockholders’ equity labeled “derivatives qualifying as hedges,” for the years ended December 31: (Amounts in millions) 2015 2014 2013 Derivatives qualifying as effective accounting hedges as of January 1 $ 2,070 $ 1,319 $ 1,909 Current period increases (decreases) in fair value, net of deferred taxes of $(29), $(427) and $305 50 788 (561 ) Reclassification to net (income) loss, net of deferred taxes of $43, $20 and $16 (75 ) (37 ) (29 ) Derivatives qualifying as effective accounting hedges as of December 31 $ 2,045 $ 2,070 $ 1,319 The total of derivatives designated as cash flow hedges of $2,045 million, net of taxes, recorded in stockholders’ equity as of December 31, 2015 is expected to be reclassified to net income (loss) in the future, concurrently with and primarily offsetting changes in interest expense and interest income on floating rate instruments and interest income on future fixed rate bond purchases. Of this amount, $70 million, net of taxes, is expected to be reclassified to net income (loss) in the next 12 months. Actual amounts may vary from this amount as a result of market conditions. All forecasted transactions associated with qualifying cash flow hedges are expected to occur by 2047. There were immaterial amounts reclassified to net income (loss) during the years ended December 31, 2015, 2014 and 2013 in connection with forecasted transactions that were no longer considered probable of occurring. Fair Value Hedges Certain derivative instruments are designated as fair value hedges. The changes in fair value of these instruments are recorded in net income (loss). In addition, changes in the fair value attributable to the hedged portion of the underlying instrument are reported in net income (loss). We designate and account for the following as fair value hedges when they have met the effectiveness requirements: (i) interest rate swaps to convert fixed rate liabilities into floating rate liabilities; (ii) cross currency swaps to convert non-U.S. dollar fixed rate liabilities to floating rate U.S. dollar liabilities; and (iii) other instruments to hedge various fair value exposures of investments. There were no pre-tax income (loss) effects of fair value hedges and related hedged items for the years ended December 31, 2015 and 2014. The following table provides information about the pre-tax income (loss) effects of fair value hedges and related hedged items for the year ended December 31, 2013: Derivative instrument Hedged item (Amounts in Gain (loss) Classification Other impacts income (loss) Classification of Gain (loss) Classification Interest rate swaps hedging liabilities $ (11 ) Net investment $ 13 Interest credited $ 11 Net investment gains (losses) Foreign currency swaps (31 ) Net investment — Interest credited 31 Net investment Total $ (42 ) $ 13 $ 42 The difference between the gain (loss) recognized for the derivative instrument and the hedged item presented above represents the net ineffectiveness of the fair value hedging relationships. The other impacts presented above represent the net income (loss) effects of the derivative instruments that are presented in the same location as the income (loss) activity from the hedged item. There were no amounts excluded from the measurement of effectiveness. Derivatives Not Designated As Hedges We also enter into certain non-qualifying derivative instruments such as: (i) interest rate swaps and financial futures to mitigate interest rate risk as part of managing regulatory capital positions; (ii) credit default swaps to enhance yield and reproduce characteristics of investments with similar terms and credit risk; (iii) equity index options, equity return swaps, interest rate swaps and financial futures to mitigate the risks associated with liabilities that have guaranteed minimum benefits, fixed index annuities and indexed universal life; (iv) interest rate swaps where the hedging relationship does not qualify for hedge accounting; (v) credit default swaps to mitigate loss exposure to certain credit risk; (vi) foreign currency swaps, options and forward contracts to mitigate currency risk associated with non-functional currency investments held by certain foreign subsidiaries and future dividends or other cash flows from certain foreign subsidiaries to our holding company; and (vii) equity index options to mitigate certain macroeconomic risks associated with certain foreign subsidiaries. Additionally, we provide GMWBs on certain variable annuities that are required to be bifurcated as embedded derivatives. We also offer fixed index annuity and indexed universal life products and have reinsurance agreements with certain features that are required to be bifurcated as embedded derivatives. We also have derivatives related to securitization entities where we were required to consolidate the related securitization entity as a result of our involvement in the structure. The counterparties for these derivatives typically only have recourse to the securitization entity. The interest rate swaps used for these entities are typically used to effectively convert the interest payments on the assets of the securitization entity to the same basis as the interest rate on the borrowings issued by the securitization entity. Credit default swaps are utilized in certain securitization entities to enhance the yield payable on the borrowings issued by the securitization entity and also include a settlement feature that allows the securitization entity to provide the par value of assets in the securitization entity for the amount of any losses incurred under the credit default swap. The following table provides the pre-tax gain (loss) recognized in net income (loss) for the effects of derivatives not designated as hedges for the years ended December 31: (Amounts in millions) 2015 2014 2013 Classification of gain (loss) recognized Interest rate swaps $ (11 ) $ 1 $ (7 ) Net investment gains (losses) Interest rate swaps related to securitization entities (1) (4 ) (9 ) 9 Net investment gains (losses) Credit default swaps 1 1 14 Net investment gains (losses) Credit default swaps related to securitization entities (1) 7 19 77 Net investment gains (losses) Equity index options (25 ) (31 ) (43 ) Net investment gains (losses) Financial futures (34 ) 90 (232 ) Net investment gains (losses) Equity return swaps (3 ) 5 (33 ) Net investment gains (losses) Other foreign currency contracts 10 (4 ) 6 Net investment gains (losses) Foreign currency swaps (22 ) (7 ) — Net investment gains (losses) Forward bond purchase commitments 2 — — Net investment gains (losses) GMWB embedded derivatives (25 ) (147 ) 277 Net investment gains (losses) Fixed index annuity embedded derivatives (7 ) (27 ) (18 ) Net investment gains (losses) Indexed universal life embedded derivatives 6 (1 ) — Net investment gains (losses) Total derivatives not designated as hedges $ (105 ) $ (110 ) $ 50 (1) See note 17 for additional information related to consolidated securitization entities. Derivative Counterparty Credit Risk Most of our derivative arrangements with counterparties require the posting of collateral upon meeting certain net exposure thresholds. For derivatives related to securitization entities, there are no arrangements that require either party to provide collateral and the recourse of the derivative counterparty is typically limited to the assets held by the securitization entity and there is no recourse to any entity other than the securitization entity. The following table presents additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of December 31: 2015 2014 (Amounts in millions) Derivatives (1) Derivatives (2) Net Derivatives (1) Derivatives (2) Net Amounts presented in the balance sheet: Gross amounts recognized $ 1,135 $ 320 $ 815 $ 1,157 $ 273 $ 884 Gross amounts offset in the balance sheet — — — — — — Net amounts presented in the balance sheet 1,135 320 815 1,157 273 884 Gross amounts not offset in the balance sheet: Financial instruments (3) (231 ) (231 ) — (227 ) (227 ) — Collateral received (642 ) — (642 ) (884 ) — (884 ) Collateral pledged — (263 ) 263 — (49 ) 49 Over collateralization 3 174 (171 ) 1 5 (4 ) Net amount $ 265 $ — $ 265 $ 47 $ 2 $ 45 (1) Included $24 million and $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2015 and 2014, respectively. (2) Included $6 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2015 and 2014. (3) Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty. Except for derivatives related to securitization entities, almost all of our master swap agreements contain credit downgrade provisions that allow either party to assign or terminate derivative transactions if the other party’s long-term unsecured debt rating or financial strength rating is below the limit defined in the applicable agreement. If the downgrade provisions had been triggered as of December 31, 2015 and 2014, we could have been allowed to claim $265 million and $47 million, respectively, or required to disburse up to $2 million as of December 31, 2014. The chart above excludes embedded derivatives and derivatives related to securitization entities as those derivatives are not subject to master netting arrangements. Credit Derivatives We sell protection under single name credit default swaps and credit default swap index tranches in combination with purchasing securities to replicate characteristics of similar investments based on the credit quality and term of the credit default swap. Credit default triggers for both indexed reference entities and single name reference entities follow the Credit Derivatives Physical Settlement Matrix published by the International Swaps and Derivatives Association. Under these terms, credit default triggers are defined as bankruptcy, failure to pay or restructuring, if applicable. Our maximum exposure to credit loss equals the notional value for credit default swaps. In the event of default for credit default swaps, we are typically required to pay the protection holder the full notional value less a recovery rate determined at auction. In addition to the credit derivatives discussed above, we also have credit derivative instruments related to securitization entities that we consolidate. These derivatives represent a customized index of reference entities with specified attachment points for certain derivatives. The credit default triggers are similar to those described above. In the event of default, the securitization entity will provide the counterparty with the par value of assets held in the securitization entity for the amount of incurred loss on the credit default swap. The maximum exposure to loss for the securitization entity is the notional value of the derivatives. Certain losses on these credit default swaps would be absorbed by the third-party noteholders of the securitization entity and the remaining losses on the credit default swaps would be absorbed by our portion of the notes issued by the securitization entity. The following table sets forth our credit default swaps where we sell protection on single name reference entities and the fair values as of December 31: 2015 2014 (Amounts in millions) Notional Assets Liabilities Notional value Assets Liabilities Investment grade Matures in less than one year $ — $ — $ — $ — $ — $ — Matures after one year through five years 39 — — 39 1 — Total credit default swaps on single name reference entities $ 39 $ — $ — $ 39 $ 1 $ — The following table sets forth our credit default swaps where we sell protection on credit default swap index tranches and the fair values as of December 31: 2015 2014 (Amounts in millions) Notional Assets Liabilities Notional Assets Liabilities Original index tranche attachment/detachment point and maturity: 7% - 15% matures in less than one year (1) $ 100 $ 1 $ — $ — $ — $ — 7% - 15% matures after one year through five years (1) — — — 100 1 — 9% - 12% matures in less than one year (2) — — — 250 2 — Total credit default swap index tranches 100 1 — 350 3 — Customized credit default swap index tranches related to securitization entities: Portion backing third-party borrowings maturing 2017 (3) 12 — 2 12 — — Portion backing our interest maturing 2017 (4) 300 — 12 300 — 17 Total customized credit default swap index tranches related to securitization entities 312 — 14 312 — 17 Total credit default swaps on index tranches $ 412 $ 1 $ 14 $ 662 $ 3 $ 17 (1) The current attachment/detachment as of December 31, 2015 and 2014 was 7% – 15%. (2) The current attachment/detachment as of December 31, 2015 and 2014 was 9% – 12%. (3) Original notional value was $39 million. (4) Original notional value was $300 million.

Deferred Acquisition Costs

Deferred Acquisition Costs	12 Months Ended
	Dec. 31, 2015
Deferred Acquisition Costs	(6) Deferred Acquisition Costs The following table presents the activity impacting DAC as of and for the years ended December 31: (Amounts in millions) 2015 2014 2013 Unamortized balance as of January 1 $ 5,200 $ 5,214 $ 5,220 Impact of foreign currency translation (23 ) (15 ) (16 ) Costs deferred 295 385 365 Amortization, net of interest accretion (448 ) (384 ) (355 ) Impairment (455 ) — — Unamortized balance as of December 31 4,569 5,200 5,214 Accumulated effect of net unrealized investment (gains) losses (171 ) (348 ) (176 ) Balance as of December 31 $ 4,398 $ 4,852 $ 5,038 We regularly review DAC to determine if it is recoverable from future income. In the fourth quarter of 2015, as part of our annual review of assumptions, we increased DAC amortization by $109 million in our universal life insurance products, reflecting updated assumptions for persistency, long-term interest rates, mortality and other refinements as well as corrections related to reinsurance inputs. On September 30, 2015, Genworth Life and Annuity Insurance Company (“GLAIC”), our indirect wholly-owned subsidiary, entered into a Master Agreement (the “Master Agreement”) for a life block transaction with Protective Life Insurance Company (“Protective Life”). Pursuant to the Master Agreement, GLAIC and Protective Life agreed to enter into a reinsurance agreement (the “Reinsurance Agreement”), under the terms of which Protective Life would coinsure certain term life insurance business of GLAIC, net of third-party reinsurance. The Reinsurance Agreement was entered into in January 2016. In connection with entering into the Master Agreement, we recorded a DAC impairment of $455 million as a result of loss recognition testing of certain term life insurance policies as part of this life block transaction. As of December 31, 2015, we believe all of our other businesses had sufficient future income and therefore the related DAC was recoverable. As of December 31, 2014, all of our businesses had sufficient future income and therefore the related DAC was recoverable.

Intangible Assets and Goodwill

Intangible Assets and Goodwill	12 Months Ended
	Dec. 31, 2015
Intangible Assets and Goodwill	The following table presents our intangible assets as of December 31: 2015 2014 (Amounts in millions) Gross Accumulated Gross Accumulated PVFP $ 2,084 $ (1,941 ) $ 1,995 $ (1,917 ) Capitalized software 665 (571 ) 641 (532 ) Deferred sales inducements to contractholders 268 (178 ) 209 (153 ) Other 66 (50 ) 55 (49 ) Total $ 3,083 $ (2,740 ) $ 2,900 $ (2,651 ) Amortization expense related to PVFP, capitalized software and other intangible assets for the years ended December 31, 2015, 2014 and 2013 was $64 million, $70 million and $109 million, respectively. Amortization expense related to deferred sales inducements of $25 million, $30 million and $24 million, respectively, for the years ended December 31, 2015, 2014 and 2013 was included in benefits and other changes in policy reserves. Present Value of Future Profits The following table presents the activity in PVFP as of and for the years ended December 31: (Amounts in millions) 2015 2014 2013 Unamortized balance as of January 1 $ 229 $ 246 $ 297 Interest accreted at 6.45%, 5.89% and 5.52% 14 14 15 Amortization (38 ) (31 ) (66 ) Unamortized balance as of December 31 205 229 246 Accumulated effect of net unrealized investment (gains) losses (62 ) (151 ) (85 ) Balance as of December 31 $ 143 $ 78 $ 161 We regularly review our assumptions and periodically test PVFP for recoverability in a manner similar to our treatment of DAC. In the fourth quarter of 2015, as part of our annual review of assumptions, we increased PVFP amortization for our universal life insurance products by $14 million. The updated assumptions largely reflected changes to persistency, long-term interest rates, mortality and other refinements. As of December 31, 2015, we believe all of our other businesses have sufficient future income and therefore the related PVFP is recoverable. For the years ended December 31, 2015 and 2013, there were no charges to income as a result of our PVFP recoverability testing. During the fourth quarter of 2014, the loss recognition testing for our acquired block of long-term care insurance business resulted in a premium deficiency. As a result, we wrote off the entire PVFP balance for our long-term care insurance business of $6 million through amortization with a corresponding change to net unrealized investment gains (losses). The results of the test were driven by changes to assumptions and methodologies primarily impacting claim termination rates, most significantly in later-duration claims, and benefit utilization rates. The percentage of the December 31, 2015 PVFP balance net of interest accretion, before the effect of unrealized investment gains or losses, estimated to be amortized over each of the next five years is as follows: 2016 15.1 % 2017 13.7 % 2018 11.7 % 2019 10.0 % 2020 8.7 % Amortization expense for PVFP in future periods will be affected by acquisitions, dispositions, net investment gains (losses) or other factors affecting the ultimate amount of gross profits realized from certain lines of business. Similarly, future amortization expense for other intangibles will depend on future acquisitions, dispositions and other business transactions. Goodwill As of December 31, 2015 and 2014, our goodwill balance was $14 million and $16 million, respectively, which changed due to foreign currency translation. Of those amounts as of December 31, 2015 and 2014, our Canada Mortgage Insurance segment has goodwill of $8 million and $10 million, respectively, and our Australia Mortgage Insurance segment has goodwill of $6 million. No goodwill impairment charges were recorded in 2015 or 2013. During 2014, we wrote off the entire goodwill balance of our U.S. Life Insurance segment and recorded goodwill impairments of $849 million, including $354 million for our long-term care insurance reporting unit and $495 million for our life insurance reporting unit. Based on the fair value of projected new business for our long-term care insurance and life insurance reporting units, we recorded goodwill impairments of $200 million and $350 million, respectively, during the third quarter of 2014. The remaining goodwill balances for our long-term care insurance and life insurance reporting units of $154 million and $145 million, respectively, were deemed recoverable as of September 30, 2014 based on our determination of implied goodwill. During the fourth quarter of 2014 and in connection with the preparation of the financial statements, due to negative actions taken by rating agencies and suspension of sales by certain distributors, we performed an interim goodwill impairment analysis for our long-term care and life insurance businesses. As a result of market conditions, decreases in sales projections from negative rating actions and overall uncertainty created as a result of the long-term care insurance reserve increases, we recorded a goodwill impairment of $154 million in our long-term care insurance business and $145 million in our life insurance business. The uncertainty associated with the level and value of new business that a market participant would place on our long-term care and life insurance businesses resulted in concluding the goodwill balances were no longer recoverable.

Reinsurance

Reinsurance	12 Months Ended
	Dec. 31, 2015
Reinsurance	We reinsure a portion of our policy risks to other insurance companies in order to reduce our ultimate losses, diversify our exposures and provide capital flexibility. We also assume certain policy risks written by other insurance companies. Reinsurance accounting is followed for assumed and ceded transactions when there is adequate risk transfer. Otherwise, the deposit method of accounting is followed. Reinsurance does not relieve us from our obligations to policyholders. In the event that the reinsurers are unable to meet their obligations, we remain liable for the reinsured claims. We monitor both the financial condition of individual reinsurers and risk concentrations arising from similar geographic regions, activities and economic characteristics of reinsurers to lessen the risk of default by such reinsurers. Other than the relationship discussed below with Union Fidelity Life Insurance Company (“UFLIC”), we do not have significant concentrations of reinsurance with any one reinsurer that could have a material impact on our financial position. As of December 31, 2015, the maximum amount of individual ordinary life insurance normally retained by us on any one individual life policy was $5 million. We have several significant reinsurance transactions (“Reinsurance Transactions”) with UFLIC. In these transactions, we ceded to UFLIC in-force blocks of structured settlements issued prior to 2004, substantially all of our in-force blocks of variable annuities issued prior to 2004 and a block of long-term care insurance policies that we reinsured in 2000 from MetLife Insurance Company USA. Although we remain directly liable under these contracts and policies as the ceding insurer, the Reinsurance Transactions have the effect of transferring the financial results of the reinsured blocks to UFLIC. As of December 31, 2015 and 2014, we had a reinsurance recoverable of $14,363 million and $14,494 million, respectively, associated with those Reinsurance Transactions. To secure the payment of its obligations to us under the reinsurance agreements governing the Reinsurance Transactions, UFLIC has established trust accounts to maintain an aggregate amount of assets with a statutory book value at least equal to the statutory general account reserves attributable to the reinsured business less an amount required to be held in certain claims paying accounts. A trustee administers the trust accounts and we are permitted to withdraw from the trust accounts amounts due to us pursuant to the terms of the reinsurance agreements that are not otherwise paid by UFLIC. In addition, pursuant to a Capital Maintenance Agreement, General Electric Capital Corporation, an indirect subsidiary of General Electric Company (“GE”), previously agreed to maintain sufficient capital in UFLIC to maintain UFLIC’s risk-based capital (“RBC”) at not less than 150% of its company action level, as defined from time to time by the National Association of Insurance Commissioners (“NAIC”). In connection with its announced realignment and reorganization of the business of General Electric Capital Corporation in December 2015, General Electric Capital Corporation merged with and into GE. As a result, GE is the successor obligor under the Capital Maintenance Agreement. Under the terms of certain reinsurance agreements that our life insurance subsidiaries have with external parties, we pledged assets in either separate portfolios or in trust for the benefit of external reinsurers. These assets support the reserves ceded to those external reinsurers. We had pledged fixed maturity securities and commercial mortgage loans of $8,324 million and $347 million, respectively, as of December 31, 2015 and $8,737 million and $544 million, respectively, as of December 31, 2014 in connection with these reinsurance agreements. However, we maintain the ability to substitute these pledged assets for other qualified collateral, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. As of December 31, 2014, under the terms of certain reinsurance agreements that our international insurance subsidiaries had with external parties, we deposited $33 million of assets in an authorized account for the benefit of the external reinsurers. These pledged assets supported the reserves and certain expenses in accordance with the reinsurance agreement. In 2015, these reinsurance agreements were terminated and the related assets previously held on deposit were no longer pledged. The following table sets forth net domestic life insurance in-force as of December 31: (Amounts in millions) 2015 2014 2013 Direct life insurance in-force $ 686,446 $ 701,797 $ 708,271 Amounts assumed from other companies 899 935 1,070 Amounts ceded to other companies (1) (411,340 ) (393,244 ) (313,593 ) Net life insurance in-force $ 276,005 $ 309,488 $ 395,748 Percentage of amount assumed to net — % — % — % (1) Includes amounts accounted for under the deposit method. The following table sets forth the effects of reinsurance on premiums written and earned for the years ended December 31: Written Earned (Amounts in millions) 2015 2014 2013 2015 2014 2013 Direct: Life insurance $ 1,030 $ 1,131 $ 1,088 $ 1,030 $ 1,131 $ 1,088 Accident and health insurance 2,764 2,706 2,584 2,778 2,697 2,565 Mortgage insurance 1,754 1,814 1,682 1,514 1,588 1,608 Total direct 5,548 5,651 5,354 5,322 5,416 5,261 Assumed: Life insurance 34 34 3 34 34 3 Accident and health insurance 342 343 345 347 348 350 Mortgage insurance 10 20 19 22 31 33 Total assumed 386 397 367 403 413 386 Ceded: Life insurance (372 ) (332 ) (340 ) (372 ) (332 ) (340 ) Accident and health insurance (682 ) (708 ) (709 ) (688 ) (706 ) (700 ) Mortgage insurance (86 ) (95 ) (92 ) (86 ) (91 ) (91 ) Total ceded (1,140 ) (1,135 ) (1,141 ) (1,146 ) (1,129 ) (1,131 ) Net premiums $ 4,794 $ 4,913 $ 4,580 $ 4,579 $ 4,700 $ 4,516 Percentage of amount assumed to net 9 % 9 % 9 % Reinsurance recoveries recognized as a reduction of benefits and other changes in policy reserves amounted to $2,771 million, $2,846 million and $2,641 million during 2015, 2014 and 2013, respectively.

Insurance Reserves

Insurance Reserves	12 Months Ended
	Dec. 31, 2015
Insurance Reserves	(9) Insurance Reserves Future Policy Benefits The following table sets forth our recorded liabilities and the major assumptions underlying our future policy benefits as of December 31: (Amounts in millions) Mortality/ Interest rate 2015 2014 Long-term care insurance contracts (a ) 3.50% - 7.50% $ 20,563 $ 19,310 Structured settlements with life contingencies (b ) 1.50% - 8.00% 8,991 9,133 Annuity contracts with life contingencies (b ) 1.50% - 8.00% 4,010 4,470 Traditional life insurance contracts (c ) 3.00% - 7.50% 2,638 2,733 Supplementary contracts with life contingencies (b ) 1.50% - 8.00% 269 265 Accident and health insurance contracts (d ) 3.50% - 7.00% 4 4 Total future policy benefits $ 36,475 $ 35,915 (a) The 1983 Individual Annuitant Mortality Table or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality Table or 1994 Group Annuitant Mortality Table and company experience. (b) Assumptions for limited-payment contracts come from either the U.S. Population Table, 1983 Group Annuitant Mortality Table, 1983 Individual Annuitant Mortality Table, Annuity 2000 Mortality Table or 2012 Individual Annuity Reserving Table. (c) Principally modifications based on company experience of the Society of Actuaries 1965-70 or 1975-80 Select and Ultimate Tables, 1941, 1958, 1980 and 2001 Commissioner’s Standard Ordinary Tables, 1980 Commissioner’s Extended Term table and (IA) Standard Table 1996 (modified). (d) The 1958 and 1980 Commissioner’s Standard Ordinary Tables, or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality. We regularly review our assumptions and perform loss recognition testing at least annually. During the fourth quarter of 2014, loss recognition testing for our acquired block of long-term care insurance business resulted in a premium deficiency. As a result, we wrote off the PVFP balance of $6 million and increased reserves $710 million. The results of the test in 2014 were driven by changes to assumptions and methodologies primarily impacting claim termination rates, most significantly in later-duration claims, and benefit utilization rates. The 2015 test did not result in a charge. The liability for future policy benefits for our acquired block of long-term care insurance business represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could possibly be significant and result in further increases in the related future policy benefit reserves for this block of business by an amount that could be material to our results of operations and financial condition and liquidity. As of December 31, 2015, we recorded additional future policy benefit reserves of $13 million on our consolidated balance sheet to accrue for profits followed by losses in our long-term care insurance business and increased benefits and other changes in policy reserves in our consolidated income statement for the same amount for the year ended December 31, 2015. Given there were no profits in our long-term care insurance business in 2014, no accrual was recorded in that year. The current present value of expected losses was approximately $500 million as of December 31, 2015. However, there may be future adjustments to this estimate reflecting any variety of new and adverse trends that could result in increases to future policy benefit reserves for profits followed by losses accrual, and such future increases could possibly be material to our results of operations and financial condition and liquidity. Policyholder Account Balances The following table sets forth our recorded liabilities for policyholder account balances as of December 31: (Amounts in millions) 2015 2014 Annuity contracts $ 14,376 $ 14,406 GICs, funding agreements and FABNs 410 493 Structured settlements without life contingencies 1,694 1,828 Supplementary contracts without life contingencies 762 742 Other 16 17 Total investment contracts 17,258 17,486 Universal life insurance contracts 8,951 8,546 Total policyholder account balances $ 26,209 $ 26,032 In the fourth quarter of 2015, as part of our annual review of assumptions, we increased our liability for policyholder account balances by $175 million for our universal and term universal life insurance products, reflecting updated assumptions for persistency, long-term interest rates, mortality and other refinements. Certain of our U.S. life insurance companies are members of the Federal Home Loan Bank (the “FHLB”) system in their respective regions. As of December 31, 2015 and 2014, we held $30 million and $33 million, respectively, of FHLB common stock related to those memberships which was included in equity securities. We have outstanding funding agreements with the FHLBs and also have letters of credit which have not been drawn upon. The FHLBs have been granted a lien on certain of our invested assets to collateralize our obligations; however, we maintain the ability to substitute these pledged assets for other qualified collateral, and may use, commingle, encumber or dispose of any portion of the collateral as long as there is no event of default and the remaining qualified collateral is sufficient to satisfy the collateral maintenance level. Upon any event of default by us, the FHLB’s recovery on the collateral is limited to the amount of our funding agreement liabilities to the FHLB. The amount of funding agreements outstanding with the FHLB was $105 million and $199 million, respectively, as of December 31, 2015 and 2014 which was included in policyholder account balances. We had letters of credit related to the FHLB of $583 million as of December 31, 2015 and 2014. These funding agreements and letters of credit were collateralized by fixed maturity securities with a fair value of $742 million and $854 million, respectively, as of December 31, 2015 and 2014. Certain Non-traditional Long-Duration Contracts The following table sets forth information about our variable annuity products with death and living benefit guarantees as of December 31: (Dollar amounts in millions) 2015 2014 Account values with death benefit guarantees (net of reinsurance): Standard death benefits (return of net deposits) account value $ 2,512 $ 2,877 Net amount at risk $ 5 $ 5 Average attained age of contractholders 73 72 Enhanced death benefits (ratchet, rollup) account value $ 2,866 $ 3,443 Net amount at risk $ 188 $ 119 Average attained age of contractholders 73 73 Account values with living benefit guarantees: GMWBs $ 3,111 $ 3,675 Guaranteed annuitization benefits $ 1,181 $ 1,362 Variable annuity contracts may contain more than one death or living benefit; therefore, the amounts listed above are not mutually exclusive. Substantially all of our variable annuity contracts have some form of GMDB. As of December 31, 2015 and 2014, our total liability associated with variable annuity contracts with minimum guarantees was approximately $6,170 million and $7,108 million, respectively. The liability, net of reinsurance, for our variable annuity contracts with GMDB and guaranteed annuitization benefits was $72 million and $55 million as of December 31, 2015 and 2014, respectively. The contracts underlying the lifetime benefits such as GMWB and guaranteed annuitization benefits are considered “in the money” if the contractholder’s benefit base, or the protected value, is greater than the account value. As of December 31, 2015 and 2014, our exposure related to GMWB and guaranteed annuitization benefit contracts that were considered “in the money” was $745 million and $532 million, respectively. For GMWBs and guaranteed annuitization benefits, the only way the contractholder can monetize the excess of the benefit base over the account value of the contract is through lifetime withdrawals or lifetime income payments after annuitization. Account balances of variable annuity contracts with death or living benefit guarantees were invested in separate account investment options as follows as of December 31: (Amounts in millions) 2015 2014 Balanced funds $ 3,304 $ 3,848 Equity funds 1,387 1,639 Bond funds 576 707 Money market funds 85 96 Total $ 5,352 $ 6,290

Liability for Policy and Contra

Liability for Policy and Contract Claims	12 Months Ended
	Dec. 31, 2015
Liability for Policy and Contract Claims	(10) Liability for Policy and Contract Claims The following table sets forth our recorded liability for policy and contract claims by business as of December 31: (Amounts in millions) 2015 2014 Long-term care insurance $ 6,749 $ 6,216 U.S. mortgage insurance 849 1,180 Life insurance 202 197 Australia mortgage insurance 165 152 Canada mortgage insurance 87 91 Fixed annuities 18 21 Runoff 18 15 Other mortgage insurance 7 9 Total liability for policy and contract claims $ 8,095 $ 7,881 The liability for policy and contract claims represents our current best estimate; however, there may be future adjustments to this estimate and related assumptions. Such adjustments, reflecting any variety of new and adverse trends, could possibly be significant, and result in increases in reserves by an amount that could be material to our results of operations and financial condition and liquidity. Long-term care insurance The following table sets forth changes in the liability for policy and contract claims for our long-term care insurance business for the dates indicated: (Amounts in millions) 2015 2014 2013 Beginning balance as of January 1 $ 6,216 $ 4,999 $ 4,655 Less reinsurance recoverables (1,926 ) (1,707 ) (1,574 ) Net balance as of January 1 4,290 3,292 3,081 Incurred related to insured events of: Current year 1,655 1,474 1,323 Prior years 39 726 3 Total incurred 1,694 2,200 1,326 Paid related to insured events of: Current year (151 ) (134 ) (131 ) Prior years (1,371 ) (1,263 ) (1,160 ) Total paid (1,522 ) (1,397 ) (1,291 ) Interest on liability for policy and contract claims 232 195 176 Net balance as of December 31 4,694 4,290 3,292 Add reinsurance recoverables 2,055 1,926 1,707 Ending balance as of December 31 $ 6,749 $ 6,216 $ 4,999 In 2015, the incurred amount of $39 million related to insured events of prior years increased primarily from lower claim termination rates, partially offset by $25 million of net favorable corrections and adjustments in 2015. In 2014, the incurred amount of $726 million related to insured events of prior years increased largely as a result of the completion of a comprehensive review of our long-term care insurance claim reserves conducted during the third quarter of 2014 which resulted in recording higher reserves of $604 million and an increase in reinsurance recoverables of $73 million. This review was commenced as a result of adverse claims experience during the second quarter of 2014 and in connection with our regular review of our claim reserves assumptions during the third quarter of each year. As a result of this review, we made changes to our assumptions and methodologies relating to our long-term care insurance claim reserves primarily impacting claim termination rates, most significantly in later-duration claims, and benefit utilization rates, reflecting that claims are not terminating as quickly and claimants are utilizing more of their available benefits in aggregate than had previously been assumed in our reserve calculations. In conducting the review, we increased the population of claims reviewed, utilizing more of our recent data. During the third quarter of 2014, we also recorded a $61 million unfavorable correction to claim reserves related to a calculation of benefit utilization for policies with a benefit inflation option. This error arose prior to 2011 and was not material to earnings in any interim or annual period. During the fourth quarter of 2014, we recorded an $81 million unfavorable correction to claim reserves primarily related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014 and a $21 million unfavorable adjustment related to a revised interest rate assumption, partially offset by a $49 million favorable refinement of assumptions for claim termination rates. As a result of these items, we also recorded an increase in reinsurance recoverables of $17 million in 2014. The remaining increase was attributable to aging and growth of the in-force block. In 2013, the incurred amount of $3 million related to insured events of prior years increased predominantly from growth and aging of the in-force block. U.S. mortgage insurance The following table sets forth changes in the liability for policy and contract claims for our U.S. mortgage insurance business for the dates indicated: (Amounts in millions) 2015 2014 2013 Beginning balance as of January 1 $ 1,180 $ 1,482 $ 2,009 Less reinsurance recoverables (24 ) (44 ) (80 ) Net balance as of January 1 1,156 1,438 1,929 Incurred related to insured events of: Current year 236 328 476 Prior years (14 ) 29 (63 ) Total incurred 222 357 413 Paid related to insured events of: Current year (13 ) (21 ) (45 ) Prior years (521 ) (618 ) (859 ) Total paid (534 ) (639 ) (904 ) Net balance as of December 31 844 1,156 1,438 Add reinsurance recoverables 5 24 44 Ending balance as of December 31 $ 849 $ 1,180 $ 1,482 In 2015, the incurred amount of $14 million related to insured events of prior years decreased largely related to favorable aging of existing delinquencies. In 2014, the incurred amount of $29 million related to insured events of prior years increased primarily related to an aggregate increase in our claim reserves of $53 million in connection with the settlement agreement with Bank of America, N.A. and discussions with another servicer in an effort to resolve pending disputes over loss mitigation activities. This increase was partially offset by favorable aging on existing delinquencies in 2014. In 2013, the incurred amount of $63 million related to insured events of prior years decreased primarily from improvements in net cures.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2015
Employee Benefit Plans	(11) Employee Benefit Plans (a) Pension and Retiree Health and Life Insurance Benefit Plans Essentially all of our employees are enrolled in a qualified defined contribution pension plan. The plan is 100% funded by Genworth. We make annual contributions to each employee’s pension plan account based on the employee’s age, service and eligible pay. Employees are vested in the plan after three years of service. As of December 31, 2015 and 2014, we recorded a liability related to these benefits of $13 million. In addition, certain employees also participate in non-qualified defined contribution plans and in qualified and non-qualified defined benefit pension plans. The plan assets, projected benefit obligation and accumulated benefit obligation liabilities of these plans were not material to our consolidated financial statements individually or in the aggregate. As of December 31, 2015 and 2014, we recorded a liability related to these plans of $78 million and $71 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. In 2015, we recognized an increase of $30 million in OCI. In 2014, we recognized a decrease of $34 million in OCI related to these plans. In connection with the sale of our lifestyle protection insurance business in December 2015, we wrote off our pension benefit assets of $17 million and recognized all of the unrealized actuarial losses of $15 million related to the U.K. pension plan. In addition, related to the settlement of the U.K. pension plan, we agreed to purchase a group annuity contract. To fully fund this group annuity contract, we incurred $69 million of expense in 2015, of which $58 million was paid in 2015. These items resulted in $101 million of pension settlement costs related to the sale. The amounts associated with the group annuity contract are held in a third-party trust for the benefit of the participants. It is our intent to completely settle the U.K. pension plan in 2016. See note 24 for additional details related to the sale of our lifestyle protection insurance business. We provide retiree health benefits to domestic employees hired prior to January 1, 2005 who meet certain service requirements. Under this plan, retirees over 65 years of age receive a subsidy towards the purchase of a Medigap policy, and retirees under 65 years of age receive medical benefits similar to our employees’ medical benefits. In December 2009, we announced that eligibility for retiree medical benefits will be limited to associates who are within 10 years of retirement eligibility as of January 1, 2010. This resulted in a negative plan amendment which will be amortized over the average future service of the participants. We also provide retiree life and long-term care insurance benefits. The plans are funded as claims are incurred. As of December 31, 2015 and 2014, the accumulated postretirement benefit obligation associated with these benefits was $78 million and $90 million, respectively, which we accrued in other liabilities in the consolidated balance sheets. In 2015, we recognized an increase of $13 million in OCI. In 2014, we recognized a decrease of $10 million in OCI. Our cost associated with our pension, retiree health and life insurance benefit plans was $25 million, $21 million and $22 million for the years ended December 31, 2015, 2014 and 2013, respectively. (b) Savings Plans Our domestic employees participate in qualified and non-qualified defined contribution savings plans that allow employees to contribute a portion of their pay to the plan on a pre-tax basis. We match these contributions, which vest immediately, up to 6% of the employee’s pay. Employees hired on or after January 1, 2011 will not vest immediately in Genworth matching contributions but will fully vest in the matching contributions after two complete years of service. One option available to employees in the defined contribution savings plan is the ClearCourse ® (c) Health and Welfare Benefits for Active Employees We provide health and welfare benefits to our employees, including health, life, disability, dental and long-term care insurance. Our long-term care insurance is provided through our group long-term care insurance products. The premiums recorded by this business related to these benefits were insignificant during 2015, 2014 and 2013.

Borrowings and Other Financings

Borrowings and Other Financings	12 Months Ended
	Dec. 31, 2015
Borrowings and Other Financings	(a) Short-Term Borrowings Revolving Credit Facility In September 2013, Genworth Financial and Genworth Holdings entered into a Credit Agreement (the “Credit Agreement”) which provides Genworth Holdings with a $300 million multi-currency revolving credit facility, with a $100 million sublimit for letters of credit. The credit facility is available on a revolving basis until September 26, 2016, unless the commitments are terminated earlier either at the request of Genworth Holdings or by the lenders as a result of any event of default. The proceeds of the loans may be used for working capital and general corporate purposes. As of December 31, 2015 and 2014, there was no amount outstanding under the credit facility. The obligations under the Credit Agreement are unsecured and payment of Genworth Holdings’ obligations is fully and unconditionally guaranteed by Genworth Financial. Any borrowings under the revolving credit facility will bear interest at a rate per annum equal to, at the option of Genworth Holdings, (i) a rate based on the greater of JPMorgan Chase Bank N.A.’s prime rate, the federal funds rate and the one-month adjusted London Interbank Offered Rate (“LIBOR”) from time to time, or (ii) with respect to euro currency borrowings, a rate based on the LIBOR from time to time, plus in each case a margin that fluctuates based upon the ratings assigned from time to time by Moody’s Investors Service, Inc. and Standard & Poor’s Rating Group to Genworth Holdings’ senior unsecured long-term indebtedness for borrowed money that is not guaranteed by any other person other than Genworth Financial or subject to any other credit enhancement. Genworth Holdings will also pay a commitment fee at a rate that varies with Genworth Holdings’ senior unsecured long-term indebtedness ratings and that is calculated on the average daily unused amount of the commitments, payable quarterly in arrears. The Credit Agreement contains representations, warranties, covenants, terms and conditions customary for transactions of this type. These include negative covenants limiting the ability of Genworth Holdings and its subsidiaries, to: (1) create liens other than permitted liens; (2) in the case of Genworth Holdings and Genworth Life Insurance Company (“GLIC”), merge into or consolidate with any other person or permit any person to merge into or consolidate with them unless Genworth Holdings or GLIC, as applicable, is the surviving person; (3) sell, transfer, lease, or otherwise dispose of all or substantially all of the assets of Genworth Holdings and its subsidiaries, taken as a whole, and the equity interest in or assets of GLIC, subject to certain excluded transactions; (4) enter into certain transactions with affiliates; and (5) enter into certain restrictive agreements. In addition, Genworth Financial agrees not to permit Priority Indebtedness (as defined in the Credit Agreement) to exceed 7.5% of its consolidated total capitalization (as defined in the Credit Agreement) as of the end of any fiscal quarter ending on and after September 30, 2013. The Credit Agreement also contains financial covenants that require Genworth Financial not to permit (i) its capitalization ratio (as defined in the Credit Agreement) to be greater than 0.35 to 1.00, and (ii) its consolidated net worth (as defined in the Credit Agreement) to be less than the sum of $8.9 billion plus 50% of its consolidated net income (as defined in the Credit Agreement), in each case as of the end of each fiscal quarter ending on and after September 30, 2013. The Credit Agreement contains certain customary events of default, subject to customary grace periods, including, among others: (1) failure to pay when due principal, interest or any other amounts due and payable under the Credit Agreement; (2) incorrectness in any material respect of representations and warranties when made or deemed made; (3) breach of specified covenants; (4) cross-defaults with other material indebtedness (as defined in the Credit Agreement) exceeding an aggregate principal amount of $100 million; (5) certain ERISA (Employee Retirement Income Security Act of 1974) events, (6) bankruptcy and insolvency events, (7) occurrence of a change in control of either Genworth Financial or Genworth Holdings; (8) inability to pay debts as they become due; (9) certain undischarged judgments; (10) Genworth Financial’s guarantee ceases to be valid, binding and enforceable in accordance with its terms; or (11) issuance by any insurance regulatory official of any material corrective order or initiation by any such official of any material regulatory proceeding to oversee or direct management, if such order of proceeding continues undismissed for a period of 30 days. (b) Long-Term Borrowings The following table sets forth total long-term borrowings as of December 31: (Amounts in millions) 2015 2014 Genworth Holdings 8.625% Senior Notes, due 2016 $ 298 $ 300 6.52% Senior Notes, due 2018 598 600 7.70% Senior Notes, due 2020 397 400 7.20% Senior Notes, due 2021 389 399 7.625% Senior Notes, due 2021 724 758 4.90% Senior Notes, due 2023 399 399 4.80% Senior Notes, due 2024 400 400 6.50% Senior Notes, due 2034 297 297 6.15% Fixed-to-Floating Rate Junior Subordinated Notes, due 2066 598 598 Subtotal 4,100 4,151 Deferred borrowing charges (21 ) (24 ) Total Genworth Holdings 4,079 4,127 Canada 5.68% Senior Notes, due 2020 199 236 4.24% Senior Notes, due 2024 116 138 Subtotal 315 374 Deferred borrowing charges (2 ) (2 ) Total Canada 313 372 Australia Floating Rate Junior Notes, due 2021 36 114 Floating Rate Junior Notes, due 2025 146 — Subtotal 182 114 Deferred borrowing charges (4 ) (1 ) Total Australia 178 113 Total $ 4,570 $ 4,612 Genworth Holdings Long-Term Senior Notes As of December 31, 2015, Genworth Holdings had outstanding eight series of fixed rate senior notes with varying interest rates between 4.80% and 8.625% and maturity dates between 2016 and 2034. The senior notes are Genworth Holdings’ direct, unsecured obligations and rank equally in right of payment with all of its existing and future unsecured and unsubordinated obligations. Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior notes and the holders of the senior notes, on an unsecured unsubordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, each outstanding series of senior notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior notes indenture in respect of such senior notes. We have the option to redeem all or a portion of each series of senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread. In January 2016, Genworth Holdings redeemed $298 million of its 8.625% senior notes due 2016 issued in December 2009 (the “2016 Notes”) and paid accrued and unpaid interest and a make-whole premium of approximately $23 million pre-tax. During the third quarter of 2015, Genworth Holdings repurchased $50 million aggregate principal amount of its senior notes for a pre-tax loss of $1 million and paid accrued and unpaid interest thereon. Genworth Holdings repaid $485 million of its 5.75% senior notes due 2014 issued in June 2004 (the “2014 Notes”) in June 2014 from cash on hand. In December 2013, Genworth Holdings issued $400 million aggregate principal amount of senior notes, with an interest rate of 4.80% per year payable semi-annually, and maturing in 2024 (“2024 Notes”). The net proceeds of $397 million from the issuance of the 2024 Notes, together with cash on hand at Genworth Financial, were used to contribute $100 million to GMICO, our primary U.S. mortgage insurance subsidiary, and an additional $300 million was contributed to a U.S. mortgage holding company to be used to satisfy all or part of the higher capital requirements expected to be imposed by the government-sponsored enterprises (“GSEs”) as part of the anticipated revisions to their asset-and capital-related requirements. In May 2014, our U.S. mortgage holding company contributed the additional $300 million to GMICO. In August 2013, Genworth Holdings issued $400 million aggregate principal amount of 4.90% senior notes due 2023 (the “2023 Notes”). The net proceeds of $396 million from the issuance of the 2023 Notes, together with cash on hand at Genworth Holdings, were used to redeem all $346 million of the remaining outstanding aggregate principal amount of Genworth Holdings’ 4.95% senior notes due 2015 (the “2015 Notes”) and pay accrued and unpaid interest on such notes and pay a make-whole payment of approximately $30 million pre-tax. During 2013, Genworth Holdings repurchased $15 million aggregate principal amount of the 2014 Notes, and paid accrued and unpaid interest thereon. In June 2013, Genworth Holdings repurchased $4 million aggregate principal amount of the 2015 Notes, and paid accrued and unpaid interest thereon. Long-Term Junior Subordinated Notes As of December 31, 2015, Genworth Holdings had outstanding fixed-to-floating rate junior notes having an aggregate principal amount of $598 million, with an annual interest rate equal to 6.15% payable semi-annually, until November 15, 2016, at which point the annual interest rate will be equal to the three-month LIBOR plus 2.0025% payable quarterly, until the notes mature in November 2066 (“2066 Notes”). Subject to certain conditions, Genworth Holdings has the right, on one or more occasions, to defer the payment of interest on the 2066 Notes during any period of up to 10 years without giving rise to an event of default and without permitting acceleration under the terms of the 2066 Notes. Genworth Holdings will not be required to settle deferred interest payments until it has deferred interest for five years or made a payment of current interest. In the event of our bankruptcy, holders will have a limited claim for deferred interest. Genworth Holdings may redeem the 2066 Notes on November 15, 2036, the “scheduled redemption date,” but only to the extent that it has received net proceeds from the sale of certain qualifying capital securities. Genworth Holdings may redeem the 2066 Notes (i) in whole or in part, at any time on or after November 15, 2016 at their principal amount plus accrued and unpaid interest to the date of redemption or (ii) in whole or in part, prior to November 15, 2016 at their principal amount plus accrued and unpaid interest to the date of redemption or, if greater, a make-whole price. The 2066 Notes will be subordinated to all existing and future senior, subordinated and junior subordinated debt of Genworth Holdings, except for any future debt that by its terms is not superior in right of payment, and will be effectively subordinated to all liabilities of our subsidiaries. Genworth Financial provides a full and unconditional guarantee to the trustee of the 2066 Notes and the holders of the 2066 Notes, on an unsecured subordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding 2066 Notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the 2066 Notes indenture in respect of the 2066 Notes. In connection with the issuance of the 2066 Notes, we entered into a Replacement Capital Covenant (the “Replacement Capital Covenant”), whereby we agreed, for the benefit of holders of our 6.5% Senior Notes due 2034, that Genworth Holdings will not repay, redeem or repurchase all or any part of the 2066 Notes on or before November 15, 2046, unless such repayment, redemption or repurchase is made from the proceeds of the issuance of certain replacement capital securities and pursuant to the other terms and conditions set forth in the Replacement Capital Covenant. Canada As of December 31, 2015, Genworth MI Canada Inc. (“Genworth Canada”), our indirect majority-owned subsidiary, had outstanding two series of fixed rate senior notes with interest rates of 5.68% and 4.24% and maturity dates of 2020 and 2024, respectively. The senior notes are redeemable at the option of Genworth Canada, in whole or in part, at any time. In April 2014, Genworth Canada issued CAD$160 million aggregate principal amount of 4.24% senior notes (the “2024 Canada Notes”). The net proceeds of the offering of the 2024 Canada Notes were used to redeem, in full, the CAD$150 million outstanding principal on its existing 4.59% senior notes due 2015. In conjunction with the redemption, Genworth Canada made an early redemption payment to existing noteholders of approximately CAD$7 million and accrued interest of approximately CAD$2 million in the second quarter of 2014. Australia As of December 31, 2015, Genworth Financial Mortgage Insurance Pty Limited, our indirect majority-owned subsidiary, had outstanding two series of subordinated floating rate notes with an interest rate of three-month Bank Bill Swap reference rate plus a margin of 4.75% and 3.50% and maturity dates of 2021 and 2025, respectively. In July 2015, Genworth Financial Mortgage Insurance Pty Limited issued AUD$200 million of subordinated floating rate notes due 2025 (the “2025 Australia Notes”) with an interest rate of three-month Bank Bill Swap reference rate plus a margin of 3.50%. Genworth Financial Mortgage Insurance Pty Limited used the proceeds it received from this transaction to redeem AUD$90 million of its outstanding debt and for general corporate purposes and incurred a $2 million pre-tax early redemption payment. (c) Non-Recourse Funding Obligations The following table sets forth the non-recourse funding obligations (surplus notes) of our wholly-owned, special purpose consolidated captive insurance subsidiaries as of December 31: (Amounts in millions) Issuance 2015 2014 River Lake Insurance Company (a) $ 570 $ 570 River Lake Insurance Company (b) 405 435 River Lake Insurance Company II (a) 192 192 River Lake Insurance Company II (b) 453 484 Rivermont Life Insurance Company I (a) 315 315 Subtotal 1,935 1,996 Deferred borrowing charges (15 ) (15 ) Total $ 1,920 $ 1,981 (a) Accrual of interest based on one-month LIBOR that resets every 28 days plus a fixed margin. (b) Accrual of interest based on one-month LIBOR that resets on a specified date each month plus a contractual margin. These surplus notes bear a floating rate of interest and have been deposited into a series of trusts that have issued money market or term securities. Both principal and interest payments on the money market and term securities are guaranteed by a third-party insurance company. The holders of the money market or term securities cannot require repayment from us or any of our subsidiaries, other than the River Lake and Rivermont Insurance Companies, as applicable, the direct issuers of the notes. We have provided a limited guarantee to Rivermont Life Insurance Company I (“Rivermont I”), where under adverse interest rate, mortality or lapse scenarios (or combination thereof), we may be required to provide additional funds to Rivermont I. GLAIC, our wholly-owned subsidiary, has agreed to indemnify the issuers and the third-party insurer for certain limited costs related to the issuance of these obligations. Any payment of principal, including by redemption, or interest on the notes may only be made with the prior approval of the Director of Insurance of the State of South Carolina in accordance with the terms of its licensing orders and in accordance with applicable law. The holders of the notes have no rights to accelerate payment of principal of the notes under any circumstances, including without limitation, for non-payment or breach of any covenant. Each issuer reserves the right to repay the notes that it has issued at any time, subject to prior regulatory approval. During 2015, 2014 and 2013, River Lake Insurance Company, our indirect wholly-owned subsidiary, repaid $30 million, $26 million and $28 million, respectively, of its total outstanding floating rate subordinated notes due in 2033. During 2015 and 2014, River Lake Insurance Company II (“River Lake II”), our indirect wholly-owned subsidiary, repaid $31 million and $16 million, respectively, of its total outstanding floating rate subordinated notes due in 2035. The weighted-average interest rates on the non-recourse funding obligations as of December 31, 2015 and 2014 were 1.73% and 1.51%, respectively. In connection with the life block transaction with Protective Life discussed in note 6, River Lake Insurance Company and River Lake II will redeem their outstanding floating rate subordinated notes in the first quarter of 2016. (d) Liquidity Principal amounts under our long-term borrowings (including senior notes) and non-recourse funding obligations by maturity were as follows as of December 31, 2015: (Amounts in millions) Amount 2016 $ 298 2017 — 2018 598 2019 — 2020 and thereafter (1) 5,636 Total $ 6,532 (1) Repayment of $1.9 billion of our non-recourse funding obligations requires regulatory approval. Our liquidity requirements are principally met through cash flows from operations. (e) Repurchase agreements and securities lending activity Repurchase agreements As of December 31, 2015 and 2014, the fair value of securities pledged under the repurchase program was $231 million and $592 million, respectively, and the repurchase obligation of $229 million and $553 million, respectively, was included in other liabilities in the consolidated balance sheets. Securities lending activity Under our securities lending program in the United States, the borrower is required to provide collateral, which can consist of cash or government securities, on a daily basis in amounts equal to or exceeding 102% of the value of the loaned securities. Currently, we only accept cash collateral from borrowers under the program. Cash collateral received by us on securities lending transactions is reflected in other invested assets with an offsetting liability recognized in other liabilities for the obligation to return the collateral. Any cash collateral received is reinvested by our custodian based upon the investment guidelines provided within our agreement. In the United States, the reinvested cash collateral is primarily invested in a money market fund approved by the NAIC, U.S. and foreign government securities, U.S. government agency securities, asset-backed securities and corporate debt securities. As of December 31, 2015 and 2014, the fair value of securities loaned under our securities lending program in the United States was $334 million and $288 million, respectively. As of December 31, 2015 and 2014, the fair value of collateral held under our securities lending program in the United States was $347 million and $289 million, respectively, and the offsetting obligation to return collateral of $347 million and $299 million, respectively, was included in other liabilities in the consolidated balance sheets. We did not have any non-cash collateral provided by the borrowers in our securities lending program in the United States as of December 31, 2015 and 2014. Under our securities lending program in Canada, the borrower is required to provide collateral consisting of government securities on a daily basis in amounts equal to or exceeding 105% of the fair value of the applicable securities loaned. Securities received from counterparties as collateral are not recorded on our consolidated balance sheet given that the risk and rewards of ownership is not transferred from the counterparties to us in the course of such transactions. Additionally, there was no cash collateral because it is not permitted as an acceptable form of collateral under the program. In Canada, the lending institution must be included on the approved Securities Lending Borrowers List with the Canadian regulator and the intermediary must be rated at least “AA-” by Standard & Poor’s Financial Services LLC. As of December 31, 2015 and 2014, the fair value of securities loaned under our securities lending program in Canada was $340 million and $371 million, respectively. Risks associated with repurchase agreements and securities lending programs Our repurchase agreement and securities lending programs expose us to liquidity risk if we did not have enough cash or collateral readily available to return to the counterparty when required to do so under the agreements. We manage this risk by regularly monitoring our available sources of cash and collateral to ensure we can meet short-term liquidity demands under normal and stressed scenarios. We are also exposed to credit risk in the event of default of our counterparties or changes in collateral values. This risk is significantly reduced because our programs require over collateralization and collateral exposures are trued up on a daily basis. We manage this risk by using multiple counterparties and ensuring that changes in required collateral are monitored and adjusted daily. We also monitor the creditworthiness, including credit ratings, of our counterparties on a regular basis. Contractual maturity The following tables present the remaining contractual maturity of the agreements as of December 31: 2015 (Amounts in millions) Overnight and Up to 30 days 31 - 90 days Greater than Total Repurchase agreements: U.S. government, agencies and government-sponsored enterprises $ — $ 58 $ 25 $ 146 $ 229 Securities lending: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises 18 — — — 18 Non-U.S. government 39 — — — 39 U.S. corporate 95 — — — 95 Non-U.S. corporate 190 — — — 190 Subtotal, fixed maturity securities 342 — — — 342 Equity securities 5 — — — 5 Total securities lending 347 — — — 347 Total repurchase agreements and securities lending $ 347 $ 58 $ 25 $ 146 $ 576 2014 (Amounts in millions) Overnight and Up to 30 days 31 - 90 days Greater than Total Repurchase agreements: U.S. government, agencies and government-sponsored enterprises $ — $ 129 $ 123 $ 301 $ 553 Securities lending: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises 36 — — — 36 Non-U.S. government 32 — — — 32 U.S. corporate 66 — — — 66 Non-U.S. corporate 163 — — — 163 Subtotal, fixed maturity securities 297 — — — 297 Equity securities 2 — — — 2 Total securities lending 299 — — — 299 Total repurchase agreements and securities lending $ 299 $ 129 $ 123 $ 301 $ 852

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2015
Income Taxes	(13) Income Taxes Income (loss) from continuing operations before income taxes included the following components for the years ended December 31: (Amounts in millions) 2015 2014 2013 Domestic $ (468 ) $ (2,022 ) $ 283 Foreign 453 723 710 Income (loss) from continuing operations before income taxes $ (15 ) $ (1,299 ) $ 993 The total provision (benefit) for income taxes was as follows for the years ended December 31: (Amounts in millions) 2015 2014 2013 Current federal income taxes $ 1 $ (3 ) $ (12 ) Deferred federal income taxes (199 ) (305 ) 137 Total federal income taxes (198 ) (308 ) 125 Current state income taxes — 4 (1 ) Deferred state income taxes 4 (4 ) (9 ) Total state income taxes 4 — (10 ) Current foreign income taxes 186 246 426 Deferred foreign income taxes (1 ) (32 ) (228 ) Total foreign income taxes 185 214 198 Total provision (benefit) for income taxes $ (9 ) $ (94 ) $ 313 Our current income tax payable was $10 million and $35 million as of December 31, 2015 and 2014, respectively. The reconciliation of the federal statutory tax rate to the effective income tax rate was as follows for the years ended December 31: (Amounts in millions) 2015 2014 2013 Pre-tax income (loss) $ (15 ) $ (1,299 ) $ 993 Statutory U.S. federal income tax rate $ (5 ) 35.0 % $ (455 ) 35.0 % $ 348 35.0 % Increase (reduction) in rate resulting from: State income tax, net of federal income tax effect 2 (18.0 ) — — (2 ) (0.2 ) Benefit on tax favored investments (14 ) 93.3 (19 ) 1.4 (18 ) (1.8 ) Effect of foreign operations (20 ) 129.2 (66 ) 5.1 (66 ) (6.6 ) Net impact of repatriating foreign earnings — — 205 (15.8 ) — — Interest on uncertain tax positions — — (2 ) 0.1 (1 ) (0.1 ) Non-deductible expenses (3 ) 22.0 4 (0.3 ) 2 0.2 Non-deductible goodwill — — 245 (18.8 ) — — Valuation allowance 25 (165.0 ) (6 ) 0.5 16 1.6 Stock-based compensation 5 (31.7 ) 4 (0.3 ) 25 2.5 Other, net 1 (6.8 ) (4 ) 0.3 9 0.9 Effective rate $ (9 ) 58.0 % $ (94 ) 7.2 % $ 313 31.5 % For the year ended December 31, 2015, the increase in the effective tax rate was primarily attributable to tax benefits on lower taxed foreign income, changes in uncertain tax positions and tax favored investments in relation to pre-tax results in 2015 as well as non-deductible goodwill impairments in 2014. These increases were partially offset by a valuation allowance established on a specific capital loss, tax expense related to our agreement to sell our European mortgage insurance business and stock-based compensation expense in 2015. For the year ended December 31, 2014, the decrease in the effective tax rate was primarily attributable to non-deductible goodwill impairments in 2014 and a charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business and $31 million in connection with our plans to sell our lifestyle protection insurance business from a change to the permanent reinvestment assertion on one of its legal entities. The components of the net deferred income tax liability were as follows as of December 31: (Amounts in millions) 2015 2014 Assets: Foreign tax credit carryforwards $ 787 $ 666 Accrued commission and general expenses 199 203 State income taxes 302 275 Net operating loss carryforwards 1,727 1,797 Other 51 21 Gross deferred income tax assets 3,066 2,962 Valuation allowance (353 ) (296 ) Total deferred income tax assets 2,713 2,666 Liabilities: Investments 29 86 Net unrealized gains on investment securities 639 1,260 Net unrealized gains on derivatives 218 222 Insurance reserves 751 491 DAC 863 1,115 PVFP and other intangibles 20 3 Investment in foreign subsidiaries 10 310 Other 52 37 Total deferred income tax liabilities 2,582 3,524 Net deferred income tax asset (liability) $ 131 $ (858 ) The above valuation allowances of $353 million and $296 million, respectively, related to state deferred tax assets, foreign net operating losses, capital losses, a specific federal separate tax return net operating loss deferred tax asset and foreign tax credits as of December 31, 2015 and 2014, respectively. The state deferred tax assets related primarily to the future deductions associated with the Section 338 elections and non-insurance net operating loss (“NOL”) carryforwards. The net increase in the valuation allowance during 2015 related to current year operations and changes in judgments regarding the future realization of deferred tax assets. Based on our analysis, we believe it is more likely than not that the results of future operations will generate sufficient taxable income to enable us to realize the deferred tax assets for which we have not established valuation allowances. NOL carryforwards amounted to $4,972 million as of December 31, 2015, and, if unused, will expire beginning in 2021. Foreign tax credit carryforwards amounted to $787 million as of December 31, 2015, and, if unused will begin to expire in 2019. As a result of the losses incurred in 2015, we are in a three-year cumulative pre-tax loss position in our U.S. jurisdiction as of December 31, 2015. A cumulative loss position is considered significant negative evidence in assessing the realizability of our deferred tax assets. Our ability to realize our net U.S. deferred tax asset of $137 million, which includes deferred tax assets of $2,514 million related to net operating loss and foreign tax credit carryforwards, is primarily dependent upon generating sufficient taxable income in future years. Management has concluded that there is sufficient positive evidence to overcome this negative evidence. This positive evidence includes the fact that: (i) our three-year cumulative pre-tax loss position includes significant charges that are not expected to recur in the future, including goodwill impairments, long-term care acquired block loss recognition testing in our U.S. Life Insurance segment in 2014 that did not recur in 2015, a loss on the sale of our lifestyle protection insurance business in 2015 and an estimated loss recorded in 2015 related to the planned sale of our mortgage insurance business in Europe; (ii) our profitable U.S. operating forecasts, exclusive of tax planning strategies, result in full utilization of the net deferred tax assets within the U.S. federal carryforward periods based on our current projections, including already obtained and expected in-force premium rate actions in our long-term care insurance business and the lack of future sales for our traditional life insurance and fixed annuity products given our suspension of new sales included in these forecasts; and (iii) overall domestic losses that we have incurred are allowed to be reclassified as foreign source income to the extent of 50% of domestic source income produced in subsequent years, and such resulting foreign source income is sufficient to cover the foreign tax credits being carried forward. If our actual results do not validate the current projections of pre-tax income, we may be required to record a valuation allowance that could have a material impact on our consolidated financial statements in future periods. As a consequence of our separation from GE, and our joint election with GE to treat that separation as an asset sale under Section 338 of the Internal Revenue Code, we became entitled to additional tax deductions in post IPO periods. As of December 31, 2015 and 2014, we have recorded in our consolidated balance sheets our estimates of the remaining deferred tax benefits associated with these deductions of $599 million. We are obligated, pursuant to our Tax Matters Agreement with GE, to make fixed payments to GE, over the next eight years, on an after-tax basis and subject to a cumulative maximum of $640 million, which is 80% of the projected tax savings associated with the Section 338 deductions. We recorded net interest expense of $11 million, $13 million and $15 million for the years ended December 31, 2015, 2014 and 2013, respectively, reflecting accretion of our liability at the Tax Matters Agreement rate of 5.72%. As of December 31, 2015 and 2014, we have recorded the estimated present value of our remaining obligation to GE of $188 million and $216 million, respectively, as a liability in our consolidated balance sheets. Both our IPO-related deferred tax assets and our obligation to GE are estimates that are subject to change. In 2014 and 2013, we increased our deferred tax liability by $6 million and $17 million, respectively, with an offset to additional paid-in capital related to an unsupported tax balance that arose prior to our IPO. U.S. deferred income taxes are not provided on unremitted foreign income that is considered permanently reinvested, which as of December 31, 2015, amounted to approximately $1,712 million related to our Canadian mortgage insurance business. It is not practicable to determine the income tax liability that might be incurred if all such income was remitted to the United States due to the inherent complexities associated with any hypothetical calculation. We will record deferred taxes in the period in which we are no longer able to assert unremitted earnings of foreign operations are permanently reinvested. Our Canadian mortgage insurance business held cash and short-term investments of $178 million related to the unremitted earnings of foreign operations considered to be permanently reinvested as of December 31, 2015. A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: (Amounts in millions) 2015 2014 2013 Balance as of January 1 $ 49 $ 41 $ 55 Tax positions related to the current period: Gross additions 5 7 3 Gross reductions — (3 ) — Tax positions related to the prior years: Gross additions — 17 4 Gross reductions (26 ) (13 ) (21 ) Balance as of December 31 $ 28 $ 49 $ 41 The total amount of unrecognized tax benefits was $28 million as of December 31, 2015, of which $21 million, if recognized, would affect the effective rate on continuing operations. These unrecognized tax benefits included the impact of foreign currency translation from our international operations. We recognize accrued interest and penalties related to unrecognized tax benefits as components of income tax expense. We recorded $1 million, $3 million and $1 million, respectively, of benefits related to interest and penalties during 2015, 2014 and 2013. We had no interest and penalties accrued as of December 31, 2015 and 2014. Our companies have elected to file a single U.S. consolidated income tax return (the “life/non-life consolidated return”). All companies domesticated in the United States and our Bermuda and Guernsey subsidiaries, which have elected to be taxed as U.S. domestic companies, are included in the life/non-life consolidated return as allowed by the tax law and regulations. We have a tax sharing agreement in place and all intercompany balances related to this agreement are settled at least annually. With possible exceptions, we are no longer subject to U.S. Federal tax examinations for years through 2010. Any exposure with respect to these pre-2011 years has been sufficiently recorded in the financial statements. Potential state and local examinations for those years are generally restricted to results that are based on closed U.S. Federal examinations. For our life and non-life consolidated company federal income tax returns, all tax years prior to 2011 have been examined or reviewed. We are also responsible for any tax liability of any separate U.S. Federal and state pre-disposition period returns of former life insurance and non-insurance subsidiaries sold in the years 2011 to 2013. With respect to our foreign affiliates, there are various examinations ongoing by foreign jurisdictions with any material exposure liability related thereto being duly recorded in the financial statements. We believe it is reasonably possible that in 2016 as a result of our open audits and appeals, up to approximately $11 million of unrecognized tax benefits will be recognized. These tax benefits are related to certain insurance tax attributes in the United States and in foreign jurisdictions.

Supplemental Cash Flow Informat

Supplemental Cash Flow Information	12 Months Ended
	Dec. 31, 2015
Supplemental Cash Flow Information	(14) Supplemental Cash Flow Information Net cash paid for taxes was $153 million, $645 million and $125 million and cash paid for interest was $424 million, $437 million and $453 million for the years ended December 31, 2015, 2014 and 2013, respectively.

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Dec. 31, 2015
Stock-Based Compensation	(15) Stock-Based Compensation Prior to May 2012, we granted share-based awards to employees and directors, including stock options, SARs, RSUs and deferred stock units (“DSUs”) under the 2004 Genworth Financial, Inc. Omnibus Incentive Plan (the “2004 Omnibus Incentive Plan”). In May 2012, the 2012 Genworth Financial, Inc. Omnibus Incentive Plan (the “2012 Omnibus Incentive Plan,” together with the 2004 Omnibus Incentive Plan, the “Omnibus Incentive Plans”) was approved by stockholders. Under the 2012 Omnibus Incentive Plan, we are authorized to grant 16 million equity awards, plus a number of additional shares not to exceed 25 million underlying awards outstanding under the prior Plan. From and after May 2012, no further awards have been or will be granted under the 2004 Omnibus Incentive Plan and the 2004 Omnibus Incentive Plan will remain in effect only as long as awards granted thereunder remain outstanding. We recorded stock-based compensation expense under the Omnibus Incentive Plans of $17 million, $20 million and $28 million, respectively, for the years ended December 31, 2015, 2014 and 2013. For awards issued prior to January 1, 2006, stock-based compensation expense was recognized on a graded vesting attribution method over the awards’ respective vesting schedule. For awards issued after January 1, 2006, stock-based compensation expense was recognized evenly on a straight-line attribution method over the awards’ respective vesting period. For purposes of determining the fair value of stock-based payment awards on the date of grant, we typically use the Black-Scholes Model. The Black-Scholes Model requires the input of certain assumptions that involve judgment. Management periodically evaluates the assumptions and methodologies used to calculate fair value of share-based compensation. Circumstances may change and additional data may become available over time, which could result in changes to these assumptions and methodologies. The following table contains the stock option and SAR weighted-average grant-date fair value information and related valuation assumptions for the years ended December 31: Stock Options and SARs 2015 2014 2013 Black-Scholes Black-Scholes Black-Scholes Monte-Carlo (1) Awards granted (in thousands) 1,378 2,960 3,404 1,200 Maximum share value at exercise of SARs $ 75.00 $ 75.00 $ 75.00 $ 75.00 Fair value per options and SARs $ 3.43 $ 3.05 $ 2.53 $ 5.88 Valuation assumptions: Expected term (years) 6.0 6.0 5.9 NA Expected volatility 66.0 % 100.2 % 100.7 % 102.5 % Expected dividend yield — % 0.5 % 0.5 % 0.5 % Risk-free interest rate 1.9 % 1.9 % 1.1 % 1.1 % (1) For purposes of determining the fair value of 1.2 million shares of performance-accelerated SARs that were issued in January 2013, we used a Monte-Carlo Simulation technique. Monte-Carlo Simulation is a method used to simulate future stock price movements in order to determine the fair value due to unique vesting and exercising provisions. The performance-accelerated SARs have a derived service period of one year on average and have a grant price of $7.90. The performance-accelerated SARs vest on the third anniversary of the grant date but are subject to earlier vesting on or after the one year anniversary of the grant date based on the closing price of our Class A Common Stock exceeding certain specified amounts ($12.00, $16.00 and $20.00, respectively) for 45 consecutive trading days. Based on the closing price of our Class A Common Stock, the first tranche at $12.00 vested in January 2014 and the second tranche at $16.00 vested in June 2014. During 2015 and 2014, we granted SARs with exercise prices ranging from $4.96 to $7.99 and $14.30 to $17.89, respectively. These SARs have a feature that places a cap on the amount of gain that can be recognized upon exercise of the SARs. Specifically, if the price of our Class A Common Stock reaches $75.00, any vested portion of the SAR will be automatically exercised. The SAR grant price equaled the closing market prices of our Class A Common Stock on the date of the grant and the awards have an exercise term of 10 years. The SARs granted in 2015 have an average vesting period of three years, while the SARs granted in 2014 and 2013 have average vesting periods of four years. Vesting occurs in annual increments commencing on the first anniversary of the grant date. Additionally, during 2015 and 2014, we issued RSUs with average restriction periods of four years and a fair value of $4.96 to $7.99 and $9.19 to $17.89, respectively, which were measured at the market price of a share of our Class A Common Stock on the grant date. In 2015 and 2014, we granted performance stock units (“PSUs”) with a fair value of $7.75 and fair value ranges of $15.23 to $17.89, respectively. The PSUs were granted at market price as of the grant date. PSUs may be earned over a three-year period based upon the achievement of certain performance goals. The performance goals for the PSUs granted in 2015 are based upon the average daily closing price of our Class A Common Stock during the fourth quarter of 2017 and the two point average of our book value per share, excluding accumulated other comprehensive income (loss), during the close of the third and fourth quarters of 2017. The PSUs will be payable in Genworth Class A Common Stock in March 2018 provided we have attained or exceeded threshold levels related to the performance goals. Our book value per share is divided into the average daily closing price of our Class A Common Stock to calculate the book value multiplier, which determines the potential number of shares to be paid out. If the respective levels have not been achieved by December 31, 2017, no payout will occur and all the related expenses recorded to date will be reversed. The performance goals for the PSUs granted in 2014 were based upon the achievement of goals related to our 2016 annual operating return on equity and book value per share, excluding accumulated other comprehensive income (loss). We do not expect to achieve the respective threshold levels for the PSUs granted in 2014 by the December 31, 2016 deadline; therefore, all the related expenses recorded to date were reversed in 2015. In 2015, we granted $10 million in cash retention awards with a fair value of $1.00. During 2015, approximately $1 million awards were forfeited due to employees leaving Genworth prior to the vesting date. The remaining cash awards vest over two years, with half of the payout occurring per year, beginning on the first anniversary of the grant date. No stock options were granted in 2015, 2014 or 2013. The following table summarizes stock option activity as of December 31, 2015 and 2014: (Shares in thousands) Shares subject Weighted-average Balance as of January 1, 2014 4,310 $ 13.17 Granted — $ — Exercised (921 ) $ 8.10 Expired and forfeited (885 ) $ 19.32 Balance as of January 1, 2015 2,504 $ 12.86 Granted — $ — Exercised (47 ) $ 4.39 Expired and forfeited (317 ) $ 17.62 Balance as of December 31, 2015 2,140 $ 12.34 Exercisable as of December 31, 2015 2,140 $ 12.34 The following table summarizes information about stock options outstanding as of December 31, 2015: Outstanding and Exercisable Exercise price range Shares in Average (1) Average $2.00 - $2.46 (2) 362 3.04 $ 2.43 $7.36 - $7.80 433 1.77 $ 7.79 $9.10 - $14.18 1,119 3.95 $ 14.14 $14.92 - $22.80 100 2.33 $ 21.80 $30.52 - $34.13 126 0.99 $ 32.86 2,140 $ 12.34 (1) Average contractual life remaining in years. (2) These shares have an aggregate intrinsic value of $1 million each for total options outstanding and exercisable. The following tables summarize the status of our other equity-based awards as of December 31, 2015 and 2014: RSUs PSUs DSUs SARs (Awards in thousands) Number Weighted- date fair Number Weighted- value Number Weighted- value Number Weighted- date fair Balance as of January 1, 2014 2,887 $ 10.21 — $ — 579 $ 9.43 12,365 $ 4.00 Granted 1,226 $ 15.00 343 $ 15.31 113 $ 12.98 2,960 $ 3.05 Exercised (938 ) $ 10.06 — $ — (58 ) $ 6.65 (1,353 ) $ 3.88 Terminated (262 ) $ 12.16 (39 ) $ 15.23 — $ — (1,905 ) $ 5.23 Balance as of January 1, 2015 2,913 $ 12.09 304 $ 15.32 634 $ 9.96 12,067 $ 3.62 Granted 2,087 $ 7.50 535 $ 7.75 256 $ 3.90 1,378 $ 3.43 Exercised (1,390 ) $ 11.60 — $ — (10 ) $ 2.14 (59 ) $ 1.28 Terminated (355 ) $ 10.10 (129 ) $ 9.72 — $ — (1,238 ) $ 4.05 Balance as of December 31, 2015 3,255 $ 9.22 710 $ 10.63 880 $ 8.18 12,148 $ 3.56 As of December 31, 2015 and 2014, total unrecognized stock-based compensation expense related to non-vested awards not yet recognized was $29 million and $35 million, respectively. This expense is expected to be recognized over a weighted-average period of approximately two years. In 2015, there was less than $1 million in cash received from stock options exercised. There was $20 million in cash received from stock options exercised 2014. New shares were issued to settle all exercised awards. The actual tax benefit realized for the tax deductions from the exercise of share-based awards was $4 million and $11 million as of December 31, 2015 and 2014, respectively. Genworth Canada, our indirect subsidiary and a public company, grants stock options and other equity-based awards to its Canadian employees. The following table summarizes the status of Genworth Canada’s stock option activity and other equity-based awards as of December 31, 2015 and 2014: Stock options RSUs and PSUs DSUs Executive deferred (Shares and awards in thousands) Shares subject Number of Number of Number of awards Balance as of January 1, 2014 987 177 45 20 Granted 114 93 9 1 Exercised (93 ) (67 ) — — Terminated (6 ) — — — Balance as of January 1, 2015 1,002 203 54 21 Granted 53 78 14 10 Exercised (88 ) (60 ) (14 ) — Terminated (12 ) (27 ) — — Balance as of December 31, 2015 955 194 54 31 As of December 31, 2015 and 2014, the DSUs were fully vested and the stock options, RSUs, PSUs and EDSUs were partially vested. The EDSUs were introduced in 2013 as part of a share-based compensation plan intended for executive level employees entitling them to receive an amount equal to the fair value of Genworth Canada stock. For the years ended December 31, 2015, 2014 and 2013, we recorded an increase (decrease) to stock-based compensation expense of $(3) million, $6 million and $11 million, respectively. For the years ended December 31, 2015, 2014 and 2013, we estimated total unrecognized expense of $2 million, $3 million and $3 million, respectively, related to these awards. In connection with the IPO of Genworth Mortgage Insurance Australia Limited (“Genworth Australia”) in May 2014, our indirect subsidiary, Genworth Australia, granted stock options and other equity-based awards to its Australian employees. The following table summarizes the status of Genworth Australia’s restricted share rights as of December 31, 2015 and 2014: Restricted share rights (Shares in thousands) Shares subject to Balance as of January 1, 2014 — Granted 2,846 Exercised (5 ) Terminated (38 ) Balance as of January 1, 2015 2,803 Granted 147 Exercised (40 ) Terminated (145 ) Balance as of December 31, 2015 2,765 As of December 31, 2015 and 2014, none of the restricted share rights were vested. For the years ended December 31, 2015 and 2014, we recorded stock-based compensation expense of $2 million in each year and we estimated total unrecognized expense of $4 million and $5 million, respectively, related to these awards.

Fair Value of Financial Instrum

Fair Value of Financial Instruments	12 Months Ended
	Dec. 31, 2015
Fair Value of Financial Instruments	(16) Fair Value of Financial Instruments Assets and liabilities that are reflected in the accompanying consolidated financial statements at fair value are not included in the following disclosure of fair value. Such items include cash and cash equivalents, investment securities, separate accounts, securities held as collateral and derivative instruments. Other financial assets and liabilities—those not carried at fair value—are discussed below. Apart from certain of our borrowings and certain marketable securities, few of the instruments discussed below are actively traded and their fair values must often be determined using models. The fair value estimates are made at a specific point in time, based upon available market information and judgments about the financial instruments, including estimates of the timing and amount of expected future cash flows and the credit standing of counterparties. Such estimates do not reflect any premium or discount that could result from offering for sale at one time our entire holdings of a particular financial instrument, nor do they consider the tax impact of the realization of unrealized gains or losses. In many cases, the fair value estimates cannot be substantiated by comparison to independent markets. The basis on which we estimate fair value is as follows: Commercial mortgage loans. Restricted commercial mortgage loans. Other invested assets. Long-term borrowings. Non-recourse funding obligations. Borrowings related to securitization entities. Investment contracts. The following represents our estimated fair value of financial assets and liabilities that are not required to be carried at fair value as of December 31: 2015 Notional amount Carrying amount Fair value (Amounts in millions) Total Level 1 Level 2 Level 3 Assets: Commercial mortgage loans $ (1) $ 6,170 $ 6,476 $ — $ — $ 6,476 Restricted commercial mortgage loans (2) (1) 161 179 — — 179 Other invested assets (1) 273 279 — 197 82 Liabilities: Long-term borrowings (3) (1) 4,570 3,518 — 3,343 175 Non-recourse funding obligations (3) (1) 1,920 1,401 — — 1,401 Borrowings related to securitization entities (2) (1) 98 104 — 104 — Investment contracts (1) 17,258 17,910 — 5 17,905 Other firm commitments: Commitments to fund limited partnerships 131 — — — — — Ordinary course of business lending commitments 40 — — — — — 2014 Notional amount Carrying amount Fair value (Amounts in millions) Total Level 1 Level 2 Level 3 Assets: Commercial mortgage loans $ (1) $ 6,100 $ 6,573 $ — $ — $ 6,573 Restricted commercial mortgage loans (2) (1) 201 228 — — 228 Other invested assets (1) 311 323 — 238 85 Liabilities: Long-term borrowings (3) (1) 4,612 4,273 — 4,155 118 Non-recourse funding obligations (3) (1) 1,981 1,423 — — 1,423 Borrowings related to securitization entities (2) (1) 134 146 — 146 — Investment contracts (1) 17,486 18,012 — 7 18,005 Other firm commitments: Commitments to fund limited partnerships 53 — — — — — Ordinary course of business lending commitments 155 — — — — — (1) These financial instruments do not have notional amounts. (2) See note 17 for additional information related to consolidated securitization entities. (3) See note 12 for additional information related to borrowings. Recurring Fair Value Measurements We have fixed maturity, equity and trading securities, derivatives, embedded derivatives, securities held as collateral, separate account assets and certain other financial instruments, which are carried at fair value. Below is a description of the valuation techniques and inputs used to determine fair value by class of instrument. Fixed maturity, equity and trading securities The fair value of fixed maturity, equity and trading securities are estimated primarily based on information derived from third-party pricing services (“pricing services”), internal models and/or third-party broker provided prices (“broker quotes”), which use a market approach, income approach or a combination of the market and income approach depending on the type of instrument and availability of information. In general, a market approach is utilized if there is readily available and relevant market activity for an individual security. In certain cases where market information is not available for a specific security but is available for similar securities, a security is valued using that market information for similar securities, which is also a market approach. When market information is not available for a specific security or is available but such information is less relevant or reliable, an income approach or a combination of a market and income approach is utilized. For securities with optionality, such as call or prepayment features (including mortgage-backed or asset-backed securities), an income approach may be used. In addition, a combination of the results from market and income approaches may be used to estimate fair value. These valuation techniques may change from period to period, based on the relevance and availability of market data. We utilize certain third-party data providers when determining fair value. We consider information obtained from pricing services as well as broker quotes in our determination of fair value. Additionally, we utilize internal models to determine the valuation of securities using an income approach where the inputs are based on third-party provided market inputs. While we consider the valuations provided by pricing services and broker quotes to be of high quality, management determines the fair value of our investment securities after considering all relevant and available information. We also use various methods to obtain an understanding of the valuation methodologies and procedures used by third-party data providers to ensure sufficient understanding to evaluate the valuation data received, including an understanding of the assumptions and inputs utilized to determine the appropriate fair value. For pricing services, we analyze the prices provided by our primary pricing services to other readily available pricing services and perform a detailed review of the assumptions and inputs from each pricing service to determine the appropriate fair value when pricing differences exceed certain thresholds. We evaluate changes in fair value that are greater than certain pre-defined thresholds each month to further aid in our review of the accuracy of fair value measurements and our understanding of changes in fair value, with more detailed reviews performed by the asset managers responsible for the related asset class associated with the security being reviewed. A pricing committee provides additional oversight and guidance in the evaluation and review of the pricing methodologies used to value our investment portfolio. In general, we first obtain valuations from pricing services. If a price is not supplied by a pricing service, we will typically seek a broker quote for public or private fixed maturity securities. In certain instances, we utilize price caps for broker quoted securities where the estimated market yield results in a valuation that may exceed the amount that we believe would be received in a market transaction. For certain private fixed maturity securities where we do not obtain valuations from pricing services, we utilize an internal model to determine fair value since transactions for identical securities are not readily observable and these securities are not typically valued by pricing services. For all securities, excluding certain private fixed maturity securities, if neither a pricing service nor broker quotes valuation is available, we determine fair value using internal models. For pricing services, we obtain an understanding of the pricing methodologies and procedures for each type of instrument. Additionally, on a monthly basis we review a sample of securities, examining the pricing service’s assumptions to determine if we agree with the service’s derived price. When available, we also evaluate the prices sampled as compared to other public prices. If a variance greater than a pre-defined threshold is noted, additional review of the price is executed to ensure accuracy. In general, a pricing service does not provide a price for a security if sufficient information is not readily available to determine fair value or if such security is not in the specific sector or class covered by a particular pricing service. Given our understanding of the pricing methodologies and procedures of pricing services, the securities valued by pricing services are typically classified as Level 2 unless we determine the valuation process for a security or group of securities utilizes significant unobservable inputs, which would result in the valuation being classified as Level 3. For private fixed maturity securities, we utilize an income approach where we obtain public bond spreads and utilize those in an internal model to determine fair value. Other inputs to the model include rating and weighted-average life, as well as sector which is used to assign the spread. We then add an additional premium, which represents an unobservable input, to the public bond spread to adjust for the liquidity and other features of our private placements. We utilize the estimated market yield to discount the expected cash flows of the security to determine fair value. We utilize price caps for securities where the estimated market yield results in a valuation that may exceed the amount that would be received in a market transaction and value all private fixed maturity securities at par that have less than 12 months to maturity. When a security does not have an external rating, we assign the security an internal rating to determine the appropriate public bond spread that should be utilized in the valuation. To evaluate the reasonableness of the internal model, we review a sample of private fixed maturity securities each month. In that review we compare the modeled prices to the prices of similar public securities in conjunction with analysis on current market indicators. If a pricing variance greater than a pre-defined threshold is noted, additional review of the price is executed to ensure accuracy. At the end of each month, all internally modeled prices are compared to the prior month prices with an evaluation of all securities with a month-over-month change greater than a pre-defined threshold. While we generally consider the public bond spreads by sector and maturity to be observable inputs, we evaluate the similarities of our private placement with the public bonds, any price caps utilized, liquidity premiums applied, and whether external ratings are available for our private placements to determine whether the spreads utilized would be considered observable inputs. We classify private securities without an external rating and public bond spread as Level 3. In general, increases (decreases) in credit spreads will decrease (increase) the fair value for our fixed maturity securities. For broker quotes, we consider the valuation methodology utilized by the third party and analyze a sample each month to assess reasonableness given then-current market conditions. Additionally, for broker quotes on certain structured securities, we validate prices received against other publicly available pricing sources. Broker quotes are typically based on an income approach given the lack of available market data. As the valuation typically includes significant unobservable inputs, we classify the securities where fair value is based on our consideration of broker quotes as Level 3 measurements. For remaining securities priced using internal models, we determine fair value using an income approach. We analyze a sample each month to assess reasonableness given then-current market conditions. We maximize the use of observable inputs but typically utilize significant unobservable inputs to determine fair value. Accordingly, the valuations are typically classified as Level 3. A summary of the inputs used for our fixed maturity, equity and trading securities based on the level in which instruments are classified is included below. We have combined certain classes of instruments together as the nature of the inputs is similar. Level 1 measurements Equity securities. Level 2 measurements Fixed maturity securities • Third-party pricing services: The following table presents a summary of the significant inputs used by our third-party pricing services for certain fair value measurements of fixed maturity securities that are classified as Level 2 as of December 31, 2015: (Amounts in millions) Fair value Primary methodologies Significant inputs U.S. government, agencies and government-sponsored enterprises $ 6,200 Price quotes from trading desk, broker feeds Bid side prices, trade prices, Option Adjusted Spread (“OAS”) to swap curve, Bond Market Association (“BMA”) OAS, Treasury Curve, Agency Bullet Curve, maturity to issuer spread State and political subdivisions $ 2,403 Multi-dimensional attribute-based modeling systems, third-party pricing vendors Trade prices, material event notices, Municipal Market Data benchmark yields, broker quotes Non-U.S. government $ 1,996 Matrix pricing, spread priced to benchmark curves, price quotes from market makers Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources U.S. corporate $ 21,505 Multi-dimensional attribute-based modeling systems, broker quotes, price quotes from market makers, internal models, OAS-based models Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine (“TRACE”) reports Non-U.S. corporate $ 10,364 Multi-dimensional attribute-based modeling systems, OAS-based models, price quotes from market makers Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources Residential mortgage-backed $ 4,985 OAS-based models, To Be Announced pricing models, single factor binomial models, internally priced Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average life, weighted-average loan age, issuer program and delinquency ratio, pay up and pay down factors, TRACE reports Commercial $ 2,549 Multi-dimensional attribute-based modeling systems, pricing matrix, spread matrix priced to swap curves, Trepp commercial mortgage-backed securities analytics model Credit risk, interest rate risk, prepayment speeds, new issue data, collateral performance, origination year, tranche type, original credit ratings, weighted-average life, cash flows, spreads derived from broker quotes, bid side prices, spreads to daily updated swaps curves Other asset-backed $ 2,139 Multi-dimensional attribute-based modeling systems, spread matrix priced to swap curves, price quotes from market makers, internal models Spreads to daily updated swaps curves, spreads derived from trade prices and broker quotes, bid side prices, new issue data, collateral performance, analysis of prepayment speeds, cash flows, collateral loss analytics, historical issue analysis, trade data from market makers, TRACE reports • Internal models: Equity securities. Level 3 measurements Fixed maturity securities • Internal models: • Broker quotes: Equity securities. Restricted other invested assets related to securitization entities We have trading securities related to securitization entities that are classified as restricted other invested assets and are carried at fair value. The trading securities represent asset-backed securities. The valuation for trading securities is determined using a market approach and/or an income approach depending on the availability of information. For certain highly rated asset-backed securities, there is observable market information for transactions of the same or similar instruments, which is provided to us by a third-party pricing service and is classified as Level 2. For certain securities that are not actively traded, we determine fair value after considering third-party broker provided prices or discounted expected cash flows using current yields for similar securities and classify these valuations as Level 3. Securities lending collateral The fair value of securities held as collateral is primarily based on Level 2 inputs from market information for the collateral that is held on our behalf by the custodian. We determine fair value after considering prices obtained by third-party pricing services. Contingent consideration We have certain contingent purchase price payments and receivables related to acquisitions and sales that are recorded at fair value each period. Fair value is determined using an income approach whereby we project the expected performance of the business and compare our projections of the relevant performance metric to the thresholds established in the purchase or sale agreement to determine our expected payments or receipts. We then discount these expected amounts to calculate the fair value as of the valuation date. We evaluate the underlying projections used in determining fair value each period and update these underlying projections when there have been significant changes in our expectations of the future business performance. The inputs used to determine the discount rate and expected payments or receipts are primarily based on significant unobservable inputs and result in the fair value of the contingent consideration being classified as Level 3. An increase in the discount rate or a decrease in expected payments or receipts will result in a decrease in the fair value of contingent consideration. Separate account assets The fair value of separate account assets is based on the quoted prices of the underlying fund investments and, therefore, represents Level 1 pricing. Derivatives We consider counterparty collateral arrangements and rights of set-off when evaluating our net credit risk exposure to our derivative counterparties. Accordingly, we are permitted to include consideration of these arrangements when determining whether any incremental adjustment should be made for both the counterparty’s and our non-performance risk in measuring fair value for our derivative instruments. As a result of these counterparty arrangements, we determined that any adjustment for credit risk would not be material and we have not recorded any incremental adjustment for our non-performance risk or the non-performance risk of the derivative counterparty for our derivative assets or liabilities. We determine fair value for our derivatives using an income approach with internal models based on relevant market inputs for each derivative instrument. We also compare the fair value determined using our internal model to the valuations provided by our derivative counterparties with any significant differences or changes in valuation being evaluated further by our derivatives professionals that are familiar with the instrument and market inputs used in the valuation. Interest rate swaps. Interest rate swaps related to securitization entities. Inflation indexed swaps. Foreign currency swaps. Credit default swaps. Credit default swaps related to securitization entities. Equity index options. Financial futures. Equity return swaps. Forward bond purchase commitments. Other foreign currency contracts. GMWB embedded derivatives We are required to bifurcate an embedded derivative for certain features associated with annuity products and related reinsurance agreements where we provide a GMWB to the policyholder and are required to record the GMWB embedded derivative at fair value. The valuation of our GMWB embedded derivative is based on an income approach that incorporates inputs such as forward interest rates, equity index volatility, equity index and fund correlation, and policyholder assumptions such as utilization, lapse and mortality. In addition to these inputs, we also consider risk and expense margins when determining the projected cash flows that would be determined by another market participant. While the risk and expense margins are considered in determining fair value, these inputs do not have a significant impact on the valuation. We determine fair value using an internal model based on the various inputs noted above. The resulting fair value measurement from the model is reviewed by the product actuarial, risk and finance professionals each reporting period with changes in fair value also being compared to changes in derivatives and other instruments used to mitigate changes in fair value from certain market risks, such as equity index volatility and interest rates. For GMWB liabilities, non-performance risk is integrated into the discount rate. Our discount rate used to determine fair value of our GMWB liabilities includes market credit spreads above U.S. Treasury rates to reflect an adjustment for the non-performance risk of the GMWB liabilities. As of December 31, 2015 and 2014, the impact of non-performance risk resulted in a lower fair value of our GMWB liabilities of $79 million and $74 million, respectively. To determine the appropriate discount rate to reflect the non-performance risk of the GMWB liabilities, we evaluate the non-performance risk in our liabilities based on a hypothetical exit market transaction as there is no exit market for these types of liabilities. A hypothetical exit market can be viewed as a hypothetical transfer of the liability to another similarly rated insurance company which would closely resemble a reinsurance transaction. Another hypothetical exit market transaction can be viewed as a hypothetical transaction from the perspective of the GMWB policyholder. In determining the appropriate discount rate to incorporate non-performance risk of the GMWB liabilities, we also considered the impacts of state guarantees embedded in the related insurance product as a form of inseparable third-party guarantee. We believe that a hypothetical exit market participant would use a similar discount rate as described above to value the liabilities. For equity index volatility, we determine the projected equity market volatility using both historical volatility and projected equity market volatility with more significance being placed on projected near-term volatility and recent historical data. Given the different attributes and market characteristics of GMWB liabilities compared to equity index options in the derivative market, the equity index volatility assumption for GMWB liabilities may be different from the volatility assumption for equity index options, especially for the longer dated points on the curve. Equity index and fund correlations are determined based on historical price observations for the fund and equity index. For policyholder assumptions, we use our expected lapse, mortality and utilization assumptions and update these assumptions for our actual experience, as necessary. For our lapse assumption, we adjust our base lapse assumption by policy based on a combination of the policyholder’s current account value and GMWB benefit. We classify the GMWB valuation as Level 3 based on having significant unobservable inputs, with equity index volatility and non-performance risk being considered the more significant unobservable inputs. As equity index volatility increases, the fair value of the GMWB liabilities will increase. Any increase in non-performance risk would increase the discount rate and would decrease the fair value of the GMWB liability. Additionally, we consider lapse and utilization assumptions to be significant unobservable inputs. An increase in our lapse assumption would decrease the fair value of the GMWB liability, whereas an increase in our utilization rate would increase the fair value. Fixed index annuity embedded derivatives We offer fixed indexed annuity products where interest is credited to the policyholder’s account balance based on equity index changes. This feature is required to be bifurcated as an embedded derivative and recorded at fair value. Fair value is determined using an income approach where the present value of the excess cash flows above the guaranteed cash flows is used to determine the value attributed to the equity index feature. The inputs used in determining the fair value include policyholder behavior (lapses and withdrawals), near-term equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance risk and risk margins. As a result of our assumptions for policyholder behavior and expected future interest credited being considered significant unobservable inputs, we classify these instruments as Level 3. As lapses and withdrawals increase, the value of our embedded derivative liability will decrease. As expected future interest credited decreases, the value of our embedded derivative liability will decrease. Indexed universal life embedded derivatives We offer indexed universal life products where interest is credited to the policyholder’s account balance based on equity index changes. This feature is required to be bifurcated as an embedded derivative and recorded at fair value. Fair value is determined using an income approach where the present value of the excess cash flows above the guaranteed cash flows is used to determine the value attributed to the equity index feature. The inputs used in determining the fair value include policyholder behavior (lapses and withdrawals), near-term equity index volatility, expected future interest credited, forward interest rates and an adjustment to the discount rate to incorporate non-performance risk and risk margins. As a result of our assumptions for policyholder behavior and expected future interest credited being considered significant unobservable inputs, we classify these instruments as Level 3. As lapses and withdrawals increase, the value of our embedded derivative liability will decrease. As expected future interest credited decreases, the value of our embedded derivative liability will decrease. Borrowings related to securitization entities We record certain borrowings related to securitization entities at fair value. The fair value of these borrowings is determined using either a market approach or income approach, depending on the instrument and availability of market information. Given the unique characteristics of the securitization entities that issued these borrowings as well as the lack of comparable instruments, we determine fair value considering the valuation of the underlying assets held by the securitization entities and any derivatives, as well as any unique characteristics of the borrowings that may impact the valuation. After considering all relevant inputs, we determine fair value of the borrowings using the net valuation of the underlying assets and derivatives that are backing the borrowings. Accordingly, these instruments are classified as Level 3. Increases in the valuation of the underlying assets or decreases in the derivative liabilities will result in an increase in the fair value of these borrowings. The following tables set forth our assets by class of instrument that are measured at fair value on a recurring basis as of December 31: 2015 (Amounts in millions) Total Level 1 Level 2 Level 3 Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 6,203 $ — $ 6,200 $ 3 State and political subdivisions 2,438 — 2,403 35 Non-U.S. government 2,015 — 2,015 — U.S. corporate: Utilities 3,693 — 3,244 449 Energy 2,501 — 2,248 253 Finance and insurance 5,632 — 4,917 715 Consumer—non-cyclical 4,096 — 3,987 109 Technology and communications 2,193 — 2,158 35 Industrial 1,173 — 1,112 61 Capital goods 1,950 — 1,770 180 Consumer—cyclical 1,675 — 1,436 239 Transportation 1,086 — 980 106 Other 402 — 220 182 Total U.S. corporate 24,401 — 22,072 2,329 Non-U.S. corporate: Utilities 843 — 556 287 Energy 1,686 — 1,434 252 Finance and insurance 2,473 — 2,282 191 Consumer—non-cyclical 752 — 583 169 Technology and communications 988 — 926 62 Industrial 986 — 902 84 Capital goods 604 — 391 213 Consumer—cyclical 526 — 455 71 Transportation 605 — 461 144 Other 2,736 — 2,664 72 Total non-U.S. corporate 12,199 — 10,654 1,545 Residential mortgage-backed 5,101 — 4,985 116 Commercial mortgage-backed 2,559 — 2,549 10 Other asset-backed 3,281 — 2,139 1,142 Total fixed maturity securities 58,197 — 53,017 5,180 Equity securities 310 270 2 38 Other invested assets: Trading securities 447 — 447 — Derivative assets: Interest rate swaps 1,054 — 1,054 — Foreign currency swaps 8 — 8 — Credit default swaps 1 — — 1 Equity index options 30 — — 30 Equity return swaps 2 — 2 — Other foreign currency contracts 17 — 14 3 Total derivative assets 1,112 — 1,078 34 Securities lending collateral 347 — 347 — Total other invested assets 1,906 — 1,872 34 Restricted other invested assets related to securitization entities (1) 413 — 181 232 Reinsurance recoverable (2) 17 — — 17 Separate account assets 7,883 7,883 — — Total assets $ 68,726 $ 8,153 $ 55,072 $ 5,501 (1) See note 17 for additional information related to consolidated securitization entities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. 2014 (Amounts in millions) Total Level 1 Level 2 Level 3 Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 6,000 $ — $ 5,996 $ 4 State and political subdivisions 2,222 — 2,192 30 Non-U.S. government 1,902 — 1,895 7 U.S. corporate: Utilities 3,864 — 3,420 444 Energy 2,742 — 2,457 285 Finance and insurance 5,646 — 5,030 616 Consumer—non-cyclical 4,013 — 3,873 140 Technology and communications 2,325 — 2,280 45 Industrial 1,287 — 1,251 36 Capital goods 2,006 — 1,840 166 Consumer—cyclical 1,900 — 1,537 363 Transportation 1,039 — 886 153 Other 401 — 230 171 Total U.S. corporate 25,223 — 22,804 2,419 Non-U.S. corporate: Utilities 903 — 575 328 Energy 2,036 — 1,712 324 Finance and insurance 2,957 — 2,736 221 Consumer—non-cyclical 796 — 599 197 Technology and communications 1,053 — 1,011 42 Industrial 1,213 — 1,082 131 Capital goods 618 — 381 237 Consumer—cyclical 534 — 445 89 Transportation 590 — 436 154 Other 3,395 — 3,314 81 Total non-U.S. corporate 14,095 — 12,291 1,804 Residential mortgage-backed 5,228 — 5,163 65 Commercial mortgage-backed 2,702 — 2,697 5 Other asset-backed 3,705 — 2,285 1,420 Total fixed maturity securities 61,077 — 55,323 5,754 Equity securities 275 237 4 34 Other invested assets: Trading securities 241 — 241 — Derivative assets: Interest rate swaps 1,091 — 1,091 — Foreign currency swaps 6 — 6 — Credit default swaps 4 — 1 3 Equity index options 17 — — 17 Other foreign currency contracts 14 — 14 — Total derivative assets 1,132 — 1,112 20 Securities lending collateral 289 — 289 — Total other invested assets 1,662 — 1,642 20 Restricted other invested assets related to securitization entities (1) 411 — 181 230 Reinsurance recoverable (2) 13 — — 13 Separate account assets 9,208 9,208 — — Total assets $ 72,646 $ 9,445 $ 57,150 $ 6,051 (1) See note 17 for additional information related to consolidated securitization entities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers between levels at the beginning fair value for the reporting period in which the changes occur. Given the types of assets classified as Level 1, which primarily represents mutual fund investments, we typically do not have any transfers between Level 1 and Level 2 measurement categories and did not have any such transfers during any period presented. Our assessment of whether or not there were significant unobservable inputs related to fixed maturity securities was based on our observations obtained through the course of managing our investment portfolio, including interaction with other market participants, observations related to the availability and consistency of pricing and/or rating, and understanding of general market activity such as new issuance and the level of secondary market trading for a class of securities. Additionally, we considered

Variable Interest and Securitiz

Variable Interest and Securitization Entities	12 Months Ended
	Dec. 31, 2015
Variable Interest and Securitization Entities	(17) Variable Interest and Securitization Entities VIEs are generally entities that have either a total equity investment that is insufficient to permit the entity to finance its activities without additional subordinated financial support or whose equity investors lack the characteristics of a controlling financial interest. We evaluate VIEs to determine whether we are the primary beneficiary and are required to consolidate the assets and liabilities of the entity. The determination of the primary beneficiary for a VIE can be complex and requires management judgment regarding the expected results of the entity and who directs the activities of the entity that most significantly impact the economic results of the VIE. (a) Asset Securitizations We have used former affiliates and third-party entities to facilitate asset securitizations. Disclosure requirements related to off-balance sheet arrangements encompass a broader array of arrangements than those at risk for consolidation. These arrangements include transactions with term securitization entities, as well as transactions with conduits that are sponsored by third parties. The following table summarizes the total securitized assets as of December 31: (Amounts in millions) 2015 2014 Receivables secured by: Other assets $ 136 $ 142 Total securitized assets not required to be consolidated 136 142 Total securitized assets required to be consolidated 267 300 Total securitized assets $ 403 $ 442 We do not have any additional exposure or guarantees associated with these securitization entities. There has been no new asset securitization activity in 2015 or 2014. (b) Securitization and Variable Interest Entities Required To Be Consolidated For VIEs related to asset securitization transactions, we consolidate two securitization entities as a result of our involvement in the entities’ design or having certain decision making ability regarding the assets held by the securitization entity. These securitization entities were designed to have significant limitations on the types of assets owned and the types and extent of permitted activities and decision making rights. The two securitization entities that are consolidated comprise one securitization entity backed by commercial mortgage loans and one backed by residual interests in certain policy loan securitization entities. For the commercial mortgage loan securitization entity, our primary economic interest represents the excess interest of the commercial mortgage loans and the subordinated notes of the securitization entity. Our primary economic interest in the policy loan securitization entity represents the excess interest received from the residual interest in certain policy loan securitization entities and the floating rate obligation issued by the securitization entity, where our economic interest is not expected to be material in any future years. Upon consolidation, we elected fair value option for the assets and liabilities for the securitization entity. For VIEs related to certain investments, we were required to consolidate three securitization entities as a result of having certain decision making rights related to instruments held by the entities. Upon consolidation, we elected fair value option for the assets and liabilities for the securitization entity. The following table shows the assets and liabilities that were recorded for the consolidated securitization entities as of December 31: (Amounts in millions) 2015 2014 Assets Investments: Restricted commercial mortgage loans $ 161 $ 201 Restricted other invested assets: Trading securities 413 411 Total restricted other invested assets 413 411 Total investments 574 612 Cash and cash equivalents 1 1 Accrued investment income 1 1 Other assets 5 — Total assets $ 581 $ 614 Liabilities Other liabilities: Derivative liabilities $ 44 $ 43 Other liabilities 2 2 Total other liabilities 46 45 Borrowings related to securitization entities 179 219 Total liabilities $ 225 $ 264 The assets and other instruments held by the securitization entities are restricted and can only be used to fulfill the obligations of the securitization entity. Additionally, the obligations of the securitization entities do not have any recourse to the general credit of any other consolidated subsidiaries. The following table shows the activity presented in our consolidated statement of income related to the consolidated securitization entities for the years ended December 31: (Amounts in millions) 2015 2014 2013 Revenues: Net investment income: Restricted commercial mortgage loans $ 14 $ 14 $ 23 Restricted other invested assets 5 5 4 Total net investment income 19 19 27 Net investment gains (losses): Trading securities (2 ) 15 (4 ) Derivatives 3 10 86 Borrowings related to securitization entities recorded at fair value 4 (9 ) (13 ) Total net investment gains (losses) 5 16 69 Total revenues 24 35 96 Expenses: Interest expense 9 10 16 Total expenses 9 10 16 Income before income taxes 15 25 80 Provision for income taxes 5 9 27 Net income $ 10 $ 16 $ 53 (c) Borrowings Related To Consolidated Securitization Entities Borrowings related to securitization entities were as follows as of December 31: 2015 2014 (Amounts in millions) Principal Carrying Principal Carrying GFCM LLC, due 2035, 5.2541% $ — $ — $ 21 $ 21 GFCM LLC, due 2035, 5.7426% 98 98 113 113 Marvel Finance 2007-4 LLC, due 2017 (1),(2) 12 10 12 12 Genworth Special Purpose Five, LLC, due 2040 (1),(2) NA (3) 71 NA (3) 73 Total $ 110 $ 179 $ 146 $ 219 (1) Accrual of interest based on three-month LIBOR that resets every three months plus a fixed margin. (2) Carrying value represents fair value as a result of electing fair value option for these liabilities. (3) Principal amount not applicable. Notional balance was $118 million and $115 million as of December 31, 2015 and 2014, respectively. These borrowings are required to be paid down as principal is collected on the restricted investments held by the securitization entities and accordingly the repayment of these borrowings follows the maturity or prepayment, as permitted, of the restricted investments.

Insurance Subsidiary Financial

Insurance Subsidiary Financial Information and Regulatory Matters	12 Months Ended
	Dec. 31, 2015
Insurance Subsidiary Financial Information and Regulatory Matters	(18) Insurance Subsidiary Financial Information and Regulatory Matters Dividends Our insurance company subsidiaries are restricted by state and foreign laws and regulations as to the amount of dividends they may pay to their parent without regulatory approval in any year, the purpose of which is to protect affected insurance policyholders or contractholders, not stockholders. Any dividends in excess of limits are deemed “extraordinary” and require approval. Based on estimated statutory results as of December 31, 2015, in accordance with applicable dividend restrictions, our subsidiaries could pay dividends of approximately $140 million to us in 2016 without obtaining regulatory approval, and the remaining net assets are considered restricted. While the $140 million is unrestricted, our insurance subsidiaries may not pay dividends to us in 2016 at this level if they need to retain capital for growth and to meet capital requirements and desired thresholds. As of December 31, 2015, Genworth Financial’s and Genworth Holdings’ subsidiaries had restricted net assets of $12.7 billion and $12.8 billion, respectively. There are no regulatory restrictions on the ability of Genworth Financial to pay dividends. Our Board of Directors has suspended the payment of dividends on our common stock indefinitely. The declaration and payment of future dividends to holders of our common stock will be at the discretion of our Board of Directors and will be dependent on many factors including the receipt of dividends from our operating subsidiaries, our financial condition and operating results, the capital requirements of our subsidiaries, legal requirements, regulatory constraints, our credit and financial strength ratings and such other factors as the Board of Directors deems relevant. Our domestic insurance subsidiaries paid dividends of $41 million (none of which were deemed “extraordinary”), $108 million (none of which were deemed “extraordinary”) and $418 million (none of which were deemed “extraordinary”) during 2015, 2014 and 2013, respectively. Our international insurance subsidiaries paid dividends of $640 million, $630 million and $317 million during 2015, 2014 and 2013, respectively. U.S. domiciled insurance subsidiaries—statutory financial information Our U.S. domiciled insurance subsidiaries file financial statements with state insurance regulatory authorities and the NAIC that are prepared on an accounting basis either prescribed or permitted by such authorities. Statutory accounting practices differ from U.S. GAAP in several respects, causing differences in reported net income (loss) and stockholders’ equity. Permitted statutory accounting practices encompass all accounting practices not so prescribed but that have been specifically allowed by individual state insurance authorities. Our U.S. domiciled insurance subsidiaries have no material permitted accounting practices, except for River Lake Insurance Company VI (“River Lake VI”), River Lake Insurance Company VII (“River Lake VII”), River Lake Insurance Company VIII (“River Lake VIII”), River Lake Insurance Company IX (“River Lake IX”), River Lake Insurance Company X ((“River Lake X”), together with River Lake VI, River Lake VII, River Lake VIII and River Lake IX, the “SPFCs”) and Genworth Life Insurance Company of New York (“GLICNY”). The permitted practices of the SPFCs were an essential element of their design and were expressly included in their plans of operation and in the licensing orders issued by their domiciliary state regulators and without those permitted practices, these entities could be subject to regulatory action. Accordingly, we believe that the permitted practices will remain in effect for so long as we maintain the SPFCs. The permitted practices were as follows: • River Lake IX and River Lake X were granted a permitted accounting practice from the State of Vermont to carry its excess of loss reinsurance agreement with Brookfield Life and Annuity Insurance Company Limited (“BLAIC”) and Hannover Life Reassurance Company Of America, respectively, as an admitted asset. • River Lake VII and River Lake VIII were granted a permitted accounting practice from the State of Vermont to carry their reserves on a basis similar to U.S. GAAP. • River Lake VI was granted a permitted accounting practice from the State of Delaware to carry its excess of loss reinsurance agreement with The Canada Life Assurance Company as an admitted asset. • GLICNY received a permitted practice from New York to exempt certain of its investments from a NAIC structured security valuation and ratings process. The impact of these permitted practices on our combined U.S. domiciled life insurance subsidiaries’ statutory capital and surplus was $120 million and $365 million as of December 31, 2015 and 2014, respectively. If permitted practices had not been used, no regulatory event would have been triggered. The tables below include the combined statutory net income (loss) and statutory capital and surplus for our U.S. domiciled insurance subsidiaries for the periods indicated: Years ended December 31, (Amounts in millions) 2015 2014 2013 Combined statutory net income (loss): Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ (330 ) $ (179 ) $ 359 Mortgage insurance subsidiaries 287 198 85 Combined statutory net income (loss), excluding captive reinsurance subsidiaries (43 ) 19 444 Captive life insurance subsidiaries (276 ) (281 ) (102 ) Combined statutory net income (loss) $ (319 ) $ (262 ) $ 342 As of December 31, (Amounts in millions) 2015 2014 Combined statutory capital and surplus: Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ 2,548 $ 2,560 Mortgage insurance subsidiaries 1,722 1,792 Combined statutory capital and surplus $ 4,270 $ 4,352 The statutory net income (loss) from our captive life reinsurance subsidiaries relates to the reinsurance of term and universal life insurance statutory reserves assumed from our U.S. domiciled life insurance companies. These reserves are, in turn, funded through the issuance of surplus notes (non-recourse funding obligations) to third parties or secured by a third-party letter of credit or excess of loss reinsurance treaties with third parties. Accordingly, the life insurance subsidiaries’ combined statutory net income (loss) and distributable income (loss) are not affected by the statutory net income (loss) of the captives, except to the extent dividends are received from the captives. The combined statutory capital and surplus of our life insurance subsidiaries does not include the capital and surplus of our captive life reinsurance subsidiaries of $671 million and $1,057 million as of December 31, 2015 and 2014, respectively. Capital and surplus of our captive life reinsurance subsidiaries, excluding River Lake VI, River Lake VII, River Lake VIII, River Lake IX and River Lake X, include surplus notes (non-recourse funding obligations) as further described in note 12. The NAIC has adopted RBC requirements to evaluate the adequacy of statutory capital and surplus in relation to risks associated with: (i) asset risk; (ii) insurance risk; (iii) interest rate and equity market risk; and (iv) business risk. The RBC formula is designated as an early warning tool for the states to identify possible undercapitalized companies for the purpose of initiating regulatory action. In the course of operations, we periodically monitor the RBC level of each of our life insurance subsidiaries. As of December 31, 2015 and 2014, each of our life insurance subsidiaries exceeded the minimum required RBC levels. The consolidated RBC ratio of our U.S. domiciled life insurance subsidiaries was approximately 393% and 435% of the company action level as of December 31, 2015 and 2014, respectively. On September 11, 2013, the New York Department of Financial Services announced that it would require New York licensed companies to use an alternative interpretation of Actuarial Guideline 38 (more commonly known as “AG 38”) for universal life insurance products with secondary guarantees from the NAIC interpretation. We did not record any additional statutory reserves as of December 31, 2015 and we recorded $70 million of additional statutory reserves as of December 31, 2014 in our life insurance subsidiary domiciled in New York. As of December 31, 2015, this subsidiary had a total of $150 million of additional AG 38 reserves recorded. As of December 31, 2015, we established $198 million of additional statutory reserves resulting from updates to our universal life insurance products with secondary guarantees in our Virginia and Delaware licensed life insurance subsidiaries. In addition, as a result of our annual statutory cash flow testing of our long-term care insurance business, our New York insurance subsidiary recorded $89 million and $39 million of additional statutory reserves in the fourth quarters of 2015 and 2014, respectively, and expects to record an aggregate of $267 million of additional statutory reserves over the next three years. For regulatory purposes, our U.S. mortgage insurance subsidiaries are required to maintain a statutory contingency reserve. Annual additions to the statutory contingency reserve must equal the greater of: (i) 50% of earned premiums or (ii) the required level of policyholders position, as defined by state insurance laws. These contingency reserves generally are held until the earlier of: (i) the time that loss ratios exceed 35% or (ii) 10 years. However, approval by the North Carolina Department of Insurance (“NCDOI”) is required for contingency reserve releases when loss ratios exceed 35%. The statutory contingency reserve for our U.S. mortgage insurance subsidiaries was approximately $500 million and $193 million, respectively, as of December 31, 2015 and 2014 and, was included in the table above containing combined statutory capital and surplus balances. Mortgage insurers are not subject to the NAIC’s RBC requirements but certain states and other regulators impose another form of capital requirement on mortgage insurers requiring maintenance of a risk-to-capital ratio not to exceed 25:1. Fifteen other states maintain similar risk-to-capital requirements. As of December 31, 2015, GMICO’s risk-to-capital ratio under the current regulatory framework as established under North Carolina law and enforced by the NCDOI, GMICO’s domestic insurance regulator, was approximately 16.4:1, compared with a risk-to-capital ratio of approximately 14.3:1 as of December 31, 2014. In May 2014, Genworth Mortgage Holdings, LLC, a U.S. mortgage insurance holding company contributed $300 million to GMICO, our primary U.S. mortgage insurance subsidiary. Effective December 31, 2015, each GSE adopted revised private mortgage insurer eligibility requirements (“PMIERs”) which set forth operational and financial requirements that mortgage insurers must meet in order to remain eligible. By March 1, 2016, an approved insurer must certify as to its compliance with PMIERs as of December 31, 2015. If an approved insurer meets all of PMIERs except the financial requirements that approved insurer may submit by March 31, 2016 a transition plan that each GSE in its sole and absolute discretion may approve or disapprove. If approved, the GSEs will permit a transition period deemed by the GSEs to be reasonably sufficient for the approved insurer to meet the financial requirements, which in any case may not extend beyond June 30, 2017. If an approved insurer is unable to certify as to its compliance with the non-financial requirements of PMIERs, then by March 1, 2016, it may submit a corrective action plan detailing how it expects to achieve compliance. An approved insurer will retain its ability to write insurance on loans eligible for delivery to the GSEs from December 31, 2015 until a transition plan or corrective action plan, as the case may be, has been specifically approved or disapproved, subject to the approved insurer continuing to meet all other PMIERs requirements. As of the December 31, 2015 effective date of PMIERs, our U.S mortgage insurance business met the PMIERs operational and financial requirements, based in part on: (i) our entry during 2015 into three separate excess of loss reinsurance transactions with three panels of reinsurers covering our 2009 through 2015 book years that we believe, based on indications from the GSEs, provide up to approximately $535 million of PMIERs credit; (ii) the intercompany sale during 2015 by our U.S. mortgage insurance business of its ownership interest in affiliated preferred securities for approximately $200 million; and (iii) an internal restructuring of legal entities during 2015. International insurance subsidiaries—statutory financial information Our international insurance subsidiaries also prepare financial statements in accordance with local regulatory requirements. As of December 31, 2015 and 2014, combined local statutory capital and surplus included in continuing operations for our international insurance subsidiaries, excluding our lifestyle protection insurance and European mortgage insurance businesses, was $5,249 million and $5,773 million, respectively. Combined local statutory net income (loss) included in continuing operations for our international insurance subsidiaries, excluding our lifestyle protection insurance business, was $412 million, $(66) million and $573 million for the years ended December 31, 2015, 2014 and 2013, respectively. The regulatory authorities in these international jurisdictions generally establish supervisory solvency requirements. Our international insurance subsidiaries, excluding our lifestyle protection insurance and European mortgage insurance businesses, had combined surplus levels included in continuing operations that exceeded local solvency requirements by $1,673 million and $1,642 million as of December 31, 2015 and 2014, respectively. Our international insurance subsidiaries do not have any material accounting practices that differ from local regulatory requirements other than one of our insurance subsidiaries domiciled in Bermuda, which was granted approval from the Bermuda Monetary Authority to record a parental guarantee as statutory capital related to an internal reinsurance agreement. The amount recorded as statutory capital is equal to the excess of NAIC statutory reserves less the economic reserves up to the amount of the guarantee resulting in an increase in statutory capital of $205 million as of December 31, 2015 and 2014. Certain of our insurance subsidiaries have securities on deposit with various state or foreign government insurance departments in order to comply with relevant insurance regulations. See note 4(d) for additional information related to these deposits. Additionally, under the terms of certain reinsurance agreements that our life insurance subsidiaries have with external parties, we pledged assets in either separate portfolios or in trust for the benefit of external reinsurers. These assets support the reserves ceded to those external reinsurers. See note 8 for additional information related to these pledged assets under reinsurance agreements. Certain of our U.S. life insurance subsidiaries are also members of regional FHLBs and the FHLBs have been granted a lien on certain of our invested assets to collateralize our obligations. See note 9 for additional information related to these pledged assets with the FHLBs. Guarantees of obligations In addition to the guarantees discussed in notes 17 and 21, we have provided guarantees to third parties for the performance of certain obligations of our subsidiaries. We estimate that our potential obligations under such guarantees, other than the Rivermont I guarantee, were $25 million and $28 million as of December 31, 2015 and 2014, respectively. We provide a limited guarantee to Rivermont I, an indirect subsidiary, which is accounted for as a derivative carried at fair value and is eliminated in consolidation. As of December 31, 2015 and 2014, the fair value of this derivative was $4 million and $5 million, respectively. Genworth Holdings provides a guarantee for the benefit of policyholders for the payment of valid claims by our mortgage insurance subsidiary located in the United Kingdom. This guarantee is unlimited while we own the business. As of December 31, 2015, the risk in-force of the business subject to the Genworth Holdings guarantee was approximately $2.0 billion. Following the sale of this U.K. subsidiary to AmTrust Financial Services, Inc., the guarantee would be limited to the payment of valid claims on policies in-force prior to the sale date and those written approximately 90 days subsequent to the date of the sale and AmTrust Financial Services, Inc. has agreed to provide us with a limited indemnification in the event there is any exposure under the guarantee. The transaction is expected to close in the first quarter of 2016 and is subject to customary conditions, including requisite regulatory approvals. Fifty percent of our in-force long-term care insurance business (excluding policies assumed from a non-affiliate third-party reinsurer) of GLIC, a Delaware insurance company and our indirect wholly-owned subsidiary, is reinsured to BLAIC, a Bermuda insurance company and our indirect wholly-owned subsidiary. Genworth Financial International Holdings, LLC (“GFIH”), our indirect wholly-owned subsidiary, has entered into a capital maintenance agreement whereby GFIH has agreed to provide capital to BLAIC to fund payment obligations of BLAIC to GLIC or GLAIC, as applicable, under certain reinsurance agreements, including the one covering our long-term care insurance business. As of December 31, 2015, GFIH directly or indirectly owns 52.0% of our Australian mortgage insurance subsidiaries and 40.6% of our Canadian mortgage insurance subsidiary. As a result of GFIH’s capital maintenance agreement, adverse developments in our reinsured long-term care insurance business (including the recent increases in our reserves of that business) have adversely impacted BLAIC’s financial condition, which could, in turn, adversely impact GFIH’s willingness or ability to pay dividends to Genworth Holdings.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2015
Segment Information	(a) Operating Segment Information Beginning in the fourth quarter of 2015, we changed how we review our operating businesses and no longer have separate reporting divisions. Under our new structure, we have the following five operating business segments: U.S. Mortgage Insurance; Canada Mortgage Insurance; Australia Mortgage Insurance; U.S Life Insurance (which includes our long-term care insurance, life insurance and fixed annuities businesses); and Runoff (which includes the results of non-strategic products which are no longer actively sold). In addition to our five operating business segments, we also have Corporate and Other activities which include debt financing expenses that are incurred at the Genworth Holdings level, unallocated corporate income and expenses, eliminations of inter-segment transactions and the results of other businesses that are managed outside of our operating segments, including certain smaller international mortgage insurance businesses and discontinued operations. Financial information has been updated for all periods to reflect the reorganized segment reporting structure. The following discussion reflects our reorganized operating segments. In the first quarter of 2015, we revised how we allocate our consolidated provision for income taxes to our operating segments to simplify our process and reflect how our chief operating decision maker is evaluating segment performance. Our revised methodology applies a specific tax rate to the pre-tax income (loss) of each segment, which is then adjusted in each segment to reflect the tax attributes of items unique to that segment such as foreign income. The difference between the consolidated provision for income taxes and the sum of the provision for income taxes in each segment is reflected in Corporate and Other activities. Previously, we calculated a unique income tax provision for each segment based on quarterly changes to tax attributes and implications of transactions specific to each product within the segment. The annually-determined tax rates and adjustments to each segment’s provision for income taxes are estimates which are subject to review and could change from year to year. Prior year amounts have not been re-presented to reflect this revised presentation and are, therefore, not comparable to the current year provision for income taxes by segment. However, we do not believe that the previous methodology would have resulted in a materially different segment-level provision for income taxes. We use the same accounting policies and procedures to measure segment income (loss) and assets as our consolidated net income and assets. Our chief operating decision maker evaluates segment performance and allocates resources on the basis of “net operating income (loss).” We define net operating income (loss) as income (loss) from continuing operations excluding the after-tax effects of income attributable to noncontrolling interests, net investment gains (losses), goodwill impairments, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, gains (losses) on insurance block transactions, restructuring costs and infrequent or unusual non-operating items. Gains (losses) on insurance block transactions are defined as gains (losses) on the early extinguishment of non-recourse funding obligations, early termination fees for other financing restructuring and/or resulting gains (losses) on reinsurance restructuring for certain blocks of business. We exclude net investment gains (losses) and infrequent or unusual non-operating items because we do not consider them to be related to the operating performance of our segments and Corporate and Other activities. A component of our net investment gains (losses) is the result of impairments, the size and timing of which can vary significantly depending on market credit cycles. In addition, the size and timing of other investment gains (losses) can be subject to our discretion and are influenced by market opportunities, as well as asset-liability matching considerations. Goodwill impairments, gains (losses) on the sale of businesses, gains (losses) on the early extinguishment of debt, gains (losses) on insurance block transactions and restructuring costs are also excluded from net operating income (loss) because, in our opinion, they are not indicative of overall operating trends. Infrequent or unusual non-operating items are also excluded from net operating income (loss) if, in our opinion, they are not indicative of overall operating trends. While some of these items may be significant components of net income (loss) available to Genworth Financial, Inc.’s common stockholders in accordance with U.S. GAAP, we believe that net operating income (loss), and measures that are derived from or incorporate net operating income (loss), are appropriate measures that are useful to investors because they identify the income (loss) attributable to the ongoing operations of the business. Management also uses net operating income (loss) as a basis for determining awards and compensation for senior management and to evaluate performance on a basis comparable to that used by analysts. However, the items excluded from net operating income (loss) have occurred in the past and could, and in some cases will, recur in the future. Net operating income (loss) is not a substitute for net income (loss) available to Genworth Financial, Inc.’s common stockholders determined in accordance with U.S. GAAP. In addition, our definition of net operating income (loss) may differ from the definitions used by other companies. In the first quarter of 2015, we modified our definition to explicitly state that restructuring costs, which were previously included in the infrequent and unusual category, are excluded from net operating income (loss). In 2015, we recorded an after-tax expense of $5 million related to restructuring costs as part of an expense reduction plan as the company evaluates and appropriately sizes its organizational needs and expenses. Also, in the second quarter of 2013, we recorded a $10 million after-tax expense related to restructuring costs. In 2014, we recorded goodwill impairments of $296 million, net of taxes, in our long-term care insurance business and $495 million, net of taxes, in our life insurance business. In 2015, we recorded an estimated loss of $141 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe. In the third quarter of 2015, we paid an early redemption payment of approximately $1 million, net of taxes and portion attributable to noncontrolling interests, related to the early redemption of Genworth Financial Mortgage Insurance Pty Limited’s notes that were scheduled to mature in 2021. In the third quarter of 2015, we also repurchased approximately $50 million principal amount of Genworth Holdings, Inc.’s notes with various maturity dates for a loss of $1 million, net of taxes. In the second quarter of 2014, we paid an early redemption payment of approximately $2 million, net of taxes and portion attributable to noncontrolling interests, related to the early redemption of Genworth Canada’s notes that were scheduled to mature in 2015. In the third quarter of 2013, we paid a make-whole expense of approximately $20 million, net of taxes, related to the early redemption of Genworth Holdings’ 2015 Notes. These transactions were excluded from net operating income (loss) for the periods presented as they related to the loss on the early extinguishment of debt. In the third quarter of 2015, we recorded a DAC impairment of $296 million, net of taxes, on certain term life insurance policies in connection with entering into an agreement with Protective Life to complete a life block transaction. There were no infrequent or unusual items excluded from net operating income (loss) during the periods presented other than the following items. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we could no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. Adjustments to reconcile net income (loss) attributable to Genworth Financial, Inc.’s common stockholders and net operating income (loss) assume a 35% tax rate and are net of the portion attributable to noncontrolling interests. Net investment gains (losses) are also adjusted for DAC and other intangible amortization and certain benefit reserves. The following is a summary of our segments and Corporate and Other activities as of or for the years ended December 31: 2015 U.S. Canada Australia U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 602 $ 466 $ 357 $ 3,128 $ 1 $ 25 $ 4,579 Net investment income 58 130 114 2,701 138 (3 ) 3,138 Net investment gains (losses) 1 (32 ) 6 (10 ) (69 ) 29 (75 ) Policy fees and other income 4 — (3 ) 726 189 (10 ) 906 Total revenues 665 564 474 6,545 259 41 8,548 Benefits and other changes in policy reserves 222 96 81 4,692 44 14 5,149 Interest credited — — — 596 124 — 720 Acquisition and operating expenses, net of deferrals 155 66 98 684 76 230 1,309 Amortization of deferred acquisition costs and intangibles 10 36 18 872 29 1 966 Interest expense — 18 10 92 1 298 419 Total benefits and expenses 387 216 207 6,936 274 543 8,563 Income (loss) from continuing operations before income taxes 278 348 267 (391 ) (15 ) (502 ) (15 ) Provision (benefit) for income taxes 99 90 80 (138 ) (10 ) (130 ) (9 ) Income (loss) from continuing operations 179 258 187 (253 ) (5 ) (372 ) (6 ) Income (loss) from discontinued operations, net of taxes — — — — — (407 ) (407 ) Net income (loss) 179 258 187 (253 ) (5 ) (779 ) (413 ) Less: net income attributable to noncontrolling interests — 118 84 — — — 202 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 179 $ 140 $ 103 $ (253 ) $ (5 ) $ (779 ) $ (615 ) Segment assets $ 2,899 $ 4,520 $ 2,987 $ 79,530 $ 12,115 $ 4,253 $ 106,304 Assets held for sale — — — — — 127 127 Total assets $ 2,899 $ 4,520 $ 2,987 $ 79,530 $ 12,115 $ 4,380 $ 106,431 2014 U.S. Canada Australia U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 578 $ 515 $ 406 $ 3,169 $ 3 $ 29 $ 4,700 Net investment income 59 155 144 2,665 129 (10 ) 3,142 Net investment gains (losses) — (2 ) 3 41 (66 ) 2 (22 ) Policy fees and other income 2 1 (16 ) 712 209 1 909 Total revenues 639 669 537 6,587 275 22 8,729 Benefits and other changes in policy reserves 357 102 78 5,820 37 24 6,418 Interest credited — — — 618 119 — 737 Acquisition and operating expenses, net of deferrals 140 90 97 658 84 69 1,138 Amortization of deferred acquisition costs and intangibles 7 38 21 345 39 3 453 Goodwill impairment — — — 849 — — 849 Interest expense — 21 10 87 1 314 433 Total benefits and expenses 504 251 206 8,377 280 410 10,028 Income (loss) from continuing operations before income taxes 135 418 331 (1,790 ) (5 ) (388 ) (1,299 ) Provision (benefit) for income taxes 44 111 248 (385 ) (19 ) (93 ) (94 ) Income (loss) from continuing operations 91 307 83 (1,405 ) 14 (295 ) (1,205 ) Income from discontinued operations, net of taxes — — — — — 157 157 Net income (loss) 91 307 83 (1,405 ) 14 (138 ) (1,048 ) Less: net income attributable to noncontrolling interests — 140 56 — — — 196 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 91 $ 167 $ 27 $ (1,405 ) $ 14 $ (138 ) $ (1,244 ) Segment assets $ 2,324 $ 4,920 $ 3,494 $ 82,891 $ 12,971 $ 2,573 $ 109,173 Assets held for sale — — — — — 2,143 2,143 Total assets $ 2,324 $ 4,920 $ 3,494 $ 82,891 $ 12,971 $ 4,716 $ 111,316 2013 U.S. Canada Australia U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 554 $ 560 $ 398 $ 2,957 $ 5 $ 42 $ 4,516 Net investment income 60 170 159 2,621 139 6 3,155 Net investment gains (losses) — 31 (2 ) (3 ) (58 ) (32 ) (64 ) Policy fees and other income 2 (1 ) — 755 216 46 1,018 Total revenues 616 760 555 6,330 302 62 8,625 Benefits and other changes in policy reserves 412 139 134 3,975 32 45 4,737 Interest credited — — — 619 119 — 738 Acquisition and operating expenses, net of deferrals 144 93 110 658 81 158 1,244 Amortization of deferred acquisition costs and intangibles 6 37 22 384 6 8 463 Interest expense — 22 11 97 2 318 450 Total benefits and expenses 562 291 277 5,733 240 529 7,632 Income (loss) from continuing operations before income taxes 54 469 278 597 62 (467 ) 993 Provision (benefit) for income taxes 17 133 51 213 13 (114 ) 313 Income (loss) from continuing operations 37 336 227 384 49 (353 ) 680 Income from discontinued operations, net of taxes — — — — — 34 34 Net income (loss) 37 336 227 384 49 (319 ) 714 Less: net income attributable to noncontrolling interests — 154 — — — — 154 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 37 $ 182 $ 227 $ 384 $ 49 $ (319 ) $ 560 (b) Revenues of Major Product Groups The following is a summary of revenues of major product groups for our segments and Corporate and Other activities for the years ended December 31: (Amounts in millions) 2015 2014 2013 Revenues: U.S. Mortgage Insurance segment’s revenues $ 665 $ 639 $ 616 Canada Mortgage Insurance segment’s revenues 564 669 760 Australia Mortgage Insurance segment’s revenues 474 537 555 U.S. Life Insurance segment: Long-term care insurance 3,752 3,523 3,316 Life insurance 1,902 1,981 1,982 Fixed annuities 891 1,083 1,032 U.S. Life Insurance segment’s revenues 6,545 6,587 6,330 Runoff segment’s revenues 259 275 302 Corporate and Other’s revenues 41 22 62 Total revenues $ 8,548 $ 8,729 $ 8,625 (c) Net Operating Income (Loss) The following is a summary of net operating income (loss) for our segments and Corporate and Other activities and a reconciliation of net operating income (loss) for our segments and Corporate and Other activities to net income (loss) available to Genworth Financial, Inc.’s common stockholders for the years ended December 31: (Amounts in millions) 2015 2014 2013 U.S. Mortgage Insurance segment’s net operating income $ 179 $ 91 $ 37 Canada Mortgage Insurance segment’s net operating income 152 170 170 Australia Mortgage Insurance segment’s net operating income 102 200 228 U.S. Life Insurance segment: Long-term care insurance 29 (815 ) 129 Life insurance (80 ) 74 173 Fixed annuities 94 100 92 U.S. Life Insurance segment’s net operating income (loss) 43 (641 ) 394 Runoff segment’s net operating income 27 48 66 Corporate and Other’s net operating loss (248 ) (266 ) (310 ) Net operating income (loss) 255 (398 ) 585 Net investment gains (losses), net (19 ) (5 ) (29 ) Goodwill impairment, net — (791 ) — Gains (losses) from sale of businesses, net (141 ) — — Gains (losses) on early extinguishment of debt, net (2 ) (2 ) (20 ) Gains (losses) from life block transactions, net (296 ) — — Expenses related to restructuring, net (5 ) — (10 ) Tax impact from potential business portfolio changes — (205 ) — Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders (208 ) (1,401 ) 526 Net income attributable to noncontrolling interests 202 196 154 Income (loss) from continuing operations (6 ) (1,205 ) 680 Income (loss) from discontinued operations, net of taxes (407 ) 157 34 Net income (loss) (413 ) (1,048 ) 714 Less: net income attributable to noncontrolling interests 202 196 154 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (615 ) $ (1,244 ) $ 560 (d) Geographic Segment Information We conduct our operations in the following geographic regions: (1) United States (2) Canada (3) Australia and (4) Other Countries. The following is a summary of geographic region activity as of or for the years ended December 31: 2015 (Amounts in millions) United States Canada Australia Other Total Total revenues $ 7,483 $ 564 $ 474 $ 27 $ 8,548 Income (loss) from continuing operations $ (430 ) $ 258 $ 187 $ (21 ) $ (6 ) Net income (loss) $ (430 ) $ 258 $ 187 $ (428 ) $ (413 ) Segment assets $ 98,738 $ 4,520 $ 2,987 $ 59 $ 106,304 Assets held for sale $ — $ — $ — $ 127 $ 127 Total assets $ 98,738 $ 4,520 $ 2,987 $ 186 $ 106,431 2014 (Amounts in millions) United States Canada Australia Other Total Total revenues $ 7,487 $ 669 $ 537 $ 36 $ 8,729 Income (loss) from continuing operations $ (1,570 ) $ 307 $ 83 $ (25 ) $ (1,205 ) Net income (loss) $ (1,570 ) $ 307 $ 83 $ 132 $ (1,048 ) Segment assets $ 100,690 $ 4,920 $ 3,494 $ 69 $ 109,173 Assets held for sale $ — $ — $ — $ 2,143 $ 2,143 Total assets $ 100,690 $ 4,920 $ 3,494 $ 2,212 $ 111,316 2013 (Amounts in millions) United States Canada Australia Other Total Total revenues $ 7,259 $ 760 $ 555 $ 51 $ 8,625 Income (loss) from continuing operations $ 153 $ 336 $ 227 $ (36 ) $ 680 Net income $ 141 $ 336 $ 227 $ 10 $ 714

Quarterly Results of Operations

Quarterly Results of Operations (unaudited)	12 Months Ended
	Dec. 31, 2015
Quarterly Results of Operations (unaudited)	(20) Quarterly Results of Operations (unaudited) Our unaudited quarterly results of operations for the year ended December 31, 2015 are summarized in the table below. Three months ended (Amounts in millions, except per share amounts) March 31, June 30, September 30, December 31, Total revenues (1) $ 2,135 $ 2,157 $ 2,100 $ 2,156 Total benefits and expenses (2) $ 1,841 $ 1,912 $ 2,451 $ 2,359 Income (loss) from continuing operations (3) $ 203 $ 175 $ (217 ) $ (167 ) Income (loss) from discontinued operations, net of taxes (4) $ 1 $ (314 ) $ (21 ) $ (73 ) Net income (loss) (3), (4) $ 204 $ (139 ) $ (238 ) $ (240 ) Net income attributable to noncontrolling interests $ 50 $ 54 $ 46 $ 52 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 154 $ (193 ) $ (284 ) $ (292 ) Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per common share: Basic $ 0.31 $ 0.24 $ (0.53 ) $ (0.44 ) Diluted $ 0.31 $ 0.24 $ (0.53 ) $ (0.44 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders per common share: Basic $ 0.31 $ (0.39 ) $ (0.57 ) $ (0.59 ) Diluted $ 0.31 $ (0.39 ) $ (0.57 ) $ (0.59 ) Weighted-average common shares outstanding: Basic 497.0 497.4 497.4 497.6 Diluted (5) 498.9 499.3 497.4 497.6 (1) We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $12 million of higher revenue, which included $5 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements. (2) We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $310 million of charges, which included $60 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements. We also recorded an expected loss of $140 million related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015. (3) We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015. (4) We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale. (5) Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2015 and December 31, 2015, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2015 and December 31, 2015, as the inclusion of shares for stock options, RSUs and SARs of 1.3 million and 1.4 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2015 and December 31, 2015, dilutive potential weighted-average common shares outstanding would have been 498.7 and 499.0 million, respectively. Our unaudited quarterly results of operations for the year ended December 31, 2014 are summarized in the table below. Three months ended (Amounts in millions, except per share amounts) March 31, June 30, September 30, December 31, Total revenues $ 2,116 $ 2,194 $ 2,190 $ 2,229 Total benefits and expenses (1) $ 1,819 $ 1,886 $ 3,170 $ 3,153 Income (loss) from continuing operations (2) $ 210 $ 224 $ (793 ) $ (846 ) Income from discontinued operations, net of taxes $ 9 $ 4 $ 6 $ 138 Net income (loss) (2) $ 219 $ 228 $ (787 ) $ (708 ) Net income attributable to noncontrolling interests $ 35 $ 52 $ 57 $ 52 Net income (loss) available to Genworth Financial, Inc.’s common stockholders (2) $ 184 $ 176 $ (844 ) $ (760 ) Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per common share: Basic $ 0.35 $ 0.35 $ (1.71 ) $ (1.81 ) Diluted $ 0.35 $ 0.34 $ (1.71 ) $ (1.81 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders per common share: Basic $ 0.37 $ 0.35 $ (1.70 ) $ (1.53 ) Diluted $ 0.37 $ 0.35 $ (1.70 ) $ (1.53 ) Weighted-average common shares outstanding: Basic 495.8 496.6 496.6 496.7 Diluted (3) 502.7 503.6 496.6 496.7 (1) During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates. (2) During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. (3) Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2014 and December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2014 and December 31, 2014, as the inclusion of shares for stock options, RSUs and SARs of 5.4 million and 3.2 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2014 and December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million and 499.9 million, respectively.

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2015
Commitments and Contingencies	(21) Commitments and Contingencies (a) Litigation and Regulatory Matters We face the risk of litigation and regulatory investigations and actions in the ordinary course of operating our businesses, including the risk of class action lawsuits. Our pending legal and regulatory actions include proceedings specific to us and others generally applicable to business practices in the industries in which we operate. In our insurance operations, we are, have been, or may become subject to class actions and individual suits alleging, among other things, issues relating to sales or underwriting practices, increases to in-force long-term care insurance premiums, payment of contingent or other sales commissions, claims payments and procedures, product design, product disclosure, administration, additional premium charges for premiums paid on a periodic basis, denial or delay of benefits, charging excessive or impermissible fees on products, recommending unsuitable products to customers, our pricing structures and business practices in our mortgage insurance businesses, such as captive reinsurance arrangements with lenders and contract underwriting services, violations of the Real Estate Settlement and Procedures Act of 1974 (“RESPA”) or related state anti-inducement laws, and mortgage insurance policy rescissions and curtailments, and breaching fiduciary or other duties to customers, including but not limited to breach of customer information. Plaintiffs in class action and other lawsuits against us may seek very large or indeterminate amounts which may remain unknown for substantial periods of time. In our investment-related operations, we are subject to litigation involving commercial disputes with counterparties. We are also subject to litigation arising out of our general business activities such as our contractual and employment relationships and securities lawsuits. In addition, we are also subject to various regulatory inquiries, such as information requests, subpoenas, books and record examinations and market conduct and financial examinations from state, federal and international regulators and other authorities. A substantial legal liability or a significant regulatory action against us could have an adverse effect on our business, financial condition and results of operations. Moreover, even if we ultimately prevail in the litigation, regulatory action or investigation, we could suffer significant reputational harm, which could have an adverse effect on our business, financial condition or results of operations. In August 2014, Genworth Financial, Inc., its current chief executive officer and its then current chief financial officer were named in a putative class action lawsuit captioned Manuel Esguerra v. Genworth Financial, Inc. et al City of Pontiac General Employees’ Retirement System v. Genworth Financial, Inc. et al. Esguerra City of Pontiac Esguerra City of Pontiac City of Pontiac In re Genworth Financial, Inc. Securities Litigation. In April 2014, Genworth Financial, Inc., its former chief executive officer and its then current chief financial officer were named in a putative class action lawsuit captioned City of Hialeah Employees’ Retirement System v. Genworth Financial, Inc. et al. In re Genworth Financial, Inc. Securities Litigation. In August 2015, Genworth Financial, Inc., its former chief executive officer, its current chief executive officer, its then current chief financial officer and the current members of its board of directors were named in two separate shareholder derivative suits, each of which was filed in the United States District Court for the Eastern District of Virginia, alleging breaches of fiduciary duties concerning Genworth’s long-term care insurance reserves and concerning Genworth’s Australian mortgage insurance business, including our plans for an initial public offering of the business. The cases are captioned, Pinkoski v. McInerney, et al. Salberg v. McInerney, et al. Pinkoski Salberg In August 2015, Genworth Financial, Inc., its current chief executive officer, its then current chief financial officer and the current members of its board of directors were named in a shareholder derivative suit filed in the United States District Court for the Eastern District of Virginia, alleging breaches of fiduciary duties relating to Genworth’s long-term care insurance reserves. The case is captioned Cohen v. McInerney, et al. Cohen s In September 2015, Genworth Financial, Inc., its former chief executive officer, its current chief executive officer, its then current chief financial officer and the current members of its board of directors were named in a shareholder derivative suit filed in the United States District Court for the Eastern District of Virginia, alleging breaches of fiduciary duties relating to Genworth’s long-term care insurance reserves. The case is captioned Int’l Union of Operating Engineers Local No. 478 Pension Fund v. McInerney, et al. Pinkoski v. McInerney, et al. In Re Genworth Financial Securities Litigation In January 2016, Genworth Financial, Inc., its current chief executive officer, its former chief executive officer, its former chief financial officer and the current members of its board of directors were named in a shareholder derivative suit filed by International Union of Operating Engineers Local No. 478 Pension Fund, Richard L. Salberg and David Pinkoski in the Court of Chancery of the State of Delaware. The case is captioned Int’l Union of Operating Engineers Local No. 478 Pension Fund, et al v. McInerney, et al. Cohen v. McInerney, et al Genworth Financial, Inc. Consolidated Derivative Litigation Beginning in December 2011 and continuing through January 2013, one of our U.S. mortgage insurance subsidiaries was named along with several other mortgage insurance participants and mortgage lenders as a defendant in twelve putative class action lawsuits alleging that certain “captive reinsurance arrangements” were in violation of RESPA. Those cases are captioned as follows: Samp, et al. v. JPMorgan Chase Bank, N.A., et al., White, et al., v. The PNC Financial Services Group, Inc., et al., Menichino, et al. v. Citibank NA, et al., McCarn, et al. v. HSBC USA, Inc., et al. Manners, et al., v. Fifth Third Bank, et al. Riddle, et al. v. Bank of America Corporation, et al. Rulison et al. v. ABN AMRO Mortgage Group, Inc. et al. Barlee, et al. v. First Horizon National Corporation, et al Cunningham, et al. v. M&T Bank Corp., et al Orange, et al. v. Wachovia Bank, N.A., et al Hill et al. v. Flagstar Bank, FSB, et al., Moriba Ba, et al. v. HSBC USA, Inc., et al., McCarn Rulison Barlee Manners Samp Orange White Menichino Riddle Hill Ba Cunningham Riddle Hill Cunningham Hill Hill Riddle Riddle In December 2009, one of our former non-insurance subsidiaries, one of the former subsidiary’s officers and Genworth Financial, Inc. (now known as Genworth Holdings, Inc.) were named in a putative class action lawsuit captioned Michael J. Goodman and Linda Brown v. Genworth Financial Wealth Management, Inc. et al In April 2012, two of our U.S. mortgage insurance subsidiaries were named as respondents in two arbitrations, one brought by Bank of America, N.A. and one brought by Countrywide Home Loans, Inc. and Bank of America, N.A. as claimants. Claimants alleged breach of contract and breach of the covenant of good faith and fair dealing and sought a declaratory judgment relating to our denial, curtailment and rescission of mortgage insurance coverage. In June 2012, our U.S. mortgage insurance subsidiaries responded to the arbitration demands and asserted numerous counterclaims against the claimants. On December 31, 2013, the parties reached an agreement to resolve that portion of both arbitrations involving rescission practices, which settlement took effect in the second quarter of 2014. As a result, the arbitration demands and counterclaims related to that portion of both arbitrations involving rescission practices were dismissed in the third quarter of 2014. In October 2014, the parties executed a definitive settlement agreement to settle all remaining claims in the arbitrations. Implementation of the settlement to resolve the remaining claims was subject to the consent of the GSEs. The settlement provides that our U.S. mortgage insurance subsidiaries will remit a portion of the previously curtailed claim amounts to Bank of America, N.A. and will agree to certain limits on future curtailment activity for loans that are part of the settlement. The consents of the GSEs were obtained in January 2015, and therefore, the parties moved to dismiss all remaining matters in the arbitration. Such dismissals occurred in the fourth quarter of 2015. In addition to the negotiated settlement with Bank of America, N.A. discussed above, we have resolved a matter involving a second servicer’s dispute with us on loss mitigation. This second dispute did not involve any formal legal proceeding, as is the case with other discussions we have had from time to time with other lenders and servicers over disputed loss mitigation activities. During the third quarter of 2014, we recorded an aggregate increase in our claim reserves for our U.S. mortgage insurance business of $53 million principally to provide for the anticipated financial impact in connection with the settlement of the Bank of America, N.A. arbitration, as well as the second dispute, both of which were settled for amounts which in the aggregate were included within the claim reserve increase mentioned above. In early 2006 as part of an industry-wide review, one of our U.S. mortgage insurance subsidiaries received an administrative subpoena from the Minnesota Department of Commerce, which has jurisdiction over insurance matters, with respect to our reinsurance arrangements, including captive reinsurance transactions with lender-affiliated reinsurers. Since 2006, the Minnesota Department of Commerce has periodically requested additional information. In June 2015, we entered into a Consent Order with the Minnesota Department of Commerce pursuant to the terms and conditions of which we agreed to pay a civil penalty of $90,000 and agreed not to enter into any new captive reinsurance transactions from a lender-affiliated reinsurer or to obtain reinsurance under an existing captive reinsurance transaction from a lender-affiliated reinsurer on any new mortgage transactions after the date of the Consent Order for a period of 10 years. Pursuant to the Consent Order, we were discharged from all potential liability that has or might have been asserted by the Minnesota Department of Commerce based on our captive mortgage reinsurance policies or practices, to the extent such practices occurred prior to the date of the Consent Order. Inquiries from other regulatory bodies with respect to the same subject matter have been resolved or dormant for a number of years. At this time, other than as noted above, we cannot determine or predict the ultimate outcome of any of the pending legal and regulatory matters specifically identified above or the likelihood of potential future legal and regulatory matters against us. Except as disclosed above, we also are not able to provide an estimate or range of reasonably possible losses related to these matters. Therefore, we cannot ensure that the current investigations and proceedings will not have a material adverse effect on our business, financial condition or results of operations. In addition, it is possible that related investigations and proceedings may be commenced in the future, and we could become subject to additional unrelated investigations and lawsuits. Increased regulatory scrutiny and any resulting investigations or proceedings could result in new legal precedents and industry-wide regulations or practices that could adversely affect our business, financial condition and results of operations. (b) Commitments As of December 31, 2015, we were committed to fund $131 million in limited partnership investments, $17 million in U.S. commercial mortgage loan investments and $23 million in private placement investments. In connection with the issuance of non-recourse funding obligations by Rivermont I, Genworth entered into a liquidity commitment agreement with the third-party trusts in which the floating rate notes have been deposited. The liquidity agreement may require that Genworth issue to the trusts either a loan or a letter of credit (“LOC”), at maturity of the notes (2050), in the amount equal to the then market value of the assets supporting the notes held in the trust. Any loan or LOC issued is an obligation of the trust and shall accrue interest at LIBOR plus a margin. In consideration for entering into this agreement, Genworth received, from Rivermont I, a one-time commitment fee of approximately $2 million. The expected amount of future obligation under this agreement is approximately $15 million based on current projections.

Changes In Accumulated Other Co

Changes In Accumulated Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 31, 2015
Changes In Accumulated Other Comprehensive Income (Loss)	(22) Changes In Accumulated Other Comprehensive Income (Loss) The following tables show the changes in accumulated other comprehensive income (loss), net of taxes, by component as of and for the periods indicated: (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2015 $ 2,453 $ 2,070 $ (77 ) $ 4,446 OCI before reclassifications (1,218 ) 50 (530 ) (1,698 ) Amounts reclassified from (to) OCI 5 (75 ) — (70 ) Current period OCI (1,213 ) (25 ) (530 ) (1,768 ) Balances as of December 31, 2015 before noncontrolling interests 1,240 2,045 (607 ) 2,678 Less: change in OCI attributable to noncontrolling interests (14 ) — (318 ) (332 ) Balances as of December 31, 2015 $ 1,254 $ 2,045 $ (289 ) $ 3,010 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional information. (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2014 $ 926 $ 1,319 $ 297 $ 2,542 OCI before reclassifications 1,595 788 (537 ) 1,846 Amounts reclassified from (to) OCI (12 ) (37 ) — (49 ) Current period OCI 1,583 751 (537 ) 1,797 Balances as of December 31, 2014 before noncontrolling interests 2,509 2,070 (240 ) 4,339 Less: change in OCI attributable to noncontrolling interests 56 — (163 ) (107 ) Balances as of December 31, 2014 $ 2,453 $ 2,070 $ (77 ) $ 4,446 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional information. (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2013 $ 2,638 $ 1,909 $ 655 $ 5,202 OCI before reclassifications (1,772 ) (561 ) (442 ) (2,775 ) Amounts reclassified from (to) OCI 21 (29 ) — (8 ) Current period OCI (1,751 ) (590 ) (442 ) (2,783 ) Balances as of December 31, 2013 before noncontrolling interests 887 1,319 213 2,419 Less: change in OCI attributable to noncontrolling interests (39 ) — (84 ) (123 ) Balances as of December 31, 2013 $ 926 $ 1,319 $ 297 $ 2,542 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional information. The foreign currency translation and other adjustments balance included $5 million, $37 million and $6 million, respectively, net of taxes of $3 million, $14 million and $1 million, respectively, related to a net unrecognized postretirement benefit obligation as of December 31, 2015, 2014 and 2013. Amount also included taxes of $(63) million, $(10) million and $39 million, respectively, related to foreign currency translation adjustments as of December 31, 2015, 2014 and 2013. The following table shows reclassifications out of accumulated other comprehensive income (loss), net of taxes, for the periods presented: Amount reclassified from accumulated other comprehensive income (loss) Affected line item in the consolidated statements of income Years ended December 31, (Amounts in millions) 2015 2014 2013 Net unrealized investment (gains) losses: Unrealized (gains) losses on investments (1) $ 7 $ (19 ) $ 33 Net investment (gains) losses Provision for income taxes (2 ) 7 (12 ) Provision for income taxes Total $ 5 $ (12 ) $ 21 Derivatives qualifying as hedges: Interest rate swaps hedging assets $ (85 ) $ (63 ) $ (47 ) Net investment income Interest rate swaps hedging assets — (2 ) (1 ) Net investment (gains) losses Interest rate swaps hedging liabilities — (1 ) (2 ) Interest expense Inflation indexed swaps — 9 5 Net investment income Forward bond purchase commitments (1 ) — — Net investment income Forward bond purchase commitments (32 ) — — Net investment (gains) losses Provision for income taxes 43 20 16 Provision for income taxes Total $ (75 ) $ (37 ) $ (29 ) (1) Amounts exclude adjustments to DAC, PVFP, sales inducements and benefit reserves.

Noncontrolling Interests

Noncontrolling Interests	12 Months Ended
	Dec. 31, 2015
Noncontrolling Interests	Canada In July 2009, Genworth Canada, our indirect subsidiary, completed an IPO of its common shares and we beneficially owned 57.5% of the common shares of Genworth Canada through subsidiaries. We currently hold approximately 57.3% of the outstanding common shares of Genworth Canada on a consolidated basis through subsidiaries. In addition, we have the right, exercisable at our discretion, to purchase for cash these common shares of Genworth Canada from our U.S. mortgage insurance companies at the then-current market price. We also have a right of first refusal with respect to the transfer of these common shares of Genworth Canada by our U.S. mortgage insurance companies. In April 2015, Genworth Canada announced acceptance by the Toronto Stock Exchange of its Notice of Intention to Make a Normal Course Issuer Bid (“NCIB”). Pursuant to the NCIB, Genworth Canada may purchase from time to time through May 2016, up to an aggregate of 4.7 million of its issued and outstanding common shares. During 2015, Genworth Canada repurchased 1.4 million of its shares for CAD$50 million through a NCIB. We participated in the NCIB in order to maintain our overall ownership percentage at 57.3% and received $23 million in cash. During 2014, Genworth Canada repurchased 1.9 million shares for CAD$75 million through a NCIB authorized by its board for up to 4.7 million shares. We participated in the NCIB in order to maintain our overall ownership percentage at its then current level and received $38 million in cash. During 2013, Genworth Canada repurchased 3.9 million shares for CAD$105 million through a NCIB authorized by its board for up to 4.9 million shares. We participated in the NCIB in order to maintain our overall ownership percentage at its then current level and received $58 million in cash. In 2015, 2014 and 2013, dividends of $49 million, $69 million and $52 million, respectively, were paid to the noncontrolling interests of Genworth Canada. Australia On May 15, 2014, Genworth Australia, a holding company for Genworth’s Australian mortgage insurance business, priced an IPO of 220,000,000 of its ordinary shares at an IPO price of AUD$2.65 per ordinary share. The offering closed on May 21, 2014. Following completion of the offering, Genworth Financial beneficially owned 66.2% of the ordinary shares of Genworth Australia through subsidiaries. The net proceeds of the offering were used by Genworth Australia to repay a portion of certain intercompany funding arrangements with our subsidiaries and those funds were then distributed to Genworth Holdings. The gross proceeds of the offering (before payment of fees and expenses) were approximately $541 million. Fees and expenses in connection with the offering were approximately $27 million, including approximately $3 million paid in 2013. On May 11, 2015, we sold 92,300,000 of our shares in Genworth Australia at AUD$3.08 per ordinary share. The offering closed on May 15, 2015. Following completion of the offering, Genworth Financial beneficially owns 52.0% of the ordinary shares of Genworth Australia through subsidiaries. The majority of the net proceeds of the offering were distributed to Genworth Holdings. The net proceeds of the offering were approximately $226 million. On October 30, 2015, Genworth Australia announced its intention to commence an on-market share buy-back program. Pursuant to the program, in November and December 2015, Genworth Australia repurchased 54.6 million of its shares for AUD$150 million. As the majority shareholder, we participated in on-market sales transactions during the buy-back period to maintain our ownership position of 52.0% and received $55 million in cash. Consistent with applicable accounting guidance, changes in noncontrolling interests that do not result in a change of control are accounted for as equity transactions. When there are changes in noncontrolling interests of a subsidiary that do not result in a change of control, any difference between carrying value and fair value related to the change in ownership is recorded as an adjustment to stockholders’ equity. A summary of the changes in ownership interests and the effect on stockholders’ equity as a result of the initial public offering of Genworth Australia was as follows for the years ended December 31: (Amounts in millions) 2015 2014 Net loss available to Genworth Financial, Inc.’s common stockholders $ (615 ) $ (1,244 ) Transfers to the noncontrolling interests: Decrease in Genworth Financial, Inc.’s additional paid-in capital for initial sale of Genworth Australia shares to noncontrolling interests — (145 ) Decrease in Genworth Financial, Inc.’s additional paid-in capital for additional sale of Genworth Australia shares to noncontrolling interests (65 ) — Net transfers to noncontrolling interests (65 ) (145 ) Change from net loss available to Genworth Financial, Inc.’s common stockholders and transfers to noncontrolling interests $ (680 ) $ (1,389 ) In 2015 and 2014, dividends of $108 million and $6 million, respectively, were paid to the noncontrolling interests of Genworth Australia.

Sale of Businesses

Sale of Businesses	12 Months Ended
	Dec. 31, 2015
Sale of Businesses	European mortgage insurance business As discussed in note 1, GMICO entered into an agreement to sell our European mortgage insurance business to AmTrust Financial Services, Inc. that is expected to result in net proceeds of approximately $55 million. As the held-for-sale criteria were satisfied during 2015, we recorded an estimated after-tax loss of approximately $141 million related to the sale, net of taxes of $1 million. In accordance with the accounting guidance for groups of assets that are held-for-sale, we recorded an impairment of $135 million to record the carrying value of the business at its fair value, which was based on estimated proceeds less $5 million closing costs. The transaction is expected to close in the first quarter of 2016 and is subject to customary conditions, including requisite regulatory approvals. The major assets and liability categories of our European mortgage insurance business were as follows as of December 31: (Amounts in millions) 2015 2014 Assets Investments: Fixed maturity securities available-for-sale, at fair value $ 195 $ 199 Other invested assets 6 36 Total investments 201 235 Cash and cash equivalents 28 71 Accrued investment income 3 4 Intangible assets — 1 Reinsurance recoverable 21 23 Other assets 14 — Assets held for sale 267 334 Fair value less closing costs impairment (140 ) — Total assets held for sale $ 127 $ 334 Liabilities Liability for policy and contract claims $ 56 $ 56 Unearned premiums 58 62 Other liabilities 12 48 Deferred tax liability 1 — Liabilities held for sale $ 127 $ 166 Deferred tax liabilities that result in future taxable or deductible amounts to the remaining consolidated group have been reflected in liabilities of continuing operations and not reflected in liabilities held for sale. Lifestyle protection insurance As discussed in note 1, our lifestyle protection insurance business is reported as discontinued operations. The assets and liabilities held for sale for this business were segregated in our consolidated balance sheets until the closing of the sale on December 1, 2015. The major assets and liability categories of our lifestyle protection insurance business were as follows as of December 31: (Amounts in millions) 2015 2014 Assets Investments: Fixed maturity securities available-for-sale, at fair value $ — $ 1,171 Equity securities available-for-sale, at fair value — 7 Other invested assets — 52 Total investments — 1,230 Cash and cash equivalents — 202 Accrued investment income — 21 Deferred acquisition costs — 193 Intangible assets — 22 Reinsurance recoverable — 32 Other assets — 109 Assets held for sale $ — $ 1,809 Liabilities Policyholder account balances $ — $ 11 Liability for policy and contract claims — 106 Unearned premiums — 439 Other liabilities — 322 Deferred tax liability — 50 Liabilities held for sale $ — $ 928 Deferred tax assets and liabilities that result in future taxable or deductible amounts to the remaining consolidated group have been reflected in assets or liabilities of continuing operations and not reflected in assets or liabilities held for sale. Summary operating results of discontinued operations were as follows for the years ended December 31: (Amounts in millions) 2015 2014 2013 Revenues: Premiums $ 627 $ 731 $ 632 Net investment income 74 100 116 Net investment gains (losses) — 2 27 Policy fees and other income — 3 3 Total revenues 701 836 778 Benefits and expenses: Benefits and other changes in policy reserves 182 202 158 Acquisition and operating expenses 396 447 415 Amortization of deferred acquisition costs and intangibles 83 118 106 Interest expense 29 46 42 Total benefits and expenses 690 813 721 Income (loss) before income taxes and loss on sale 11 23 57 Provision (benefit) for income taxes 37 (134 ) 11 Income (loss) before loss on sale (26 ) 157 46 Loss on sale, net of taxes (381 ) — — Income (loss) from discontinued operations, net of taxes $ (407 ) $ 157 $ 46 On December 1, 2015, we completed the sale of our lifestyle protection insurance business and received approximately $493 million with net proceeds of approximately $400 million, subject to the finalization of closing balance sheet purchase price adjustments. During 2015, we recorded an after-tax loss of approximately $381 million, net of taxes of $155 million, including $63 million in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business and was substantially liquidated in the fourth quarter of 2015. We retained liabilities for the U.K. pension plan, as described in note 11, as well as taxes and certain claims and sales practices that occurred while we owned the lifestyle protection insurance business. We have established our current best estimates for these liabilities, where appropriate; however, there may be future adjustments to these estimates. Wealth management In 2013, we completed the sale of our wealth management business to AqGen Liberty Acquisition, Inc., a subsidiary of AqGen Liberty Holdings LLC, a partnership of Aquiline Capital Partners and Genstar Capital, for approximately $412 million with net proceeds of approximately $360 million. The loss on sale was approximately $29 million. Historically, this business had been reported as a separate segment. As a result of the sale agreement, this business was accounted for as discontinued operations and its results of operations and cash flows were separately reported for all periods presented. Summary operating results of discontinued operations related to our wealth management business were as follows for the year ended December 31: (Amounts in millions) 2013 Revenues: Policy fees and other income $ 211 Total revenues 211 Benefits and expenses: Acquisition and operating expenses, net of deferrals 178 Amortization of deferred acquisition costs and intangibles 4 Total benefits and expenses 182 Income before income taxes and other items 29 Provision for income taxes 12 Income before other items 17 Goodwill impairment and other loss from sale, net of taxes (29 ) Loss from discontinued operations, net of taxes $ (12 ) Reverse mortgage business Effective April 1, 2013 (immediately prior to the holding company reorganization), Genworth Holdings completed the sale of its reverse mortgage business (which had been part of Corporate and Other activities) for total proceeds of $22 million. The gain on the sale was not significant.

Condensed Consolidating Financi

Condensed Consolidating Financial Information	12 Months Ended
	Dec. 31, 2015
Condensed Consolidating Financial Information	(25) Condensed Consolidating Financial Information Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior notes and the holders of the senior notes, on an unsecured unsubordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, each outstanding series of senior notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior notes indenture in respect of such senior notes. Genworth Financial also provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding subordinated notes and the holders of the subordinated notes, on an unsecured subordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the subordinated notes indenture in respect of the subordinated notes. The following condensed consolidating financial information of Genworth Financial and its direct and indirect subsidiaries have been prepared pursuant to rules regarding the preparation of consolidating financial information of Regulation S-X. The condensed consolidating financial information has been prepared as if the guarantee had been in place during the periods presented herein. The condensed consolidating financial information presents the condensed consolidating balance sheet information as of December 31, 2015 and 2014 and the condensed consolidating income statement information, condensed consolidating comprehensive income statement information and condensed consolidating cash flow statement information for the years ended December 31, 2015, 2014 and 2013. The condensed consolidating financial information reflects Genworth Financial (“Parent Guarantor”), Genworth Holdings (“Issuer”) and each of Genworth Financial’s other direct and indirect subsidiaries (the “All Other Subsidiaries”) on a combined basis, none of which guarantee the senior notes or subordinated notes, as well as the eliminations necessary to present Genworth Financial’s financial information on a consolidated basis and total consolidated amounts. The accompanying condensed consolidating financial information is presented based on the equity method of accounting for all periods presented. Under this method, investments in subsidiaries are recorded at cost and adjusted for the subsidiaries’ cumulative results of operations, capital contributions and distributions, and other changes in equity. Elimination entries include consolidating and eliminating entries for investments in subsidiaries and intercompany activity. The following table presents the condensed consolidating balance sheet information as of December 31, 2015: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Assets Investments: Fixed maturity securities available-for-sale, at fair value $ — $ 150 $ 58,247 $ (200 ) $ 58,197 Equity securities available-for-sale, at fair value — — 310 — 310 Commercial mortgage loans — — 6,170 — 6,170 Restricted commercial mortgage loans related to securitization entities — — 161 — 161 Policy loans — — 1,568 — 1,568 Other invested assets — 114 2,198 (3 ) 2,309 Restricted other invested assets related to securitization entities, at fair value — — 413 — 413 Investments in subsidiaries 12,814 12,989 — (25,803 ) — Total investments 12,814 13,253 69,067 (26,006 ) 69,128 Cash and cash equivalents — 1,124 4,841 — 5,965 Accrued investment income — — 657 (4 ) 653 Deferred acquisition costs — — 4,398 — 4,398 Intangible assets and goodwill — — 357 — 357 Reinsurance recoverable — — 17,245 — 17,245 Other assets — 199 323 (2 ) 520 Intercompany notes receivable — 2 458 (460 ) — Deferred tax assets 25 1,038 (908 ) — 155 Separate account assets — — 7,883 — 7,883 Assets held for sale — — 127 — 127 Total assets $ 12,839 $ 15,616 $ 104,448 $ (26,472 ) $ 106,431 Liabilities and stockholders’ equity Liabilities: Future policy benefits $ — $ — $ 36,475 $ — $ 36,475 Policyholder account balances — — 26,209 — 26,209 Liability for policy and contract claims — — 8,095 — 8,095 Unearned premiums — — 3,308 — 3,308 Other liabilities 13 279 2,722 (10 ) 3,004 Intercompany notes payable 2 658 — (660 ) — Borrowings related to securitization entities — — 179 — 179 Non-recourse funding obligations — — 1,920 — 1,920 Long-term borrowings — 4,078 492 — 4,570 Deferred tax liability — — 24 — 24 Separate account liabilities — — 7,883 — 7,883 Liabilities held for sale — — 127 — 127 Total liabilities 15 5,015 87,434 (670 ) 91,794 Equity: Common stock 1 — — — 1 Additional paid-in capital 11,949 9,097 17,007 (26,104 ) 11,949 Accumulated other comprehensive income (loss) 3,010 3,116 3,028 (6,144 ) 3,010 Retained earnings 564 (1,612 ) (5,134 ) 6,746 564 Treasury stock, at cost (2,700 ) — — — (2,700 ) Total Genworth Financial, Inc.’s stockholders’ equity 12,824 10,601 14,901 (25,502 ) 12,824 Noncontrolling interests — — 2,113 (300 ) 1,813 Total equity 12,824 10,601 17,014 (25,802 ) 14,637 Total liabilities and equity $ 12,839 $ 15,616 $ 104,448 $ (26,472 ) $ 106,431 The following table presents the condensed consolidating balance sheet information as of December 31, 2014: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Assets Investments: Fixed maturity securities available-for-sale, at fair value $ — $ 150 $ 61,127 $ (200 ) $ 61,077 Equity securities available-for-sale, at fair value — — 275 — 275 Commercial mortgage loans — — 6,100 — 6,100 Restricted commercial mortgage loans related to securitization entities — — 201 — 201 Policy loans — — 1,501 — 1,501 Other invested assets — 14 2,199 (5 ) 2,208 Restricted other invested assets related to securitization entities, at fair value — — 411 — 411 Investments in subsidiaries 14,895 15,003 — (29,898 ) — Total investments 14,895 15,167 71,814 (30,103 ) 71,773 Cash and cash equivalents — 953 3,692 — 4,645 Accrued investment income — — 664 (4 ) 660 Deferred acquisition costs — — 4,852 — 4,852 Intangible assets and goodwill — — 265 — 265 Reinsurance recoverable — — 17,291 — 17,291 Other assets 2 183 295 (1 ) 479 Intercompany notes receivable 9 267 395 (671 ) — Separate account assets — — 9,208 — 9,208 Assets held for sale — — 2,143 — 2,143 Total assets $ 14,906 $ 16,570 $ 110,619 $ (30,779 ) $ 111,316 Liabilities and stockholders’ equity Liabilities: Future policy benefits $ — $ — $ 35,915 $ — $ 35,915 Policyholder account balances — — 26,032 — 26,032 Liability for policy and contract claims — — 7,881 — 7,881 Unearned premiums — — 3,485 — 3,485 Other liabilities 3 251 2,991 (11 ) 3,234 Intercompany notes payable — 604 267 (871 ) — Borrowings related to securitization entities — — 219 — 219 Non-recourse funding obligations — — 1,981 — 1,981 Long-term borrowings — 4,127 485 — 4,612 Deferred tax liability (20 ) (970 ) 1,848 — 858 Separate account liabilities — — 9,208 — 9,208 Liabilities held for sale — — 1,094 — 1,094 Total liabilities (17 ) 4,012 91,406 (882 ) 94,519 Equity: Common stock 1 — — — 1 Additional paid-in capital 11,997 9,162 17,080 (26,242 ) 11,997 Accumulated other comprehensive income (loss) 4,446 4,449 4,459 (8,908 ) 4,446 Retained earnings 1,179 (1,053 ) (4,205 ) 5,258 1,179 Treasury stock, at cost (2,700 ) — — — (2,700 ) Total Genworth Financial, Inc.’s stockholders’ equity 14,923 12,558 17,334 (29,892 ) 14,923 Noncontrolling interests — — 1,879 (5 ) 1,874 Total equity 14,923 12,558 19,213 (29,897 ) 16,797 Total liabilities and equity $ 14,906 $ 16,570 $ 110,619 $ (30,779 ) $ 111,316 The following table presents the condensed consolidating income statement information for the year ended December 31, 2015: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Revenues: Premiums $ — $ — $ 4,579 $ — $ 4,579 Net investment income (3 ) 1 3,154 (14 ) 3,138 Net investment gains (losses) — 43 (118 ) — (75 ) Policy fees and other income — (32 ) 940 (2 ) 906 Total revenues (3 ) 12 8,555 (16 ) 8,548 Benefits and expenses: Benefits and other changes in policy reserves — — 5,149 — 5,149 Interest credited — — 720 — 720 Acquisition and operating expenses, net of deferrals 32 2 1,275 — 1,309 Amortization of deferred acquisition costs and intangibles — — 966 — 966 Interest expense — 307 128 (16 ) 419 Total benefits and expenses 32 309 8,238 (16 ) 8,563 Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries (35 ) (297 ) 317 — (15 ) Provision (benefit) for income taxes (8 ) (103 ) 102 — (9 ) Equity in income (loss) of subsidiaries (579 ) (463 ) — 1,042 — Income (loss) from continuing operations (606 ) (657 ) 215 1,042 (6 ) Income (loss) from discontinued operations, net of taxes (9 ) — (398 ) — (407 ) Net income (loss) (615 ) (657 ) (183 ) 1,042 (413 ) Less: net income attributable to noncontrolling interests — — 202 — 202 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (615 ) $ (657 ) $ (385 ) $ 1,042 $ (615 ) The following table presents the condensed consolidating income statement information for the year ended December 31, 2014: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Revenues: Premiums $ — $ — $ 4,700 $ — $ 4,700 Net investment income (2 ) — 3,159 (15 ) 3,142 Net investment gains (losses) — 4 (26 ) — (22 ) Policy fees and other income — (4 ) 914 (1 ) 909 Total revenues (2 ) — 8,747 (16 ) 8,729 Benefits and expenses: Benefits and other changes in policy reserves — — 6,418 — 6,418 Interest credited — — 737 — 737 Acquisition and operating expenses, net of deferrals 21 — 1,117 — 1,138 Amortization of deferred acquisition costs and intangibles — — 453 — 453 Goodwill impairment — — 849 — 849 Interest expense — 321 128 (16 ) 433 Total benefits and expenses 21 321 9,702 (16 ) 10,028 Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries (23 ) (321 ) (955 ) — (1,299 ) Provision (benefit) for income taxes (8 ) (112 ) 30 (4 ) (94 ) Equity in income (loss) of subsidiaries (1,229 ) (1,147 ) — 2,376 — Income (loss) from continuing operations (1,244 ) (1,356 ) (985 ) 2,380 (1,205 ) Income (loss) from discontinued operations, net of taxes — — 157 — 157 Net income (loss) (1,244 ) (1,356 ) (828 ) 2,380 (1,048 ) Less: net income attributable to noncontrolling interests — — 196 — 196 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (1,244 ) $ (1,356 ) $ (1,024 ) $ 2,380 $ (1,244 ) The following table presents the condensed consolidating income statement information for the year ended December 31, 2013: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Revenues: Premiums $ — $ — $ 4,516 $ — $ 4,516 Net investment income (1 ) 1 3,170 (15 ) 3,155 Net investment gains (losses) — 6 (70 ) — (64 ) Policy fees and other income — — 1,022 (4 ) 1,018 Total revenues (1 ) 7 8,638 (19 ) 8,625 Benefits and expenses: Benefits and other changes in policy reserves — — 4,737 — 4,737 Interest credited — — 738 — 738 Acquisition and operating expenses, net of deferrals 33 32 1,179 — 1,244 Amortization of deferred acquisition costs and intangibles — — 463 — 463 Interest expense — 322 147 (19 ) 450 Total benefits and expenses 33 354 7,264 (19 ) 7,632 Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries (34 ) (347 ) 1,374 — 993 Provision (benefit) for income taxes 13 (120 ) 420 — 313 Equity in income (loss) of subsidiaries 607 796 — (1,403 ) — Income from continuing operations 560 569 954 (1,403 ) 680 Income (loss) from discontinued operations, net of taxes — (29 ) 63 — 34 Net income 560 540 1,017 (1,403 ) 714 Less: net income attributable to noncontrolling interests — — 154 — 154 Net income available to Genworth Financial, Inc.’s common stockholders $ 560 $ 540 $ 863 $ (1,403 ) $ 560 The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2015: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Net income (loss) $ (615 ) $ (657 ) $ (183 ) $ 1,042 $ (413 ) Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities not other-than-temporarily impaired (1,181 ) (1,158 ) (1,210 ) 2,340 (1,209 ) Net unrealized gains (losses) on other-than-temporarily impaired securities (4 ) (4 ) (4 ) 8 (4 ) Derivatives qualifying as hedges (25 ) (24 ) (19 ) 43 (25 ) Foreign currency translation and other adjustments (250 ) (171 ) (530 ) 421 (530 ) Total other comprehensive income (loss) (1,460 ) (1,357 ) (1,763 ) 2,812 (1,768 ) Total comprehensive income (loss) (2,075 ) (2,014 ) (1,946 ) 3,854 (2,181 ) Less: comprehensive income attributable to noncontrolling interests — — (106 ) — (106 ) Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders $ (2,075 ) $ (2,014 ) $ (1,840 ) $ 3,854 $ (2,075 ) The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2014: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Net income (loss) $ (1,244 ) $ (1,356 ) $ (828 ) $ 2,380 $ (1,048 ) Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities not other-than-temporarily impaired 1,539 1,510 1,573 (3,049 ) 1,573 Net unrealized gains (losses) on other-than- temporarily impaired securities 10 11 10 (21 ) 10 Derivatives qualifying as hedges 751 751 794 (1,545 ) 751 Foreign currency translation and other adjustments (339 ) (273 ) (537 ) 612 (537 ) Total other comprehensive income (loss) 1,961 1,999 1,840 (4,003 ) 1,797 Total comprehensive income (loss) 717 643 1,012 (1,623 ) 749 Less: comprehensive income attributable to noncontrolling interests — — 32 — 32 Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders $ 717 $ 643 $ 980 $ (1,623 ) $ 717 The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2013: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Net income $ 560 $ 540 $ 1,017 $ (1,403 ) $ 714 Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities not other-than-temporarily impaired (1,778 ) (1,733 ) (1,817 ) 3,511 (1,817 ) Net unrealized gains (losses) on other-than- temporarily impaired securities 66 65 66 (131 ) 66 Derivatives qualifying as hedges (590 ) (590 ) (615 ) 1,205 (590 ) Foreign currency translation and other adjustments (358 ) (335 ) (442 ) 693 (442 ) Total other comprehensive income (loss) (2,660 ) (2,593 ) (2,808 ) 5,278 (2,783 ) Total comprehensive income (loss) (2,100 ) (2,053 ) (1,791 ) 3,875 (2,069 ) Less: comprehensive income attributable to noncontrolling interests — — 31 — 31 Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders $ (2,100 ) $ (2,053 ) $ (1,822 ) $ 3,875 $ (2,100 ) The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2015: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Cash flows from operating activities: Net income (loss) $ (615 ) $ (657 ) $ (183 ) $ 1,042 $ (413 ) Less (income) loss from discontinued operations, net of taxes 9 — 398 — 407 Adjustments to reconcile net income (loss) to net cash from operating activities: Equity in (income) loss from subsidiaries 579 463 — (1,042 ) — Dividends from subsidiaries — 530 (530 ) — — Loss on sale of subsidiaries — — 141 — 141 Amortization of fixed maturity discounts and premiums and limited partnerships — — (106 ) — (106 ) Net investment losses (gains) — (43 ) 118 — 75 Charges assessed to policyholders — — (788 ) — (788 ) Acquisition costs deferred — — (293 ) — (293 ) Amortization of deferred acquisition costs and intangibles — — 966 — 966 Deferred income taxes (4 ) (65 ) (127 ) — (196 ) Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments — 41 (280 ) — (239 ) Stock-based compensation expense 21 — (5 ) — 16 Change in certain assets and liabilities: Accrued investment income and other assets 3 13 (123 ) 1 (106 ) Insurance reserves — — 1,847 — 1,847 Current tax liabilities (3 ) 18 (30 ) — (15 ) Other liabilities, policy and contract claims and other policy-related balances 2 (38 ) 328 1 293 Cash from operating activities—held for sale — — 2 — 2 Net cash from operating activities (8 ) 262 1,335 2 1,591 Cash flows from investing activities: Proceeds from maturities and repayments of investments: Fixed maturity securities — 1 4,540 — 4,541 Commercial mortgage loans — — 882 — 882 Restricted commercial mortgage loans related to securitization entities — — 41 — 41 Proceeds from sales of investments: Fixed maturity and equity securities — — 4,391 — 4,391 Purchases and originations of investments: Fixed maturity and equity securities — — (9,750 ) — (9,750 ) Commercial mortgage loans — — (956 ) — (956 ) Other invested assets, net — (100 ) 277 (2 ) 175 Policy loans, net — — 25 — 25 Intercompany notes receivable 9 265 (63 ) (211 ) — Capital contributions to subsidiaries — (25 ) 25 — — Proceeds from sale of a subsidiary, net of cash transferred — — 273 — 273 Payments for businesses purchased, net of cash acquired — (197 ) 197 — — Cash from investing activities—held for sale — — (26 ) — (26 ) Net cash from investing activities 9 (56 ) (144 ) (213 ) (404 ) Cash flows from financing activities: Deposits to universal life and investment contracts — — 2,257 — 2,257 Withdrawals from universal life and investment contracts — — (2,144 ) — (2,144 ) Redemption and repurchase of non-recourse funding obligations — — (61 ) — (61 ) Proceeds from the issuance of long-term debt — — 150 — 150 Repayment and repurchase of long-term debt — (50 ) (70 ) — (120 ) Repayment of borrowings related to securitization entities — — (36 ) — (36 ) Proceeds from intercompany notes payable 2 54 (267 ) 211 — Repurchase of subsidiary shares — — (68 ) — (68 ) Dividends paid to noncontrolling interests — — (157 ) — (157 ) Proceeds from the sale of subsidiary shares to noncontrolling interests — — 226 — 226 Other, net (3 ) (39 ) (56 ) — (98 ) Cash from financing activities—held for sale — — 9 — 9 Net cash from financing activities (1 ) (35 ) (217 ) 211 (42 ) Effect of exchange rate changes on cash and cash equivalents — — (70 ) — (70 ) Net change in cash and cash equivalents — 171 904 — 1,075 Cash and cash equivalents at beginning of period — 953 3,965 — 4,918 Cash and cash equivalents at end of period — 1,124 4,869 — 5,993 Less cash and cash equivalents held for sale at end of period — — 28 — 28 Cash and cash equivalents of continuing operations at end of period $ — $ 1,124 $ 4,841 $ — $ 5,965 The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2014: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Cash flows from operating activities: Net income (loss) $ (1,244 ) $ (1,356 ) $ (828 ) $ 2,380 $ (1,048 ) Less (income) loss from discontinued operations, net of taxes — — (157 ) — (157 ) Adjustments to reconcile net income (loss) to net cash from operating activities: Equity in (income) loss from subsidiaries 1,229 1,147 — (2,376 ) — Dividends from subsidiaries — 630 (630 ) — — Amortization of fixed maturity discounts and premiums and limited partnerships — — (111 ) — (111 ) Net investment losses (gains) — (4 ) 26 — 22 Charges assessed to policyholders — — (777 ) — (777 ) Acquisition costs deferred — — (383 ) — (383 ) Amortization of deferred acquisition costs and intangibles — — 453 — 453 Goodwill impairment — — 849 — 849 Deferred income taxes 4 (146 ) (195 ) (4 ) (341 ) Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments — 1 205 — 206 Stock-based compensation expense 21 — 7 — 28 Change in certain assets and liabilities: Accrued investment income and other assets (4 ) (9 ) (151 ) 1 (163 ) Insurance reserves — — 2,497 — 2,497 Current tax liabilities (2 ) (77 ) (117 ) — (196 ) Other liabilities, policy and contract claims and other policy-related balances 11 91 1,421 (6 ) 1,517 Cash from operating activities-held for sale — — 42 — 42 Net cash from operating activities 15 277 2,151 (5 ) 2,438 Cash flows from investing activities: Proceeds from maturities and repayments of investments: Fixed maturity securities — 150 5,048 — 5,198 Commercial mortgage loans — — 765 — 765 Restricted commercial mortgage loans related to securitization entities — — 32 — 32 Proceeds from sales of investments: Fixed maturity and equity securities — — 2,386 — 2,386 Purchases and originations of investments: Fixed maturity and equity securities — (150 ) (9,038 ) — (9,188 ) Commercial mortgage loans — — (967 ) — (967 ) Other invested assets, net — — (40 ) 5 (35 ) Policy loans, net — — 12 — 12 Intercompany notes receivable (1 ) (19 ) (2 ) 22 — Capital contributions to subsidiaries (12 ) — 12 — — Cash from investing activities-held for sale — — (39 ) — (39 ) Net cash from investing activities (13 ) (19 ) (1,831 ) 27 (1,836 ) Cash flows from financing activities: Deposits to universal life and investment contracts — — 2,993 — 2,993 Withdrawals from universal life and investment contracts — — (2,588 ) — (2,588 ) Redemption and repurchase of non-recourse funding obligations — — (42 ) — (42 ) Proceeds from the issuance of long-term debt — — 144 — 144 Repayment and repurchase of long-term debt — (485 ) (136 ) — (621 ) Repayment of borrowings related to securitization entities — — (32 ) — (32 ) Proceeds from intercompany notes payable — 3 19 (22 ) — Repurchase of subsidiary shares — — (28 ) — (28 ) Dividends paid to noncontrolling interests — — (75 ) — (75 ) Proceeds from the sale of subsidiary shares to noncontrolling interests — — 517 — 517 Other, net (2 ) (42 ) 14 — (30 ) Cash from financing activities-held for sale — — (33 ) — (33 ) Net cash from financing activities (2 ) (524 ) 753 (22 ) 205 Effect of exchange rate changes on cash and cash equivalents — — (103 ) — (103 ) Net change in cash and cash equivalents — (266 ) 970 — 704 Cash and cash equivalents at beginning of period — 1,219 2,995 — 4,214 Cash and cash equivalents at end of period — 953 3,965 — 4,918 Less cash and cash equivalents held for sale at end of period — — 273 — 273 Cash and cash equivalents of continuing operations at end of period $ — $ 953 $ 3,692 $ — $ 4,645 The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2013: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Cash flows from operating activities: Net income (loss) $ 560 $ 540 $ 1,017 $ (1,403 ) $ 714 Less income from discontinued operations, net of taxes — 29 (63 ) — (34 ) Adjustments to reconcile net income (loss) to net cash from operating activities: Equity in (income) loss from subsidiaries (607 ) (796 ) — 1,403 — Dividends from subsidiaries 535 376 (497 ) (414 ) — Amortization of fixed maturity discounts and premiums and limited partnerships — — (105 ) — (105 ) Net investment losses (gains) — (6 ) 70 — 64 Charges assessed to policyholders — — (812 ) — (812 ) Acquisition costs deferred — — (363 ) — (363 ) Amortization of deferred acquisition costs and intangibles — — 463 — 463 Deferred income taxes 24 (138 ) 14 — (100 ) Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments — 1 (60 ) — (59 ) Stock-based compensation expense 26 — 13 — 39 Change in certain assets and liabilities: Accrued investment income and other assets 2 67 (122 ) — (53 ) Insurance reserves — — 1,644 — 1,644 Current tax liabilities 3 45 293 — 341 Other liabilities, policy and contract claims and other policy-related balances (4 ) (11 ) (346 ) — (361 ) Cash from operating activities—held for sale — — 21 — 21 Net cash from operating activities 539 107 1,167 (414 ) 1,399 Cash flows from investing activities: Proceeds from maturities and repayments of investments: Fixed maturity securities — — 4,891 — 4,891 Commercial mortgage loans — — 896 — 896 Restricted commercial mortgage loans related to securitization entities — — 60 — 60 Proceeds from sales of investments: Fixed maturity and equity securities — 150 3,997 — 4,147 Purchases and originations of investments: Fixed maturity and equity securities — (150 ) (10,308 ) — (10,458 ) Commercial mortgage loans — — (873 ) — (873 ) Other invested assets, net — — 65 — 65 Policy loans, net — — 242 — 242 Intercompany notes receivable (8 ) (3 ) 95 (84 ) — Capital contributions to subsidiaries (531 ) (1 ) 532 — — Proceeds from sale of a subsidiary, net of cash transferred — 425 (60 ) — 365 Cash from investing activities—held for sale — (30 ) 115 — 85 Net cash from investing activities (539 ) 391 (348 ) (84 ) (580 ) Cash flows from financing activities: Deposits to universal life and investment contracts — — 2,999 — 2,999 Withdrawals from universal life and investment contracts — — (3,269 ) — (3,269 ) Redemption and repurchase of non-recourse funding obligations — — (28 ) — (28 ) Proceeds from the issuance of long-term debt — 793 — — 793 Repayment and repurchase of long-term debt — (365 ) — — (365 ) Repayment of borrowings related to securitization entities — — (108 ) — (108 ) Proceeds from intercompany notes payable — (87 ) 3 84 — Repurchase of subsidiary shares — — (43 ) — (43 ) Dividends paid to noncontrolling interests — — (52 ) — (52 ) Dividends paid to parent — (414 ) — 414 — Other, net — (49 ) (4 ) — (53 ) Cash from financing activities—held for sale — — (23 ) — (23 ) Net cash from financing activities — (122 ) (525 ) 498 (149 ) Effect of exchange rate changes on cash and cash equivalents — — (109 ) — (109 ) Net change in cash and cash equivalents — 376 185 — 561 Cash and cash equivalents at beginning of period — 843 2,810 — 3,653 Cash and cash equivalents at end of period — 1,219 2,995 — 4,214 Less cash and cash equivalents held for sale at end of period — — 557 — 557 Cash and cash equivalents of continuing operations at end of period $ — $ 1,219 $ 2,438 $ — $ 3,657 For information on significant restrictions on dividends by, or loans or advances from, subsidiaries of Genworth Financial and Genworth Holdings, and the restricted net assets of those subsidiaries, see note 18.

Schedule I Genworth Financial,

Schedule I Genworth Financial, Inc. Summary of investments-other than investments in related parties	12 Months Ended
	Dec. 31, 2015
Schedule I Genworth Financial, Inc. Summary of investments-other than investments in related parties	Schedule I Genworth Financial, Inc. Summary of Investments—Other Than Investments in Related Parties (Amounts in millions) As of December 31, 2015, the amortized cost or cost, fair value and carrying value of our invested assets were as follows: Type of investment Amortized cost Fair Carrying Fixed maturity securities: Bonds: U.S. government, agencies and authorities $ 5,487 $ 6,203 $ 6,203 State and political subdivisions 2,287 2,438 2,438 Non-U.S. government 1,910 2,015 2,015 Public utilities 4,170 4,536 4,536 All other corporate bonds 41,307 43,005 43,005 Total fixed maturity securities 55,161 58,197 58,197 Equity securities 325 310 310 Commercial mortgage loans 6,170 xxxxx 6,170 Restricted commercial mortgage loans related to securitization entities 161 xxxxx 161 Policy loans 1,568 xxxxx 1,568 Other invested assets (1) 1,208 xxxxx 2,309 Restricted other invested assets related to securitization entities 413 xxxxx 413 Total investments $ 65,006 xxxxx $ 69,128 (1) The amount shown in the consolidated balance sheet for other invested assets differs from amortized cost or cost presented, as other invested assets include certain assets with a carrying amount that differs from amortized cost or cost.

Schedule II Genworth Financial,

Schedule II Genworth Financial, Inc. (Parent Company Only)	12 Months Ended
	Dec. 31, 2015
Schedule II Genworth Financial, Inc. (Parent Company Only)	Schedule II Genworth Financial, Inc. (Parent Company Only) Balance Sheets (Amounts in millions) December 31, 2015 2014 Assets Investments in subsidiaries $ 12,814 $ 14,895 Deferred tax asset 25 20 Other assets — 2 Intercompany notes receivable — 9 Total assets $ 12,839 $ 14,926 Liabilities and stockholders’ equity Liabilities: Other liabilities $ 13 $ 3 Intercompany notes payable 2 — Total liabilities 15 3 Commitments and contingencies Stockholders’ equity: Common stock 1 1 Additional paid-in capital 11,949 11,997 Accumulated other comprehensive income (loss): Net unrealized investment gains (losses): Net unrealized gains (losses) on securities not other-than-temporarily impaired 1,236 2,431 Net unrealized gains (losses) on other-than-temporarily impaired securities 18 22 Net unrealized investment gains (losses) 1,254 2,453 Derivatives qualifying as hedges 2,045 2,070 Foreign currency translation and other adjustments (289 ) (77 ) Total accumulated other comprehensive income (loss) 3,010 4,446 Retained earnings 564 1,179 Treasury stock, at cost (2,700 ) (2,700 ) Total Genworth Financial, Inc.’s stockholders’ equity 12,824 14,923 Total liabilities and stockholders’ equity $ 12,839 $ 14,926 See Notes to Schedule II See Accompanying Report of Independent Registered Public Accounting Firm Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Income (Amounts in millions) Years ended December 31, 2015 2014 2013 Revenues: Net investment income $ (3 ) $ (2 ) $ (1 ) Total revenues (3 ) (2 ) (1 ) Expenses: Acquisition and operating expenses, net of deferrals 32 21 33 Total expenses 32 21 33 Loss before income taxes and equity in income (loss) of subsidiaries (35 ) (23 ) (34 ) Provision (benefit) from income taxes (8 ) (8 ) 13 Equity in income (loss) of subsidiaries (579 ) (1,229 ) 607 Loss from discontinued operations, net of taxes (9 ) — — Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (615 ) $ (1,244 ) $ 560 See Notes to Schedule II See Accompanying Report of Independent Registered Public Accounting Firm Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Comprehensive Income (Amounts in millions) Years ended December 31, 2015 2014 2013 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (615 ) $ (1,244 ) $ 560 Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities not other-than-temporarily impaired (1,181 ) 1,539 (1,778 ) Net unrealized gains (losses) on other-than-temporarily impaired securities (4 ) 10 66 Derivatives qualifying as hedges (25 ) 751 (590 ) Foreign currency translation and other adjustments (250 ) (339 ) (358 ) Total other comprehensive income (loss) (1,460 ) 1,961 (2,660 ) Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders $ (2,075 ) $ 717 $ (2,100 ) See Notes to Schedule II See Accompanying Report of Independent Registered Public Accounting Firm Schedule II Genworth Financial, Inc. (Parent Company Only) Statements of Cash Flows (Amounts in millions) Years ended December 31, 2015 2014 2013 Cash flows from operating activities: Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (615 ) $ (1,244 ) $ 560 Less loss from discontinued operations, net of taxes 9 — — Adjustments to reconcile net income (loss) available to Genworth Financial, Inc.’s common stockholders to net cash from operating activities: Equity in (income) loss from subsidiaries 579 1,229 (607 ) Dividends from subsidiaries — — 535 Deferred income taxes (4 ) 4 24 Stock-based compensation expense 21 21 26 Change in certain assets and liabilities: Accrued investment income and other assets 3 (4 ) 2 Current tax liabilities (3 ) (2 ) 3 Other liabilities and other policy-related balances 2 11 (4 ) Net cash from operating activities (8 ) 15 539 Cash flows from investing activities: Intercompany notes receivable 9 (1 ) (8 ) Capital contribution paid to subsidiaries — (12 ) (531 ) Net cash from investing activities 9 (13 ) (539 ) Cash flows from financing activities: Other, net (3 ) (2 ) — Intercompany notes payable 2 — — Net cash from financing activities (1 ) (2 ) — Effect of exchange rate changes on cash and cash equivalents — — Cash and cash equivalents at beginning of year — — — Cash and cash equivalents at end of year $ — $ — $ — See Notes to Schedule II See Accompanying Report of Independent Registered Public Accounting Firm Schedule II Genworth Financial, Inc. (Parent Company Only) Notes to Schedule II Years Ended December 31, 2015, 2014 and 2013 (1) Organization and Purpose Genworth Holdings, Inc. (“Genworth Holdings”) (formerly known as Genworth Financial, Inc.) was incorporated in Delaware in 2003 in preparation for an initial public offering of Genworth common stock, which was completed on May 28, 2004. On April 1, 2013, Genworth Holdings completed a holding company reorganization pursuant to which Genworth Holdings became a direct, 100% owned subsidiary of a new public holding company that it had formed. The new public holding company was incorporated in Delaware on December 5, 2012, in connection with the reorganization, under the name Sub XLVI, Inc., and was renamed Genworth Financial, Inc. (“Genworth Financial”) upon the completion of the reorganization. To implement the reorganization, Genworth Holdings formed Genworth Financial and Genworth Financial, in turn, formed Sub XLII, Inc. (“Merger Sub”). The holding company structure was implemented pursuant to Section 251(g) of the General Corporation Law of the State of Delaware (“DGCL”) by the merger of Merger Sub with and into Genworth Holdings (the “Merger”). Genworth Holdings survived the Merger as a direct, 100% owned subsidiary of Genworth Financial and each share of Genworth Holdings Class A Common Stock, par value $0.001 per share (“Genworth Holdings Class A Common Stock”), issued and outstanding immediately prior to the Merger and each share of Genworth Holdings Class A Common Stock held in the treasury of Genworth Holdings immediately prior to the Merger converted into one issued and outstanding or treasury, as applicable, share of Genworth Financial Class A Common Stock, par value $0.001 per share, having the same designations, rights, powers and preferences and the qualifications, limitations and restrictions as the Genworth Holdings Class A Common Stock being converted. Immediately after the consummation of the Merger, Genworth Financial had the same authorized, outstanding and treasury capital stock as Genworth Holdings immediately prior to the Merger. Each share of Genworth Financial common stock outstanding immediately prior to the Merger was cancelled. Effective upon the consummation of the Merger, Genworth Financial adopted an amended and restated certificate of incorporation and amended and restated bylaws that were identical to those of Genworth Holdings immediately prior to the consummation of the Merger (other than provisions regarding certain technical matters, as permitted by Section 251(g) of the DGCL). Genworth Financial’s directors and executive officers immediately after the consummation of the Merger were the same as the directors and executive officers of Genworth Holdings immediately prior to the consummation of the Merger. Immediately after the consummation of the Merger, Genworth Financial had, on a consolidated basis, the same assets, businesses and operations as Genworth Holdings had immediately prior to the consummation of the Merger. On April 1, 2013, in connection with the reorganization, immediately following the consummation of the Merger, Genworth Holdings distributed to Genworth Financial (as its sole stockholder), through a dividend (the “Distribution”), the 84.6% membership interest in one of its subsidiaries (Genworth Mortgage Holdings, LLC (“GMHL”)) that it held directly, and 100% of the shares of another of its subsidiaries (Genworth Mortgage Holdings, Inc. (“GMHI”)), that held the remaining 15.4% of outstanding membership interests of GMHL. At the time of the Distribution, GMHL and GMHI together owned (directly or indirectly) 100% of the shares or other equity interests of all of the subsidiaries that conducted Genworth Holdings’ U.S. mortgage insurance business (these subsidiaries also owned the subsidiaries that conducted Genworth Holdings’ European mortgage insurance business). As part of the comprehensive U.S. mortgage insurance capital plan, on April 1, 2013, immediately prior to the Distribution, Genworth Holdings contributed $100 million to the U.S. mortgage insurance subsidiaries. The financial information contained herein has been prepared as if the reorganization occurred on January 1, 2013. Genworth Financial is a holding company whose subsidiaries offer mortgage and long-term care insurance products and service life insurance, as well as annuities and other investment products. (2) Commitments Genworth Financial provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding senior notes and the holders of the senior notes, on an unsecured unsubordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, each outstanding series of senior notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the senior notes indenture in respect of such senior notes. Genworth Financial also provides a full and unconditional guarantee to the trustee of Genworth Holdings’ outstanding subordinated notes and the holders of the subordinated notes, on an unsecured subordinated basis, of the full and punctual payment of the principal of, premium, if any and interest on, and all other amounts payable under, the outstanding subordinated notes, and the full and punctual payment of all other amounts payable by Genworth Holdings under the subordinated notes indenture in respect of the subordinated notes. Genworth Financial also provides a full and unconditional guarantee of Genworth Holdings’ obligations associated with Rivermont Life Insurance Company I and the Tax Matters Agreement. Any obligations under Genworth Holdings’ credit agreement are unsecured and payment of Genworth Holdings’ obligations is fully and unconditionally guaranteed by Genworth Financial. (3) Income Taxes As of December 31, 2015 and 2014, Genworth Financial had a deferred tax asset of $25 million and $20 million, respectively, primarily comprised of share-based compensation. These amounts are undiscounted pursuant to the applicable rules governing deferred taxes. Genworth Financial’s current income tax receivable was zero and $3 million as of December 31, 2015 and 2014, respectively. Net cash received for taxes was $1 million, $23 million and $5 million for the years ended December 31, 2015, 2014 and 2013, respectively.

Schedule III Genworth Financial

Schedule III Genworth Financial, Inc. Supplemental Insurance Information	12 Months Ended
	Dec. 31, 2015
Schedule III Genworth Financial, Inc. Supplemental Insurance Information	Schedule III Genworth Financial, Inc. Supplemental Insurance Information (Amounts in millions) Segment Deferred Future Policy Policyholder Liability for Policy Unearned December 31, 2015 U.S. Mortgage Insurance $ 22 $ — $ — $ 849 $ 258 Canada Mortgage Insurance 108 — — 87 1,460 Australia Mortgage Insurance 35 — — 165 963 U.S. Life Insurance 3,963 36,471 23,009 6,969 621 Runoff 270 4 3,200 18 6 Corporate and Other — — — 7 — Total $ 4,398 $ 36,475 $ 26,209 $ 8,095 $ 3,308 December 31, 2014 U.S. Mortgage Insurance $ 16 $ — $ — $ 1,180 $ 178 Canada Mortgage Insurance 112 — — 91 1,548 Australia Mortgage Insurance 41 — — 152 1,112 U.S. Life Insurance 4,390 35,911 22,874 6,434 639 Runoff 293 4 3,158 15 7 Corporate and Other — — — 9 1 Total $ 4,852 $ 35,915 $ 26,032 $ 7,881 $ 3,485 See Accompanying Report of Independent Registered Public Accounting Firm Schedule III—Continued Genworth Financial, Inc. Supplemental Insurance Information (Amounts in millions) Segment Premium Net Interest Credited Amortization of Other Premiums December 31, 2015 U.S. Mortgage Insurance $ 602 $ 58 $ 222 $ 7 $ 158 $ 682 Canada Mortgage Insurance 466 130 96 35 85 641 Australia Mortgage Insurance 357 114 81 16 110 328 U.S. Life Insurance 3,128 2,701 5,288 816 832 3,115 Runoff 1 138 168 28 78 1 Corporate and Other 25 (3 ) 14 — 529 27 Total $ 4,579 $ 3,138 $ 5,869 $ 902 $ 1,792 $ 4,794 December 31, 2014 U.S. Mortgage Insurance $ 578 $ 59 $ 357 $ 5 $ 142 $ 628 Canada Mortgage Insurance 515 155 102 35 114 583 Australia Mortgage Insurance 406 144 78 15 113 509 U.S. Life Insurance 3,169 2,665 6,438 291 1,648 3,172 Runoff 3 129 156 37 87 2 Corporate and Other 29 (10 ) 24 — 386 19 Total $ 4,700 $ 3,142 $ 7,155 $ 383 $ 2,490 $ 4,913 December 31, 2013 U.S. Mortgage Insurance $ 554 $ 60 $ 412 $ 4 $ 146 $ 567 Canada Mortgage Insurance 560 170 139 31 121 499 Australia Mortgage Insurance 398 159 134 17 126 519 U.S. Life Insurance 2,957 2,621 4,594 298 841 2,963 Runoff 5 139 151 4 85 4 Corporate and Other 42 6 45 — 484 28 Total $ 4,516 $ 3,155 $ 5,475 $ 354 $ 1,803 $ 4,580 See Accompanying Report of Independent Registered Public Accounting Firm

Summary of Significant Accoun37

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2015
Premiums	a) Premiums For traditional long-duration insurance contracts, we report premiums as earned when due. For short-duration insurance contracts, we report premiums as revenue over the terms of the related insurance policies on a pro-rata basis or in proportion to expected claims. For single premium mortgage insurance contracts, we report premiums over the estimated policy life in accordance with the expected pattern of risk emergence as further described in our accounting policy for unearned premiums. In addition, we have a practice of refunding the post-delinquent premiums in our U.S. mortgage insurance business to the insured party if the delinquent loan goes to claim. We record a liability for premiums received on the delinquent loans where our practice is to refund post-delinquent premiums. Premiums received under annuity contracts without significant mortality risk and premiums received on investment and universal life insurance products are not reported as revenues but rather as deposits and are included in liabilities for policyholder account balances.
Net Investment Income and Net Investment Gains and Losses	b) Net Investment Income and Net Investment Gains and Losses Investment income is recognized when earned. Income or losses upon call or prepayment of available-for-sale fixed maturity securities is recognized in net investment income, except for hybrid securities where the income or loss upon call is recognized in net investment gains and losses. Investment gains and losses are calculated on the basis of specific identification on the trade date. Investment income on mortgage-backed and asset-backed securities is initially based upon yield, cash flow and prepayment assumptions at the date of purchase. Subsequent revisions in those assumptions are recorded using the retrospective or prospective method. Under the retrospective method used for mortgage-backed and asset-backed securities of high credit quality (ratings equal to or greater than “AA” or that are backed by a U.S. agency) which cannot be contractually prepaid in such a manner that we would not recover a substantial portion of the initial investment, amortized cost of the security is adjusted to the amount that would have existed had the revised assumptions been in place at the date of purchase. The adjustments to amortized cost are recorded as a charge or credit to net investment income. Under the prospective method, which is used for all other mortgage-backed and asset-backed securities, future cash flows are estimated and interest income is recognized going forward using the new internal rate of return.
Policy Fees and Other Income	c) Policy Fees and Other Income Policy fees and other income consists primarily of insurance charges assessed on universal and term universal life insurance contracts and fees assessed against customer account values. For universal and term universal life insurance contracts, charges to policyholder accounts for cost of insurance are recognized as revenue when due. Variable product fees are charged to variable annuity contractholders and variable life insurance policyholders based upon the daily net assets of the contractholder’s and policyholder’s account values and are recognized as revenue when charged. Policy surrender fees are recognized as income when the policy is surrendered.
Investment Securities	d) Investment Securities At the time of purchase, we designate our investment securities as either available-for-sale or trading and report them in our consolidated balance sheets at fair value. Our portfolio of fixed maturity securities comprises primarily investment grade securities. Changes in the fair value of available-for-sale investments, net of the effect on deferred acquisition costs (“DAC”), present value of future profits (“PVFP”), benefit reserves and deferred income taxes, are reflected as unrealized investment gains or losses in a separate component of accumulated other comprehensive income (loss). Realized and unrealized gains and losses related to trading securities are reflected in net investment gains (losses). Trading securities are included in other invested assets in our consolidated balance sheets and primarily represent fixed maturity securities where we utilized the fair value option. Other-Than-Temporary Impairments On Available-For-Sale Securities As of each balance sheet date, we evaluate securities in an unrealized loss position for other-than-temporary impairments. For debt securities, we consider all available information relevant to the collectability of the security, including information about past events, current conditions, and reasonable and supportable forecasts, when developing the estimate of cash flows expected to be collected. More specifically for mortgage-backed and asset-backed securities, we also utilize performance indicators of the underlying assets including default or delinquency rates, loan to collateral value ratios, third-party credit enhancements, current levels of subordination, vintage and other relevant characteristics of the security or underlying assets to develop our estimate of cash flows. Estimating the cash flows expected to be collected is a quantitative and qualitative process that incorporates information received from third-party sources along with certain internal assumptions and judgments regarding the future performance of the underlying collateral. Where possible, this data is benchmarked against third-party sources. We recognize other-than-temporary impairments on debt securities in an unrealized loss position when one of the following circumstances exists: • we do not expect full recovery of our amortized cost basis, • the present value of cash flows expected to be collected is less than our amortized cost basis, • we intend to sell a security or • it is more likely than not that we will be required to sell a security prior to recovery. For other-than-temporary impairments recognized during the period, we present the total other-than-temporary impairments, the portion of other-than-temporary impairments included in other comprehensive income (loss) (“OCI”) and the net other-than-temporary impairments as supplemental disclosure presented on the face of our consolidated statements of income. Total other-than-temporary impairments that emerged in the current period are calculated as the difference between the amortized cost and fair value. For other-than-temporarily impaired securities where we do not intend to sell the security and it is not more likely than not that we will be required to sell the security prior to recovery, total other-than-temporary impairments are adjusted by the portion of other-than-temporary impairments recognized in OCI (“non-credit”). Net other-than-temporary impairments recorded in net income (loss) represent the credit loss on the other-than-temporarily impaired securities with the offset recognized as an adjustment to the amortized cost to determine the new amortized cost basis of the securities. For securities that were deemed to be other-than-temporarily impaired and a non-credit loss was recorded in OCI, the amount recorded as an unrealized gain (loss) represents the difference between the current fair value and the new amortized cost for each period presented. The unrealized gain (loss) on an other-than-temporarily impaired security is recorded as a separate component in OCI until the security is sold or until we record an other-than-temporary impairment where we intend to sell the security or will be required to sell the security prior to recovery. To estimate the amount of other-than-temporary impairment attributed to credit losses on debt securities where we do not intend to sell the security and it is not more likely than not that we will be required to sell the security prior to recovery, we determine our best estimate of the present value of the cash flows expected to be collected from a security using the effective yield on the security prior to recording any other-than-temporary impairment. If the present value of the discounted cash flows is lower than the amortized cost of the security, the difference between the present value and amortized cost represents the credit loss associated with the security with the remaining difference between fair value and amortized cost recorded as a non-credit other-than-temporary impairment in OCI. The evaluation of other-than-temporary impairments is subject to risks and uncertainties and is intended to determine the appropriate amount and timing for recognizing an impairment charge. The assessment of whether such impairment has occurred is based on management’s best estimate of the cash flows expected to be collected at the individual security level. We regularly monitor our investment portfolio to ensure that securities that may be other-than-temporarily impaired are identified in a timely manner and that any impairment charge is recognized in the proper period. While the other-than-temporary impairment model for debt securities generally includes fixed maturity securities, there are certain hybrid securities that are classified as fixed maturity securities where the application of a debt impairment model depends on whether there has been any evidence of deterioration in credit of the issuer, such as a downgrade to below investment grade. Under certain circumstances, evidence of deterioration in credit of the issuer may result in the application of the equity securities impairment model. For equity securities, we recognize an impairment charge in the period in which we determine that the security will not recover to book value within a reasonable period. We determine what constitutes a reasonable period on a security-by-security basis based upon consideration of all the evidence available to us, including the magnitude of an unrealized loss and its duration. In any event, this period does not exceed 18 months for common equity securities. We measure other-than-temporary impairments based upon the difference between the amortized cost of a security and its fair value.
Fair Value Measurements	e) Fair Value Measurements Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. We have fixed maturity, equity and trading securities, derivatives, embedded derivatives, securities held as collateral, separate account assets and certain other financial instruments, which are carried at fair value. Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We utilize valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs. All assets and liabilities carried at fair value are classified and disclosed in one of the following three categories: • Level 1—Quoted prices for identical instruments in active markets. • Level 2—Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations whose inputs are observable or whose significant value drivers are observable. • Level 3—Instruments whose significant value drivers are unobservable. Level 1 primarily consists of financial instruments whose value is based on quoted market prices such as exchange-traded derivatives and actively traded mutual fund investments. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. These models are primarily industry-standard models that consider various inputs, such as interest rate, credit spread and foreign exchange rates for the underlying financial instruments. All significant inputs are observable, or derived from observable, information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed maturity and equity securities; government or agency securities; certain mortgage-backed and asset-backed securities; securities held as collateral; and certain non-exchange-traded derivatives such as interest rate or cross currency swaps. Level 3 comprises financial instruments whose fair value is estimated based on industry-standard pricing methodologies and internally developed models utilizing significant inputs not based on, nor corroborated by, readily available market information. In certain instances, this category may also utilize non-binding broker quotes. This category primarily consists of certain less liquid fixed maturity, equity and trading securities and certain derivative instruments or embedded derivatives where we cannot corroborate the significant valuation inputs with market observable data. As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment, and considers factors specific to the asset or liability, such as the relative impact on the fair value as a result of including a particular input. We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3 at the beginning fair value for the reporting period in which the changes occur. See note 16 for additional information related to fair value measurements.
Commercial Mortgage Loans	f) Commercial Mortgage Loans The carrying value of commercial mortgage loans is stated at original cost, net of principal payments, amortization and allowance for loan losses. Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Commercial mortgage loans are considered past due when contractual payments have not been received from the borrower by the required payment date. “Impaired” loans are defined by U.S. GAAP as loans for which it is probable that the lender will be unable to collect all amounts due according to original contractual terms of the loan agreement. In determining whether it is probable that we will be unable to collect all amounts due, we consider current payment status, debt service coverage ratios, occupancy levels and current loan-to-value. Impaired loans are carried on a non-accrual status. Loans are placed on non-accrual status when, in management’s opinion, the collection of principal or interest is unlikely, or when the collection of principal or interest is 90 days or more past due. Income on impaired loans is not recognized until the loan is sold or the cash received exceeds the carrying amount recorded. We evaluate the impairment of commercial mortgage loans first on an individual loan basis. If an individual loan is not deemed impaired, then we evaluate the remaining loans collectively to determine whether an impairment should be recorded. For individually impaired loans, we record an impairment charge when it is probable that a loss has been incurred. The impairment is recorded as an increase in the allowance for loan losses. All losses of principal are charged to the allowance for loan losses in the period in which the loan is deemed to be uncollectible. For loans that are not individually impaired where we evaluate the loans collectively, the allowance for loan losses is maintained at a level that we determine is adequate to absorb estimated probable incurred losses in the loan portfolio. Our process to determine the adequacy of the allowance utilizes an analytical model based on historical loss experience adjusted for current events, trends and economic conditions that would result in a loss in the loan portfolio over the next 12 months. Key inputs into our evaluation include debt service coverage ratios, loan-to-value, property-type, occupancy levels, geographic region, and probability weighting of the scenarios generated by the model. The actual amounts realized could differ in the near term from the amounts assumed in arriving at the allowance for loan losses reported in the consolidated financial statements. Additions and reductions to the allowance through periodic provisions or benefits are recorded in net investment gains (losses). For commercial mortgage loans classified as held-for-sale, each loan is carried at the lower of cost or market and is included in commercial mortgage loans in our consolidated balance sheets. See note 4 for additional disclosures related to commercial mortgage loans.
Repurchase Agreements	g) Repurchase Agreements We have a repurchase program in which we sell an investment security at a specified price and agree to repurchase that security at another specified price at a later date. Repurchase agreements are treated as collateralized financing transactions and are carried at the amounts at which the securities will be subsequently reacquired, including accrued interest, as specified in the respective agreement. The fair value of securities to be repurchased is monitored and collateral levels are adjusted where appropriate to protect the counterparty against credit exposure. Cash received is invested in fixed maturity securities. See note 12 for additional information related to our repurchase agreements.
Securities Lending Activity	h) Securities Lending Activity In the United States and Canada, we engage in certain securities lending transactions for the purpose of enhancing the yield on our investment securities portfolio. We maintain effective control over all loaned securities and, therefore, continue to report such securities as fixed maturity securities on the consolidated balance sheets. We are currently indemnified against counterparty credit risk by the intermediary. See note 12 for additional information related to our securities lending activity.
Cash and Cash Equivalents	i) Cash and Cash Equivalents Certificates of deposit, money market funds and other time deposits with original maturities of 90 days or less are considered cash equivalents in the consolidated balance sheets and consolidated statements of cash flows. Items with maturities greater than 90 days but less than one year at the time of acquisition are considered short-term investments.
Deferred Acquisition Costs	j) Deferred Acquisition Costs Acquisition costs include costs that are directly related to the successful acquisition of new or renewal insurance contracts. Acquisition costs are deferred and amortized to the extent they are recoverable from future profits. Long-Duration Contracts Amortization for deferred annuity and universal life insurance contracts is based on expected gross profits. Expected gross profits are adjusted quarterly to reflect actual experience to date or for changes in underlying assumptions relating to future gross profits. Estimates of gross profits for DAC amortization are based on assumptions including interest rates, policyholder persistency or lapses, insured life expectancy or longevity and expenses. Short-Duration Contracts. We regularly review our assumptions and test DAC for recoverability at least annually. For deferred annuity and universal life insurance contracts, if the present value of expected future gross profits is less than the unamortized DAC for a line of business, a charge to income is recorded for additional DAC amortization. For traditional long-duration and short-duration contracts, if the benefit reserve plus anticipated future premiums and interest income for a line of business are less than the current estimate of future benefits and expenses (including any unamortized DAC), a charge to income is recorded for additional DAC amortization or for increased benefit reserves. See note 6 for additional information related to DAC including loss recognition and recoverability.
Intangible Assets	k) Intangible Assets Present Value of Future Profits. We regularly review our PVFP assumptions and periodically test PVFP for recoverability similar to our treatment of DAC. See note 7 for additional information related to PVFP including loss recognition and recoverability. Deferred Sales Inducements to Contractholders. Other Intangible Assets
Goodwill	l) Goodwill Goodwill is not amortized but is tested for impairment annually or between annual tests if an event occurs or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying value. The determination of fair value requires the use of estimates and judgment, at the “reporting unit” level. A reporting unit is the operating segment, or a business, one level below that operating segment (the “component” level) if discrete financial information is prepared and regularly reviewed by management at the component level. If the reporting unit’s fair value is below its carrying value, we must determine the amount of implied goodwill that would be established if the reporting unit was hypothetically purchased on the impairment assessment date. We recognize an impairment charge for any amount by which the carrying amount of a reporting unit’s goodwill exceeds the amount of implied goodwill. See note 7 for additional information related to goodwill and impairments recorded.
Reinsurance	m) Reinsurance Premium revenue, benefits and acquisition and operating expenses, net of deferrals, are reported net of the amounts relating to reinsurance ceded to and assumed from other companies. Amounts due from reinsurers for incurred and estimated future claims are reflected in the reinsurance recoverable asset. Amounts received from reinsurers that represent recovery of acquisition costs are netted against DAC so that the net amount is capitalized. The cost of reinsurance is accounted for over the terms of the related treaties using assumptions consistent with those used to account for the underlying reinsured policies. Premium revenue, benefits and acquisition and operating expenses, net of deferrals, for reinsurance contracts that do not qualify for reinsurance accounting are accounted for under the deposit method of accounting.
Derivatives	n) Derivatives Derivative instruments are used to manage risk through one of four principal risk management strategies including: (i) liabilities; (ii) invested assets; (iii) portfolios of assets or liabilities; and (iv) forecasted transactions. On the date we enter into a derivative contract, management designates the derivative as a hedge of the identified exposure (fair value, cash flow or foreign currency). If a derivative does not qualify for hedge accounting, the changes in its fair value and all scheduled periodic settlement receipts and payments are reported in income. We formally document all relationships between hedging instruments and hedged items, as well as our risk management objective and strategy for undertaking various hedge transactions. In this documentation, we specifically identify the asset, liability or forecasted transaction that has been designated as a hedged item, state how the hedging instrument is expected to hedge the risks related to the hedged item, and set forth the method that will be used to retrospectively and prospectively assess the hedging instrument’s effectiveness and the method that will be used to measure hedge ineffectiveness. We generally determine hedge effectiveness based on total changes in fair value of the hedged item attributable to the hedged risk and the total changes in fair value of the derivative instrument. We discontinue hedge accounting prospectively when: (i) it is determined that the derivative is no longer effective in offsetting changes in the fair value or cash flows of a hedged item; (ii) the derivative expires or is sold, terminated or exercised; (iii) the derivative is de-designated as a hedge instrument; or (iv) it is no longer probable that the forecasted transaction will occur. For all qualifying and highly effective cash flow hedges, the effective portion of changes in fair value of the derivative instrument is reported as a component of OCI. The ineffective portion of changes in fair value of the derivative instrument is reported as a component of income. When hedge accounting is discontinued because it is probable that a forecasted transaction will not occur, the derivative continues to be carried in the consolidated balance sheets at its fair value, and gains and losses that were accumulated in OCI are recognized immediately in income. When the hedged forecasted transaction is no longer probable, but is reasonably possible, the accumulated gain or loss remains in OCI and is recognized when the transaction affects income; however, prospective hedge accounting for the transaction is terminated. In all other situations in which hedge accounting is discontinued on a cash flow hedge, amounts previously deferred in OCI are reclassified into income when income is impacted by the variability of the cash flow of the hedged item. For all qualifying and highly effective fair value hedges, the changes in fair value of the derivative instrument are reported in income. In addition, changes in fair value attributable to the hedged portion of the underlying instrument are reported in income. When hedge accounting is discontinued because it is determined that the derivative no longer qualifies as an effective fair value hedge, the derivative continues to be carried in the consolidated balance sheets at its fair value, but the hedged asset or liability will no longer be adjusted for changes in fair value. In all other situations in which hedge accounting is discontinued, the derivative is carried at its fair value in the consolidated balance sheets, with changes in its fair value recognized in current period income. We may enter into contracts that are not themselves derivative instruments but contain embedded derivatives. For each contract, we assess whether the economic characteristics of the embedded derivative are clearly and closely related to those of the host contract and determine whether a separate instrument with the same terms as the embedded instrument would meet the definition of a derivative instrument. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and that a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is separated from the host contract and accounted for as a stand-alone derivative. Such embedded derivatives are recorded in the consolidated balance sheets at fair value and are classified consistent with their host contract. Changes in their fair value are recognized in current period income. If we are unable to properly identify and measure an embedded derivative for separation from its host contract, the entire contract is carried in the consolidated balance sheets at fair value, with changes in fair value recognized in current period income. Changes in the fair value of non-qualifying derivatives, including embedded derivatives, changes in fair value of certain derivatives and related hedged items in fair value hedge relationships and hedge ineffectiveness on cash flow hedges are reported in net investment gains (losses). The majority of our derivative arrangements require the posting of collateral upon meeting certain net exposure thresholds. The amounts recognized for derivative counterparty collateral received by us was recorded in cash and cash equivalents with a corresponding amount recorded in other liabilities to represent our obligation to return the collateral retained by us. We also receive non-cash collateral that is not recognized in our balance sheet unless we exercise our right to sell or re-pledge the underlying asset. As of December 31, 2015 and 2014, the fair value of non-cash collateral received was $86 million and $287 million, respectively, and the underlying assets were not sold or re-pledged. Additionally, we have pledged $263 million and $49 million of fixed maturity securities as of December 31, 2015 and 2014, respectively. We have not pledged any cash as collateral to derivative counterparties. Fixed maturity securities that we pledge as collateral remain on our balance sheet within fixed maturity securities available-for-sale. Any cash collateral pledged to a derivative counterparty is derecognized with a receivable recorded in other assets for the right to receive our cash collateral back from the counterparty.
Separate Accounts and Related Insurance Obligations	o) Separate Accounts and Related Insurance Obligations Separate account assets represent funds for which the investment income and investment gains and losses accrue directly to the contractholders and are reflected in our consolidated balance sheets at fair value, reported as summary total separate account assets with an equivalent summary total reported for liabilities. Amounts assessed against the contractholders for mortality, administrative and other services are included in revenues. Changes in liabilities for minimum guarantees are included in benefits and other changes in policy reserves. Net investment income, net investment gains (losses) and the related liability changes associated with the separate account are offset within the same line item in the consolidated statements of income. There were no gains or losses on transfers of assets from the general account to the separate account. We offer certain minimum guarantees associated with our variable annuity contracts. Our variable annuity contracts usually contain a basic guaranteed minimum death benefit (“GMDB”) which provides a minimum benefit to be paid upon the annuitant’s death equal to the larger of account value and the return of net deposits. Some variable annuity contracts permit contractholders to purchase through riders, at an additional charge, enhanced death benefits such as the highest contract anniversary value (“ratchets”), accumulated net deposits at a stated rate (“rollups”), or combinations thereof. Additionally, some of our variable annuity contracts provide the contractholder with living benefits such as a guaranteed minimum withdrawal benefit (“GMWB”) or certain types of guaranteed annuitization benefits. The GMWB allows contractholders to withdraw a pre-defined percentage of account value or benefit base each year, either for a specified period of time or for life. The guaranteed annuitization benefit generally provides for a guaranteed minimum level of income upon annuitization accompanied by the potential for upside market participation. Most of our reserves for additional insurance and annuitization benefits are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future experience. The projections utilize stochastic scenarios of separate account returns incorporating reversion to the mean, as well as assumptions for mortality and lapses. Some of our minimum guarantees, mainly GMWBs, are accounted for as embedded derivatives; see notes 5 and 16 for additional information on these embedded derivatives and related fair value measurement disclosures.
Insurance Reserves	p) Insurance Reserves Future Policy Benefits The liability for future policy benefits is equal to the present value of expected benefits and expenses less the present value of expected future net premiums based on assumptions, including, investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured life expectancy or longevity, insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses, all of which are locked-in at the time the policies are issued or acquired. Claim termination rates refer to the expected rates at which claims end. Benefit utilization rates estimate how much of the available policy benefits are expected to be used. The liability for future policy benefits is evaluated at least annually to determine if a premium deficiency exists. Loss recognition testing is generally performed at the line of business level, with acquired blocks and certain reinsured blocks tested separately. If the liability for future policy benefits plus the current present value of expected future premiums are less than the current present value of expected future benefits and expenses (including any unamortized DAC), a charge to income is recorded for accelerated DAC amortization and, if necessary, a premium deficiency reserve is established. If a charge is recorded, DAC amortization and the liability for future policy benefits are measured using updated assumptions, which become the new locked-in assumptions utilized going forward unless another premium deficiency charge is recorded. Our estimates of future premiums used in loss recognition testing for our long-term care insurance business include assumptions for significant premium rate increases that have been filed and approved or are anticipated to be approved. Beginning in the fourth quarter of 2014, estimates of future premiums also include significant anticipated (but not yet filed) future rate increases or benefit reductions. These anticipated future increases are based on our best estimate of the rate increases we expect to obtain, considering, among other factors, our historical experience from prior rate increase approvals and based on our best estimate of expected claim costs. We are also required to accrue additional future policy benefit reserves when the overall reserve is adequate, but profits are projected in early periods followed by losses projected in later periods. When this pattern of profits followed by losses exists, we ratably accrue this additional profits followed by losses liability over time, increasing reserves in the profitable periods to offset estimated losses expected during the periods that follow. We calculate and adjust the additional reserves using our current best estimate of the amount necessary to offset the losses in future periods, based on the pattern of expected income and current best estimate assumptions consistent with our loss recognition testing. We adjust the accrual rate prospectively, going forward over the remaining profit periods, without any catch-up adjustment. For long-term care insurance products, benefit reductions are treated as partial lapse of coverage with the balance of our future policy benefits and DAC both reduced in proportion to the reduced coverage. For level premium term life insurance products, we floor the liability for future policy benefits on each policy at zero. Estimates and actuarial assumptions used for establishing the liability for future policy benefits and in loss recognition testing involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for future policy benefits and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The risk that our claims experience may differ significantly from our pricing and valuation assumptions is particularly significant for our long-term care insurance products. Long-term care insurance policies provide for long-duration coverage and, therefore, our actual claims experience will emerge over many years after pricing and locked-in valuation assumptions have been established. Policyholder Account Balances The liability for policyholder account balances represents the contract value that has accrued to the benefit of the policyholder as of the balance sheet date for investment-type and universal life insurance contracts. We are also required to establish additional benefit reserves for guarantees or product features in addition to the contract value where the additional benefit reserves are calculated by applying a benefit ratio to accumulated contractholder assessments, and then deducting accumulated paid claims. The benefit ratio is equal to the ratio of benefits to assessments, accumulated with interest and considering both past and anticipated future experience. Investment-type contracts are broadly defined to include contracts without significant mortality or morbidity risk. Payments received from sales of investment contracts are recognized by providing a liability equal to the current account value of the policyholders’ contracts. Interest rates credited to investment contracts are guaranteed for the initial policy term with renewal rates determined as necessary by management.
Liability for Policy and Contract Claims	q) Liability for Policy and Contract Claims The liability for policy and contract claims, or claim reserves, represents the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. The estimated liability includes requirements for future payments of: (a) claims that have been reported to the insurer; (b) claims related to insured events that have occurred but that have not been reported to the insurer as of the date the liability is estimated; and (c) claim adjustment expenses. Claim adjustment expenses include costs incurred in the claim settlement process such as legal fees and costs to record, process and adjust claims. Our liability for policy and contract claims is reviewed regularly, with changes in our estimates of future claims recorded through net income (loss). Estimates and actuarial assumptions used for establishing the liability for policy and contract claims involve the exercise of significant judgment, and changes in assumptions or deviations of actual experience from assumptions can have material impacts on our liability for policy and contract claims and net income (loss). Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The liability for policy and contract claims for our long-term care insurance products represents the present value of the amount needed to provide for the estimated ultimate cost of settling claims relating to insured events that have occurred on or before the end of the respective reporting period. Key assumptions include investment returns, health care experience (including type of care and cost of care), policyholder persistency or lapses (i.e., the probability that a policy or contract will remain in-force from one period to the next), insured mortality (i.e., life expectancy or longevity), insured morbidity (i.e., frequency and severity of claim, including claim termination rates and benefit utilization rates) and expenses. Claim termination rates refer to the expected rates at which claims end. Benefit utilization rates estimate how much of the available policy benefits are expected to be used. Both claim termination rates and benefit utilization rates are influenced by, among other things, gender, age at claim, diagnosis, type of care needed, benefit period, and daily benefit amount. Because these assumptions relate to factors that are not known in advance, change over time, are difficult to accurately predict and are inherently uncertain, we cannot determine with precision the ultimate amounts we will pay for actual claims or the timing of those payments. Small changes in assumptions or small deviations of actual experience from assumptions can have, and in the past have had, material impacts on our reserves, results of operations and financial condition. The liabilities for our mortgage insurance policies represent our best estimates of the liabilities at the time based on known facts, trends and other external factors, including economic conditions, housing prices and employment rates. For our mortgage insurance policies, reserves for losses and loss adjustment expenses are based on notices of mortgage loan defaults and estimates of defaults that have been incurred but have not been reported by loan servicers, using assumptions of claim rates for loans in default and the average amount paid for loans that result in a claim. As is common accounting practice in the mortgage insurance industry and in accordance with U.S. GAAP, we begin to provide for the ultimate claim payment relating to a potential claim on a defaulted loan when the status of that loan first goes delinquent. Over time, as the status of the underlying delinquent loans move toward foreclosure and the likelihood of the associated claim loss increases, the amount of the loss reserves associated with the potential claims may also increase. Management considers the liability for policy and contract claims provided to be satisfactory to cover the losses that have occurred. Management monitors actual experience, and where circumstances warrant, will revise its assumptions. The methods of determining such estimates and establishing the reserves are reviewed periodically and any adjustments are reflected in operations in the period in which they become known. Future developments may result in losses and loss expenses greater or less than the liability for policy and contract claims provided.
Unearned Premiums	r) Unearned Premiums For single premium insurance contracts, we recognize premiums over the policy life in accordance with the expected pattern of risk emergence. We recognize a portion of the revenue in premiums earned in the current period, while the remaining portion is deferred as unearned premiums and earned over time in accordance with the expected pattern of risk emergence. If single premium policies are cancelled and the premium is non-refundable, then the remaining unearned premium related to each cancelled policy is recognized to earned premiums upon notification of the cancellation. Expected pattern of risk emergence on which we base premium recognition is inherently judgmental and is based on actuarial analysis of historical experience. We periodically review our premium earnings recognition models with any adjustments to the estimates reflected in current period income. For the years ended December 31, 2015, 2014 and 2013, we updated our premium recognition factors for our international mortgage insurance businesses. These updates included the consideration of recent and projected loss experience, policy cancellation experience and refinement of actuarial methods. In 2015, 2014 and 2013, adjustments associated with this update resulted in an increase in earned premiums of $8 million, $6 million and $12 million, respectively.
Stock-Based Compensation	s) Stock-Based Compensation We determine a grant date fair value and recognize the related compensation expense, adjusted for expected forfeitures, through the income statement over the respective vesting period of the awards.
Employee Benefit Plans	t) Employee Benefit Plans We provide employees with a defined contribution pension plan and recognize expense throughout the year based on the employee’s age, service and eligible pay. We make an annual contribution to the plan. We also provide employees with defined contribution savings plans. We recognize expense for our contributions to the savings plans at the time employees make contributions to the plans. Some employees participate in defined benefit pension and postretirement benefit plans. We recognize expense for these plans based upon actuarial valuations performed by external experts. We estimate aggregate benefits by using assumptions for employee turnover, future compensation increases, rates of return on pension plan assets and future health care costs. We recognize an expense for differences between actual experience and estimates over the average future service period of participants. We recognize the overfunded or underfunded status of a defined benefit plan as an asset or liability in our consolidated balance sheets and recognize changes in that funded status in the year in which the changes occur through OCI.
Income Taxes	u) Income Taxes We determine deferred tax assets and/or liabilities by multiplying the differences between the financial reporting and tax reporting bases for assets and liabilities by the enacted tax rates expected to be in effect when such differences are recovered or settled if there is no change in law. The effect on deferred taxes of a change in tax rates is recognized in income in the period that includes the enactment date. Valuation allowances on deferred tax assets are estimated based on our assessment of the realizability of such amounts. We do not record U.S. deferred taxes on foreign income that we do not expect to remit or repatriate to U.S. corporations within our consolidated group. Under U.S. GAAP, we are generally required to record U.S. deferred taxes on the anticipated repatriation of foreign income as the income is recognized for financial reporting purposes. An exception under certain accounting guidance permits us not to record a U.S. deferred tax liability for foreign income that we expect to reinvest in our foreign operations and for which remittance will be postponed indefinitely. If it becomes apparent that we cannot positively assert that some or all undistributed income will be reinvested indefinitely, the related deferred taxes are recorded in that period. In determining indefinite reinvestment, we regularly evaluate the capital needs of our domestic and foreign operations considering all available information, including operating and capital plans, regulatory capital requirements, parent company financing and cash flow needs, as well as the applicable tax laws to which our domestic and foreign subsidiaries are subject. Our estimates are based on our historical experience and our expectation of future performance. Our judgments and assumptions are subject to change given the inherent uncertainty in predicting future capital needs, which are impacted by such things as regulatory requirements, policyholder behavior, competitor pricing, new product introductions, and specific industry and market conditions. Similarly, under another exception to the recognition of deferred taxes under U.S. GAAP, we do not record deferred taxes on U.S. domestic subsidiary entities for the excess of the financial statement carrying amount over the tax basis in the stock of the subsidiary (commonly referred to as “outside basis difference”) if we have the ability under the tax law and intent to recover the basis difference in a tax free manner. Deferred taxes would be recognized in the period of a change to our ability or intent. Our companies have elected to file a single U.S. consolidated income tax return (the “life/non-life consolidated return”). All companies domesticated in the United States and our Bermuda and Guernsey subsidiaries, which have elected to be taxed as U.S. domestic companies, are included in the life/non-life consolidated return as allowed by the tax law and regulations. We have a tax sharing agreement (the “life/non-life tax sharing agreement”) in place and all intercompany balances related to this agreement are settled at least annually. Our subsidiaries based in Bermuda and Guernsey are treated as U.S. insurance companies under provisions of the U.S. Internal Revenue Code, are included in the life/non-life consolidated return, and have adopted the life-non/life tax sharing agreement. Jurisdictions outside the United States in which our various subsidiaries incur significant taxes include Australia and Canada.
Foreign Currency Translation	v) Foreign Currency Translation The determination of the functional currency is made based on the appropriate economic and management indicators. The assets and liabilities of foreign operations are translated into U.S. dollars at the exchange rates in effect at the balance sheet date. Translation adjustments are included as a separate component of accumulated other comprehensive income (loss). Revenues and expenses of the foreign operations are translated into U.S. dollars at the average rates of exchange during the period of the transaction. Gains and losses from foreign currency transactions are reported in income and have not been material in any years presented in our consolidated statements of income.
Variable Interest Entities	w) Variable Interest Entities We are involved in certain entities that are considered VIEs as defined under U.S. GAAP, and, accordingly, we evaluate the VIE to determine whether we are the primary beneficiary and are required to consolidate the assets and liabilities of the entity. The primary beneficiary of a VIE is the enterprise that has the power to direct the activities of a VIE that most significantly impacts the VIE’s economic performance and has the obligation to absorb losses or receive benefits that could potentially be significant to the VIE. The determination of the primary beneficiary for a VIE can be complex and requires management judgment regarding the expected results of the entity and how those results are absorbed by beneficial interest holders, as well as which party has the power to direct activities that most significantly impact the performance of the VIEs. Our primary involvement related to VIEs includes securitization transactions, certain investments and certain mortgage insurance policies. We have retained interests in VIEs where we are the servicer and transferor of certain assets that were sold to a newly created VIE. Additionally, for certain securitization transactions, we were the transferor of certain assets that were sold to a newly created VIE but did not retain any beneficial interest in the VIE other than acting as the servicer of the underlying assets. We hold investments in certain structures that are considered VIEs. Our investments represent beneficial interests that are primarily in the form of structured securities or alternative investments. Our involvement in these structures typically represent a passive investment in the returns generated by the VIE and typically do not result in having significant influence over the economic performance of the VIE. We also provide mortgage insurance on certain residential mortgage loans originated and securitized by third parties using VIEs to issue mortgage-backed securities. While we provide mortgage insurance on the underlying loans, we do not typically have any ongoing involvement with the VIE other than our mortgage insurance coverage and do not act in a servicing capacity for the underlying loans held by the VIE. See note 17 for additional information related to these consolidated entities.
Accounting Changes	x) Accounting Changes Debt Issuance Costs On December 31, 2015, we early adopted new accounting guidance related to the presentation of debt issuance costs. The new guidance requires that debt issuance costs be presented in the balance sheet as a direct deduction from the carrying amount of that debt liability. This guidance was applied on a retrospective basis. Upon adoption, in our consolidated balance sheet as of December 31, 2014, we recorded a reduction in other assets and total assets of $42 million, with a related reduction in long-term debt of $27 million, a reduction in non-recourse funding obligations of $15 million and a reduction in total liabilities of $42 million. We also adopted new guidance that allows debt issuance costs related to revolving credit facilities to be presented as either an asset or as a direct deduction from the carrying amount of that debt liability. We elected to continue to present debt issuance costs related to revolving credit facilities in other assets in our consolidated balance sheet. See note 12 for more information related to our long-term debt and non-recourse funding obligations. Financial Assets and Liabilities of a Collateralized Financing Entity On January 1, 2015, we early adopted new accounting guidance related to measuring the financial assets and financial liabilities of a consolidated collateralized financing entity. The guidance addresses the accounting for the measurement difference between the fair value of financial assets and the fair value of financial liabilities of a collateralized financing entity. The new guidance provides an alternative whereby a reporting entity could measure the financial assets and financial liabilities of the collateralized financing entity in its consolidated financial statements using the more observable of the fair values. There was no impact on our consolidated financial statements. Repurchase Financings On January 1, 2015, we adopted new accounting guidance related to the accounting for repurchase-to-maturity transactions and repurchase financings. The new guidance changed the accounting for repurchase-to-maturity transactions and repurchase financing such that they were consistent with secured borrowing accounting. In addition, the guidance required new disclosures for all repurchase agreements and securities lending transactions which were effective beginning in the second quarter of 2015. We do not have repurchase-to-maturity transactions, but have repurchase agreements and securities lending transactions that are subject to additional disclosures. This new guidance did not have an impact on our consolidated financial statements but did impact our disclosures. Investments In Affordable Housing Projects On January 1, 2015, we adopted new accounting guidance related to the accounting for investments in affordable housing projects that qualify for the low-income housing tax credit. The new guidance permits reporting entities to make an accounting policy election to account for investments in qualified affordable housing projects by amortizing the initial cost of the investment in proportion to the tax benefits received and recognize the net investment performance as a component of income tax expense (called the proportional amortization method) if certain conditions are met. The new guidance requires use of the equity method or cost method for investments in qualified affordable housing projects not accounted for using the proportional amortization method. The adoption of this new guidance did not have a material impact on our consolidated financial statements. Share-Based Payment Awards On January 1, 2015, we early adopted new accounting guidance related to the accounting for share-based payment awards when the terms of an award provide that a performance target can be achieved after the requisite service period. The guidance requires that such performance targets should not be reflected in estimating the grant-date fair value of an award, and that compensation cost should be recognized in the period in which it becomes probable that the performance target will be achieved. We have performance stock unit grants where awards for employees who are retirement eligible can vest on a pro-rata basis upon retirement even if retirement occurs before the performance target is achieved. There was no impact on our consolidated financial statements from the adoption of this accounting guidance. Investment Companies On January 1, 2014, we adopted new accounting guidance on the scope, measurement and disclosure requirements for investment companies. The new guidance clarified the characteristics of an investment company, provided comprehensive guidance for assessing whether an entity is an investment company, required investment companies to measure noncontrolling ownership interest in other investment companies at fair value rather than using the equity method of accounting and required additional disclosures. The adoption of this accounting guidance did not have any impact on our consolidated financial statements. Benchmarking Interest Rates Used When Applying Hedge Accounting In July 2013, we adopted new accounting guidance to provide additional flexibility in the benchmark interest rates used when applying hedge accounting. The new guidance permits the use of the Federal Funds Effective Swap Rate as a benchmark interest rate for hedge accounting purposes and removes certain restrictions on being able to apply hedge accounting for similar hedges using different benchmark interest rates. The adoption of this accounting guidance did not have a material impact on our consolidated financial statements.
Accounting Pronouncements Not Yet Adopted	y) Accounting Pronouncements Not Yet Adopted In January 2016, the Financial Accounting Standards Board (the “FASB”) issued new accounting guidance related to the recognition and measurement of financial assets and financial liabilities. Changes to the current financial instruments accounting primarily affects equity investments, financial liabilities under the fair value option, and the presentation and disclosure requirements for financial instruments. Under the new guidance, equity investments with readily determinable fair value, except those accounted for under the equity method of accounting, will be measured at fair value with changes in fair value recognized in net income. The new guidance also clarifies that the need for a valuation allowance on a deferred tax asset related to available-for-sale securities should be evaluated in combination with other deferred tax assets. This new guidance will be effective for us on January 1, 2018. We are still in process of evaluating the impact the guidance may have on our consolidated financial statements. In May 2015, the FASB issued new disclosure requirements for short-duration insurance contracts. The new guidance requires additional disclosures on short-duration policy and contract claims liabilities for incurred and paid claims development, unpaid claims and claims frequency. These new disclosures will be effective for us on December 31, 2016 with early adoption permitted and will only impact our disclosures. In February 2015, the FASB issued new accounting guidance related to consolidation. This guidance primarily impacts limited partnerships and similar legal entities, evaluation of fees paid to a decision maker as a variable interest, the effect of fee arrangements and related parties on the primary beneficiary determination and certain investment funds. This guidance is effective for us on January 1, 2016, with early adoption permitted. We do not expect any significant impact on our consolidated financial statements. In May 2014, the FASB issued new accounting guidance related to revenue from contracts with customers, effective for us on January 1, 2018. The key principle of the new guidance is that entities should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for such goods or services. The standard permits the use of either the retrospective or modified retrospective (cumulative effect) transition method. Insurance contracts are specifically excluded from this new guidance. The FASB has proposed a technical correction to clarify the scope that both insurance and investment contracts are excluded from the scope of this new guidance. In addition, we believe that mortgage insurance, although excluded from insurance revenue guidance, is not within scope of the new revenue recognition rules and will continue to follow existing industry revenue practices. As such, while we are still evaluating the full impact, at this time we do not expect any significant impacts from this new guidance on our consolidated financial statements.
Accounting Correction	z) Cash Flow Statement Reclassification We have revised our consolidated statements of cash flows previously reported in our 2014 Annual Report on Form 10-K for the years ended December 31, 2014 and 2013 to reflect a correction related to the calculation of the change in reinsurance recoverable that impacted the lines “insurance reserves” and “other liabilities, policy and contract claims and other policy-related balances.” As a result, the change in insurance reserves decreased by $720 million and $613 million, respectively, and the change in other liabilities, policy and contract claims and other policy-related balances increased by $720 million and $613 million, respectively, for the years ended December 31, 2014 and 2013. The revisions had no impact on net cash flows from operating activities or the total change in cash and cash equivalents within our consolidated statements of cash flows. Additionally, there was no impact on our consolidated balance sheets or consolidated statements of income.

Earnings (Loss) Per Share (Tabl

Earnings (Loss) Per Share (Tables)	12 Months Ended
	Dec. 31, 2015
Earnings (Loss) per Share	Basic and diluted earnings (loss) per share are calculated by dividing each income (loss) category presented below by the weighted-average basic and diluted common shares outstanding for the years ended December 31: (Amounts in millions, except per share amounts) 2015 2014 2013 Weighted-average common shares used in basic earnings (loss) per common share calculations 497.4 496.4 493.6 Potentially dilutive securities: Stock options, restricted stock units and stock appreciation rights — — 5.1 Weighted-average common shares used in diluted earnings (loss) per common share calculations (1) 497.4 496.4 498.7 Income (loss) from continuing operations: Income (loss) from continuing operations $ (6 ) $ (1,205 ) $ 680 Less: income from continuing operations attributable to noncontrolling interests 202 196 154 Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders $ (208 ) $ (1,401 ) $ 526 Basic per common share $ (0.42 ) $ (2.82 ) $ 1.07 Diluted per common share $ (0.42 ) $ (2.82 ) $ 1.05 Income (loss) from discontinued operations: Income (loss) from discontinued operations, net of taxes $ (407 ) $ 157 $ 34 Less: income from discontinued operations, net of taxes, attributable to noncontrolling interests — — — Income (loss) from discontinued operations, net of taxes, available to Genworth Financial, Inc.’s common stockholders $ (407 ) $ 157 $ 34 Basic per common share $ (0.82 ) $ 0.32 $ 0.07 Diluted per common share $ (0.82 ) $ 0.32 $ 0.07 Net income (loss): Income (loss) from continuing operations $ (6 ) $ (1,205 ) $ 680 Income (loss) from discontinued operations, net of taxes (407 ) 157 34 Net income (loss) (413 ) (1,048 ) 714 Less: net income attributable to noncontrolling interests 202 196 154 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (615 ) $ (1,244 ) $ 560 Basic per common share $ (1.24 ) $ (2.51 ) $ 1.13 Diluted per common share $ (1.24 ) $ (2.51 ) $ 1.12 (1) Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the years ended December 31, 2015 and 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the years ended December 31, 2015 and 2014, as the inclusion of shares for stock options, restricted stock units (“RSUs”) and stock appreciation rights (“SARs”) of 1.6 million and 5.6 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the years ended December 31, 2015 and 2014, dilutive potential weighted-average common shares outstanding would have been 499.0 million and 502.0 million, respectively.

Investments (Tables)

Investments (Tables)	12 Months Ended
	Dec. 31, 2015
Net Investment Income	Sources of net investment income were as follows for the years ended December 31: (Amounts in millions) 2015 2014 2013 Fixed maturity securities—taxable $ 2,558 $ 2,598 $ 2,603 Fixed maturity securities—non-taxable 12 12 9 Commercial mortgage loans 337 333 335 Restricted commercial mortgage loans related to securitization entities (1) 14 14 23 Equity securities 15 14 17 Other invested assets (2) 135 105 108 Restricted other invested assets related to securitization entities (1) 5 5 4 Policy loans 137 129 129 Cash, cash equivalents and short-term investments 13 24 19 Gross investment income before expenses and fees 3,226 3,234 3,247 Expenses and fees (88 ) (92 ) (92 ) Net investment income $ 3,138 $ 3,142 $ 3,155 (1) See note 17 for additional information related to consolidated securitization entities. (2) Included in other invested assets was $9 million, $8 million and $13 million of net investment income related to trading securities for the years ended December 31, 2015, 2014 and 2013, respectively.
Net Investment Gains (Losses)	The following table sets forth net investment gains (losses) for the years ended December 31: (Amounts in millions) 2015 2014 2013 Available-for-sale securities: Realized gains $ 102 $ 72 $ 149 Realized losses (82 ) (46 ) (184 ) Net realized gains (losses) on available-for-sale securities 20 26 (35 ) Impairments: Total other-than-temporary impairments (28 ) (9 ) (16 ) Portion of other-than-temporary impairments included in other comprehensive income (loss) 1 — (9 ) Net other-than-temporary impairments (27 ) (9 ) (25 ) Trading securities (7 ) 39 (23 ) Commercial mortgage loans 7 11 4 Net gains (losses) related to securitization entities (1) 5 16 69 Derivative instruments (2) (76 ) (103 ) (49 ) Contingent consideration adjustment 2 (2 ) — Other 1 — (5 ) Net investment gains (losses) $ (75 ) $ (22 ) $ (64 ) (1) See note 17 for additional information related to consolidated securitization entities. (2) See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses).
Credit Losses Recognized in Net Income (Loss)	The following represents the activity for credit losses recognized in net income (loss) on debt securities where an other-than-temporary impairment was identified and a portion of other-than-temporary impairments was included in OCI as of and for the years ended December 31: (Amounts in millions) 2015 2014 2013 Beginning balance $ 83 $ 101 $ 387 Additions: Other-than-temporary impairments not previously recognized — 1 4 Increases related to other-than-temporary impairments previously recognized — 1 11 Reductions: Securities sold, paid down or disposed (19 ) (20 ) (301 ) Ending balance $ 64 $ 83 $ 101
Unrealized Investment Gains and Losses	Net unrealized gains and losses on available-for-sale investment securities reflected as a separate component of accumulated other comprehensive income (loss) were as follows as of December 31: (Amounts in millions) 2015 2014 2013 Net unrealized gains (losses) on investment securities: Fixed maturity securities $ 3,140 $ 5,560 $ 2,346 Equity securities (10 ) 32 23 Other invested assets — (2 ) (4 ) Subtotal 3,130 5,590 2,365 Adjustments to DAC, PVFP, sales inducements and benefit reserves (1,070 ) (1,656 ) (869 ) Income taxes, net (711 ) (1,372 ) (517 ) Net unrealized investment gains (losses) 1,349 2,562 979 Less: net unrealized investment gains (losses) attributable to noncontrolling interests 95 109 53 Net unrealized investment gains (losses) attributable to Genworth Financial, Inc. $ 1,254 $ 2,453 $ 926
Change in Net Unrealized Gains (Losses) on Available-for-Sale Investment Securities Reported in Accumulated Other Comprehensive Income (Loss)	The change in net unrealized gains (losses) on available-for-sale investment securities reported in accumulated other comprehensive income (loss) was as follows as of and for the years ended December 31: (Amounts in millions) 2015 2014 2013 Beginning balance $ 2,453 $ 926 $ 2,638 Unrealized gains (losses) arising during the period: Unrealized gains (losses) on investment securities (2,467 ) 3,244 (3,780 ) Adjustment to DAC 177 (172 ) 248 Adjustment to PVFP 89 (66 ) 95 Adjustment to sales inducements 30 (15 ) 40 Adjustment to benefit reserves 290 (534 ) 673 Provision for income taxes 663 (862 ) 952 Change in unrealized gains (losses) on investment securities (1,218 ) 1,595 (1,772 ) Reclassification adjustments to net investment (gains) losses, net of taxes of $(2), $7 and $(12) 5 (12 ) 21 Change in net unrealized investment gains (losses) (1,213 ) 1,583 (1,751 ) Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests (14 ) 56 (39 ) Ending balance $ 1,254 $ 2,453 $ 926
Fixed Maturity and Equity Securities	As of December 31, 2015, the amortized cost or cost, gross unrealized gains (losses) and fair value of our fixed maturity and equity securities classified as available-for-sale were as follows: Amortized Gross unrealized gains Gross unrealized losses Fair (Amounts in millions) Not other-than- Other-than- Not other-than- Other-than- Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 5,487 $ 732 $ — $ (16 ) $ — $ 6,203 State and political subdivisions 2,287 181 — (30 ) — 2,438 Non-U.S. government 1,910 110 — (5 ) — 2,015 U.S. corporate: Utilities 3,355 364 — (26 ) — 3,693 Energy 2,560 103 — (162 ) — 2,501 Finance and insurance 5,268 392 15 (43 ) — 5,632 Consumer—non-cyclical 3,755 371 — (30 ) — 4,096 Technology and communications 2,108 123 — (38 ) — 2,193 Industrial 1,164 53 — (44 ) — 1,173 Capital goods 1,774 188 — (12 ) — 1,950 Consumer—cyclical 1,602 95 — (22 ) — 1,675 Transportation 1,023 75 — (12 ) — 1,086 Other 385 22 — (5 ) — 402 Total U.S. corporate 22,994 1,786 15 (394 ) — 24,401 Non-U.S. corporate: Utilities 815 37 — (9 ) — 843 Energy 1,700 64 — (78 ) — 1,686 Finance and insurance 2,327 152 2 (8 ) — 2,473 Consumer—non-cyclical 746 24 — (18 ) — 752 Technology and communications 978 36 — (26 ) — 988 Industrial 1,063 19 — (96 ) — 986 Capital goods 602 19 — (17 ) — 604 Consumer—cyclical 522 8 — (4 ) — 526 Transportation 559 52 — (6 ) — 605 Other 2,574 187 — (25 ) — 2,736 Total non-U.S. corporate 11,886 598 2 (287 ) — 12,199 Residential mortgage-backed 4,777 330 11 (17 ) — 5,101 Commercial mortgage-backed 2,492 84 3 (20 ) — 2,559 Other asset-backed 3,328 11 1 (59 ) — 3,281 Total fixed maturity securities 55,161 3,832 32 (828 ) — 58,197 Equity securities 325 8 — (23 ) — 310 Total available-for-sale securities $ 55,486 $ 3,840 $ 32 $ (851 ) $ — $ 58,507 As of December 31, 2014, the amortized cost or cost, gross unrealized gains (losses) and fair value of our fixed maturity and equity securities classified as available-for-sale were as follows: Amortized Gross unrealized gains Gross unrealized losses Fair (Amounts in millions) Not other-than- Other-than- Not other-than- Other-than- Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 5,006 $ 995 $ — $ (1 ) $ — $ 6,000 State and political subdivisions 2,013 236 — (27 ) — 2,222 Non-U.S. government 1,761 143 — (2 ) — 1,902 U.S. corporate: Utilities 3,292 577 — (5 ) — 3,864 Energy 2,498 265 — (21 ) — 2,742 Finance and insurance 5,102 537 20 (13 ) — 5,646 Consumer—non-cyclical 3,483 538 — (8 ) — 4,013 Technology and communications 2,112 217 — (4 ) — 2,325 Industrial 1,195 100 — (8 ) — 1,287 Capital goods 1,748 263 — (5 ) — 2,006 Consumer—cyclical 1,750 158 — (8 ) — 1,900 Transportation 929 114 — (4 ) — 1,039 Other 370 31 — — — 401 Total U.S. corporate 22,479 2,800 20 (76 ) — 25,223 Non-U.S. corporate: Utilities 857 48 — (2 ) — 903 Energy 1,911 163 — (38 ) — 2,036 Finance and insurance 2,757 203 — (3 ) — 2,957 Consumer—non-cyclical 764 41 — (9 ) — 796 Technology and communications 986 71 — (4 ) — 1,053 Industrial 1,166 65 — (18 ) — 1,213 Capital goods 592 31 — (5 ) — 618 Consumer—cyclical 520 14 — — — 534 Transportation 521 70 — (1 ) — 590 Other 3,153 257 — (15 ) — 3,395 Total non-U.S. corporate 13,227 963 — (95 ) — 14,095 Residential mortgage-backed 4,871 362 13 (17 ) (1 ) 5,228 Commercial mortgage-backed 2,564 143 4 (9 ) — 2,702 Other asset-backed 3,735 23 1 (54 ) — 3,705 Total fixed maturity securities 55,656 5,665 38 (281 ) (1 ) 61,077 Equity securities 250 32 — (7 ) — 275 Total available-for-sale securities $ 55,906 $ 5,697 $ 38 $ (288 ) $ (1 ) $ 61,352
Gross Unrealized Losses and Fair Values of Investment Securities	The following table presents the gross unrealized losses and fair values of our investment securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, as of December 31, 2015: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 883 $ (16 ) 32 $ — $ — — $ 883 $ (16 ) 32 State and political subdivisions 464 (15 ) 81 163 (15 ) 17 627 (30 ) 98 Non-U.S. government 366 (5 ) 49 — — — 366 (5 ) 49 U.S. corporate 5,836 (332 ) 817 466 (62 ) 83 6,302 (394 ) 900 Non-U.S. corporate 3,016 (170 ) 400 486 (117 ) 87 3,502 (287 ) 487 Residential mortgage-backed 756 (10 ) 88 103 (7 ) 38 859 (17 ) 126 Commercial mortgage-backed 780 (19 ) 116 39 (1 ) 13 819 (20 ) 129 Other asset-backed 1,944 (22 ) 349 336 (37 ) 55 2,280 (59 ) 404 Subtotal, fixed maturity securities 14,045 (589 ) 1,932 1,593 (239 ) 293 15,638 (828 ) 2,225 Equity securities 153 (23 ) 64 — — — 153 (23 ) 64 Total for securities in an unrealized loss position $ 14,198 $ (612 ) 1,996 $ 1,593 $ (239 ) 293 $ 15,791 $ (851 ) 2,289 % Below cost—fixed maturity securities: <20% Below cost $ 13,726 $ (472 ) 1,877 $ 1,259 $ (78 ) 238 $ 14,985 $ (550 ) 2,115 20%-50% Below cost 319 (116 ) 54 316 (139 ) 50 635 (255 ) 104 >50% Below cost — (1 ) 1 18 (22 ) 5 18 (23 ) 6 Total fixed maturity securities 14,045 (589 ) 1,932 1,593 (239 ) 293 15,638 (828 ) 2,225 % Below cost—equity securities: <20% Below cost 133 (18 ) 56 — — — 133 (18 ) 56 20%-50% Below cost 20 (5 ) 8 — — — 20 (5 ) 8 Total equity securities 153 (23 ) 64 — — — 153 (23 ) 64 Total for securities in an unrealized loss position $ 14,198 $ (612 ) 1,996 $ 1,593 $ (239 ) 293 $ 15,791 $ (851 ) 2,289 Investment grade $ 13,342 $ (524 ) 1,834 $ 1,245 $ (135 ) 225 $ 14,587 $ (659 ) 2,059 Below investment grade 856 (88 ) 162 348 (104 ) 68 1,204 (192 ) 230 Total for securities in an unrealized loss position $ 14,198 $ (612 ) 1,996 $ 1,593 $ (239 ) 293 $ 15,791 $ (851 ) 2,289 The following table presents the gross unrealized losses and fair values of our corporate securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2015: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities U.S. corporate: Utilities $ 485 $ (25 ) 74 $ 14 $ (1 ) 7 $ 499 $ (26 ) 81 Energy 1,162 (134 ) 163 131 (28 ) 22 1,293 (162 ) 185 Finance and insurance 1,142 (35 ) 160 94 (8 ) 15 1,236 (43 ) 175 Consumer—non-cyclical 836 (26 ) 107 51 (4 ) 10 887 (30 ) 117 Technology and communications 658 (36 ) 95 23 (2 ) 5 681 (38 ) 100 Industrial 476 (33 ) 64 44 (11 ) 9 520 (44 ) 73 Capital goods 293 (10 ) 48 26 (2 ) 4 319 (12 ) 52 Consumer—cyclical 427 (18 ) 60 63 (4 ) 10 490 (22 ) 70 Transportation 273 (10 ) 38 20 (2 ) 1 293 (12 ) 39 Other 84 (5 ) 8 — — — 84 (5 ) 8 Subtotal, U.S. corporate securities 5,836 (332 ) 817 466 (62 ) 83 6,302 (394 ) 900 Non-U.S. corporate: Utilities 130 (6 ) 20 32 (3 ) 6 162 (9 ) 26 Energy 589 (48 ) 71 127 (30 ) 20 716 (78 ) 91 Finance and insurance 478 (7 ) 77 30 (1 ) 8 508 (8 ) 85 Consumer—non-cyclical 261 (14 ) 27 37 (4 ) 4 298 (18 ) 31 Technology and communications 324 (15 ) 37 33 (11 ) 9 357 (26 ) 46 Industrial 495 (54 ) 67 110 (42 ) 18 605 (96 ) 85 Capital goods 154 (8 ) 22 41 (9 ) 9 195 (17 ) 31 Consumer—cyclical 155 (4 ) 20 — — — 155 (4 ) 20 Transportation 147 (6 ) 17 — — — 147 (6 ) 17 Other 283 (8 ) 42 76 (17 ) 13 359 (25 ) 55 Subtotal, non-U.S. corporate securities 3,016 (170 ) 400 486 (117 ) 87 3,502 (287 ) 487 Total for corporate securities in an unrealized loss position $ 8,852 $ (502 ) 1,217 $ 952 $ (179 ) 170 $ 9,804 $ (681 ) 1,387 The following table presents the gross unrealized losses and fair values of our investment securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, as of December 31, 2014: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross (1) Number of Fair Gross (1) Number of Description of Securities Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ — $ — — $ 75 $ (1 ) 10 $ 75 $ (1 ) 10 State and political subdivision 9 — 7 267 (27 ) 45 276 (27 ) 52 Non-U.S. government 64 (1 ) 15 22 (1 ) 4 86 (2 ) 19 U.S. corporate 1,639 (33 ) 231 1,201 (43 ) 174 2,840 (76 ) 405 Non-U.S. corporate 1,456 (67 ) 199 504 (28 ) 67 1,960 (95 ) 266 Residential mortgage-backed 180 (1 ) 24 249 (17 ) 87 429 (18 ) 111 Commercial mortgage-backed 163 — 21 362 (9 ) 49 525 (9 ) 70 Other asset-backed 1,551 (12 ) 215 487 (42 ) 55 2,038 (54 ) 270 Subtotal, fixed maturity securities 5,062 (114 ) 712 3,167 (168 ) 491 8,229 (282 ) 1,203 Equity securities 30 (3 ) 46 48 (4 ) 6 78 (7 ) 52 Total for securities in an unrealized loss position $ 5,092 $ (117 ) 758 $ 3,215 $ (172 ) 497 $ 8,307 $ (289 ) 1,255 % Below cost—fixed maturity securities: <20% Below cost $ 5,025 $ (103 ) 708 $ 3,036 $ (114 ) 470 $ 8,061 $ (217 ) 1,178 20%-50% Below cost 37 (11 ) 4 131 (53 ) 15 168 (64 ) 19 >50% Below cost — — — — (1 ) 6 — (1 ) 6 Total fixed maturity securities 5,062 (114 ) 712 3,167 (168 ) 491 8,229 (282 ) 1,203 % Below cost—equity securities: <20% Below cost 26 (2 ) 40 48 (4 ) 6 74 (6 ) 46 20%-50% Below cost 4 (1 ) 6 — — — 4 (1 ) 6 Total equity securities 30 (3 ) 46 48 (4 ) 6 78 (7 ) 52 Total for securities in an unrealized loss position $ 5,092 $ (117 ) 758 $ 3,215 $ (172 ) 497 $ 8,307 $ (289 ) 1,255 Investment grade $ 4,501 $ (75 ) 631 $ 2,918 $ (145 ) 424 $ 7,419 $ (220 ) 1,055 Below investment grade (2) 591 (42 ) 127 297 (27 ) 73 888 (69 ) 200 Total for securities in an unrealized loss position $ 5,092 $ (117 ) 758 $ 3,215 $ (172 ) 497 $ 8,307 $ (289 ) 1,255 (1) Amounts included $1 million of unrealized losses on other-than-temporarily impaired securities. (2) Amounts that have been in a continuous unrealized loss position for 12 months or more included $1 million of unrealized losses on other-than-temporarily impaired securities. The following table presents the gross unrealized losses and fair values of our corporate securities, aggregated by investment type and length of time that individual investment securities have been in a continuous unrealized loss position, based on industry, as of December 31, 2014: Less than 12 months 12 months or more Total (Dollar amounts in millions) Fair Gross Number of Fair Gross Number of Fair Gross Number of Description of Securities U.S. corporate: Utilities $ 55 $ — 10 $ 164 $ (5 ) 23 $ 219 $ (5 ) 33 Energy 404 (16 ) 56 96 (5 ) 15 500 (21 ) 71 Finance and insurance 399 (3 ) 56 257 (10 ) 35 656 (13 ) 91 Consumer—non-cyclical 160 (3 ) 20 182 (5 ) 32 342 (8 ) 52 Technology and communications 181 (3 ) 27 97 (1 ) 15 278 (4 ) 42 Industrial 151 (4 ) 21 80 (4 ) 11 231 (8 ) 32 Capital goods 85 — 13 122 (5 ) 18 207 (5 ) 31 Consumer—cyclical 132 (2 ) 17 139 (6 ) 18 271 (8 ) 35 Transportation 52 (2 ) 9 57 (2 ) 6 109 (4 ) 15 Other 20 — 2 7 — 1 27 — 3 Subtotal, U.S. corporate securities 1,639 (33 ) 231 1,201 (43 ) 174 2,840 (76 ) 405 Non-U.S. corporate: Utilities 79 — 13 43 (2 ) 5 122 (2 ) 18 Energy 442 (33 ) 57 58 (5 ) 13 500 (38 ) 70 Finance and insurance 237 (2 ) 32 29 (1 ) 6 266 (3 ) 38 Consumer—non-cyclical 134 (6 ) 10 83 (3 ) 9 217 (9 ) 19 Technology and communications 77 (2 ) 13 81 (2 ) 8 158 (4 ) 21 Industrial 214 (9 ) 30 116 (9 ) 15 330 (18 ) 45 Capital goods 63 (2 ) 7 38 (3 ) 4 101 (5 ) 11 Consumer—cyclical 8 — 1 — — — 8 — 1 Transportation 30 — 6 14 (1 ) 1 44 (1 ) 7 Other 172 (13 ) 30 42 (2 ) 6 214 (15 ) 36 Subtotal, non-U.S. corporate securities 1,456 (67 ) 199 504 (28 ) 67 1,960 (95 ) 266 Total for corporate securities in an unrealized loss position $ 3,095 $ (100 ) 430 $ 1,705 $ (71 ) 241 $ 4,800 $ (171 ) 671
Fixed Maturity Securities More Than 20% Below Cost and in Continuous Loss Position for 12 Months or More by Asset Class	The following tables present the concentration of gross unrealized losses and fair values of fixed maturity securities that were more than 20% below cost and in a continuous unrealized loss position for 12 months or more by asset class as of December 31, 2015: Investment Grade 20% to 50% Greater than 50% (Dollar amounts in millions) Fair Gross % of total Number of Fair Gross % of total Number of Fixed maturity securities: State and political subdivisions $ 9 $ (3 ) — % 1 $ — $ — — % — U.S. corporate: Energy 23 (8 ) 1 4 — — — — Industrial 18 (9 ) 1 3 — — — — Total U.S. corporate 41 (17 ) 2 7 — — — — Non-U.S. corporate: Utilities 8 (2 ) — 1 — — — — Energy 21 (8 ) 1 2 — — — — Industrial 29 (14 ) 2 4 — — — — Capital goods 6 (5 ) 1 2 — — — — Other 5 (2 ) — 1 — — — — Total non-U.S. corporate 69 (31 ) 4 10 — — — — Structured securities: Other asset-backed 66 (25 ) 3 4 — — — — Total structured securities 66 (25 ) 3 4 — — — — Total $ 185 $ (76 ) 9 % 22 $ — $ — — % — Below Investment Grade 20% to 50% Greater than 50% (Dollar amounts in millions) Fair Gross % of total Number Fair Gross % of total Number Fixed maturity securities: U.S. corporate: Energy $ 21 $ (9 ) 1 % 6 $ — $ — — % — Finance and insurance 7 (3 ) 1 1 — — — — Technology and communications 5 (2 ) — 1 — — — — Industrial 4 (1 ) — 1 — — — — Total U.S. corporate 37 (15 ) 2 9 — — — — Non-U.S. corporate: Energy 44 (20 ) 2 8 — — — — Technology and communications 5 (4 ) 1 2 4 (5 ) 1 1 Industrial 10 (6 ) 1 2 14 (17 ) 2 4 Capital goods 3 (2 ) 1 1 — — — — Other 24 (10 ) — 5 — — — — Total non-U.S. corporate 86 (42 ) 5 18 18 (22 ) 3 5 Structured securities: Other asset-backed 8 (6 ) 1 1 — — — — Total structured securities 8 (6 ) 1 1 — — — — Total $ 131 $ (63 ) 8 % 28 $ 18 $ (22 ) 3 % 5
Maturity Distribution of Fixed Maturity Securities	The scheduled maturity distribution of fixed maturity securities as of December 31, 2015 is set forth below. Actual maturities may differ from contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties. (Amounts in millions) Amortized Fair Due one year or less $ 1,729 $ 1,744 Due after one year through five years 9,814 10,192 Due after five years through ten years 11,772 11,917 Due after ten years 21,249 23,403 Subtotal 44,564 47,256 Residential mortgage-backed 4,777 5,101 Commercial mortgage-backed 2,492 2,559 Other asset-backed 3,328 3,281 Total $ 55,161 $ 58,197
Commercial Mortgage Loans by Property Type	The following tables set forth the distribution across property type and geographic region for commercial mortgage loans as of December 31: 2015 2014 (Amounts in millions) Carrying % of Carrying % of Property type: Retail $ 2,355 38 % $ 2,150 35 % Industrial 1,562 25 1,597 26 Office 1,516 24 1,643 27 Apartments 465 8 494 8 Mixed use/other 289 5 239 4 Subtotal 6,187 100 % 6,123 100 % Unamortized balance of loan origination fees and costs (2 ) (1 ) Allowance for losses (15 ) (22 ) Total $ 6,170 $ 6,100
Commercial Mortgage Loans by Geographic Region	2015 2014 (Amounts in millions) Carrying % of Carrying % of Geographic region: Pacific $ 1,581 26 % $ 1,636 27 % South Atlantic 1,574 25 1,673 27 Middle Atlantic 890 14 826 14 Mountain 585 10 536 9 West North Central 416 7 382 6 East North Central 386 6 397 7 West South Central 294 5 268 4 New England 268 4 264 4 East South Central 193 3 141 2 Subtotal 6,187 100 % 6,123 100 % Unamortized balance of loan origination fees and costs (2 ) (1 ) Allowance for losses (15 ) (22 ) Total $ 6,170 $ 6,100
Aging of Past Due Commercial Mortgage Loans by Property Type	The following tables set forth the aging of past due commercial mortgage loans by property type as of December 31: 2015 (Amounts in millions) 31 - 60 days 61 - 90 days Greater than Total Current Total Property type: Retail $ — $ — $ — $ — $ 2,355 $ 2,355 Industrial — — — — 1,562 1,562 Office 6 — 5 11 1,505 1,516 Apartments — — — — 465 465 Mixed use/other — — — — 289 289 Total recorded investment $ 6 $ — $ 5 $ 11 $ 6,176 $ 6,187 % of total commercial mortgage loans — % — % — % — % 100 % 100 % 2014 (Amounts in millions) 31 - 60 days 61 - 90 days Greater than Total Current Total Property type: Retail $ — $ — $ — $ — $ 2,150 $ 2,150 Industrial — — 2 2 1,595 1,597 Office — — 6 6 1,637 1,643 Apartments — — — — 494 494 Mixed use/other — — — — 239 239 Total recorded investment $ — $ — $ 8 $ 8 $ 6,115 $ 6,123 % of total commercial mortgage loans — % — % — % — % 100 % 100 %
Allowance for Credit Losses and Recorded Investment in Commercial Mortgage Loans	The following table sets forth the allowance for credit losses and recorded investment in commercial mortgage loans as of or for the years ended December 31: (Amounts in millions) 2015 2014 2013 Allowance for credit losses: Beginning balance $ 22 $ 33 $ 42 Charge-offs (4 ) (1 ) (2 ) Recoveries — — — Provision (3 ) (10 ) (7 ) Ending balance $ 15 $ 22 $ 33 Ending allowance for individually impaired loans $ — $ — $ — Ending allowance for loans not individually impaired that were evaluated collectively for impairment $ 15 $ 22 $ 33 Recorded investment: Ending balance $ 6,187 $ 6,123 $ 5,932 Ending balance of individually impaired loans $ 19 $ 15 $ 2 Ending balance of loans not individually impaired that were evaluated collectively for impairment $ 6,168 $ 6,108 $ 5,930
Average Loan-to-Value of Commercial Mortgage Loans by Property Type	The following tables set forth the loan-to-value of commercial mortgage loans by property type as of December 31: 2015 (Amounts in millions) 0%-50% 51%-60% 61%-75% 76%-100% Greater (1) Total Property type: Retail $ 846 $ 465 $ 924 $ 106 $ 14 $ 2,355 Industrial 515 478 499 65 5 1,562 Office 493 341 580 83 19 1,516 Apartments 196 66 182 21 — 465 Mixed use/other 49 55 185 — — 289 Total recorded investment $ 2,099 $ 1,405 $ 2,370 $ 275 $ 38 $ 6,187 % of total 34 % 23 % 38 % 4 % 1 % 100 % Weighted-average debt service coverage ratio 2.13 1.82 1.57 1.12 0.55 1.79 (1) Included $38 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 123%. 2014 (Amounts in millions) 0%-50% 51%-60% 61%-75% 76%-100% Greater (1) Total Property type: Retail $ 671 $ 419 $ 967 $ 75 $ 18 $ 2,150 Industrial 451 285 778 60 23 1,597 Office 383 278 782 164 36 1,643 Apartments 211 76 199 8 — 494 Mixed use/other 45 43 145 6 — 239 Total recorded investment $ 1,761 $ 1,101 $ 2,871 $ 313 $ 77 $ 6,123 % of total 29 % 18 % 47 % 5 % 1 % 100 % Weighted-average debt service coverage ratio 2.27 1.75 1.61 1.02 0.72 1.78 (1) Included $15 million of impaired loans, $6 million of loans past due and not individually impaired and $56 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 120%.
Debt Service Coverage Ratio for Fixed Rate Commercial Mortgage Loans by Property Type	The following tables set forth the debt service coverage ratio for fixed rate commercial mortgage loans by property type as of December 31: 2015 (Amounts in millions) Less than 1.00 1.00-1.25 1.26-1.50 1.51-2.00 Greater Total Property type: Retail $ 70 $ 232 $ 466 $ 1,017 $ 570 $ 2,355 Industrial 94 181 208 672 407 1,562 Office 85 114 265 699 346 1,509 Apartments 6 41 74 199 145 465 Mixed use/other — 58 141 60 30 289 Total recorded investment $ 255 $ 626 $ 1,154 $ 2,647 $ 1,498 $ 6,180 % of total 4 % 10 % 19 % 43 % 24 % 100 % Weighted-average loan-to-value 74 % 64 % 58 % 58 % 43 % 56 % 2014 (Amounts in millions) Less than 1.00 1.00-1.25 1.26-1.50 1.51-2.00 Greater Total Property type: Retail $ 80 $ 253 $ 524 $ 870 $ 423 $ 2,150 Industrial 158 142 246 706 343 1,595 Office 119 101 247 780 389 1,636 Apartments 1 48 88 186 171 494 Mixed use/other 6 1 61 135 36 239 Total recorded investment $ 364 $ 545 $ 1,166 $ 2,677 $ 1,362 $ 6,114 % of total 6 % 9 % 19 % 44 % 22 % 100 % Weighted-average loan-to-value 77 % 64 % 64 % 59 % 45 % 59 %

Derivative Instruments (Tables)

Derivative Instruments (Tables)	12 Months Ended
	Dec. 31, 2015
Schedule Of Positions in Derivative Instruments	The following table sets forth our positions in derivative instruments as of December 31: Derivative assets Derivative liabilities Balance sheet Fair value Balance sheet Fair value (Amounts in millions) 2015 2014 2015 2014 Derivatives designated as hedges Cash flow hedges: Interest rate swaps Other invested assets $ 629 $ 639 Other liabilities $ 37 $ 27 Inflation indexed swaps Other invested assets — — Other liabilities 33 42 Foreign currency swaps Other invested assets 8 6 Other liabilities — — Total cash flow hedges 637 645 70 69 Total derivatives designated as hedges 637 645 70 69 Derivatives not designated as hedges Interest rate swaps Other invested assets 425 452 Other liabilities 183 177 Interest rate swaps related to securitization entities (1) Restricted other invested assets — — Other liabilities 30 26 Credit default swaps Other invested assets 1 4 Other liabilities — — Credit default swaps related to securitization entities (1) Restricted other invested assets — — Other liabilities 14 17 Foreign currency swaps Other invested assets — — Other liabilities 27 7 Equity index options Other invested assets 30 17 Other liabilities — — Financial futures Other invested assets — — Other liabilities — — Equity return swaps Other invested assets 2 — Other liabilities 1 1 Other foreign currency contracts Other invested assets 17 14 Other liabilities 34 13 GMWB embedded derivatives Reinsurance recoverable (2) 17 13 Policyholder account balances (3) 352 291 Fixed index annuity embedded derivatives Other assets — — Policyholder account balances (4) 342 276 Indexed universal life embedded derivatives Reinsurance recoverable — — Policyholder account balances (5) 10 7 Total derivatives not designated as hedges 492 500 993 815 Total derivatives $ 1,129 $ 1,145 $ 1,063 $ 884 (1) See note 17 for additional information related to consolidated securitization entities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. (3) Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. (4) Represents the embedded derivatives associated with our fixed index annuity liabilities. (5) Represents the embedded derivatives associated with our indexed universal life liabilities.
Activity Associated with Derivative Instruments	The following tables represent activity associated with derivative instruments as of the dates indicated: (Notional in millions) Measurement December 31, Additions Maturities/ December 31, Derivatives designated as hedges Cash flow hedges: Interest rate swaps Notional $ 11,961 $ — $ (747 ) $ 11,214 Inflation indexed swaps Notional 571 13 (13 ) 571 Foreign currency swaps Notional 35 — — 35 Total cash flow hedges 12,567 13 (760 ) 11,820 Total derivatives designated as hedges 12,567 13 (760 ) 11,820 Derivatives not designated as hedges Interest rate swaps Notional 5,074 2,100 (2,242 ) 4,932 Interest rate swaps related to securitization entities (1) Notional 77 — (10 ) 67 Credit default swaps Notional 394 — (250 ) 144 Credit default swaps related to securitization entities (1) Notional 312 — — 312 Equity index options Notional 994 1,455 (1,369 ) 1,080 Financial futures Notional 1,331 5,700 (5,700 ) 1,331 Equity return swaps Notional 108 386 (360 ) 134 Foreign currency swaps Notional 104 58 — 162 Forward bond purchase commitments Notional — 1,140 (1,140 ) — Other foreign currency contracts Notional 425 2,516 (1,285 ) 1,656 Total derivatives not designated as hedges 8,819 13,355 (12,356 ) 9,818 Total derivatives $ 21,386 $ 13,368 $ (13,116 ) $ 21,638 (1) See note 17 for additional information related to consolidated securitization entities. (Number of policies) Measurement December 31, Additions Maturities/ December 31, Derivatives not designated as hedges GMWB embedded derivatives Policies 39,015 — (2,869 ) 36,146 Fixed index annuity embedded derivatives Policies 13,901 3,939 (358 ) 17,482 Indexed universal life embedded derivatives Policies 421 595 (34 ) 982
Schedule of Pre-Tax Income (Loss) Effects of Cash Flow Hedges	The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2015: (Amounts in millions) Gain (loss) Gain (loss) Classification of gain Gain (loss) (1) Classification of gain Interest rate swaps hedging assets $ 78 $ 85 Net investment $ — Net investment Interest rate swaps hedging liabilities (10 ) — Interest — Net investment Inflation indexed swaps 9 — Net investment — Net investment Foreign currency swaps 2 — Net investment — Net investment Forward bond purchase commitments — 1 Net investment — Net investment Forward bond purchase commitments — 32 Net investment — Net investment Total $ 79 $ 118 $ — (1) Represents ineffective portion of cash flow hedges as there were no amounts excluded from the measurement of effectiveness. The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2014: (Amounts in millions) Gain (loss) Gain (loss) Classification of gain Gain (loss) (1) Classification of gain Interest rate swaps hedging assets $ 1,229 $ 63 Net investment $ 15 Net investment Interest rate swaps hedging assets — 2 Net investment — Net investment Interest rate swaps hedging liabilities (69 ) 1 Interest expense — Net investment Inflation indexed swaps 17 (9 ) Net investment — Net investment Foreign currency swaps 4 — Interest expense — Net investment Forward bond purchase commitments 34 — Net investment — Net investment Total $ 1,215 $ 57 $ 15 (1) Represents ineffective portion of cash flow hedges, as there were no amounts excluded from the measurement of effectiveness. The following table provides information about the pre-tax income (loss) effects of cash flow hedges for the year ended December 31, 2013: (Amounts in millions) Gain (loss) Gain (loss) Classification of gain Gain (loss) (1) Classification of gain Interest rate swaps hedging assets $ (892 ) $ 47 Net investment $ (14 ) Net investment Interest rate swaps hedging assets — 1 Net investment — Net investment Interest rate swaps hedging liabilities 42 2 Interest expense — Net investment Inflation indexed swaps 45 (5 ) Net investment — Net investment Foreign currency swaps (1 ) — Interest expense — Net investment Forward bond purchase commitments (60 ) — Net investment — Net investment Total $ (866 ) $ 45 $ (14 ) (1) Represents ineffective portion of cash flow hedges, as there were no amounts excluded from the measurement of effectiveness.
Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedges	The following table provides a reconciliation of current period changes, net of applicable income taxes, for these designated derivatives presented in the separate component of stockholders’ equity labeled “derivatives qualifying as hedges,” for the years ended December 31: (Amounts in millions) 2015 2014 2013 Derivatives qualifying as effective accounting hedges as of January 1 $ 2,070 $ 1,319 $ 1,909 Current period increases (decreases) in fair value, net of deferred taxes of $(29), $(427) and $305 50 788 (561 ) Reclassification to net (income) loss, net of deferred taxes of $43, $20 and $16 (75 ) (37 ) (29 ) Derivatives qualifying as effective accounting hedges as of December 31 $ 2,045 $ 2,070 $ 1,319
Schedule of Pre-Tax Income (Loss) Effects of Fair Value Hedges and Related Hedged Items	The following table provides information about the pre-tax income (loss) effects of fair value hedges and related hedged items for the year ended December 31, 2013: Derivative instrument Hedged item (Amounts in Gain (loss) Classification Other impacts income (loss) Classification of Gain (loss) Classification Interest rate swaps hedging liabilities $ (11 ) Net investment $ 13 Interest credited $ 11 Net investment gains (losses) Foreign currency swaps (31 ) Net investment — Interest credited 31 Net investment Total $ (42 ) $ 13 $ 42
Schedule of Pre-Tax Gain (Loss) Recognized in Net Income (Loss) for Effects of Derivatives Not Designated as Hedges	The following table provides the pre-tax gain (loss) recognized in net income (loss) for the effects of derivatives not designated as hedges for the years ended December 31: (Amounts in millions) 2015 2014 2013 Classification of gain (loss) recognized Interest rate swaps $ (11 ) $ 1 $ (7 ) Net investment gains (losses) Interest rate swaps related to securitization entities (1) (4 ) (9 ) 9 Net investment gains (losses) Credit default swaps 1 1 14 Net investment gains (losses) Credit default swaps related to securitization entities (1) 7 19 77 Net investment gains (losses) Equity index options (25 ) (31 ) (43 ) Net investment gains (losses) Financial futures (34 ) 90 (232 ) Net investment gains (losses) Equity return swaps (3 ) 5 (33 ) Net investment gains (losses) Other foreign currency contracts 10 (4 ) 6 Net investment gains (losses) Foreign currency swaps (22 ) (7 ) — Net investment gains (losses) Forward bond purchase commitments 2 — — Net investment gains (losses) GMWB embedded derivatives (25 ) (147 ) 277 Net investment gains (losses) Fixed index annuity embedded derivatives (7 ) (27 ) (18 ) Net investment gains (losses) Indexed universal life embedded derivatives 6 (1 ) — Net investment gains (losses) Total derivatives not designated as hedges $ (105 ) $ (110 ) $ 50 (1) See note 17 for additional information related to consolidated securitization entities.
Derivative Assets and Liabilities Subject to Master Netting Arrangement	The following table presents additional information about derivative assets and liabilities subject to an enforceable master netting arrangement as of December 31: 2015 2014 (Amounts in millions) Derivatives (1) Derivatives (2) Net Derivatives (1) Derivatives (2) Net Amounts presented in the balance sheet: Gross amounts recognized $ 1,135 $ 320 $ 815 $ 1,157 $ 273 $ 884 Gross amounts offset in the balance sheet — — — — — — Net amounts presented in the balance sheet 1,135 320 815 1,157 273 884 Gross amounts not offset in the balance sheet: Financial instruments (3) (231 ) (231 ) — (227 ) (227 ) — Collateral received (642 ) — (642 ) (884 ) — (884 ) Collateral pledged — (263 ) 263 — (49 ) 49 Over collateralization 3 174 (171 ) 1 5 (4 ) Net amount $ 265 $ — $ 265 $ 47 $ 2 $ 45 (1) Included $24 million and $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2015 and 2014, respectively. (2) Included $6 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2015 and 2014. (3) Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty.
Schedule of Credit Default Swaps Where We Sell Protection on Single Name Reference Entities and Fair Values	The following table sets forth our credit default swaps where we sell protection on single name reference entities and the fair values as of December 31: 2015 2014 (Amounts in millions) Notional Assets Liabilities Notional value Assets Liabilities Investment grade Matures in less than one year $ — $ — $ — $ — $ — $ — Matures after one year through five years 39 — — 39 1 — Total credit default swaps on single name reference entities $ 39 $ — $ — $ 39 $ 1 $ —
Schedule of Credit Default Swaps Where We Sell Protection on Credit Default Swap Index Tranches and Fair Values	The following table sets forth our credit default swaps where we sell protection on credit default swap index tranches and the fair values as of December 31: 2015 2014 (Amounts in millions) Notional Assets Liabilities Notional Assets Liabilities Original index tranche attachment/detachment point and maturity: 7% - 15% matures in less than one year (1) $ 100 $ 1 $ — $ — $ — $ — 7% - 15% matures after one year through five years (1) — — — 100 1 — 9% - 12% matures in less than one year (2) — — — 250 2 — Total credit default swap index tranches 100 1 — 350 3 — Customized credit default swap index tranches related to securitization entities: Portion backing third-party borrowings maturing 2017 (3) 12 — 2 12 — — Portion backing our interest maturing 2017 (4) 300 — 12 300 — 17 Total customized credit default swap index tranches related to securitization entities 312 — 14 312 — 17 Total credit default swaps on index tranches $ 412 $ 1 $ 14 $ 662 $ 3 $ 17 (1) The current attachment/detachment as of December 31, 2015 and 2014 was 7% – 15%. (2) The current attachment/detachment as of December 31, 2015 and 2014 was 9% – 12%. (3) Original notional value was $39 million. (4) Original notional value was $300 million.

Deferred Acquisition Costs (Tab

Deferred Acquisition Costs (Tables)	12 Months Ended
	Dec. 31, 2015
Activity Impacting Deferred Acquisition Costs	The following table presents the activity impacting DAC as of and for the years ended December 31: (Amounts in millions) 2015 2014 2013 Unamortized balance as of January 1 $ 5,200 $ 5,214 $ 5,220 Impact of foreign currency translation (23 ) (15 ) (16 ) Costs deferred 295 385 365 Amortization, net of interest accretion (448 ) (384 ) (355 ) Impairment (455 ) — — Unamortized balance as of December 31 4,569 5,200 5,214 Accumulated effect of net unrealized investment (gains) losses (171 ) (348 ) (176 ) Balance as of December 31 $ 4,398 $ 4,852 $ 5,038

Intangible Assets and Goodwill

Intangible Assets and Goodwill (Tables)	12 Months Ended
	Dec. 31, 2015
Intangible Assets	The following table presents our intangible assets as of December 31: 2015 2014 (Amounts in millions) Gross Accumulated Gross Accumulated PVFP $ 2,084 $ (1,941 ) $ 1,995 $ (1,917 ) Capitalized software 665 (571 ) 641 (532 ) Deferred sales inducements to contractholders 268 (178 ) 209 (153 ) Other 66 (50 ) 55 (49 ) Total $ 3,083 $ (2,740 ) $ 2,900 $ (2,651 )
Activity in Present Value of Future Profits	The following table presents the activity in PVFP as of and for the years ended December 31: (Amounts in millions) 2015 2014 2013 Unamortized balance as of January 1 $ 229 $ 246 $ 297 Interest accreted at 6.45%, 5.89% and 5.52% 14 14 15 Amortization (38 ) (31 ) (66 ) Unamortized balance as of December 31 205 229 246 Accumulated effect of net unrealized investment (gains) losses (62 ) (151 ) (85 ) Balance as of December 31 $ 143 $ 78 $ 161
Percentage of Current PVFP Balance Estimated to be Amortized	The percentage of the December 31, 2015 PVFP balance net of interest accretion, before the effect of unrealized investment gains or losses, estimated to be amortized over each of the next five years is as follows: 2016 15.1 % 2017 13.7 % 2018 11.7 % 2019 10.0 % 2020 8.7 %

Reinsurance (Tables)

Reinsurance (Tables)	12 Months Ended
	Dec. 31, 2015
Net Domestic Life Insurance In-Force	The following table sets forth net domestic life insurance in-force as of December 31: (Amounts in millions) 2015 2014 2013 Direct life insurance in-force $ 686,446 $ 701,797 $ 708,271 Amounts assumed from other companies 899 935 1,070 Amounts ceded to other companies (1) (411,340 ) (393,244 ) (313,593 ) Net life insurance in-force $ 276,005 $ 309,488 $ 395,748 Percentage of amount assumed to net — % — % — % (1) Includes amounts accounted for under the deposit method.
Schedule of Effects of Reinsurance on Premiums Written and Earned	The following table sets forth the effects of reinsurance on premiums written and earned for the years ended December 31: Written Earned (Amounts in millions) 2015 2014 2013 2015 2014 2013 Direct: Life insurance $ 1,030 $ 1,131 $ 1,088 $ 1,030 $ 1,131 $ 1,088 Accident and health insurance 2,764 2,706 2,584 2,778 2,697 2,565 Mortgage insurance 1,754 1,814 1,682 1,514 1,588 1,608 Total direct 5,548 5,651 5,354 5,322 5,416 5,261 Assumed: Life insurance 34 34 3 34 34 3 Accident and health insurance 342 343 345 347 348 350 Mortgage insurance 10 20 19 22 31 33 Total assumed 386 397 367 403 413 386 Ceded: Life insurance (372 ) (332 ) (340 ) (372 ) (332 ) (340 ) Accident and health insurance (682 ) (708 ) (709 ) (688 ) (706 ) (700 ) Mortgage insurance (86 ) (95 ) (92 ) (86 ) (91 ) (91 ) Total ceded (1,140 ) (1,135 ) (1,141 ) (1,146 ) (1,129 ) (1,131 ) Net premiums $ 4,794 $ 4,913 $ 4,580 $ 4,579 $ 4,700 $ 4,516 Percentage of amount assumed to net 9 % 9 % 9 %

Insurance Reserves (Tables)

Insurance Reserves (Tables)	12 Months Ended
	Dec. 31, 2015
Recorded Liabilities and Major Assumptions Underlying Future Policy Benefits	The following table sets forth our recorded liabilities and the major assumptions underlying our future policy benefits as of December 31: (Amounts in millions) Mortality/ Interest rate 2015 2014 Long-term care insurance contracts (a ) 3.50% - 7.50% $ 20,563 $ 19,310 Structured settlements with life contingencies (b ) 1.50% - 8.00% 8,991 9,133 Annuity contracts with life contingencies (b ) 1.50% - 8.00% 4,010 4,470 Traditional life insurance contracts (c ) 3.00% - 7.50% 2,638 2,733 Supplementary contracts with life contingencies (b ) 1.50% - 8.00% 269 265 Accident and health insurance contracts (d ) 3.50% - 7.00% 4 4 Total future policy benefits $ 36,475 $ 35,915 (a) The 1983 Individual Annuitant Mortality Table or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality Table or 1994 Group Annuitant Mortality Table and company experience. (b) Assumptions for limited-payment contracts come from either the U.S. Population Table, 1983 Group Annuitant Mortality Table, 1983 Individual Annuitant Mortality Table, Annuity 2000 Mortality Table or 2012 Individual Annuity Reserving Table. (c) Principally modifications based on company experience of the Society of Actuaries 1965-70 or 1975-80 Select and Ultimate Tables, 1941, 1958, 1980 and 2001 Commissioner’s Standard Ordinary Tables, 1980 Commissioner’s Extended Term table and (IA) Standard Table 1996 (modified). (d) The 1958 and 1980 Commissioner’s Standard Ordinary Tables, or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality.
Recorded Liabilities for Policyholder Account Balances	The following table sets forth our recorded liabilities for policyholder account balances as of December 31: (Amounts in millions) 2015 2014 Annuity contracts $ 14,376 $ 14,406 GICs, funding agreements and FABNs 410 493 Structured settlements without life contingencies 1,694 1,828 Supplementary contracts without life contingencies 762 742 Other 16 17 Total investment contracts 17,258 17,486 Universal life insurance contracts 8,951 8,546 Total policyholder account balances $ 26,209 $ 26,032
Information about Variable Annuity Products with Death and Living Benefit Guarantees	The following table sets forth information about our variable annuity products with death and living benefit guarantees as of December 31: (Dollar amounts in millions) 2015 2014 Account values with death benefit guarantees (net of reinsurance): Standard death benefits (return of net deposits) account value $ 2,512 $ 2,877 Net amount at risk $ 5 $ 5 Average attained age of contractholders 73 72 Enhanced death benefits (ratchet, rollup) account value $ 2,866 $ 3,443 Net amount at risk $ 188 $ 119 Average attained age of contractholders 73 73 Account values with living benefit guarantees: GMWBs $ 3,111 $ 3,675 Guaranteed annuitization benefits $ 1,181 $ 1,362
Account Balances of Variable Annuity Contract with Death or Living Benefit Guarantees Invested in Separate Account Investment Options	Account balances of variable annuity contracts with death or living benefit guarantees were invested in separate account investment options as follows as of December 31: (Amounts in millions) 2015 2014 Balanced funds $ 3,304 $ 3,848 Equity funds 1,387 1,639 Bond funds 576 707 Money market funds 85 96 Total $ 5,352 $ 6,290

Liability for Policy and Cont45

Liability for Policy and Contract Claims (Tables)	12 Months Ended
	Dec. 31, 2015
Schedule of Liability for Policy and Contract Claims	The following table sets forth our recorded liability for policy and contract claims by business as of December 31: (Amounts in millions) 2015 2014 Long-term care insurance $ 6,749 $ 6,216 U.S. mortgage insurance 849 1,180 Life insurance 202 197 Australia mortgage insurance 165 152 Canada mortgage insurance 87 91 Fixed annuities 18 21 Runoff 18 15 Other mortgage insurance 7 9 Total liability for policy and contract claims $ 8,095 $ 7,881
Long-term Care Insurance
Changes in Liability for Policy and Contract Claims	The following table sets forth changes in the liability for policy and contract claims for our long-term care insurance business for the dates indicated: (Amounts in millions) 2015 2014 2013 Beginning balance as of January 1 $ 6,216 $ 4,999 $ 4,655 Less reinsurance recoverables (1,926 ) (1,707 ) (1,574 ) Net balance as of January 1 4,290 3,292 3,081 Incurred related to insured events of: Current year 1,655 1,474 1,323 Prior years 39 726 3 Total incurred 1,694 2,200 1,326 Paid related to insured events of: Current year (151 ) (134 ) (131 ) Prior years (1,371 ) (1,263 ) (1,160 ) Total paid (1,522 ) (1,397 ) (1,291 ) Interest on liability for policy and contract claims 232 195 176 Net balance as of December 31 4,694 4,290 3,292 Add reinsurance recoverables 2,055 1,926 1,707 Ending balance as of December 31 $ 6,749 $ 6,216 $ 4,999
U.S. Mortgage Insurance
Changes in Liability for Policy and Contract Claims	The following table sets forth changes in the liability for policy and contract claims for our U.S. mortgage insurance business for the dates indicated: (Amounts in millions) 2015 2014 2013 Beginning balance as of January 1 $ 1,180 $ 1,482 $ 2,009 Less reinsurance recoverables (24 ) (44 ) (80 ) Net balance as of January 1 1,156 1,438 1,929 Incurred related to insured events of: Current year 236 328 476 Prior years (14 ) 29 (63 ) Total incurred 222 357 413 Paid related to insured events of: Current year (13 ) (21 ) (45 ) Prior years (521 ) (618 ) (859 ) Total paid (534 ) (639 ) (904 ) Net balance as of December 31 844 1,156 1,438 Add reinsurance recoverables 5 24 44 Ending balance as of December 31 $ 849 $ 1,180 $ 1,482

Borrowings and Other Financin46

Borrowings and Other Financings (Tables)	12 Months Ended
	Dec. 31, 2015
Schedule of Long Term Borrowings	The following table sets forth total long-term borrowings as of December 31: (Amounts in millions) 2015 2014 Genworth Holdings 8.625% Senior Notes, due 2016 $ 298 $ 300 6.52% Senior Notes, due 2018 598 600 7.70% Senior Notes, due 2020 397 400 7.20% Senior Notes, due 2021 389 399 7.625% Senior Notes, due 2021 724 758 4.90% Senior Notes, due 2023 399 399 4.80% Senior Notes, due 2024 400 400 6.50% Senior Notes, due 2034 297 297 6.15% Fixed-to-Floating Rate Junior Subordinated Notes, due 2066 598 598 Subtotal 4,100 4,151 Deferred borrowing charges (21 ) (24 ) Total Genworth Holdings 4,079 4,127 Canada 5.68% Senior Notes, due 2020 199 236 4.24% Senior Notes, due 2024 116 138 Subtotal 315 374 Deferred borrowing charges (2 ) (2 ) Total Canada 313 372 Australia Floating Rate Junior Notes, due 2021 36 114 Floating Rate Junior Notes, due 2025 146 — Subtotal 182 114 Deferred borrowing charges (4 ) (1 ) Total Australia 178 113 Total $ 4,570 $ 4,612
Schedule of Non-Recourse Funding Obligations of Special Purpose Consolidated Captive Insurance Subsidiaries	The following table sets forth the non-recourse funding obligations (surplus notes) of our wholly-owned, special purpose consolidated captive insurance subsidiaries as of December 31: (Amounts in millions) Issuance 2015 2014 River Lake Insurance Company (a) $ 570 $ 570 River Lake Insurance Company (b) 405 435 River Lake Insurance Company II (a) 192 192 River Lake Insurance Company II (b) 453 484 Rivermont Life Insurance Company I (a) 315 315 Subtotal 1,935 1,996 Deferred borrowing charges (15 ) (15 ) Total $ 1,920 $ 1,981 (a) Accrual of interest based on one-month LIBOR that resets every 28 days plus a fixed margin. (b) Accrual of interest based on one-month LIBOR that resets on a specified date each month plus a contractual margin.
Principal Amounts of Long Term Debt Including Senior Notes and Non-Recourse Funding by Maturity	Principal amounts under our long-term borrowings (including senior notes) and non-recourse funding obligations by maturity were as follows as of December 31, 2015: (Amounts in millions) Amount 2016 $ 298 2017 — 2018 598 2019 — 2020 and thereafter (1) 5,636 Total $ 6,532 (1) Repayment of $1.9 billion of our non-recourse funding obligations requires regulatory approval.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2015
Components of Income (Loss) before Income Taxes	Income (loss) from continuing operations before income taxes included the following components for the years ended December 31: (Amounts in millions) 2015 2014 2013 Domestic $ (468 ) $ (2,022 ) $ 283 Foreign 453 723 710 Income (loss) from continuing operations before income taxes $ (15 ) $ (1,299 ) $ 993
Components of Income Tax (Benefit) Expense	The total provision (benefit) for income taxes was as follows for the years ended December 31: (Amounts in millions) 2015 2014 2013 Current federal income taxes $ 1 $ (3 ) $ (12 ) Deferred federal income taxes (199 ) (305 ) 137 Total federal income taxes (198 ) (308 ) 125 Current state income taxes — 4 (1 ) Deferred state income taxes 4 (4 ) (9 ) Total state income taxes 4 — (10 ) Current foreign income taxes 186 246 426 Deferred foreign income taxes (1 ) (32 ) (228 ) Total foreign income taxes 185 214 198 Total provision (benefit) for income taxes $ (9 ) $ (94 ) $ 313
Reconciliation of Federal Statutory Tax Rate to Effective Income Tax Rate	The reconciliation of the federal statutory tax rate to the effective income tax rate was as follows for the years ended December 31: (Amounts in millions) 2015 2014 2013 Pre-tax income (loss) $ (15 ) $ (1,299 ) $ 993 Statutory U.S. federal income tax rate $ (5 ) 35.0 % $ (455 ) 35.0 % $ 348 35.0 % Increase (reduction) in rate resulting from: State income tax, net of federal income tax effect 2 (18.0 ) — — (2 ) (0.2 ) Benefit on tax favored investments (14 ) 93.3 (19 ) 1.4 (18 ) (1.8 ) Effect of foreign operations (20 ) 129.2 (66 ) 5.1 (66 ) (6.6 ) Net impact of repatriating foreign earnings — — 205 (15.8 ) — — Interest on uncertain tax positions — — (2 ) 0.1 (1 ) (0.1 ) Non-deductible expenses (3 ) 22.0 4 (0.3 ) 2 0.2 Non-deductible goodwill — — 245 (18.8 ) — — Valuation allowance 25 (165.0 ) (6 ) 0.5 16 1.6 Stock-based compensation 5 (31.7 ) 4 (0.3 ) 25 2.5 Other, net 1 (6.8 ) (4 ) 0.3 9 0.9 Effective rate $ (9 ) 58.0 % $ (94 ) 7.2 % $ 313 31.5 %
Components of Net Deferred Income Tax Liability	The components of the net deferred income tax liability were as follows as of December 31: (Amounts in millions) 2015 2014 Assets: Foreign tax credit carryforwards $ 787 $ 666 Accrued commission and general expenses 199 203 State income taxes 302 275 Net operating loss carryforwards 1,727 1,797 Other 51 21 Gross deferred income tax assets 3,066 2,962 Valuation allowance (353 ) (296 ) Total deferred income tax assets 2,713 2,666 Liabilities: Investments 29 86 Net unrealized gains on investment securities 639 1,260 Net unrealized gains on derivatives 218 222 Insurance reserves 751 491 DAC 863 1,115 PVFP and other intangibles 20 3 Investment in foreign subsidiaries 10 310 Other 52 37 Total deferred income tax liabilities 2,582 3,524 Net deferred income tax asset (liability) $ 131 $ (858 )
Reconciliation of Unrecognized Tax Benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits was as follows: (Amounts in millions) 2015 2014 2013 Balance as of January 1 $ 49 $ 41 $ 55 Tax positions related to the current period: Gross additions 5 7 3 Gross reductions — (3 ) — Tax positions related to the prior years: Gross additions — 17 4 Gross reductions (26 ) (13 ) (21 ) Balance as of December 31 $ 28 $ 49 $ 41

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Dec. 31, 2015
Stock Option Weighted-Average Grant-Date Fair Value Information and Related Valuation Assumptions, Excluding Exchanged Grants and Performance-Accelerated Options	The following table contains the stock option and SAR weighted-average grant-date fair value information and related valuation assumptions for the years ended December 31: Stock Options and SARs 2015 2014 2013 Black-Scholes Black-Scholes Black-Scholes Monte-Carlo (1) Awards granted (in thousands) 1,378 2,960 3,404 1,200 Maximum share value at exercise of SARs $ 75.00 $ 75.00 $ 75.00 $ 75.00 Fair value per options and SARs $ 3.43 $ 3.05 $ 2.53 $ 5.88 Valuation assumptions: Expected term (years) 6.0 6.0 5.9 NA Expected volatility 66.0 % 100.2 % 100.7 % 102.5 % Expected dividend yield — % 0.5 % 0.5 % 0.5 % Risk-free interest rate 1.9 % 1.9 % 1.1 % 1.1 % (1) For purposes of determining the fair value of 1.2 million shares of performance-accelerated SARs that were issued in January 2013, we used a Monte-Carlo Simulation technique. Monte-Carlo Simulation is a method used to simulate future stock price movements in order to determine the fair value due to unique vesting and exercising provisions. The performance-accelerated SARs have a derived service period of one year on average and have a grant price of $7.90. The performance-accelerated SARs vest on the third anniversary of the grant date but are subject to earlier vesting on or after the one year anniversary of the grant date based on the closing price of our Class A Common Stock exceeding certain specified amounts ($12.00, $16.00 and $20.00, respectively) for 45 consecutive trading days. Based on the closing price of our Class A Common Stock, the first tranche at $12.00 vested in January 2014 and the second tranche at $16.00 vested in June 2014.
Rollforward of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding	The following table summarizes stock option activity as of December 31, 2015 and 2014: (Shares in thousands) Shares subject Weighted-average Balance as of January 1, 2014 4,310 $ 13.17 Granted — $ — Exercised (921 ) $ 8.10 Expired and forfeited (885 ) $ 19.32 Balance as of January 1, 2015 2,504 $ 12.86 Granted — $ — Exercised (47 ) $ 4.39 Expired and forfeited (317 ) $ 17.62 Balance as of December 31, 2015 2,140 $ 12.34 Exercisable as of December 31, 2015 2,140 $ 12.34
Information about Stock Options Outstanding	The following table summarizes information about stock options outstanding as of December 31, 2015: Outstanding and Exercisable Exercise price range Shares in Average (1) Average $2.00 - $2.46 (2) 362 3.04 $ 2.43 $7.36 - $7.80 433 1.77 $ 7.79 $9.10 - $14.18 1,119 3.95 $ 14.14 $14.92 - $22.80 100 2.33 $ 21.80 $30.52 - $34.13 126 0.99 $ 32.86 2,140 $ 12.34 (1) Average contractual life remaining in years. (2) These shares have an aggregate intrinsic value of $1 million each for total options outstanding and exercisable.
Status of Our Other Equity-Based Awards	The following tables summarize the status of our other equity-based awards as of December 31, 2015 and 2014: RSUs PSUs DSUs SARs (Awards in thousands) Number Weighted- date fair Number Weighted- value Number Weighted- value Number Weighted- date fair Balance as of January 1, 2014 2,887 $ 10.21 — $ — 579 $ 9.43 12,365 $ 4.00 Granted 1,226 $ 15.00 343 $ 15.31 113 $ 12.98 2,960 $ 3.05 Exercised (938 ) $ 10.06 — $ — (58 ) $ 6.65 (1,353 ) $ 3.88 Terminated (262 ) $ 12.16 (39 ) $ 15.23 — $ — (1,905 ) $ 5.23 Balance as of January 1, 2015 2,913 $ 12.09 304 $ 15.32 634 $ 9.96 12,067 $ 3.62 Granted 2,087 $ 7.50 535 $ 7.75 256 $ 3.90 1,378 $ 3.43 Exercised (1,390 ) $ 11.60 — $ — (10 ) $ 2.14 (59 ) $ 1.28 Terminated (355 ) $ 10.10 (129 ) $ 9.72 — $ — (1,238 ) $ 4.05 Balance as of December 31, 2015 3,255 $ 9.22 710 $ 10.63 880 $ 8.18 12,148 $ 3.56
Genworth Canada
Status of Our Other Equity-Based Awards	The following table summarizes the status of Genworth Canada’s stock option activity and other equity-based awards as of December 31, 2015 and 2014: Stock options RSUs and PSUs DSUs Executive deferred (Shares and awards in thousands) Shares subject Number of Number of Number of awards Balance as of January 1, 2014 987 177 45 20 Granted 114 93 9 1 Exercised (93 ) (67 ) — — Terminated (6 ) — — — Balance as of January 1, 2015 1,002 203 54 21 Granted 53 78 14 10 Exercised (88 ) (60 ) (14 ) — Terminated (12 ) (27 ) — — Balance as of December 31, 2015 955 194 54 31
Genworth Australia
Status of Our Other Equity-Based Awards	The following table summarizes the status of Genworth Australia’s restricted share rights as of December 31, 2015 and 2014: Restricted share rights (Shares in thousands) Shares subject to Balance as of January 1, 2014 — Granted 2,846 Exercised (5 ) Terminated (38 ) Balance as of January 1, 2015 2,803 Granted 147 Exercised (40 ) Terminated (145 ) Balance as of December 31, 2015 2,765

Fair Value of Financial Instr49

Fair Value of Financial Instruments (Tables)	12 Months Ended
	Dec. 31, 2015
Fair Value Financial Instruments Not Required to be Carried at Fair Value	The following represents our estimated fair value of financial assets and liabilities that are not required to be carried at fair value as of December 31: 2015 Notional amount Carrying amount Fair value (Amounts in millions) Total Level 1 Level 2 Level 3 Assets: Commercial mortgage loans $ (1) $ 6,170 $ 6,476 $ — $ — $ 6,476 Restricted commercial mortgage loans (2) (1) 161 179 — — 179 Other invested assets (1) 273 279 — 197 82 Liabilities: Long-term borrowings (3) (1) 4,570 3,518 — 3,343 175 Non-recourse funding obligations (3) (1) 1,920 1,401 — — 1,401 Borrowings related to securitization entities (2) (1) 98 104 — 104 — Investment contracts (1) 17,258 17,910 — 5 17,905 Other firm commitments: Commitments to fund limited partnerships 131 — — — — — Ordinary course of business lending commitments 40 — — — — — 2014 Notional amount Carrying amount Fair value (Amounts in millions) Total Level 1 Level 2 Level 3 Assets: Commercial mortgage loans $ (1) $ 6,100 $ 6,573 $ — $ — $ 6,573 Restricted commercial mortgage loans (2) (1) 201 228 — — 228 Other invested assets (1) 311 323 — 238 85 Liabilities: Long-term borrowings (3) (1) 4,612 4,273 — 4,155 118 Non-recourse funding obligations (3) (1) 1,981 1,423 — — 1,423 Borrowings related to securitization entities (2) (1) 134 146 — 146 — Investment contracts (1) 17,486 18,012 — 7 18,005 Other firm commitments: Commitments to fund limited partnerships 53 — — — — — Ordinary course of business lending commitments 155 — — — — — (1) These financial instruments do not have notional amounts. (2) See note 17 for additional information related to consolidated securitization entities. (3) See note 12 for additional information related to borrowings.
Summary of Significant Inputs Used by Third-Party Pricing Services for Certain Fair Value Measurements of Fixed Maturity Securities that Classified as Level 2	The following table presents a summary of the significant inputs used by our third-party pricing services for certain fair value measurements of fixed maturity securities that are classified as Level 2 as of December 31, 2015: (Amounts in millions) Fair value Primary methodologies Significant inputs U.S. government, agencies and government-sponsored enterprises $ 6,200 Price quotes from trading desk, broker feeds Bid side prices, trade prices, Option Adjusted Spread (“OAS”) to swap curve, Bond Market Association (“BMA”) OAS, Treasury Curve, Agency Bullet Curve, maturity to issuer spread State and political subdivisions $ 2,403 Multi-dimensional attribute-based modeling systems, third-party pricing vendors Trade prices, material event notices, Municipal Market Data benchmark yields, broker quotes Non-U.S. government $ 1,996 Matrix pricing, spread priced to benchmark curves, price quotes from market makers Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources U.S. corporate $ 21,505 Multi-dimensional attribute-based modeling systems, broker quotes, price quotes from market makers, internal models, OAS-based models Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine (“TRACE”) reports Non-U.S. corporate $ 10,364 Multi-dimensional attribute-based modeling systems, OAS-based models, price quotes from market makers Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources Residential mortgage-backed $ 4,985 OAS-based models, To Be Announced pricing models, single factor binomial models, internally priced Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average life, weighted-average loan age, issuer program and delinquency ratio, pay up and pay down factors, TRACE reports Commercial $ 2,549 Multi-dimensional attribute-based modeling systems, pricing matrix, spread matrix priced to swap curves, Trepp commercial mortgage-backed securities analytics model Credit risk, interest rate risk, prepayment speeds, new issue data, collateral performance, origination year, tranche type, original credit ratings, weighted-average life, cash flows, spreads derived from broker quotes, bid side prices, spreads to daily updated swaps curves Other asset-backed $ 2,139 Multi-dimensional attribute-based modeling systems, spread matrix priced to swap curves, price quotes from market makers, internal models Spreads to daily updated swaps curves, spreads derived from trade prices and broker quotes, bid side prices, new issue data, collateral performance, analysis of prepayment speeds, cash flows, collateral loss analytics, historical issue analysis, trade data from market makers, TRACE reports • Internal models:
Assets and Liabilities that are Measured at Fair Value on Recurring Basis	The following tables set forth our assets by class of instrument that are measured at fair value on a recurring basis as of December 31: 2015 (Amounts in millions) Total Level 1 Level 2 Level 3 Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 6,203 $ — $ 6,200 $ 3 State and political subdivisions 2,438 — 2,403 35 Non-U.S. government 2,015 — 2,015 — U.S. corporate: Utilities 3,693 — 3,244 449 Energy 2,501 — 2,248 253 Finance and insurance 5,632 — 4,917 715 Consumer—non-cyclical 4,096 — 3,987 109 Technology and communications 2,193 — 2,158 35 Industrial 1,173 — 1,112 61 Capital goods 1,950 — 1,770 180 Consumer—cyclical 1,675 — 1,436 239 Transportation 1,086 — 980 106 Other 402 — 220 182 Total U.S. corporate 24,401 — 22,072 2,329 Non-U.S. corporate: Utilities 843 — 556 287 Energy 1,686 — 1,434 252 Finance and insurance 2,473 — 2,282 191 Consumer—non-cyclical 752 — 583 169 Technology and communications 988 — 926 62 Industrial 986 — 902 84 Capital goods 604 — 391 213 Consumer—cyclical 526 — 455 71 Transportation 605 — 461 144 Other 2,736 — 2,664 72 Total non-U.S. corporate 12,199 — 10,654 1,545 Residential mortgage-backed 5,101 — 4,985 116 Commercial mortgage-backed 2,559 — 2,549 10 Other asset-backed 3,281 — 2,139 1,142 Total fixed maturity securities 58,197 — 53,017 5,180 Equity securities 310 270 2 38 Other invested assets: Trading securities 447 — 447 — Derivative assets: Interest rate swaps 1,054 — 1,054 — Foreign currency swaps 8 — 8 — Credit default swaps 1 — — 1 Equity index options 30 — — 30 Equity return swaps 2 — 2 — Other foreign currency contracts 17 — 14 3 Total derivative assets 1,112 — 1,078 34 Securities lending collateral 347 — 347 — Total other invested assets 1,906 — 1,872 34 Restricted other invested assets related to securitization entities (1) 413 — 181 232 Reinsurance recoverable (2) 17 — — 17 Separate account assets 7,883 7,883 — — Total assets $ 68,726 $ 8,153 $ 55,072 $ 5,501 (1) See note 17 for additional information related to consolidated securitization entities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. 2014 (Amounts in millions) Total Level 1 Level 2 Level 3 Assets Investments: Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 6,000 $ — $ 5,996 $ 4 State and political subdivisions 2,222 — 2,192 30 Non-U.S. government 1,902 — 1,895 7 U.S. corporate: Utilities 3,864 — 3,420 444 Energy 2,742 — 2,457 285 Finance and insurance 5,646 — 5,030 616 Consumer—non-cyclical 4,013 — 3,873 140 Technology and communications 2,325 — 2,280 45 Industrial 1,287 — 1,251 36 Capital goods 2,006 — 1,840 166 Consumer—cyclical 1,900 — 1,537 363 Transportation 1,039 — 886 153 Other 401 — 230 171 Total U.S. corporate 25,223 — 22,804 2,419 Non-U.S. corporate: Utilities 903 — 575 328 Energy 2,036 — 1,712 324 Finance and insurance 2,957 — 2,736 221 Consumer—non-cyclical 796 — 599 197 Technology and communications 1,053 — 1,011 42 Industrial 1,213 — 1,082 131 Capital goods 618 — 381 237 Consumer—cyclical 534 — 445 89 Transportation 590 — 436 154 Other 3,395 — 3,314 81 Total non-U.S. corporate 14,095 — 12,291 1,804 Residential mortgage-backed 5,228 — 5,163 65 Commercial mortgage-backed 2,702 — 2,697 5 Other asset-backed 3,705 — 2,285 1,420 Total fixed maturity securities 61,077 — 55,323 5,754 Equity securities 275 237 4 34 Other invested assets: Trading securities 241 — 241 — Derivative assets: Interest rate swaps 1,091 — 1,091 — Foreign currency swaps 6 — 6 — Credit default swaps 4 — 1 3 Equity index options 17 — — 17 Other foreign currency contracts 14 — 14 — Total derivative assets 1,132 — 1,112 20 Securities lending collateral 289 — 289 — Total other invested assets 1,662 — 1,642 20 Restricted other invested assets related to securitization entities (1) 411 — 181 230 Reinsurance recoverable (2) 13 — — 13 Separate account assets 9,208 9,208 — — Total assets $ 72,646 $ 9,445 $ 57,150 $ 6,051 (1) See note 17 for additional information related to consolidated securitization entities. (2) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.
Assets Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value	The following tables present additional information about assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of or for the dates indicated: (Amounts in millions) Beginning as of Total realized and Purchases Sales Issuances Settlements Transfer (1) Transfer (1) Ending as of Total gains attributable Included Included Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 4 $ — $ — $ — $ — $ — $ (1 ) $ — $ — $ 3 $ — State and political subdivisions 30 3 $ 7 $ 5 $ — $ — $ — $ — $ (10 ) $ 35 $ 3 Non-U.S. government 7 — $ (1 ) $ — $ — $ — $ (1 ) $ — $ (5 ) $ — $ — U.S. corporate: Utilities 444 — (14 ) 67 — — (16 ) 10 (42 ) 449 — Energy 285 — (13 ) 4 (4 ) — (11 ) — (8 ) 253 — Finance and insurance 616 16 (28 ) 90 — — (33 ) 97 (43 ) 715 14 Consumer—non-cyclical 140 2 (3 ) 29 (9 ) — (40 ) — (10 ) 109 — Technology and communications 45 3 (2 ) — — — — — (11 ) 35 3 Industrial 36 — (3 ) 28 — — — — — 61 — Capital goods 166 — (6 ) 30 (3 ) — (1 ) — (6 ) 180 — Consumer—cyclical 363 1 (8 ) 39 — — (52 ) 11 (115 ) 239 — Transportation 153 1 (5 ) 7 — — (31 ) — (19 ) 106 1 Other 171 1 (2 ) — — — (7 ) 19 — 182 1 Total U.S. corporate 2,419 24 (84 ) 294 (16 ) — (191 ) 137 (254 ) 2,329 19 Non-U.S. corporate: Utilities 328 — (4 ) 18 — — (46 ) — (9 ) 287 — Energy 324 (1 ) (21 ) 15 (24 ) — (41 ) — — 252 (1 ) Finance and insurance 221 5 (6 ) 21 — — (26 ) — (24 ) 191 3 Consumer—non-cyclical 197 — (1 ) 15 — — (41 ) — (1 ) 169 — Technology and communications 42 — (4 ) 24 — — — — — 62 — Industrial 131 — (4 ) 7 — — (18 ) 1 (33 ) 84 — Capital goods 237 — (7 ) — — — (17 ) — — 213 — Consumer—cyclical 89 — (2 ) — — — — 15 (31 ) 71 — Transportation 154 — (2 ) — — — (8 ) — — 144 — Other 81 — 2 — — — (11 ) — — 72 — Total non-U.S. corporate 1,804 4 (49 ) 100 (24 ) — (208 ) 16 (98 ) 1,545 2 Residential mortgage-backed 65 — (1 ) 58 — — (10 ) 76 (72 ) 116 — Commercial mortgage-backed 5 — (1 ) 9 — — (2 ) 13 (14 ) 10 — Other asset-backed 1,420 2 2 152 (190 ) — (267 ) 164 (141 ) 1,142 — Total fixed maturity securities 5,754 33 (127 ) 618 (230 ) — (680 ) 406 (594 ) 5,180 24 Equity securities 34 — — 1 (6 ) — — 9 — 38 — Other invested assets: Derivative assets: Credit default swaps 3 1 — — — — (3 ) — — 1 1 Equity index options 17 (25 ) — 38 — — — — — 30 (3 ) Other foreign currency contracts — (2 ) — 5 — — — — — 3 (1 ) Total derivative assets 20 (26 ) — 43 — — (3 ) — — 34 (3 ) Total other invested assets 20 (26 ) — 43 — — (3 ) — — 34 (3 ) Restricted other invested assets related to securitization entities (2) 230 2 — — — — — — — 232 2 Reinsurance recoverable (3) 13 1 — — — 3 — — — 17 1 Total Level 3 assets $ 6,051 $ 10 $ (127 ) $ 662 $ (236 ) $ 3 $ (683 ) $ 415 $ (594 ) $ 5,501 $ 24 (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities. (2) See note 17 for additional information related to consolidated securitization entities. (3) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. (Amounts in millions) Beginning Total realized and Purchases Sales Issuances Settlements Transfer (1) Transfer (1) Ending Total gains Included Included Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 5 $ — $ — $ — $ — $ — $ (1 ) $ — $ — $ 4 $ — State and political subdivisions 27 2 (4 ) 5 — — — — — 30 2 Non-U.S. government 23 — — 2 — — (2 ) — (16 ) 7 — U.S. corporate: Utilities 420 — 11 12 — — (5 ) 58 (52 ) 444 — Energy 281 — — 40 — — (4 ) 27 (59 ) 285 — Finance and insurance 433 14 23 39 (1 ) — (10 ) 155 (37 ) 616 3 Consumer—non-cyclical 224 2 2 — (38 ) — (60 ) 10 — 140 — Technology and communications 60 3 5 — (20 ) — (13 ) 10 — 45 3 Industrial 24 2 1 27 — — (15 ) — (3 ) 36 — Capital goods 139 — 3 8 — — — 31 (15 ) 166 — Consumer—cyclical 386 1 1 62 (1 ) — (86 ) — — 363 1 Transportation 196 2 4 10 — — (11 ) — (48 ) 153 2 Other 210 2 8 8 — — (47 ) 10 (20 ) 171 1 Total U.S. corporate 2,373 26 58 206 (60 ) — (251 ) 301 (234 ) 2,419 10 Non-U.S. corporate: Utilities 260 — 6 54 — — (14 ) 22 — 328 — Energy 320 — (14 ) 55 — — (48 ) 20 (9 ) 324 — Finance and insurance 181 3 32 71 (42 ) — (8 ) 21 (37 ) 221 2 Consumer—non-cyclical 212 — (4 ) 35 — — (46 ) — — 197 — Technology and communications 58 — (1 ) 20 (35 ) — — — — 42 — Industrial 151 — 2 — (12 ) — — — (10 ) 131 — Capital goods 299 1 (3 ) 30 (35 ) — (52 ) 10 (13 ) 237 — Consumer—cyclical 96 — — 6 — — (13 ) — — 89 — Transportation 153 — 1 11 — — (25 ) 14 — 154 — Other 89 — (11 ) — — — (17 ) 20 — 81 — Total non-U.S. corporate 1,819 4 8 282 (124 ) — (223 ) 107 (69 ) 1,804 2 Residential mortgage-backed 104 — (3 ) 16 (23 ) — (9 ) 13 (33 ) 65 — Commercial mortgage-backed 6 — 2 — — — (2 ) 7 (8 ) 5 — Other asset-backed 1,166 5 (3 ) 298 (15 ) — (181 ) 244 (94 ) 1,420 1 Total fixed maturity securities 5,523 37 58 809 (222 ) — (669 ) 672 (454 ) 5,754 15 Equity securities 78 — — 1 (38 ) — — — (7 ) 34 — Other invested assets: Trading securities 34 — — — — — (3 ) — (31 ) — — Derivative assets: Credit default swaps 10 — — — — — (7 ) — — 3 — Equity index options 12 (31 ) — 36 — — — — — 17 (28 ) Other foreign currency contracts 3 (2 ) — — (1 ) — — — — — — Total derivative assets 25 (33 ) — 36 (1 ) — (7 ) — — 20 (28 ) Total other invested assets 59 (33 ) — 36 (1 ) — (10 ) — (31 ) 20 (28 ) Restricted other invested assets related to securitization entities (2) 211 19 — — — — — — — 230 18 Reinsurance recoverable (3) (1 ) 11 — — — 3 — — — 13 11 Total Level 3 assets $ 5,870 $ 34 $ 58 $ 846 $ (261 ) $ 3 $ (679 ) $ 672 $ (492 ) $ 6,051 $ 16 (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads. (2) See note 17 for additional information related to consolidated securitization entities. (3) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities. (Amounts in millions) Beginning balance Total realized and Purchases Sales Issuances Settlements Transfer (1) Transfer (1) Ending balance as of Total gains (loss) Included Included Fixed maturity securities: U.S. government, agencies and government-sponsored enterprises $ 9 $ — $ — $ — $ — $ — $ (4 ) $ — $ — $ 5 $ — State and political subdivisions 25 2 — — — — — — — 27 2 Non-U.S. government 9 — 1 — — — (2 ) 16 (1 ) 23 — U.S. corporate: Utilities 414 — 15 6 (15 ) — (20 ) 57 (37 ) 420 — Energy 240 — 12 42 (10 ) — (25 ) 26 (4 ) 281 — Finance and insurance 453 13 (3 ) 33 (11 ) — (9 ) 21 (64 ) 433 12 Consumer—non-cyclical 243 (4 ) 12 42 (13 ) — (64 ) 8 — 224 (6 ) Technology and communications 73 2 (6 ) 6 (6 ) — (1 ) 3 (11 ) 60 2 Industrial 29 — 1 — — — (6 ) — — 24 — Capital goods 169 1 4 15 (35 ) — (14 ) — (1 ) 139 1 Consumer—cyclical 496 1 8 27 (46 ) — (107 ) 35 (28 ) 386 — Transportation 205 1 — 9 — — (36 ) 18 (1 ) 196 1 Other 354 1 (58 ) — (14 ) — (66 ) 17 (24 ) 210 1 Total U.S. corporate 2,676 15 (15 ) 180 (150 ) — (348 ) 185 (170 ) 2,373 11 Non-U.S. corporate: Utilities 242 — 8 10 — — — — — 260 — Energy 286 1 7 7 (14 ) — (17 ) 50 — 320 — Finance and insurance 245 2 (16 ) 21 (19 ) — (9 ) 18 (61 ) 181 2 Consumer—non-cyclical 194 — (1 ) 42 — — (23 ) — — 212 — Technology and communications 69 — 1 — — — (12 ) — — 58 — Industrial 207 — 1 21 — — (77 ) — (1 ) 151 — Capital goods 329 — 11 4 — — (45 ) — — 299 — Consumer—cyclical 106 — 4 15 — — (30 ) 1 — 96 — Transportation 147 — 7 — — — (1 ) — — 153 — Other 135 — (46 ) — — — — — — 89 — Total non-U.S. corporate 1,960 3 (24 ) 120 (33 ) — (214 ) 69 (62 ) 1,819 2 Residential mortgage-backed 143 (9 ) 7 — (8 ) — (27 ) 14 (16 ) 104 — Commercial mortgage-backed 35 (5 ) (1 ) — — — (32 ) 11 (2 ) 6 (4 ) Other asset-backed 864 4 10 200 (49 ) — (89 ) 246 (20 ) 1,166 4 Total fixed maturity securities 5,721 10 (22 ) 500 (240 ) — (716 ) 541 (271 ) 5,523 15 Equity securities 99 2 — 1 (24 ) — — — — 78 — Other invested assets: Trading securities 76 7 — — (40 ) — (9 ) — — 34 2 Derivative assets: Interest rate swaps 2 (1 ) — — — — (1 ) — — — (1 ) Credit default swaps 7 12 — — — — (9 ) — — 10 6 Equity index options 25 (43 ) — 39 — — (9 ) — — 12 (40 ) Other foreign currency contracts — (1 ) — 4 — — — — — 3 (1 ) Total derivative assets 34 (33 ) — 43 — — (19 ) — — 25 (36 ) Total other invested assets 110 (26 ) — 43 (40 ) — (28 ) — — 59 (34 ) Restricted other invested assets related to securitization entities (2) 194 (1 ) — 19 — — (20 ) 19 — 211 (1 ) Other assets (3) 9 — — — — — (9 ) — — — — Reinsurance recoverable (4) 10 (14 ) — — — 3 — — — (1 ) (14 ) Total Level 3 assets $ 6,143 $ (29 ) $ (22 ) $ 563 $ (304 ) $ 3 $ (773 ) $ 560 $ (271 ) $ 5,870 $ (34 ) (1) The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads. (2) See note 17 for additional information related to consolidated securitization entities. (3) Represents contingent receivables associated with recent business dispositions. (4) Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.
Gains and Losses Included in Net Income (Loss) from Assets and Liabilities Recorded at Fair Value	The following table presents the gains and losses included in net income (loss) from assets measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: (Amounts in millions) 2015 2014 2013 Total realized and unrealized gains (losses) included in net income (loss): Net investment income $ 42 $ 44 $ 36 Net investment gains (losses) (32 ) (10 ) (65 ) Total $ 10 $ 34 $ (29 ) Total gains (losses) included in net income (loss) attributable to assets still held: Net investment income $ 33 $ 19 $ 35 Net investment gains (losses) (9 ) (3 ) (69 ) Total $ 24 $ 16 $ (34 ) The following table presents the gains and losses included in net (income) loss from liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value and the related income statement line item in which these gains and losses were presented for the years ended December 31: (Amounts in millions) 2015 2014 2013 Total realized and unrealized (gains) losses included in net (income) loss: Net investment income $ — $ — $ — Net investment (gains) losses 16 177 (339 ) Total $ 16 $ 177 $ (339 ) Total (gains) losses included in net (income) loss attributable to liabilities still held: Net investment income $ — $ — $ — Net investment (gains) losses 48 178 (337 ) Total $ 48 $ 178 $ (337 )
Liabilities Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value	The following tables set forth our liabilities by class of instrument that are measured at fair value on a recurring basis as of December 31: 2015 (Amounts in millions) Total Level 1 Level 2 Level 3 Liabilities Policyholder account balances: GMWB embedded derivatives (1) $ 352 $ — $ — $ 352 Fixed index annuity embedded derivatives 342 — — 342 Indexed universal life embedded derivatives 10 — — 10 Total policyholder account balances 704 — — 704 Derivative liabilities: Interest rate swaps 220 — 220 — Interest rate swaps related to securitization entities (2) 30 — 30 — Inflation indexed swaps 33 — 33 — Foreign currency swaps 27 — 27 — Credit default swaps related to securitization entities (2) 14 — — 14 Equity return swaps 1 — 1 — Other foreign currency contracts 34 — 34 — Total derivative liabilities 359 — 345 14 Borrowings related to securitization entities (2) 81 — — 81 Total liabilities $ 1,144 $ — $ 345 $ 799 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. (2) See note 17 for additional information related to consolidated securitization entities. 2014 (Amounts in millions) Total Level 1 Level 2 Level 3 Liabilities Policyholder account balances: GMWB embedded derivatives (1) $ 291 $ — $ — $ 291 Fixed index annuity embedded derivatives 276 — — 276 Indexed universal life embedded derivatives 7 — — 7 Total policyholder account balances 574 — — 574 Derivative liabilities: Interest rate swaps 204 — 204 — Interest rate swaps related to securitization entities (2) 26 — 26 — Inflation indexed swaps 42 — 42 — Foreign currency swaps 7 — 7 — Credit default swaps related to securitization entities (2) 17 — — 17 Equity return swaps 1 — 1 — Other foreign currency contracts 13 — 13 — Total derivative liabilities 310 — 293 17 Borrowings related to securitization entities (2) 85 — — 85 Total liabilities $ 969 $ — $ 293 $ 676 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. (2) See note 17 for additional information related to consolidated securitization entities. The following tables present additional information about liabilities measured at fair value on a recurring basis and for which we have utilized significant unobservable (Level 3) inputs to determine fair value as of or for the dates indicated: (Amounts in millions) Beginning as of Total realized and unrealized (gains) losses Purchases Sales Issuances Settlements Transfer Transfer Ending as of Total (gains) in net Included in net (income) Included Policyholder account balances: GMWB embedded derivatives (1) $ 291 $ 26 $ — $ — $ — $ 35 $ — $ — $ — $ 352 $ 30 Fixed index annuity embedded derivatives 276 7 — — — 65 (6 ) — — 342 7 Indexed universal life embedded derivatives 7 (6 ) — — — 9 — — — 10 (6 ) Total policyholder account balances 574 27 — — — 109 (6 ) — — 704 31 Derivative liabilities: Credit default swaps related to securitization entities (2) 17 (7 ) — 4 — — — — — 14 21 Total derivative liabilities 17 (7 ) — 4 — — — — — 14 21 Borrowings related to securitization entities (2) 85 (4 ) — — — — — — — 81 (4 ) Total Level 3 liabilities $ 676 $ 16 $ — $ 4 $ — $ 109 $ (6 ) $ — $ — $ 799 $ 48 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. (2) See note 17 for additional information related to consolidated securitization entities. Beginning as of Total realized and unrealized (gains) losses Purchases Sales Issuances Settlements Transfer Transfer Ending as of Total (Amounts in millions) Included Included Policyholder account balances: GMWB embedded derivatives (1) $ 96 $ 158 $ — $ — $ — $ 37 $ — $ — $ — $ 291 $ 160 Fixed index annuity embedded derivatives 143 27 — — — 108 (2 ) — — 276 27 Indexed universal life embedded derivatives — 1 — — — 6 — — — 7 1 Total policyholder account balances 239 186 — — — 151 (2 ) — — 574 188 Derivative liabilities: Credit default swaps related to securitization entities (2) 32 (19 ) — 4 — — — — — 17 (19 ) Other foreign currency contracts 1 1 — — (2 ) — — — — — — Total derivative liabilities 33 (18 ) — 4 (2 ) — — — — 17 (19 ) Borrowings related to securitization entities (2) 75 9 — — — 1 — — — 85 9 Total Level 3 liabilities $ 347 $ 177 $ — $ 4 $ (2 ) $ 152 $ (2 ) $ — $ — $ 676 $ 178 (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. (2) See note 17 for additional information related to consolidated securitization entities. Beginning Total realized and unrealized (gains) losses Purchases Sales Issuances Settlements Transfer Transfer Ending as of Total in net (Amounts in millions) Included Included Policyholder account balances: GMWB embedded derivatives (1) $ 350 $ (291 ) $ — $ — $ — $ 37 $ — $ — $ — $ 96 $ (289 ) Fixed index annuity embedded derivatives 27 18 — — — 98 — — — 143 18 Total policyholder account balances 377 (273 ) — — — 135 — — — 239 (271 ) Derivative liabilities: Credit default swaps 1 (1 ) — — — — — — — — (1 ) Credit default swaps related to securitization entities (2) 104 (77 ) — 5 — — — — — 32 (77 ) Equity index options — 1 — — — — (1 ) — — — 1 Other foreign current contracts — (2 ) — 3 — — — — — 1 (2 ) Total derivative liabilities 105 (79 ) — 8 — — (1 ) — — 33 (79 ) Borrowings related to securitization entities (2) 62 13 — — — — — — — 75 13 Total Level 3 liabilities $ 544 $ (339 ) $ — $ 8 $ — $ 135 $ (1 ) $ — $ — $ 347 $ (337 ) (1) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance. (2) See note 17 for additional information related to consolidated securitization entities.
Fair Value Inputs, Assets and Liabilities, Quantitative Information	The following table presents a summary of the significant unobservable inputs used for certain fair value measurements that are based on internal models and classified as Level 3 as of December 31, 2015: (Amounts in millions) Valuation technique Fair value Unobservable input Range Weighted-average Fixed maturity securities: U.S. corporate: Utilities Internal models $ 425 Credit spreads 100bps - 346bps 177bps Energy Internal models 141 Credit spreads 124bps - 365bps 208bps Finance and insurance Internal models 598 Credit spreads 96bps - 644bps 252bps Consumer—non-cyclical Internal models 109 Credit spreads 150bps - 495bps 280bps Technology and communications Internal models 35 Credit spreads 403bps Not applicable Industrial Internal models 61 Credit spreads 252bps - 354bps 305bps Capital goods Internal models 180 Credit spreads 94bps - 516bps 226bps Consumer—cyclical Internal models 239 Credit spreads 94bps - 350bps 230bps Transportation Internal models 95 Credit spreads 66bps - 335bps 223bps Other Internal models 167 Credit spreads 82bps - 495bps 154bps Total U.S. corporate Internal models $ 2,050 Credit spreads 66bps - 644bps 225bps Non-U.S. corporate: Utilities Internal models $ 287 Credit spreads 112bps - 212bps 157bps Energy Internal models 213 Credit spreads 146bps - 552bps 265bps Finance and insurance Internal models 181 Credit spreads 125bps - 230bps 147bps Consumer—non-cyclical Internal models 155 Credit spreads 94bps - 332bps 213bps Technology and communications Internal models 62 Credit spreads 179bps - 552bps 312bps Industrial Internal models 70 Credit spreads 150bps - 280bps 253bps Capital goods Internal models 180 Credit spreads 150bps - 440bps 259bps Consumer—cyclical Internal models 71 Credit spreads 109bps - 354bps 236bps Transportation Internal models 144 Credit spreads 120bps - 354bps 197bps Other Internal models 55 Credit spreads 354bps - 714bps 464bps Total non-U.S. corporate Internal models $ 1,418 Credit spreads 85bps - 690bps 222bps Derivative assets: Credit default swaps (1) Discounted cash $ 1 Credit spreads 5bps Not applicable Equity index options Discounted cash $ 30 Equity index volatility —% - 23% 17% Interest rate volatility 24% - 25% 25% Other foreign currency contracts Discounted cash $ 3 Foreign exchange rate volatility 9% - 13% 12% Policyholder account balances: Withdrawal utilization rate —% - 98% 66% Lapse rate —% - 15% 6% Non-performance risk 40bps - 85bps 70bps GMWB embedded derivatives (2) Stochastic cash flow $ 352 Equity index volatility 17% - 24% 21% Fixed index annuity embedded derivatives Option budget $ 342 Expected future —% - 3% 2% Indexed universal life embedded derivatives Option budget $ 10 Expected future 3% - 10% 6% (1) Unobservable input valuation based on the current market credit default swap premium. (2) Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.

Variable Interest and Securit50

Variable Interest and Securitization Entities (Tables)	12 Months Ended
	Dec. 31, 2015
Schedule of Securitized Assets	The following table summarizes the total securitized assets as of December 31: (Amounts in millions) 2015 2014 Receivables secured by: Other assets $ 136 $ 142 Total securitized assets not required to be consolidated 136 142 Total securitized assets required to be consolidated 267 300 Total securitized assets $ 403 $ 442
Schedule of Variable Interest Entities	The following table shows the assets and liabilities that were recorded for the consolidated securitization entities as of December 31: (Amounts in millions) 2015 2014 Assets Investments: Restricted commercial mortgage loans $ 161 $ 201 Restricted other invested assets: Trading securities 413 411 Total restricted other invested assets 413 411 Total investments 574 612 Cash and cash equivalents 1 1 Accrued investment income 1 1 Other assets 5 — Total assets $ 581 $ 614 Liabilities Other liabilities: Derivative liabilities $ 44 $ 43 Other liabilities 2 2 Total other liabilities 46 45 Borrowings related to securitization entities 179 219 Total liabilities $ 225 $ 264
Schedule of Income Statement Activity Related to Variable Interest Entities	The following table shows the activity presented in our consolidated statement of income related to the consolidated securitization entities for the years ended December 31: (Amounts in millions) 2015 2014 2013 Revenues: Net investment income: Restricted commercial mortgage loans $ 14 $ 14 $ 23 Restricted other invested assets 5 5 4 Total net investment income 19 19 27 Net investment gains (losses): Trading securities (2 ) 15 (4 ) Derivatives 3 10 86 Borrowings related to securitization entities recorded at fair value 4 (9 ) (13 ) Total net investment gains (losses) 5 16 69 Total revenues 24 35 96 Expenses: Interest expense 9 10 16 Total expenses 9 10 16 Income before income taxes 15 25 80 Provision for income taxes 5 9 27 Net income $ 10 $ 16 $ 53
Borrowings Related to Consolidated Securitization Entities	Borrowings related to securitization entities were as follows as of December 31: 2015 2014 (Amounts in millions) Principal Carrying Principal Carrying GFCM LLC, due 2035, 5.2541% $ — $ — $ 21 $ 21 GFCM LLC, due 2035, 5.7426% 98 98 113 113 Marvel Finance 2007-4 LLC, due 2017 (1),(2) 12 10 12 12 Genworth Special Purpose Five, LLC, due 2040 (1),(2) NA (3) 71 NA (3) 73 Total $ 110 $ 179 $ 146 $ 219 (1) Accrual of interest based on three-month LIBOR that resets every three months plus a fixed margin. (2) Carrying value represents fair value as a result of electing fair value option for these liabilities. (3) Principal amount not applicable. Notional balance was $118 million and $115 million as of December 31, 2015 and 2014, respectively.

Insurance Subsidiary Financia51

Insurance Subsidiary Financial Information and Regulatory Matters (Tables)	12 Months Ended
	Dec. 31, 2015
Schedule of Combined Statutory Net Income (Loss)	The tables below include the combined statutory net income (loss) and statutory capital and surplus for our U.S. domiciled insurance subsidiaries for the periods indicated: Years ended December 31, (Amounts in millions) 2015 2014 2013 Combined statutory net income (loss): Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ (330 ) $ (179 ) $ 359 Mortgage insurance subsidiaries 287 198 85 Combined statutory net income (loss), excluding captive reinsurance subsidiaries (43 ) 19 444 Captive life insurance subsidiaries (276 ) (281 ) (102 ) Combined statutory net income (loss) $ (319 ) $ (262 ) $ 342
Schedule of Combined Statutory Capital and Surplus	As of December 31, (Amounts in millions) 2015 2014 Combined statutory capital and surplus: Life insurance subsidiaries, excluding captive life reinsurance subsidiaries $ 2,548 $ 2,560 Mortgage insurance subsidiaries 1,722 1,792 Combined statutory capital and surplus $ 4,270 $ 4,352

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2015
Summary of Segments and Corporate and Other Activities	The following is a summary of our segments and Corporate and Other activities as of or for the years ended December 31: 2015 U.S. Canada Australia U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 602 $ 466 $ 357 $ 3,128 $ 1 $ 25 $ 4,579 Net investment income 58 130 114 2,701 138 (3 ) 3,138 Net investment gains (losses) 1 (32 ) 6 (10 ) (69 ) 29 (75 ) Policy fees and other income 4 — (3 ) 726 189 (10 ) 906 Total revenues 665 564 474 6,545 259 41 8,548 Benefits and other changes in policy reserves 222 96 81 4,692 44 14 5,149 Interest credited — — — 596 124 — 720 Acquisition and operating expenses, net of deferrals 155 66 98 684 76 230 1,309 Amortization of deferred acquisition costs and intangibles 10 36 18 872 29 1 966 Interest expense — 18 10 92 1 298 419 Total benefits and expenses 387 216 207 6,936 274 543 8,563 Income (loss) from continuing operations before income taxes 278 348 267 (391 ) (15 ) (502 ) (15 ) Provision (benefit) for income taxes 99 90 80 (138 ) (10 ) (130 ) (9 ) Income (loss) from continuing operations 179 258 187 (253 ) (5 ) (372 ) (6 ) Income (loss) from discontinued operations, net of taxes — — — — — (407 ) (407 ) Net income (loss) 179 258 187 (253 ) (5 ) (779 ) (413 ) Less: net income attributable to noncontrolling interests — 118 84 — — — 202 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 179 $ 140 $ 103 $ (253 ) $ (5 ) $ (779 ) $ (615 ) Segment assets $ 2,899 $ 4,520 $ 2,987 $ 79,530 $ 12,115 $ 4,253 $ 106,304 Assets held for sale — — — — — 127 127 Total assets $ 2,899 $ 4,520 $ 2,987 $ 79,530 $ 12,115 $ 4,380 $ 106,431 2014 U.S. Canada Australia U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 578 $ 515 $ 406 $ 3,169 $ 3 $ 29 $ 4,700 Net investment income 59 155 144 2,665 129 (10 ) 3,142 Net investment gains (losses) — (2 ) 3 41 (66 ) 2 (22 ) Policy fees and other income 2 1 (16 ) 712 209 1 909 Total revenues 639 669 537 6,587 275 22 8,729 Benefits and other changes in policy reserves 357 102 78 5,820 37 24 6,418 Interest credited — — — 618 119 — 737 Acquisition and operating expenses, net of deferrals 140 90 97 658 84 69 1,138 Amortization of deferred acquisition costs and intangibles 7 38 21 345 39 3 453 Goodwill impairment — — — 849 — — 849 Interest expense — 21 10 87 1 314 433 Total benefits and expenses 504 251 206 8,377 280 410 10,028 Income (loss) from continuing operations before income taxes 135 418 331 (1,790 ) (5 ) (388 ) (1,299 ) Provision (benefit) for income taxes 44 111 248 (385 ) (19 ) (93 ) (94 ) Income (loss) from continuing operations 91 307 83 (1,405 ) 14 (295 ) (1,205 ) Income from discontinued operations, net of taxes — — — — — 157 157 Net income (loss) 91 307 83 (1,405 ) 14 (138 ) (1,048 ) Less: net income attributable to noncontrolling interests — 140 56 — — — 196 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 91 $ 167 $ 27 $ (1,405 ) $ 14 $ (138 ) $ (1,244 ) Segment assets $ 2,324 $ 4,920 $ 3,494 $ 82,891 $ 12,971 $ 2,573 $ 109,173 Assets held for sale — — — — — 2,143 2,143 Total assets $ 2,324 $ 4,920 $ 3,494 $ 82,891 $ 12,971 $ 4,716 $ 111,316 2013 U.S. Canada Australia U.S. Life Runoff Corporate Total (Amounts in millions) Premiums $ 554 $ 560 $ 398 $ 2,957 $ 5 $ 42 $ 4,516 Net investment income 60 170 159 2,621 139 6 3,155 Net investment gains (losses) — 31 (2 ) (3 ) (58 ) (32 ) (64 ) Policy fees and other income 2 (1 ) — 755 216 46 1,018 Total revenues 616 760 555 6,330 302 62 8,625 Benefits and other changes in policy reserves 412 139 134 3,975 32 45 4,737 Interest credited — — — 619 119 — 738 Acquisition and operating expenses, net of deferrals 144 93 110 658 81 158 1,244 Amortization of deferred acquisition costs and intangibles 6 37 22 384 6 8 463 Interest expense — 22 11 97 2 318 450 Total benefits and expenses 562 291 277 5,733 240 529 7,632 Income (loss) from continuing operations before income taxes 54 469 278 597 62 (467 ) 993 Provision (benefit) for income taxes 17 133 51 213 13 (114 ) 313 Income (loss) from continuing operations 37 336 227 384 49 (353 ) 680 Income from discontinued operations, net of taxes — — — — — 34 34 Net income (loss) 37 336 227 384 49 (319 ) 714 Less: net income attributable to noncontrolling interests — 154 — — — — 154 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 37 $ 182 $ 227 $ 384 $ 49 $ (319 ) $ 560
Summary of Revenues of Major Product Groups for Segments and Corporate and Other Activities	The following is a summary of revenues of major product groups for our segments and Corporate and Other activities for the years ended December 31: (Amounts in millions) 2015 2014 2013 Revenues: U.S. Mortgage Insurance segment’s revenues $ 665 $ 639 $ 616 Canada Mortgage Insurance segment’s revenues 564 669 760 Australia Mortgage Insurance segment’s revenues 474 537 555 U.S. Life Insurance segment: Long-term care insurance 3,752 3,523 3,316 Life insurance 1,902 1,981 1,982 Fixed annuities 891 1,083 1,032 U.S. Life Insurance segment’s revenues 6,545 6,587 6,330 Runoff segment’s revenues 259 275 302 Corporate and Other’s revenues 41 22 62 Total revenues $ 8,548 $ 8,729 $ 8,625
Summary of Net Operating Income (Loss) Available to Company's Common Stockholders for Segments and Corporate and Other Activities	The following is a summary of net operating income (loss) for our segments and Corporate and Other activities and a reconciliation of net operating income (loss) for our segments and Corporate and Other activities to net income (loss) available to Genworth Financial, Inc.’s common stockholders for the years ended December 31: (Amounts in millions) 2015 2014 2013 U.S. Mortgage Insurance segment’s net operating income $ 179 $ 91 $ 37 Canada Mortgage Insurance segment’s net operating income 152 170 170 Australia Mortgage Insurance segment’s net operating income 102 200 228 U.S. Life Insurance segment: Long-term care insurance 29 (815 ) 129 Life insurance (80 ) 74 173 Fixed annuities 94 100 92 U.S. Life Insurance segment’s net operating income (loss) 43 (641 ) 394 Runoff segment’s net operating income 27 48 66 Corporate and Other’s net operating loss (248 ) (266 ) (310 ) Net operating income (loss) 255 (398 ) 585 Net investment gains (losses), net (19 ) (5 ) (29 ) Goodwill impairment, net — (791 ) — Gains (losses) from sale of businesses, net (141 ) — — Gains (losses) on early extinguishment of debt, net (2 ) (2 ) (20 ) Gains (losses) from life block transactions, net (296 ) — — Expenses related to restructuring, net (5 ) — (10 ) Tax impact from potential business portfolio changes — (205 ) — Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders (208 ) (1,401 ) 526 Net income attributable to noncontrolling interests 202 196 154 Income (loss) from continuing operations (6 ) (1,205 ) 680 Income (loss) from discontinued operations, net of taxes (407 ) 157 34 Net income (loss) (413 ) (1,048 ) 714 Less: net income attributable to noncontrolling interests 202 196 154 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (615 ) $ (1,244 ) $ 560
Schedule of Revenue, Net Income and Assets by Geographic Location	The following is a summary of geographic region activity as of or for the years ended December 31: 2015 (Amounts in millions) United States Canada Australia Other Total Total revenues $ 7,483 $ 564 $ 474 $ 27 $ 8,548 Income (loss) from continuing operations $ (430 ) $ 258 $ 187 $ (21 ) $ (6 ) Net income (loss) $ (430 ) $ 258 $ 187 $ (428 ) $ (413 ) Segment assets $ 98,738 $ 4,520 $ 2,987 $ 59 $ 106,304 Assets held for sale $ — $ — $ — $ 127 $ 127 Total assets $ 98,738 $ 4,520 $ 2,987 $ 186 $ 106,431 2014 (Amounts in millions) United States Canada Australia Other Total Total revenues $ 7,487 $ 669 $ 537 $ 36 $ 8,729 Income (loss) from continuing operations $ (1,570 ) $ 307 $ 83 $ (25 ) $ (1,205 ) Net income (loss) $ (1,570 ) $ 307 $ 83 $ 132 $ (1,048 ) Segment assets $ 100,690 $ 4,920 $ 3,494 $ 69 $ 109,173 Assets held for sale $ — $ — $ — $ 2,143 $ 2,143 Total assets $ 100,690 $ 4,920 $ 3,494 $ 2,212 $ 111,316 2013 (Amounts in millions) United States Canada Australia Other Total Total revenues $ 7,259 $ 760 $ 555 $ 51 $ 8,625 Income (loss) from continuing operations $ 153 $ 336 $ 227 $ (36 ) $ 680 Net income $ 141 $ 336 $ 227 $ 10 $ 714

Quarterly Results of Operatio53

Quarterly Results of Operations (unaudited) (Tables)	12 Months Ended
	Dec. 31, 2015
Quarterly Results of Operations	Our unaudited quarterly results of operations for the year ended December 31, 2015 are summarized in the table below. Three months ended (Amounts in millions, except per share amounts) March 31, June 30, September 30, December 31, Total revenues (1) $ 2,135 $ 2,157 $ 2,100 $ 2,156 Total benefits and expenses (2) $ 1,841 $ 1,912 $ 2,451 $ 2,359 Income (loss) from continuing operations (3) $ 203 $ 175 $ (217 ) $ (167 ) Income (loss) from discontinued operations, net of taxes (4) $ 1 $ (314 ) $ (21 ) $ (73 ) Net income (loss) (3), (4) $ 204 $ (139 ) $ (238 ) $ (240 ) Net income attributable to noncontrolling interests $ 50 $ 54 $ 46 $ 52 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ 154 $ (193 ) $ (284 ) $ (292 ) Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per common share: Basic $ 0.31 $ 0.24 $ (0.53 ) $ (0.44 ) Diluted $ 0.31 $ 0.24 $ (0.53 ) $ (0.44 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders per common share: Basic $ 0.31 $ (0.39 ) $ (0.57 ) $ (0.59 ) Diluted $ 0.31 $ (0.39 ) $ (0.57 ) $ (0.59 ) Weighted-average common shares outstanding: Basic 497.0 497.4 497.4 497.6 Diluted (5) 498.9 499.3 497.4 497.6 (1) We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $12 million of higher revenue, which included $5 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements. (2) We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $310 million of charges, which included $60 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements. We also recorded an expected loss of $140 million related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015. (3) We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015. (4) We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale. (5) Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2015 and December 31, 2015, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2015 and December 31, 2015, as the inclusion of shares for stock options, RSUs and SARs of 1.3 million and 1.4 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2015 and December 31, 2015, dilutive potential weighted-average common shares outstanding would have been 498.7 and 499.0 million, respectively. Our unaudited quarterly results of operations for the year ended December 31, 2014 are summarized in the table below. Three months ended (Amounts in millions, except per share amounts) March 31, June 30, September 30, December 31, Total revenues $ 2,116 $ 2,194 $ 2,190 $ 2,229 Total benefits and expenses (1) $ 1,819 $ 1,886 $ 3,170 $ 3,153 Income (loss) from continuing operations (2) $ 210 $ 224 $ (793 ) $ (846 ) Income from discontinued operations, net of taxes $ 9 $ 4 $ 6 $ 138 Net income (loss) (2) $ 219 $ 228 $ (787 ) $ (708 ) Net income attributable to noncontrolling interests $ 35 $ 52 $ 57 $ 52 Net income (loss) available to Genworth Financial, Inc.’s common stockholders (2) $ 184 $ 176 $ (844 ) $ (760 ) Income (loss) from continuing operations available to Genworth Financial, Inc.’s common stockholders per common share: Basic $ 0.35 $ 0.35 $ (1.71 ) $ (1.81 ) Diluted $ 0.35 $ 0.34 $ (1.71 ) $ (1.81 ) Net income (loss) available to Genworth Financial, Inc.’s common stockholders per common share: Basic $ 0.37 $ 0.35 $ (1.70 ) $ (1.53 ) Diluted $ 0.37 $ 0.35 $ (1.70 ) $ (1.53 ) Weighted-average common shares outstanding: Basic 495.8 496.6 496.6 496.7 Diluted (3) 502.7 503.6 496.6 496.7 (1) During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates. (2) During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates. (3) Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2014 and December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2014 and December 31, 2014, as the inclusion of shares for stock options, RSUs and SARs of 5.4 million and 3.2 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.’s common stockholders and net loss available to Genworth Financial, Inc.’s common stockholders for the three months ended September 30, 2014 and December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million and 499.9 million, respectively.

Changes In Accumulated Other 54

Changes In Accumulated Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2015
Component of Changes in Accumulated Other Comprehensive Income (Loss), Net of Taxes	The following tables show the changes in accumulated other comprehensive income (loss), net of taxes, by component as of and for the periods indicated: (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2015 $ 2,453 $ 2,070 $ (77 ) $ 4,446 OCI before reclassifications (1,218 ) 50 (530 ) (1,698 ) Amounts reclassified from (to) OCI 5 (75 ) — (70 ) Current period OCI (1,213 ) (25 ) (530 ) (1,768 ) Balances as of December 31, 2015 before noncontrolling interests 1,240 2,045 (607 ) 2,678 Less: change in OCI attributable to noncontrolling interests (14 ) — (318 ) (332 ) Balances as of December 31, 2015 $ 1,254 $ 2,045 $ (289 ) $ 3,010 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional information. (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2014 $ 926 $ 1,319 $ 297 $ 2,542 OCI before reclassifications 1,595 788 (537 ) 1,846 Amounts reclassified from (to) OCI (12 ) (37 ) — (49 ) Current period OCI 1,583 751 (537 ) 1,797 Balances as of December 31, 2014 before noncontrolling interests 2,509 2,070 (240 ) 4,339 Less: change in OCI attributable to noncontrolling interests 56 — (163 ) (107 ) Balances as of December 31, 2014 $ 2,453 $ 2,070 $ (77 ) $ 4,446 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional information. (Amounts in millions) Net (1) Derivatives (2) Foreign Total Balances as of January 1, 2013 $ 2,638 $ 1,909 $ 655 $ 5,202 OCI before reclassifications (1,772 ) (561 ) (442 ) (2,775 ) Amounts reclassified from (to) OCI 21 (29 ) — (8 ) Current period OCI (1,751 ) (590 ) (442 ) (2,783 ) Balances as of December 31, 2013 before noncontrolling interests 887 1,319 213 2,419 Less: change in OCI attributable to noncontrolling interests (39 ) — (84 ) (123 ) Balances as of December 31, 2013 $ 926 $ 1,319 $ 297 $ 2,542 (1) Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information. (2) See note 5 for additional informatio
Reclassifications in (out) of Accumulated Other Comprehensive Income (Loss), Net of Taxes	The following table shows reclassifications out of accumulated other comprehensive income (loss), net of taxes, for the periods presented: Amount reclassified from accumulated other comprehensive income (loss) Affected line item in the consolidated statements of income Years ended December 31, (Amounts in millions) 2015 2014 2013 Net unrealized investment (gains) losses: Unrealized (gains) losses on investments (1) $ 7 $ (19 ) $ 33 Net investment (gains) losses Provision for income taxes (2 ) 7 (12 ) Provision for income taxes Total $ 5 $ (12 ) $ 21 Derivatives qualifying as hedges: Interest rate swaps hedging assets $ (85 ) $ (63 ) $ (47 ) Net investment income Interest rate swaps hedging assets — (2 ) (1 ) Net investment (gains) losses Interest rate swaps hedging liabilities — (1 ) (2 ) Interest expense Inflation indexed swaps — 9 5 Net investment income Forward bond purchase commitments (1 ) — — Net investment income Forward bond purchase commitments (32 ) — — Net investment (gains) losses Provision for income taxes 43 20 16 Provision for income taxes Total $ (75 ) $ (37 ) $ (29 ) (1) Amounts exclude adjustments to DAC, PVFP, sales inducements and benefit reserves.

Noncontrolling Interests (Table

Noncontrolling Interests (Tables)	12 Months Ended
	Dec. 31, 2015
Changes in Ownership Interests and the Effect on Stockholders' Equity	A summary of the changes in ownership interests and the effect on stockholders’ equity as a result of the initial public offering of Genworth Australia was as follows for the years ended December 31: (Amounts in millions) 2015 2014 Net loss available to Genworth Financial, Inc.’s common stockholders $ (615 ) $ (1,244 ) Transfers to the noncontrolling interests: Decrease in Genworth Financial, Inc.’s additional paid-in capital for initial sale of Genworth Australia shares to noncontrolling interests — (145 ) Decrease in Genworth Financial, Inc.’s additional paid-in capital for additional sale of Genworth Australia shares to noncontrolling interests (65 ) — Net transfers to noncontrolling interests (65 ) (145 ) Change from net loss available to Genworth Financial, Inc.’s common stockholders and transfers to noncontrolling interests $ (680 ) $ (1,389 )

Sale of Businesses (Tables)

Sale of Businesses (Tables)	12 Months Ended
	Dec. 31, 2015
Summary of Operating Results of Discontinued Operations	The major assets and liability categories of our European mortgage insurance business were as follows as of December 31: (Amounts in millions) 2015 2014 Assets Investments: Fixed maturity securities available-for-sale, at fair value $ 195 $ 199 Other invested assets 6 36 Total investments 201 235 Cash and cash equivalents 28 71 Accrued investment income 3 4 Intangible assets — 1 Reinsurance recoverable 21 23 Other assets 14 — Assets held for sale 267 334 Fair value less closing costs impairment (140 ) — Total assets held for sale $ 127 $ 334 Liabilities Liability for policy and contract claims $ 56 $ 56 Unearned premiums 58 62 Other liabilities 12 48 Deferred tax liability 1 — Liabilities held for sale $ 127 $ 166 The major assets and liability categories of our lifestyle protection insurance business were as follows as of December 31: (Amounts in millions) 2015 2014 Assets Investments: Fixed maturity securities available-for-sale, at fair value $ — $ 1,171 Equity securities available-for-sale, at fair value — 7 Other invested assets — 52 Total investments — 1,230 Cash and cash equivalents — 202 Accrued investment income — 21 Deferred acquisition costs — 193 Intangible assets — 22 Reinsurance recoverable — 32 Other assets — 109 Assets held for sale $ — $ 1,809 Liabilities Policyholder account balances $ — $ 11 Liability for policy and contract claims — 106 Unearned premiums — 439 Other liabilities — 322 Deferred tax liability — 50 Liabilities held for sale $ — $ 928 Summary operating results of discontinued operations were as follows for the years ended December 31: (Amounts in millions) 2015 2014 2013 Revenues: Premiums $ 627 $ 731 $ 632 Net investment income 74 100 116 Net investment gains (losses) — 2 27 Policy fees and other income — 3 3 Total revenues 701 836 778 Benefits and expenses: Benefits and other changes in policy reserves 182 202 158 Acquisition and operating expenses 396 447 415 Amortization of deferred acquisition costs and intangibles 83 118 106 Interest expense 29 46 42 Total benefits and expenses 690 813 721 Income (loss) before income taxes and loss on sale 11 23 57 Provision (benefit) for income taxes 37 (134 ) 11 Income (loss) before loss on sale (26 ) 157 46 Loss on sale, net of taxes (381 ) — — Income (loss) from discontinued operations, net of taxes $ (407 ) $ 157 $ 46 Summary operating results of discontinued operations related to our wealth management business were as follows for the year ended December 31: (Amounts in millions) 2013 Revenues: Policy fees and other income $ 211 Total revenues 211 Benefits and expenses: Acquisition and operating expenses, net of deferrals 178 Amortization of deferred acquisition costs and intangibles 4 Total benefits and expenses 182 Income before income taxes and other items 29 Provision for income taxes 12 Income before other items 17 Goodwill impairment and other loss from sale, net of taxes (29 ) Loss from discontinued operations, net of taxes $ (12 )

Condensed Consolidating Finan57

Condensed Consolidating Financial Information (Tables)	12 Months Ended
	Dec. 31, 2015
Condensed Consolidating Balance Sheet	The following table presents the condensed consolidating balance sheet information as of December 31, 2015: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Assets Investments: Fixed maturity securities available-for-sale, at fair value $ — $ 150 $ 58,247 $ (200 ) $ 58,197 Equity securities available-for-sale, at fair value — — 310 — 310 Commercial mortgage loans — — 6,170 — 6,170 Restricted commercial mortgage loans related to securitization entities — — 161 — 161 Policy loans — — 1,568 — 1,568 Other invested assets — 114 2,198 (3 ) 2,309 Restricted other invested assets related to securitization entities, at fair value — — 413 — 413 Investments in subsidiaries 12,814 12,989 — (25,803 ) — Total investments 12,814 13,253 69,067 (26,006 ) 69,128 Cash and cash equivalents — 1,124 4,841 — 5,965 Accrued investment income — — 657 (4 ) 653 Deferred acquisition costs — — 4,398 — 4,398 Intangible assets and goodwill — — 357 — 357 Reinsurance recoverable — — 17,245 — 17,245 Other assets — 199 323 (2 ) 520 Intercompany notes receivable — 2 458 (460 ) — Deferred tax assets 25 1,038 (908 ) — 155 Separate account assets — — 7,883 — 7,883 Assets held for sale — — 127 — 127 Total assets $ 12,839 $ 15,616 $ 104,448 $ (26,472 ) $ 106,431 Liabilities and stockholders’ equity Liabilities: Future policy benefits $ — $ — $ 36,475 $ — $ 36,475 Policyholder account balances — — 26,209 — 26,209 Liability for policy and contract claims — — 8,095 — 8,095 Unearned premiums — — 3,308 — 3,308 Other liabilities 13 279 2,722 (10 ) 3,004 Intercompany notes payable 2 658 — (660 ) — Borrowings related to securitization entities — — 179 — 179 Non-recourse funding obligations — — 1,920 — 1,920 Long-term borrowings — 4,078 492 — 4,570 Deferred tax liability — — 24 — 24 Separate account liabilities — — 7,883 — 7,883 Liabilities held for sale — — 127 — 127 Total liabilities 15 5,015 87,434 (670 ) 91,794 Equity: Common stock 1 — — — 1 Additional paid-in capital 11,949 9,097 17,007 (26,104 ) 11,949 Accumulated other comprehensive income (loss) 3,010 3,116 3,028 (6,144 ) 3,010 Retained earnings 564 (1,612 ) (5,134 ) 6,746 564 Treasury stock, at cost (2,700 ) — — — (2,700 ) Total Genworth Financial, Inc.’s stockholders’ equity 12,824 10,601 14,901 (25,502 ) 12,824 Noncontrolling interests — — 2,113 (300 ) 1,813 Total equity 12,824 10,601 17,014 (25,802 ) 14,637 Total liabilities and equity $ 12,839 $ 15,616 $ 104,448 $ (26,472 ) $ 106,431 The following table presents the condensed consolidating balance sheet information as of December 31, 2014: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Assets Investments: Fixed maturity securities available-for-sale, at fair value $ — $ 150 $ 61,127 $ (200 ) $ 61,077 Equity securities available-for-sale, at fair value — — 275 — 275 Commercial mortgage loans — — 6,100 — 6,100 Restricted commercial mortgage loans related to securitization entities — — 201 — 201 Policy loans — — 1,501 — 1,501 Other invested assets — 14 2,199 (5 ) 2,208 Restricted other invested assets related to securitization entities, at fair value — — 411 — 411 Investments in subsidiaries 14,895 15,003 — (29,898 ) — Total investments 14,895 15,167 71,814 (30,103 ) 71,773 Cash and cash equivalents — 953 3,692 — 4,645 Accrued investment income — — 664 (4 ) 660 Deferred acquisition costs — — 4,852 — 4,852 Intangible assets and goodwill — — 265 — 265 Reinsurance recoverable — — 17,291 — 17,291 Other assets 2 183 295 (1 ) 479 Intercompany notes receivable 9 267 395 (671 ) — Separate account assets — — 9,208 — 9,208 Assets held for sale — — 2,143 — 2,143 Total assets $ 14,906 $ 16,570 $ 110,619 $ (30,779 ) $ 111,316 Liabilities and stockholders’ equity Liabilities: Future policy benefits $ — $ — $ 35,915 $ — $ 35,915 Policyholder account balances — — 26,032 — 26,032 Liability for policy and contract claims — — 7,881 — 7,881 Unearned premiums — — 3,485 — 3,485 Other liabilities 3 251 2,991 (11 ) 3,234 Intercompany notes payable — 604 267 (871 ) — Borrowings related to securitization entities — — 219 — 219 Non-recourse funding obligations — — 1,981 — 1,981 Long-term borrowings — 4,127 485 — 4,612 Deferred tax liability (20 ) (970 ) 1,848 — 858 Separate account liabilities — — 9,208 — 9,208 Liabilities held for sale — — 1,094 — 1,094 Total liabilities (17 ) 4,012 91,406 (882 ) 94,519 Equity: Common stock 1 — — — 1 Additional paid-in capital 11,997 9,162 17,080 (26,242 ) 11,997 Accumulated other comprehensive income (loss) 4,446 4,449 4,459 (8,908 ) 4,446 Retained earnings 1,179 (1,053 ) (4,205 ) 5,258 1,179 Treasury stock, at cost (2,700 ) — — — (2,700 ) Total Genworth Financial, Inc.’s stockholders’ equity 14,923 12,558 17,334 (29,892 ) 14,923 Noncontrolling interests — — 1,879 (5 ) 1,874 Total equity 14,923 12,558 19,213 (29,897 ) 16,797 Total liabilities and equity $ 14,906 $ 16,570 $ 110,619 $ (30,779 ) $ 111,316
Condensed Consolidating Income Statement	The following table presents the condensed consolidating income statement information for the year ended December 31, 2015: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Revenues: Premiums $ — $ — $ 4,579 $ — $ 4,579 Net investment income (3 ) 1 3,154 (14 ) 3,138 Net investment gains (losses) — 43 (118 ) — (75 ) Policy fees and other income — (32 ) 940 (2 ) 906 Total revenues (3 ) 12 8,555 (16 ) 8,548 Benefits and expenses: Benefits and other changes in policy reserves — — 5,149 — 5,149 Interest credited — — 720 — 720 Acquisition and operating expenses, net of deferrals 32 2 1,275 — 1,309 Amortization of deferred acquisition costs and intangibles — — 966 — 966 Interest expense — 307 128 (16 ) 419 Total benefits and expenses 32 309 8,238 (16 ) 8,563 Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries (35 ) (297 ) 317 — (15 ) Provision (benefit) for income taxes (8 ) (103 ) 102 — (9 ) Equity in income (loss) of subsidiaries (579 ) (463 ) — 1,042 — Income (loss) from continuing operations (606 ) (657 ) 215 1,042 (6 ) Income (loss) from discontinued operations, net of taxes (9 ) — (398 ) — (407 ) Net income (loss) (615 ) (657 ) (183 ) 1,042 (413 ) Less: net income attributable to noncontrolling interests — — 202 — 202 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (615 ) $ (657 ) $ (385 ) $ 1,042 $ (615 ) The following table presents the condensed consolidating income statement information for the year ended December 31, 2014: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Revenues: Premiums $ — $ — $ 4,700 $ — $ 4,700 Net investment income (2 ) — 3,159 (15 ) 3,142 Net investment gains (losses) — 4 (26 ) — (22 ) Policy fees and other income — (4 ) 914 (1 ) 909 Total revenues (2 ) — 8,747 (16 ) 8,729 Benefits and expenses: Benefits and other changes in policy reserves — — 6,418 — 6,418 Interest credited — — 737 — 737 Acquisition and operating expenses, net of deferrals 21 — 1,117 — 1,138 Amortization of deferred acquisition costs and intangibles — — 453 — 453 Goodwill impairment — — 849 — 849 Interest expense — 321 128 (16 ) 433 Total benefits and expenses 21 321 9,702 (16 ) 10,028 Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries (23 ) (321 ) (955 ) — (1,299 ) Provision (benefit) for income taxes (8 ) (112 ) 30 (4 ) (94 ) Equity in income (loss) of subsidiaries (1,229 ) (1,147 ) — 2,376 — Income (loss) from continuing operations (1,244 ) (1,356 ) (985 ) 2,380 (1,205 ) Income (loss) from discontinued operations, net of taxes — — 157 — 157 Net income (loss) (1,244 ) (1,356 ) (828 ) 2,380 (1,048 ) Less: net income attributable to noncontrolling interests — — 196 — 196 Net income (loss) available to Genworth Financial, Inc.’s common stockholders $ (1,244 ) $ (1,356 ) $ (1,024 ) $ 2,380 $ (1,244 ) The following table presents the condensed consolidating income statement information for the year ended December 31, 2013: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Revenues: Premiums $ — $ — $ 4,516 $ — $ 4,516 Net investment income (1 ) 1 3,170 (15 ) 3,155 Net investment gains (losses) — 6 (70 ) — (64 ) Policy fees and other income — — 1,022 (4 ) 1,018 Total revenues (1 ) 7 8,638 (19 ) 8,625 Benefits and expenses: Benefits and other changes in policy reserves — — 4,737 — 4,737 Interest credited — — 738 — 738 Acquisition and operating expenses, net of deferrals 33 32 1,179 — 1,244 Amortization of deferred acquisition costs and intangibles — — 463 — 463 Interest expense — 322 147 (19 ) 450 Total benefits and expenses 33 354 7,264 (19 ) 7,632 Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries (34 ) (347 ) 1,374 — 993 Provision (benefit) for income taxes 13 (120 ) 420 — 313 Equity in income (loss) of subsidiaries 607 796 — (1,403 ) — Income from continuing operations 560 569 954 (1,403 ) 680 Income (loss) from discontinued operations, net of taxes — (29 ) 63 — 34 Net income 560 540 1,017 (1,403 ) 714 Less: net income attributable to noncontrolling interests — — 154 — 154 Net income available to Genworth Financial, Inc.’s common stockholders $ 560 $ 540 $ 863 $ (1,403 ) $ 560
Condensed Consolidating Statement of Comprehensive Income	The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2015: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Net income (loss) $ (615 ) $ (657 ) $ (183 ) $ 1,042 $ (413 ) Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities not other-than-temporarily impaired (1,181 ) (1,158 ) (1,210 ) 2,340 (1,209 ) Net unrealized gains (losses) on other-than-temporarily impaired securities (4 ) (4 ) (4 ) 8 (4 ) Derivatives qualifying as hedges (25 ) (24 ) (19 ) 43 (25 ) Foreign currency translation and other adjustments (250 ) (171 ) (530 ) 421 (530 ) Total other comprehensive income (loss) (1,460 ) (1,357 ) (1,763 ) 2,812 (1,768 ) Total comprehensive income (loss) (2,075 ) (2,014 ) (1,946 ) 3,854 (2,181 ) Less: comprehensive income attributable to noncontrolling interests — — (106 ) — (106 ) Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders $ (2,075 ) $ (2,014 ) $ (1,840 ) $ 3,854 $ (2,075 ) The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2014: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Net income (loss) $ (1,244 ) $ (1,356 ) $ (828 ) $ 2,380 $ (1,048 ) Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities not other-than-temporarily impaired 1,539 1,510 1,573 (3,049 ) 1,573 Net unrealized gains (losses) on other-than- temporarily impaired securities 10 11 10 (21 ) 10 Derivatives qualifying as hedges 751 751 794 (1,545 ) 751 Foreign currency translation and other adjustments (339 ) (273 ) (537 ) 612 (537 ) Total other comprehensive income (loss) 1,961 1,999 1,840 (4,003 ) 1,797 Total comprehensive income (loss) 717 643 1,012 (1,623 ) 749 Less: comprehensive income attributable to noncontrolling interests — — 32 — 32 Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders $ 717 $ 643 $ 980 $ (1,623 ) $ 717 The following table presents the condensed consolidating comprehensive income statement information for the year ended December 31, 2013: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Net income $ 560 $ 540 $ 1,017 $ (1,403 ) $ 714 Other comprehensive income (loss), net of taxes: Net unrealized gains (losses) on securities not other-than-temporarily impaired (1,778 ) (1,733 ) (1,817 ) 3,511 (1,817 ) Net unrealized gains (losses) on other-than- temporarily impaired securities 66 65 66 (131 ) 66 Derivatives qualifying as hedges (590 ) (590 ) (615 ) 1,205 (590 ) Foreign currency translation and other adjustments (358 ) (335 ) (442 ) 693 (442 ) Total other comprehensive income (loss) (2,660 ) (2,593 ) (2,808 ) 5,278 (2,783 ) Total comprehensive income (loss) (2,100 ) (2,053 ) (1,791 ) 3,875 (2,069 ) Less: comprehensive income attributable to noncontrolling interests — — 31 — 31 Total comprehensive income (loss) available to Genworth Financial, Inc.’s common stockholders $ (2,100 ) $ (2,053 ) $ (1,822 ) $ 3,875 $ (2,100 )
Condensed Consolidating Statement of Cash Flows	The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2015: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Cash flows from operating activities: Net income (loss) $ (615 ) $ (657 ) $ (183 ) $ 1,042 $ (413 ) Less (income) loss from discontinued operations, net of taxes 9 — 398 — 407 Adjustments to reconcile net income (loss) to net cash from operating activities: Equity in (income) loss from subsidiaries 579 463 — (1,042 ) — Dividends from subsidiaries — 530 (530 ) — — Loss on sale of subsidiaries — — 141 — 141 Amortization of fixed maturity discounts and premiums and limited partnerships — — (106 ) — (106 ) Net investment losses (gains) — (43 ) 118 — 75 Charges assessed to policyholders — — (788 ) — (788 ) Acquisition costs deferred — — (293 ) — (293 ) Amortization of deferred acquisition costs and intangibles — — 966 — 966 Deferred income taxes (4 ) (65 ) (127 ) — (196 ) Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments — 41 (280 ) — (239 ) Stock-based compensation expense 21 — (5 ) — 16 Change in certain assets and liabilities: Accrued investment income and other assets 3 13 (123 ) 1 (106 ) Insurance reserves — — 1,847 — 1,847 Current tax liabilities (3 ) 18 (30 ) — (15 ) Other liabilities, policy and contract claims and other policy-related balances 2 (38 ) 328 1 293 Cash from operating activities—held for sale — — 2 — 2 Net cash from operating activities (8 ) 262 1,335 2 1,591 Cash flows from investing activities: Proceeds from maturities and repayments of investments: Fixed maturity securities — 1 4,540 — 4,541 Commercial mortgage loans — — 882 — 882 Restricted commercial mortgage loans related to securitization entities — — 41 — 41 Proceeds from sales of investments: Fixed maturity and equity securities — — 4,391 — 4,391 Purchases and originations of investments: Fixed maturity and equity securities — — (9,750 ) — (9,750 ) Commercial mortgage loans — — (956 ) — (956 ) Other invested assets, net — (100 ) 277 (2 ) 175 Policy loans, net — — 25 — 25 Intercompany notes receivable 9 265 (63 ) (211 ) — Capital contributions to subsidiaries — (25 ) 25 — — Proceeds from sale of a subsidiary, net of cash transferred — — 273 — 273 Payments for businesses purchased, net of cash acquired — (197 ) 197 — — Cash from investing activities—held for sale — — (26 ) — (26 ) Net cash from investing activities 9 (56 ) (144 ) (213 ) (404 ) Cash flows from financing activities: Deposits to universal life and investment contracts — — 2,257 — 2,257 Withdrawals from universal life and investment contracts — — (2,144 ) — (2,144 ) Redemption and repurchase of non-recourse funding obligations — — (61 ) — (61 ) Proceeds from the issuance of long-term debt — — 150 — 150 Repayment and repurchase of long-term debt — (50 ) (70 ) — (120 ) Repayment of borrowings related to securitization entities — — (36 ) — (36 ) Proceeds from intercompany notes payable 2 54 (267 ) 211 — Repurchase of subsidiary shares — — (68 ) — (68 ) Dividends paid to noncontrolling interests — — (157 ) — (157 ) Proceeds from the sale of subsidiary shares to noncontrolling interests — — 226 — 226 Other, net (3 ) (39 ) (56 ) — (98 ) Cash from financing activities—held for sale — — 9 — 9 Net cash from financing activities (1 ) (35 ) (217 ) 211 (42 ) Effect of exchange rate changes on cash and cash equivalents — — (70 ) — (70 ) Net change in cash and cash equivalents — 171 904 — 1,075 Cash and cash equivalents at beginning of period — 953 3,965 — 4,918 Cash and cash equivalents at end of period — 1,124 4,869 — 5,993 Less cash and cash equivalents held for sale at end of period — — 28 — 28 Cash and cash equivalents of continuing operations at end of period $ — $ 1,124 $ 4,841 $ — $ 5,965 The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2014: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Cash flows from operating activities: Net income (loss) $ (1,244 ) $ (1,356 ) $ (828 ) $ 2,380 $ (1,048 ) Less (income) loss from discontinued operations, net of taxes — — (157 ) — (157 ) Adjustments to reconcile net income (loss) to net cash from operating activities: Equity in (income) loss from subsidiaries 1,229 1,147 — (2,376 ) — Dividends from subsidiaries — 630 (630 ) — — Amortization of fixed maturity discounts and premiums and limited partnerships — — (111 ) — (111 ) Net investment losses (gains) — (4 ) 26 — 22 Charges assessed to policyholders — — (777 ) — (777 ) Acquisition costs deferred — — (383 ) — (383 ) Amortization of deferred acquisition costs and intangibles — — 453 — 453 Goodwill impairment — — 849 — 849 Deferred income taxes 4 (146 ) (195 ) (4 ) (341 ) Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments — 1 205 — 206 Stock-based compensation expense 21 — 7 — 28 Change in certain assets and liabilities: Accrued investment income and other assets (4 ) (9 ) (151 ) 1 (163 ) Insurance reserves — — 2,497 — 2,497 Current tax liabilities (2 ) (77 ) (117 ) — (196 ) Other liabilities, policy and contract claims and other policy-related balances 11 91 1,421 (6 ) 1,517 Cash from operating activities-held for sale — — 42 — 42 Net cash from operating activities 15 277 2,151 (5 ) 2,438 Cash flows from investing activities: Proceeds from maturities and repayments of investments: Fixed maturity securities — 150 5,048 — 5,198 Commercial mortgage loans — — 765 — 765 Restricted commercial mortgage loans related to securitization entities — — 32 — 32 Proceeds from sales of investments: Fixed maturity and equity securities — — 2,386 — 2,386 Purchases and originations of investments: Fixed maturity and equity securities — (150 ) (9,038 ) — (9,188 ) Commercial mortgage loans — — (967 ) — (967 ) Other invested assets, net — — (40 ) 5 (35 ) Policy loans, net — — 12 — 12 Intercompany notes receivable (1 ) (19 ) (2 ) 22 — Capital contributions to subsidiaries (12 ) — 12 — — Cash from investing activities-held for sale — — (39 ) — (39 ) Net cash from investing activities (13 ) (19 ) (1,831 ) 27 (1,836 ) Cash flows from financing activities: Deposits to universal life and investment contracts — — 2,993 — 2,993 Withdrawals from universal life and investment contracts — — (2,588 ) — (2,588 ) Redemption and repurchase of non-recourse funding obligations — — (42 ) — (42 ) Proceeds from the issuance of long-term debt — — 144 — 144 Repayment and repurchase of long-term debt — (485 ) (136 ) — (621 ) Repayment of borrowings related to securitization entities — — (32 ) — (32 ) Proceeds from intercompany notes payable — 3 19 (22 ) — Repurchase of subsidiary shares — — (28 ) — (28 ) Dividends paid to noncontrolling interests — — (75 ) — (75 ) Proceeds from the sale of subsidiary shares to noncontrolling interests — — 517 — 517 Other, net (2 ) (42 ) 14 — (30 ) Cash from financing activities-held for sale — — (33 ) — (33 ) Net cash from financing activities (2 ) (524 ) 753 (22 ) 205 Effect of exchange rate changes on cash and cash equivalents — — (103 ) — (103 ) Net change in cash and cash equivalents — (266 ) 970 — 704 Cash and cash equivalents at beginning of period — 1,219 2,995 — 4,214 Cash and cash equivalents at end of period — 953 3,965 — 4,918 Less cash and cash equivalents held for sale at end of period — — 273 — 273 Cash and cash equivalents of continuing operations at end of period $ — $ 953 $ 3,692 $ — $ 4,645 The following table presents the condensed consolidating cash flow statement information for the year ended December 31, 2013: (Amounts in millions) Parent Issuer All Other Eliminations Consolidated Cash flows from operating activities: Net income (loss) $ 560 $ 540 $ 1,017 $ (1,403 ) $ 714 Less income from discontinued operations, net of taxes — 29 (63 ) — (34 ) Adjustments to reconcile net income (loss) to net cash from operating activities: Equity in (income) loss from subsidiaries (607 ) (796 ) — 1,403 — Dividends from subsidiaries 535 376 (497 ) (414 ) — Amortization of fixed maturity discounts and premiums and limited partnerships — — (105 ) — (105 ) Net investment losses (gains) — (6 ) 70 — 64 Charges assessed to policyholders — — (812 ) — (812 ) Acquisition costs deferred — — (363 ) — (363 ) Amortization of deferred acquisition costs and intangibles — — 463 — 463 Deferred income taxes 24 (138 ) 14 — (100 ) Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments — 1 (60 ) — (59 ) Stock-based compensation expense 26 — 13 — 39 Change in certain assets and liabilities: Accrued investment income and other assets 2 67 (122 ) — (53 ) Insurance reserves — — 1,644 — 1,644 Current tax liabilities 3 45 293 — 341 Other liabilities, policy and contract claims and other policy-related balances (4 ) (11 ) (346 ) — (361 ) Cash from operating activities—held for sale — — 21 — 21 Net cash from operating activities 539 107 1,167 (414 ) 1,399 Cash flows from investing activities: Proceeds from maturities and repayments of investments: Fixed maturity securities — — 4,891 — 4,891 Commercial mortgage loans — — 896 — 896 Restricted commercial mortgage loans related to securitization entities — — 60 — 60 Proceeds from sales of investments: Fixed maturity and equity securities — 150 3,997 — 4,147 Purchases and originations of investments: Fixed maturity and equity securities — (150 ) (10,308 ) — (10,458 ) Commercial mortgage loans — — (873 ) — (873 ) Other invested assets, net — — 65 — 65 Policy loans, net — — 242 — 242 Intercompany notes receivable (8 ) (3 ) 95 (84 ) — Capital contributions to subsidiaries (531 ) (1 ) 532 — — Proceeds from sale of a subsidiary, net of cash transferred — 425 (60 ) — 365 Cash from investing activities—held for sale — (30 ) 115 — 85 Net cash from investing activities (539 ) 391 (348 ) (84 ) (580 ) Cash flows from financing activities: Deposits to universal life and investment contracts — — 2,999 — 2,999 Withdrawals from universal life and investment contracts — — (3,269 ) — (3,269 ) Redemption and repurchase of non-recourse funding obligations — — (28 ) — (28 ) Proceeds from the issuance of long-term debt — 793 — — 793 Repayment and repurchase of long-term debt — (365 ) — — (365 ) Repayment of borrowings related to securitization entities — — (108 ) — (108 ) Proceeds from intercompany notes payable — (87 ) 3 84 — Repurchase of subsidiary shares — — (43 ) — (43 ) Dividends paid to noncontrolling interests — — (52 ) — (52 ) Dividends paid to parent — (414 ) — 414 — Other, net — (49 ) (4 ) — (53 ) Cash from financing activities—held for sale — — (23 ) — (23 ) Net cash from financing activities — (122 ) (525 ) 498 (149 ) Effect of exchange rate changes on cash and cash equivalents — — (109 ) — (109 ) Net change in cash and cash equivalents — 376 185 — 561 Cash and cash equivalents at beginning of period — 843 2,810 — 3,653 Cash and cash equivalents at end of period — 1,219 2,995 — 4,214 Less cash and cash equivalents held for sale at end of period — — 557 — 557 Cash and cash equivalents of continuing operations at end of period $ — $ 1,219 $ 2,438 $ — $ 3,657

Nature of Business and Format58

Nature of Business and Formation of Genworth - Additional Information (Detail) - Segment	12 Months Ended
	Dec. 31, 2015	Apr. 01, 2013
Prior year restatement
Number of operating segments	5
Genworth Holdings
Prior year restatement
Percentage of subsidiary equity ownership		100.00%

Summary of Significant Accoun59

Summary of Significant Accounting Policies - Additional Information (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accounting Policies [Abstract]
Equity securities, impairment charge recognition within number of months		18 months
Non-accrual status of loans after number of days past due		90 days
Cash equivalents determination for original maturities of investments, maximum number of days		90 days
Short-term investments determination for original maturities of investments, minimum number of days		90 days
Unearned premiums, increase in earned premiums due to updated premium recognition factors for international mortgage insurance business		$ 8	$ 6	$ 12
Insurance reserves		1,847	2,497	1,644
Other liabilities, policy and contract claims and other policy-related balances		293	1,517	(361)
Cash Flows Statement, Operating Cash Flows Restatement
Accounting Policies [Abstract]
Insurance reserves			(720)	(613)
Other liabilities, policy and contract claims and other policy-related balances			720	$ 613
Adoption of Debt Issuance Cost Guidance | Total Assets
Accounting Policies [Abstract]
Cumulative effect of new accounting principle in period of adoption			(42)
Adoption of Debt Issuance Cost Guidance | Other assets
Accounting Policies [Abstract]
Cumulative effect of new accounting principle in period of adoption			(42)
Adoption of Debt Issuance Cost Guidance | Liabilities, Total
Accounting Policies [Abstract]
Cumulative effect of new accounting principle in period of adoption			(42)
Adoption of Debt Issuance Cost Guidance | Long-term borrowings
Accounting Policies [Abstract]
Cumulative effect of new accounting principle in period of adoption			(27)
Adoption of Debt Issuance Cost Guidance | Non-Recourse Funding Obligations
Accounting Policies [Abstract]
Cumulative effect of new accounting principle in period of adoption			(15)
Non-cash | Derivative assets
Accounting Policies [Abstract]
Fair value of non-cash collateral received		86	287
Subject to enforceable master netting arrangement
Accounting Policies [Abstract]
Fair value of non-cash collateral received		642	884
Subject to enforceable master netting arrangement | Derivative liabilities
Accounting Policies [Abstract]
Fair value of non-cash collateral pledged	[1]	263	49
Subject to enforceable master netting arrangement | Derivative assets
Accounting Policies [Abstract]
Fair value of non-cash collateral received	[2]	$ 642	$ 884
[1]	Included $6 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2015 and 2014.
[2]	Included $24 million and $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2015 and 2014, respectively.

Earnings (Loss) Per Share (Deta

Earnings (Loss) Per Share (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2015		Sep. 30, 2015		Jun. 30, 2015		Mar. 31, 2015		Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2015		Dec. 31, 2014		Dec. 31, 2013
Earnings (Loss) Per Share [Abstract]
Weighted-average common shares used in basic earnings (loss) per common share calculations	497.6		497.4		497.4		497		496.7		496.6		496.6		495.8		497.4		496.4		493.6
Stock options, restricted stock units and stock appreciation rights																	0		0		5.1
Weighted-average common shares used in diluted earnings (loss) per common share calculations	497.6	[1]	497.4	[1]	499.3	[1]	498.9	[1]	496.7	[2]	496.6	[2]	503.6	[2]	502.7	[2]	497.4	[3]	496.4	[3]	498.7	[3]
Income (loss) from continuing operations:
Income (loss) from continuing operations	$ (167)	[4]	$ (217)	[4]	$ 175	[4]	$ 203	[4]	$ (846)	[5]	$ (793)	[5]	$ 224	[5]	$ 210	[5]	$ (6)		$ (1,205)		$ 680
Less: income from continuing operations attributable to noncontrolling interests																	202		196		154
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																	$ (208)		$ (1,401)		$ 526
Basic per common share	$ (0.44)		$ (0.53)		$ 0.24		$ 0.31		$ (1.81)		$ (1.71)		$ 0.35		$ 0.35		$ (0.42)		$ (2.82)		$ 1.07
Diluted per common share	$ (0.44)		$ (0.53)		$ 0.24		$ 0.31		$ (1.81)		$ (1.71)		$ 0.34		$ 0.35		$ (0.42)		$ (2.82)		$ 1.05
Income (loss) from discontinued operations:
Income (loss) from discontinued operations, net of taxes	$ (73)	[6]	$ (21)	[6]	$ (314)	[6]	$ 1	[6]	$ 138		$ 6		$ 4		$ 9		$ (407)		$ 157		$ 34
Less: income from discontinued operations, net of taxes, attributable to noncontrolling interests																	0		0		0
Income (loss) from discontinued operations, net of taxes, available to Genworth Financial, Inc.'s common stockholders																	$ (407)		$ 157		$ 34
Basic per common share																	$ (0.82)		$ 0.32		$ 0.07
Diluted per common share																	$ (0.82)		$ 0.32		$ 0.07
Net income (loss):
Income (loss) from continuing operations	(167)	[4]	(217)	[4]	175	[4]	203	[4]	(846)	[5]	(793)	[5]	224	[5]	210	[5]	$ (6)		$ (1,205)		$ 680
Income (loss) from discontinued operations, net of taxes	(73)	[6]	(21)	[6]	(314)	[6]	1	[6]	138		6		4		9		(407)		157		34
Net income (loss)	(240)	[4],[6]	(238)	[4],[6]	(139)	[4],[6]	204	[4],[6]	(708)	[5]	(787)	[5]	228	[5]	219	[5]	(413)		(1,048)		714
Less: net income attributable to noncontrolling interests	52		46		54		50		52		57		52		35		202		196		154
Net income (loss) available to Genworth Financial, Inc.'s common stockholders	$ (292)		$ (284)		$ (193)		$ 154		$ (760)	[5]	$ (844)	[5]	$ 176	[5]	$ 184	[5]	$ (615)		$ (1,244)		$ 560
Basic per common share	$ (0.59)		$ (0.57)		$ (0.39)		$ 0.31		$ (1.53)		$ (1.70)		$ 0.35		$ 0.37		$ (1.24)		$ (2.51)		$ 1.13
Diluted per common share	$ (0.59)		$ (0.57)		$ (0.39)		$ 0.31		$ (1.53)		$ (1.70)		$ 0.35		$ 0.37		$ (1.24)		$ (2.51)		$ 1.12
[1]	Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2015 and December 31, 2015, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2015 and December 31, 2015, as the inclusion of shares for stock options, RSUs and SARs of 1.3 million and 1.4 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2015 and December 31, 2015, dilutive potential weighted-average common shares outstanding would have been 498.7 and 499.0 million, respectively.
[2]	Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2014 and December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2014 and December 31, 2014, as the inclusion of shares for stock options, RSUs and SARs of 5.4 million and 3.2 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2014 and December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million and 499.9 million, respectively.
[3]	Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the years ended December 31, 2015 and 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the years ended December 31, 2015 and 2014, as the inclusion of shares for stock options, restricted stock units ("RSUs") and stock appreciation rights ("SARs") of 1.6 million and 5.6 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the years ended December 31, 2015 and 2014, dilutive potential weighted-average common shares outstanding would have been 499.0 million and 502.0 million, respectively.
[4]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[5]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.
[6]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.

Earnings (Loss) Per Share (Pare

Earnings (Loss) Per Share (Parenthetical) (Detail) - shares shares in Millions	3 Months Ended				12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2015	Dec. 31, 2014
Earnings Per Share Disclosure [Line Items]
Weighted-average diluted common shares outstanding, antidilutive securities (stock options, RSUs and SARs)	1.4	1.3	3.2	5.4	1.6	5.6
Weighted-average number of diluted shares if not in a loss position	499	498.7	499.9	502	499	502

Net Investment Income (Detail)

Net Investment Income (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Net Investment Income [Line Items]
Gross investment income before expenses and fees		$ 3,226	$ 3,234	$ 3,247
Expenses and fees		(88)	(92)	(92)
Net investment income		3,138	3,142	3,155
Fixed maturity securities - taxable
Net Investment Income [Line Items]
Gross investment income before expenses and fees		2,558	2,598	2,603
Fixed maturity securities - non-taxable
Net Investment Income [Line Items]
Gross investment income before expenses and fees		12	12	9
Commercial mortgage loans
Net Investment Income [Line Items]
Gross investment income before expenses and fees		337	333	335
Restricted commercial mortgage loans related to securitization entities
Net Investment Income [Line Items]
Gross investment income before expenses and fees	[1]	14	14	23
Equity Securities
Net Investment Income [Line Items]
Gross investment income before expenses and fees		15	14	17
Other invested assets
Net Investment Income [Line Items]
Gross investment income before expenses and fees	[2]	135	105	108
Restricted other invested assets related to securitization entities
Net Investment Income [Line Items]
Gross investment income before expenses and fees	[1]	5	5	4
Policy Loans
Net Investment Income [Line Items]
Gross investment income before expenses and fees		137	129	129
Cash, cash equivalents and short-term investments
Net Investment Income [Line Items]
Gross investment income before expenses and fees		$ 13	$ 24	$ 19
[1]	See note 17 for additional information related to consolidated securitization entities.
[2]	Included in other invested assets was $9 million, $8 million and $13 million of net investment income related to trading securities for the years ended December 31, 2015, 2014 and 2013, respectively.

Net Investment Income (Parenthe

Net Investment Income (Parenthetical) (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Net Investment Income [Line Items]
Gross investment income before expenses and fees		$ 3,226	$ 3,234	$ 3,247
Other invested assets
Net Investment Income [Line Items]
Gross investment income before expenses and fees	[1]	135	105	108
Trading Securities | Other invested assets
Net Investment Income [Line Items]
Gross investment income before expenses and fees		$ 9	$ 8	$ 13
[1]	Included in other invested assets was $9 million, $8 million and $13 million of net investment income related to trading securities for the years ended December 31, 2015, 2014 and 2013, respectively.

Net Investment Gains (Losses) (

Net Investment Gains (Losses) (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Investments [Abstract]
Realized gains		$ 102	$ 72	$ 149
Realized losses		(82)	(46)	(184)
Net realized gains (losses) on available-for-sale securities		20	26	(35)
Total other-than-temporary impairments		(28)	(9)	(16)
Portion of other-than-temporary impairments included in other comprehensive income (loss)		1	0	(9)
Net other-than-temporary impairments		(27)	(9)	(25)
Trading securities		(7)	39	(23)
Commercial mortgage loans		7	11	4
Net gains (losses) related to securitization entities	[1]	5	16	69
Derivative instruments	[2]	(76)	(103)	(49)
Contingent consideration adjustment		2	(2)	0
Other		1	0	(5)
Net investment gains (losses)		$ (75)	$ (22)	$ (64)
[1]	See note 17 for additional information related to consolidated securitization entities.
[2]	See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses).

Investments - Additional Inform

Investments - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2015USD ($)Loan	Dec. 31, 2014USD ($)Loan		Dec. 31, 2013USD ($)
Schedule of Investments [Line Items]
Aggregate fair value of securities sold	$ 1,827	$ 857		$ 1,743
Aggregate fair value of securities sold, percentage of book value	96.00%	95.00%		91.00%
12 months or more, Gross unrealized losses	$ 239	$ 172	[1]
Gross unrealized losses	851	289	[1]
Investments subject to call provisions	$ 7,730
Percentage of investment portfolio by which no other industry group exceeded	10.00%
Percentage of stockholders' equity by which no single issuer of fixed maturity securities exceeded	10
Securities on deposit with various state or foreign government insurance departments	$ 44	49
Commercial mortgage loans outstanding more than 90 days, interest accruing	0	0
Commercial mortgage loans on nonaccrual status, past due less than 90 days	$ 0	$ 0
Commercial mortgage loans modified or extended, number of loans | Loan	21	28
Commercial mortgage loans modified or extended, carrying value	$ 110	$ 254
Commercial mortgage loans, recorded investment	6,187	6,123
Floating rate commercial mortgage loans
Schedule of Investments [Line Items]
Commercial mortgage loans, recorded investment	7	9
Investment grade
Schedule of Investments [Line Items]
12 months or more, Gross unrealized losses	135	145	[1]
Gross unrealized losses	659	220	[1]
Industrial
Schedule of Investments [Line Items]
Individually impaired commercial mortgage loans	14	15
Impaired loans, unpaid principal balance	15	16
Individually impaired loans, charge-offs		1
Individually impaired loans, interest income	1
Commercial mortgage loans, recorded investment	1,562	1,597
Office
Schedule of Investments [Line Items]
Individually impaired commercial mortgage loans	5
Impaired loans, unpaid principal balance	6
Individually impaired loans, charge-offs	1
Commercial mortgage loans, recorded investment	$ 1,516	1,643
Less Than Twelve Months
Schedule of Investments [Line Items]
Average fair value percentage below cost for securities in a continuous loss position	4.00%
Less Than Twelve Months | Less Than 20 Percent Below Cost | Investment grade
Schedule of Investments [Line Items]
Stated percentage below cost of securities in unrealized loss position	20.00%
Fixed maturity securities
Schedule of Investments [Line Items]
12 months or more, Gross unrealized losses	$ 239	168	[1]
Gross unrealized losses	828	282	[1]
Fixed maturity securities | Non-U.S. corporate
Schedule of Investments [Line Items]
12 months or more, Gross unrealized losses	117	28	[1]
Gross unrealized losses	287	95	[1]
Fixed maturity securities | Industrial | Non-U.S. corporate
Schedule of Investments [Line Items]
12 months or more, Gross unrealized losses	42	9
Gross unrealized losses	$ 96	18
Fixed maturity securities | Utilities
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	12.00%
Fixed maturity securities | Utilities | Non-U.S. corporate
Schedule of Investments [Line Items]
12 months or more, Gross unrealized losses	$ 3	2
Gross unrealized losses	$ 9	2
Fixed maturity securities | Finance and insurance
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	22.00%
Fixed maturity securities | Finance and insurance | Non-U.S. corporate
Schedule of Investments [Line Items]
12 months or more, Gross unrealized losses	$ 1	1
Gross unrealized losses	$ 8	3
Fixed maturity securities | Consumer-non-cyclical
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	13.00%
Fixed maturity securities | Consumer-non-cyclical | Non-U.S. corporate
Schedule of Investments [Line Items]
12 months or more, Gross unrealized losses	$ 4	3
Gross unrealized losses	$ 18	9
Fixed maturity securities | Energy
Schedule of Investments [Line Items]
Percent of investment portfolio, greater than 10%	11.00%
Fixed maturity securities | Energy | Non-U.S. corporate
Schedule of Investments [Line Items]
12 months or more, Gross unrealized losses	$ 30	5
Gross unrealized losses	78	38
Fixed maturity securities | Less Than 20 Percent Below Cost
Schedule of Investments [Line Items]
12 months or more, Gross unrealized losses	78	114	[1]
Gross unrealized losses	$ 550	$ 217	[1]
Fixed maturity securities | Less Than 20 Percent Below Cost | Investment grade
Schedule of Investments [Line Items]
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	75.00%
Fixed maturity securities | More Than 20% Below Cost | Non-U.S. corporate
Schedule of Investments [Line Items]
Stated percentage below cost of securities in unrealized loss position	20.00%
12 months or more, Gross unrealized losses	$ 95
Fixed maturity securities | More Than 20% Below Cost | Industrial | Non-U.S. corporate
Schedule of Investments [Line Items]
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	39.00%
Gross unrealized losses	$ 37
Fixed maturity securities | More Than 20% Below Cost | Energy | Non-U.S. corporate
Schedule of Investments [Line Items]
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	29.00%
Gross unrealized losses	$ 28
Fixed maturity securities | 12 Months Or More | Less Than 20 Percent Below Cost
Schedule of Investments [Line Items]
Stated percentage below cost of securities in unrealized loss position	20.00%
Average fair value percentage below cost for securities in a continuous loss position	6.00%
Fixed maturity securities | 12 Months Or More | More Than 20% Below Cost
Schedule of Investments [Line Items]
Stated percentage below cost of securities in unrealized loss position	20.00%
[1]	Amounts included $1 million of unrealized losses on other-than-temporarily impaired securities.

Credit Losses Recognized in Net

Credit Losses Recognized in Net Income (Loss) on Debt Securities (Detail) - Debt Securities - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Line Items]
Cumulative credit losses, beginning balance	$ 83	$ 101	$ 387
Other-than-temporary impairments not previously recognized	0	1	4
Increases related to other-than-temporary impairments previously recognized	0	1	11
Securities sold, paid down or disposed	(19)	(20)	(301)
Cumulative credit losses, ending balance	$ 64	$ 83	$ 101

Net Unrealized Gains and Losses

Net Unrealized Gains and Losses on Available-for-Sale Investment Securities Reflected as Separate Component of Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Components of Net Unrealized Investment Gains Losses Included in Accumulated Other Comprehensive Income Loss [Line Items]
Adjustments to DAC, PVFP, sales inducements and benefit reserves		$ (1,070)	$ (1,656)	$ (869)
Income taxes, net		(711)	(1,372)	(517)
Net unrealized investment gains (losses) including noncontrolling interests		1,349	2,562	979
Less: net unrealized investment gains (losses) attributable to noncontrolling interests		95	109	53
Net unrealized investment gains (losses)	[1]	1,254	2,453	926	$ 2,638
Net Unrealized Gains (Losses) On Investment Securities
Components of Net Unrealized Investment Gains Losses Included in Accumulated Other Comprehensive Income Loss [Line Items]
Fixed maturity securities		3,140	5,560	2,346
Equity securities		(10)	32	23
Other invested assets		0	(2)	(4)
Subtotal		$ 3,130	$ 5,590	$ 2,365
[1]	Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information.

Change in Net Unrealized Gains

Change in Net Unrealized Gains (Losses) on Available-for-Sale Securities Reported in Accumulated Other Comprehensive Income (Loss) (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Investments [Abstract]
Net unrealized investment gains (losses), beginning of period	[1]	$ 2,453	$ 926	$ 2,638
Unrealized gains (losses) on investment securities		(2,467)	3,244	(3,780)
Adjustment to DAC		177	(172)	248
Adjustment to PVFP		89	(66)	95
Adjustment to sales inducements		30	(15)	40
Adjustment to benefit reserves		290	(534)	673
Provision for income taxes		663	(862)	952
Change in unrealized gains (losses) on investment securities	[1]	(1,218)	1,595	(1,772)
Reclassification adjustments to net investment (gains) losses, net of taxes	[1]	5	(12)	21
Change in net unrealized investment gains (losses)	[1]	(1,213)	1,583	(1,751)
Less: change in net unrealized investment gains (losses) attributable to noncontrolling interests	[1]	(14)	56	(39)
Net unrealized investment gains (losses), end of period	[1]	$ 1,254	$ 2,453	$ 926
[1]	Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information.

Change in Net Unrealized Gain69

Change in Net Unrealized Gains (Losses) on Available-for-Sale Securities Reported in Accumulated Other Comprehensive Income (Loss) (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Components of Net Unrealized Investment Gains Losses Included in Accumulated Other Comprehensive Income Loss [Line Items]
Reclassification adjustments to net investment (gains) losses, taxes	$ (2)	$ 7	$ (12)

Amortized Cost or Cost, Gross U

Amortized Cost or Cost, Gross Unrealized Gains (Losses) and Fair Value of Fixed Maturity and Equity Securities Classified as Available-for-Sale (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	$ 55,161	$ 55,656
Fair value, fixed maturity securities	58,197	61,077
Amortized cost or cost, equity securities	325	250
Fair value, equity securities	310	275
Amortized cost or cost, total	55,486	55,906
Fair value, total	58,507	61,352
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	5,487	5,006
Fair value, fixed maturity securities	6,203	6,000
Fixed maturity securities | State and Political Subdivisions
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,287	2,013
Fair value, fixed maturity securities	2,438	2,222
Fixed maturity securities | Non-U.S. government
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,910	1,761
Fair value, fixed maturity securities	2,015	1,902
Fixed maturity securities | U.S. corporate
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	22,994	22,479
Fair value, fixed maturity securities	24,401	25,223
Fixed maturity securities | U.S. corporate | Utilities
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	3,355	3,292
Fair value, fixed maturity securities	3,693	3,864
Fixed maturity securities | U.S. corporate | Energy
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,560	2,498
Fair value, fixed maturity securities	2,501	2,742
Fixed maturity securities | U.S. corporate | Finance and insurance
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	5,268	5,102
Fair value, fixed maturity securities	5,632	5,646
Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	3,755	3,483
Fair value, fixed maturity securities	4,096	4,013
Fixed maturity securities | U.S. corporate | Technology and communications
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,108	2,112
Fair value, fixed maturity securities	2,193	2,325
Fixed maturity securities | U.S. corporate | Industrial
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,164	1,195
Fair value, fixed maturity securities	1,173	1,287
Fixed maturity securities | U.S. corporate | Capital goods
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,774	1,748
Fair value, fixed maturity securities	1,950	2,006
Fixed maturity securities | U.S. corporate | Consumer-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,602	1,750
Fair value, fixed maturity securities	1,675	1,900
Fixed maturity securities | U.S. corporate | Transportation
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,023	929
Fair value, fixed maturity securities	1,086	1,039
Fixed maturity securities | U.S. corporate | Other
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	385	370
Fair value, fixed maturity securities	402	401
Fixed maturity securities | Non-U.S. corporate
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	11,886	13,227
Fair value, fixed maturity securities	12,199	14,095
Fixed maturity securities | Non-U.S. corporate | Utilities
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	815	857
Fair value, fixed maturity securities	843	903
Fixed maturity securities | Non-U.S. corporate | Energy
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,700	1,911
Fair value, fixed maturity securities	1,686	2,036
Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,327	2,757
Fair value, fixed maturity securities	2,473	2,957
Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	746	764
Fair value, fixed maturity securities	752	796
Fixed maturity securities | Non-U.S. corporate | Technology and communications
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	978	986
Fair value, fixed maturity securities	988	1,053
Fixed maturity securities | Non-U.S. corporate | Industrial
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	1,063	1,166
Fair value, fixed maturity securities	986	1,213
Fixed maturity securities | Non-U.S. corporate | Capital goods
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	602	592
Fair value, fixed maturity securities	604	618
Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	522	520
Fair value, fixed maturity securities	526	534
Fixed maturity securities | Non-U.S. corporate | Transportation
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	559	521
Fair value, fixed maturity securities	605	590
Fixed maturity securities | Non-U.S. corporate | Other
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,574	3,153
Fair value, fixed maturity securities	2,736	3,395
Fixed maturity securities | Residential mortgage-backed
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	4,777	4,871
Fair value, fixed maturity securities	5,101	5,228
Fixed maturity securities | Commercial mortgage-backed
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	2,492	2,564
Fair value, fixed maturity securities	2,559	2,702
Fixed maturity securities | Other asset-backed
Schedule of Investments [Line Items]
Amortized cost or cost, fixed maturity securities	3,328	3,735
Fair value, fixed maturity securities	3,281	3,705
Not other-than-temporary impairments
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	3,832	5,665
Gross unrealized losses, fixed maturity securities	(828)	(281)
Gross unrealized gains, equity securities	8	32
Gross unrealized losses, equity securities	(23)	(7)
Gross unrealized gains	3,840	5,697
Gross unrealized losses	(851)	(288)
Not other-than-temporary impairments | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	732	995
Gross unrealized losses, fixed maturity securities	(16)	(1)
Not other-than-temporary impairments | Fixed maturity securities | State and Political Subdivisions
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	181	236
Gross unrealized losses, fixed maturity securities	(30)	(27)
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. government
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	110	143
Gross unrealized losses, fixed maturity securities	(5)	(2)
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	1,786	2,800
Gross unrealized losses, fixed maturity securities	(394)	(76)
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Utilities
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	364	577
Gross unrealized losses, fixed maturity securities	(26)	(5)
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Energy
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	103	265
Gross unrealized losses, fixed maturity securities	(162)	(21)
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Finance and insurance
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	392	537
Gross unrealized losses, fixed maturity securities	(43)	(13)
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	371	538
Gross unrealized losses, fixed maturity securities	(30)	(8)
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Technology and communications
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	123	217
Gross unrealized losses, fixed maturity securities	(38)	(4)
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Industrial
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	53	100
Gross unrealized losses, fixed maturity securities	(44)	(8)
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Capital goods
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	188	263
Gross unrealized losses, fixed maturity securities	(12)	(5)
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Consumer-cyclical
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	95	158
Gross unrealized losses, fixed maturity securities	(22)	(8)
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Transportation
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	75	114
Gross unrealized losses, fixed maturity securities	(12)	(4)
Not other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Other
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	22	31
Gross unrealized losses, fixed maturity securities	(5)	0
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	598	963
Gross unrealized losses, fixed maturity securities	(287)	(95)
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Utilities
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	37	48
Gross unrealized losses, fixed maturity securities	(9)	(2)
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Energy
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	64	163
Gross unrealized losses, fixed maturity securities	(78)	(38)
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	152	203
Gross unrealized losses, fixed maturity securities	(8)	(3)
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	24	41
Gross unrealized losses, fixed maturity securities	(18)	(9)
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Technology and communications
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	36	71
Gross unrealized losses, fixed maturity securities	(26)	(4)
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Industrial
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	19	65
Gross unrealized losses, fixed maturity securities	(96)	(18)
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Capital goods
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	19	31
Gross unrealized losses, fixed maturity securities	(17)	(5)
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	8	14
Gross unrealized losses, fixed maturity securities	(4)	0
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Transportation
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	52	70
Gross unrealized losses, fixed maturity securities	(6)	(1)
Not other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Other
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	187	257
Gross unrealized losses, fixed maturity securities	(25)	(15)
Not other-than-temporary impairments | Fixed maturity securities | Residential mortgage-backed
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	330	362
Gross unrealized losses, fixed maturity securities	(17)	(17)
Not other-than-temporary impairments | Fixed maturity securities | Commercial mortgage-backed
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	84	143
Gross unrealized losses, fixed maturity securities	(20)	(9)
Not other-than-temporary impairments | Fixed maturity securities | Other asset-backed
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	11	23
Gross unrealized losses, fixed maturity securities	(59)	(54)
Other-than-temporary impairments
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	32	38
Gross unrealized losses, fixed maturity securities	0	(1)
Gross unrealized gains, equity securities	0	0
Gross unrealized losses, equity securities	0	0
Gross unrealized gains	32	38
Gross unrealized losses	0	(1)
Other-than-temporary impairments | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | State and Political Subdivisions
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. government
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	15	20
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Utilities
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Energy
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Finance and insurance
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	15	20
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Technology and communications
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Industrial
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Capital goods
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Consumer-cyclical
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Transportation
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | U.S. corporate | Other
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	2	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Utilities
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Energy
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	2	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Technology and communications
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Industrial
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Capital goods
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Transportation
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Non-U.S. corporate | Other
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	0	0
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Residential mortgage-backed
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	11	13
Gross unrealized losses, fixed maturity securities	0	(1)
Other-than-temporary impairments | Fixed maturity securities | Commercial mortgage-backed
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	3	4
Gross unrealized losses, fixed maturity securities	0	0
Other-than-temporary impairments | Fixed maturity securities | Other asset-backed
Schedule of Investments [Line Items]
Gross unrealized gains, fixed maturity securities	1	1
Gross unrealized losses, fixed maturity securities	$ 0	$ 0

Gross Unrealized Losses and Fai

Gross Unrealized Losses and Fair Value of Investment Securities (Detail) $ in Millions	Dec. 31, 2015USD ($)Securities	Dec. 31, 2014USD ($)Securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 14,198	$ 5,092
Less than 12 months, Gross unrealized losses	$ (612)	$ (117)
Less than 12 months, Number of securities in a continuous loss position | Securities	1,996	758
12 months or more, Fair value	$ 1,593	$ 3,215
12 months or more, Gross unrealized losses	$ (239)	$ (172)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	293	497
Fair value	$ 15,791	$ 8,307
Gross unrealized losses	$ (851)	$ (289)	[1]
Number of securities in a continuous loss position | Securities	2,289	1,255
Below investment grade
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 856	$ 591	[2]
Less than 12 months, Gross unrealized losses	$ (88)	$ (42)	[2]
Less than 12 months, Number of securities in a continuous loss position | Securities	162	127	[2]
12 months or more, Fair value	$ 348	$ 297	[2]
12 months or more, Gross unrealized losses	$ (104)	$ (27)	[1],[2]
12 months or more, Number of securities in a continuous loss position | Securities	68	73	[2]
Fair value	$ 1,204	$ 888	[2]
Gross unrealized losses	$ (192)	$ (69)	[1],[2]
Number of securities in a continuous loss position | Securities	230	200	[2]
Investment grade
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 13,342	$ 4,501
Less than 12 months, Gross unrealized losses	$ (524)	$ (75)
Less than 12 months, Number of securities in a continuous loss position | Securities	1,834	631
12 months or more, Fair value	$ 1,245	$ 2,918
12 months or more, Gross unrealized losses	$ (135)	$ (145)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	225	424
Fair value	$ 14,587	$ 7,419
Gross unrealized losses	$ (659)	$ (220)	[1]
Number of securities in a continuous loss position | Securities	2,059	1,055
Fixed maturity securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 14,045	$ 5,062
Less than 12 months, Gross unrealized losses	$ (589)	$ (114)
Less than 12 months, Number of securities in a continuous loss position | Securities	1,932	712
12 months or more, Fair value	$ 1,593	$ 3,167
12 months or more, Gross unrealized losses	$ (239)	$ (168)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	293	491
Fair value	$ 15,638	$ 8,229
Gross unrealized losses	$ (828)	$ (282)	[1]
Number of securities in a continuous loss position | Securities	2,225	1,203
Fixed maturity securities | Less Than 20 Percent Below Cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 13,726	$ 5,025
Less than 12 months, Gross unrealized losses	$ (472)	$ (103)
Less than 12 months, Number of securities in a continuous loss position | Securities	1,877	708
12 months or more, Fair value	$ 1,259	$ 3,036
12 months or more, Gross unrealized losses	$ (78)	$ (114)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	238	470
Fair value	$ 14,985	$ 8,061
Gross unrealized losses	$ (550)	$ (217)	[1]
Number of securities in a continuous loss position | Securities	2,115	1,178
Fixed maturity securities | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 319	$ 37
Less than 12 months, Gross unrealized losses	$ (116)	$ (11)
Less than 12 months, Number of securities in a continuous loss position | Securities	54	4
12 months or more, Fair value	$ 316	$ 131
12 months or more, Gross unrealized losses	$ (139)	$ (53)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	50	15
Fair value	$ 635	$ 168
Gross unrealized losses	$ (255)	$ (64)	[1]
Number of securities in a continuous loss position | Securities	104	19
Fixed maturity securities | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 0	$ 0
Less than 12 months, Gross unrealized losses	$ (1)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	1	0
12 months or more, Fair value	$ 18	$ 0
12 months or more, Gross unrealized losses	$ (22)	$ (1)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	5	6
Fair value	$ 18	$ 0
Gross unrealized losses	$ (23)	$ (1)	[1]
Number of securities in a continuous loss position | Securities	6	6
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 883	$ 0
Less than 12 months, Gross unrealized losses	$ (16)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	32	0
12 months or more, Fair value	$ 0	$ 75
12 months or more, Gross unrealized losses	$ 0	$ (1)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	0	10
Fair value	$ 883	$ 75
Gross unrealized losses	$ (16)	$ (1)	[1]
Number of securities in a continuous loss position | Securities	32	10
Fixed maturity securities | State and Political Subdivisions
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 464	$ 9
Less than 12 months, Gross unrealized losses	$ (15)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	81	7
12 months or more, Fair value	$ 163	$ 267
12 months or more, Gross unrealized losses	$ (15)	$ (27)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	17	45
Fair value	$ 627	$ 276
Gross unrealized losses	$ (30)	$ (27)	[1]
Number of securities in a continuous loss position | Securities	98	52
Fixed maturity securities | Non-U.S. government
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 366	$ 64
Less than 12 months, Gross unrealized losses	$ (5)	$ (1)
Less than 12 months, Number of securities in a continuous loss position | Securities	49	15
12 months or more, Fair value	$ 0	$ 22
12 months or more, Gross unrealized losses	$ 0	$ (1)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	0	4
Fair value	$ 366	$ 86
Gross unrealized losses	$ (5)	$ (2)	[1]
Number of securities in a continuous loss position | Securities	49	19
Fixed maturity securities | U.S. corporate
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 5,836	$ 1,639
Less than 12 months, Gross unrealized losses	$ (332)	$ (33)
Less than 12 months, Number of securities in a continuous loss position | Securities	817	231
12 months or more, Fair value	$ 466	$ 1,201
12 months or more, Gross unrealized losses	$ (62)	$ (43)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	83	174
Fair value	$ 6,302	$ 2,840
Gross unrealized losses	$ (394)	$ (76)	[1]
Number of securities in a continuous loss position | Securities	900	405
Fixed maturity securities | U.S. corporate | Utilities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 485	$ 55
Less than 12 months, Gross unrealized losses	$ (25)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	74	10
12 months or more, Fair value	$ 14	$ 164
12 months or more, Gross unrealized losses	$ (1)	$ (5)
12 months or more, Number of securities in a continuous loss position | Securities	7	23
Fair value	$ 499	$ 219
Gross unrealized losses	$ (26)	$ (5)
Number of securities in a continuous loss position | Securities	81	33
Fixed maturity securities | U.S. corporate | Energy
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 1,162	$ 404
Less than 12 months, Gross unrealized losses	$ (134)	$ (16)
Less than 12 months, Number of securities in a continuous loss position | Securities	163	56
12 months or more, Fair value	$ 131	$ 96
12 months or more, Gross unrealized losses	$ (28)	$ (5)
12 months or more, Number of securities in a continuous loss position | Securities	22	15
Fair value	$ 1,293	$ 500
Gross unrealized losses	$ (162)	$ (21)
Number of securities in a continuous loss position | Securities	185	71
Fixed maturity securities | U.S. corporate | Finance and insurance
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 1,142	$ 399
Less than 12 months, Gross unrealized losses	$ (35)	$ (3)
Less than 12 months, Number of securities in a continuous loss position | Securities	160	56
12 months or more, Fair value	$ 94	$ 257
12 months or more, Gross unrealized losses	$ (8)	$ (10)
12 months or more, Number of securities in a continuous loss position | Securities	15	35
Fair value	$ 1,236	$ 656
Gross unrealized losses	$ (43)	$ (13)
Number of securities in a continuous loss position | Securities	175	91
Fixed maturity securities | U.S. corporate | Technology and communications
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 658	$ 181
Less than 12 months, Gross unrealized losses	$ (36)	$ (3)
Less than 12 months, Number of securities in a continuous loss position | Securities	95	27
12 months or more, Fair value	$ 23	$ 97
12 months or more, Gross unrealized losses	$ (2)	$ (1)
12 months or more, Number of securities in a continuous loss position | Securities	5	15
Fair value	$ 681	$ 278
Gross unrealized losses	$ (38)	$ (4)
Number of securities in a continuous loss position | Securities	100	42
Fixed maturity securities | U.S. corporate | Industrial
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 476	$ 151
Less than 12 months, Gross unrealized losses	$ (33)	$ (4)
Less than 12 months, Number of securities in a continuous loss position | Securities	64	21
12 months or more, Fair value	$ 44	$ 80
12 months or more, Gross unrealized losses	$ (11)	$ (4)
12 months or more, Number of securities in a continuous loss position | Securities	9	11
Fair value	$ 520	$ 231
Gross unrealized losses	$ (44)	$ (8)
Number of securities in a continuous loss position | Securities	73	32
Fixed maturity securities | U.S. corporate | Capital goods
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 293	$ 85
Less than 12 months, Gross unrealized losses	$ (10)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	48	13
12 months or more, Fair value	$ 26	$ 122
12 months or more, Gross unrealized losses	$ (2)	$ (5)
12 months or more, Number of securities in a continuous loss position | Securities	4	18
Fair value	$ 319	$ 207
Gross unrealized losses	$ (12)	$ (5)
Number of securities in a continuous loss position | Securities	52	31
Fixed maturity securities | U.S. corporate | Other
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 84	$ 20
Less than 12 months, Gross unrealized losses	$ (5)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	8	2
12 months or more, Fair value	$ 0	$ 7
12 months or more, Gross unrealized losses	$ 0	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0	1
Fair value	$ 84	$ 27
Gross unrealized losses	$ (5)	$ 0
Number of securities in a continuous loss position | Securities	8	3
Fixed maturity securities | Non-U.S. corporate
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 3,016	$ 1,456
Less than 12 months, Gross unrealized losses	$ (170)	$ (67)
Less than 12 months, Number of securities in a continuous loss position | Securities	400	199
12 months or more, Fair value	$ 486	$ 504
12 months or more, Gross unrealized losses	$ (117)	$ (28)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	87	67
Fair value	$ 3,502	$ 1,960
Gross unrealized losses	$ (287)	$ (95)	[1]
Number of securities in a continuous loss position | Securities	487	266
Fixed maturity securities | Non-U.S. corporate | Utilities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 130	$ 79
Less than 12 months, Gross unrealized losses	$ (6)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	20	13
12 months or more, Fair value	$ 32	$ 43
12 months or more, Gross unrealized losses	$ (3)	$ (2)
12 months or more, Number of securities in a continuous loss position | Securities	6	5
Fair value	$ 162	$ 122
Gross unrealized losses	$ (9)	$ (2)
Number of securities in a continuous loss position | Securities	26	18
Fixed maturity securities | Non-U.S. corporate | Energy
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 589	$ 442
Less than 12 months, Gross unrealized losses	$ (48)	$ (33)
Less than 12 months, Number of securities in a continuous loss position | Securities	71	57
12 months or more, Fair value	$ 127	$ 58
12 months or more, Gross unrealized losses	$ (30)	$ (5)
12 months or more, Number of securities in a continuous loss position | Securities	20	13
Fair value	$ 716	$ 500
Gross unrealized losses	$ (78)	$ (38)
Number of securities in a continuous loss position | Securities	91	70
Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 478	$ 237
Less than 12 months, Gross unrealized losses	$ (7)	$ (2)
Less than 12 months, Number of securities in a continuous loss position | Securities	77	32
12 months or more, Fair value	$ 30	$ 29
12 months or more, Gross unrealized losses	$ (1)	$ (1)
12 months or more, Number of securities in a continuous loss position | Securities	8	6
Fair value	$ 508	$ 266
Gross unrealized losses	$ (8)	$ (3)
Number of securities in a continuous loss position | Securities	85	38
Fixed maturity securities | Non-U.S. corporate | Technology and communications
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 324	$ 77
Less than 12 months, Gross unrealized losses	$ (15)	$ (2)
Less than 12 months, Number of securities in a continuous loss position | Securities	37	13
12 months or more, Fair value	$ 33	$ 81
12 months or more, Gross unrealized losses	$ (11)	$ (2)
12 months or more, Number of securities in a continuous loss position | Securities	9	8
Fair value	$ 357	$ 158
Gross unrealized losses	$ (26)	$ (4)
Number of securities in a continuous loss position | Securities	46	21
Fixed maturity securities | Non-U.S. corporate | Industrial
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 495	$ 214
Less than 12 months, Gross unrealized losses	$ (54)	$ (9)
Less than 12 months, Number of securities in a continuous loss position | Securities	67	30
12 months or more, Fair value	$ 110	$ 116
12 months or more, Gross unrealized losses	$ (42)	$ (9)
12 months or more, Number of securities in a continuous loss position | Securities	18	15
Fair value	$ 605	$ 330
Gross unrealized losses	$ (96)	$ (18)
Number of securities in a continuous loss position | Securities	85	45
Fixed maturity securities | Non-U.S. corporate | Capital goods
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 154	$ 63
Less than 12 months, Gross unrealized losses	$ (8)	$ (2)
Less than 12 months, Number of securities in a continuous loss position | Securities	22	7
12 months or more, Fair value	$ 41	$ 38
12 months or more, Gross unrealized losses	$ (9)	$ (3)
12 months or more, Number of securities in a continuous loss position | Securities	9	4
Fair value	$ 195	$ 101
Gross unrealized losses	$ (17)	$ (5)
Number of securities in a continuous loss position | Securities	31	11
Fixed maturity securities | Non-U.S. corporate | Other
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 283	$ 172
Less than 12 months, Gross unrealized losses	$ (8)	$ (13)
Less than 12 months, Number of securities in a continuous loss position | Securities	42	30
12 months or more, Fair value	$ 76	$ 42
12 months or more, Gross unrealized losses	$ (17)	$ (2)
12 months or more, Number of securities in a continuous loss position | Securities	13	6
Fair value	$ 359	$ 214
Gross unrealized losses	$ (25)	$ (15)
Number of securities in a continuous loss position | Securities	55	36
Fixed maturity securities | Residential mortgage-backed
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 756	$ 180
Less than 12 months, Gross unrealized losses	$ (10)	$ (1)
Less than 12 months, Number of securities in a continuous loss position | Securities	88	24
12 months or more, Fair value	$ 103	$ 249
12 months or more, Gross unrealized losses	$ (7)	$ (17)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	38	87
Fair value	$ 859	$ 429
Gross unrealized losses	$ (17)	$ (18)	[1]
Number of securities in a continuous loss position | Securities	126	111
Fixed maturity securities | Commercial mortgage-backed
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 780	$ 163
Less than 12 months, Gross unrealized losses	$ (19)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	116	21
12 months or more, Fair value	$ 39	$ 362
12 months or more, Gross unrealized losses	$ (1)	$ (9)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	13	49
Fair value	$ 819	$ 525
Gross unrealized losses	$ (20)	$ (9)	[1]
Number of securities in a continuous loss position | Securities	129	70
Fixed maturity securities | Other asset-backed
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 1,944	$ 1,551
Less than 12 months, Gross unrealized losses	$ (22)	$ (12)
Less than 12 months, Number of securities in a continuous loss position | Securities	349	215
12 months or more, Fair value	$ 336	$ 487
12 months or more, Gross unrealized losses	$ (37)	$ (42)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	55	55
Fair value	$ 2,280	$ 2,038
Gross unrealized losses	$ (59)	$ (54)	[1]
Number of securities in a continuous loss position | Securities	404	270
Fixed maturity securities | Below investment grade | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 131
12 months or more, Gross unrealized losses	$ (63)
12 months or more, Number of securities in a continuous loss position | Securities	28
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	8.00%
Fixed maturity securities | Below investment grade | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 18
12 months or more, Gross unrealized losses	$ (22)
12 months or more, Number of securities in a continuous loss position | Securities	5
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	3.00%
Fixed maturity securities | Below investment grade | U.S. corporate | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 37
12 months or more, Gross unrealized losses	$ (15)
12 months or more, Number of securities in a continuous loss position | Securities	9
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	2.00%
Fixed maturity securities | Below investment grade | U.S. corporate | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Below investment grade | U.S. corporate | Energy | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 21
12 months or more, Gross unrealized losses	$ (9)
12 months or more, Number of securities in a continuous loss position | Securities	6
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Fixed maturity securities | Below investment grade | U.S. corporate | Energy | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Below investment grade | U.S. corporate | Finance and insurance | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 7
12 months or more, Gross unrealized losses	$ (3)
12 months or more, Number of securities in a continuous loss position | Securities	1
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Fixed maturity securities | Below investment grade | U.S. corporate | Finance and insurance | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Below investment grade | U.S. corporate | Technology and communications | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 5
12 months or more, Gross unrealized losses	$ (2)
12 months or more, Number of securities in a continuous loss position | Securities	1
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Below investment grade | U.S. corporate | Technology and communications | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Below investment grade | U.S. corporate | Industrial | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 4
12 months or more, Gross unrealized losses	$ (1)
12 months or more, Number of securities in a continuous loss position | Securities	1
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Below investment grade | U.S. corporate | Industrial | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 86
12 months or more, Gross unrealized losses	$ (42)
12 months or more, Number of securities in a continuous loss position | Securities	18
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	5.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 18
12 months or more, Gross unrealized losses	$ (22)
12 months or more, Number of securities in a continuous loss position | Securities	5
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	3.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | Energy | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 44
12 months or more, Gross unrealized losses	$ (20)
12 months or more, Number of securities in a continuous loss position | Securities	8
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	2.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | Energy | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | Technology and communications | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 5
12 months or more, Gross unrealized losses	$ (4)
12 months or more, Number of securities in a continuous loss position | Securities	2
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | Technology and communications | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 4
12 months or more, Gross unrealized losses	$ (5)
12 months or more, Number of securities in a continuous loss position | Securities	1
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | Industrial | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 10
12 months or more, Gross unrealized losses	$ (6)
12 months or more, Number of securities in a continuous loss position | Securities	2
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | Industrial | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 14
12 months or more, Gross unrealized losses	$ (17)
12 months or more, Number of securities in a continuous loss position | Securities	4
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	2.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | Capital goods | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 3
12 months or more, Gross unrealized losses	$ (2)
12 months or more, Number of securities in a continuous loss position | Securities	1
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | Capital goods | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | Other | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 24
12 months or more, Gross unrealized losses	$ (10)
12 months or more, Number of securities in a continuous loss position | Securities	5
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Below investment grade | Non-U.S. corporate | Other | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | Less Than 20 Percent Below Cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	75.00%
Fixed maturity securities | Investment grade | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 185
12 months or more, Gross unrealized losses	$ (76)
12 months or more, Number of securities in a continuous loss position | Securities	22
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	9.00%
Fixed maturity securities | Investment grade | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | State and Political Subdivisions | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 9
12 months or more, Gross unrealized losses	$ (3)
12 months or more, Number of securities in a continuous loss position | Securities	1
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | State and Political Subdivisions | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | U.S. corporate | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 41
12 months or more, Gross unrealized losses	$ (17)
12 months or more, Number of securities in a continuous loss position | Securities	7
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	2.00%
Fixed maturity securities | Investment grade | U.S. corporate | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | U.S. corporate | Energy | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 23
12 months or more, Gross unrealized losses	$ (8)
12 months or more, Number of securities in a continuous loss position | Securities	4
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Fixed maturity securities | Investment grade | U.S. corporate | Energy | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | U.S. corporate | Industrial | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 18
12 months or more, Gross unrealized losses	$ (9)
12 months or more, Number of securities in a continuous loss position | Securities	3
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Fixed maturity securities | Investment grade | U.S. corporate | Industrial | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 69
12 months or more, Gross unrealized losses	$ (31)
12 months or more, Number of securities in a continuous loss position | Securities	10
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	4.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | Utilities | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 8
12 months or more, Gross unrealized losses	$ (2)
12 months or more, Number of securities in a continuous loss position | Securities	1
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | Utilities | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | Energy | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 21
12 months or more, Gross unrealized losses	$ (8)
12 months or more, Number of securities in a continuous loss position | Securities	2
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | Energy | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | Industrial | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 29
12 months or more, Gross unrealized losses	$ (14)
12 months or more, Number of securities in a continuous loss position | Securities	4
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	2.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | Industrial | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | Capital goods | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 6
12 months or more, Gross unrealized losses	$ (5)
12 months or more, Number of securities in a continuous loss position | Securities	2
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | Capital goods | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | Other | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 5
12 months or more, Gross unrealized losses	$ (2)
12 months or more, Number of securities in a continuous loss position | Securities	1
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Fixed maturity securities | Investment grade | Non-U.S. corporate | Other | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Equity Securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 153	$ 30
Less than 12 months, Gross unrealized losses	$ (23)	$ (3)
Less than 12 months, Number of securities in a continuous loss position | Securities	64	46
12 months or more, Fair value	$ 0	$ 48
12 months or more, Gross unrealized losses	$ 0	$ (4)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	0	6
Fair value	$ 153	$ 78
Gross unrealized losses	$ (23)	$ (7)	[1]
Number of securities in a continuous loss position | Securities	64	52
Equity Securities | Less Than 20 Percent Below Cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 133	$ 26
Less than 12 months, Gross unrealized losses	$ (18)	$ (2)
Less than 12 months, Number of securities in a continuous loss position | Securities	56	40
12 months or more, Fair value	$ 0	$ 48
12 months or more, Gross unrealized losses	$ 0	$ (4)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	0	6
Fair value	$ 133	$ 74
Gross unrealized losses	$ (18)	$ (6)	[1]
Number of securities in a continuous loss position | Securities	56	46
Equity Securities | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 20	$ 4
Less than 12 months, Gross unrealized losses	$ (5)	$ (1)
Less than 12 months, Number of securities in a continuous loss position | Securities	8	6
12 months or more, Fair value	$ 0	$ 0
12 months or more, Gross unrealized losses	$ 0	$ 0	[1]
12 months or more, Number of securities in a continuous loss position | Securities	0	0
Fair value	$ 20	$ 4
Gross unrealized losses	$ (5)	$ (1)	[1]
Number of securities in a continuous loss position | Securities	8	6
Structured Securities | Below investment grade | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 8
12 months or more, Gross unrealized losses	$ (6)
12 months or more, Number of securities in a continuous loss position | Securities	1
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Structured Securities | Below investment grade | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Structured Securities | Below investment grade | Other asset-backed | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 8
12 months or more, Gross unrealized losses	$ (6)
12 months or more, Number of securities in a continuous loss position | Securities	1
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	1.00%
Structured Securities | Below investment grade | Other asset-backed | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Structured Securities | Investment grade | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 66
12 months or more, Gross unrealized losses	$ (25)
12 months or more, Number of securities in a continuous loss position | Securities	4
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	3.00%
Structured Securities | Investment grade | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
Structured Securities | Investment grade | Other asset-backed | 20 To 50 percent below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 66
12 months or more, Gross unrealized losses	$ (25)
12 months or more, Number of securities in a continuous loss position | Securities	4
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	3.00%
Structured Securities | Investment grade | Other asset-backed | Greater than 50% below cost
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Fair value	$ 0
12 months or more, Gross unrealized losses	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0
12 months or more, Percentage of total gross unrealized losses for securities in a continuous loss position	0.00%
[1]	Amounts included $1 million of unrealized losses on other-than-temporarily impaired securities.
[2]	Amounts that have been in a continuous unrealized loss position for 12 months or more included $1 million of unrealized losses on other-than-temporarily impaired securities.

Gross Unrealized Losses and F72

Gross Unrealized Losses and Fair Value of Corporate Securities Based on Industries (Detail) $ in Millions	Dec. 31, 2015USD ($)Securities	Dec. 31, 2014USD ($)Securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 14,198	$ 5,092
Less than 12 months, Gross unrealized losses	$ (612)	$ (117)
Less than 12 months, Number of securities in a continuous loss position | Securities	1,996	758
12 months or more, Fair value	$ 1,593	$ 3,215
12 months or more, Gross unrealized losses	$ (239)	$ (172)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	293	497
Fair value	$ 15,791	$ 8,307
Gross unrealized losses	$ (851)	$ (289)	[1]
Number of securities in a continuous loss position | Securities	2,289	1,255
Fixed maturity securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 14,045	$ 5,062
Less than 12 months, Gross unrealized losses	$ (589)	$ (114)
Less than 12 months, Number of securities in a continuous loss position | Securities	1,932	712
12 months or more, Fair value	$ 1,593	$ 3,167
12 months or more, Gross unrealized losses	$ (239)	$ (168)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	293	491
Fair value	$ 15,638	$ 8,229
Gross unrealized losses	$ (828)	$ (282)	[1]
Number of securities in a continuous loss position | Securities	2,225	1,203
Fixed maturity securities | U.S. corporate
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 5,836	$ 1,639
Less than 12 months, Gross unrealized losses	$ (332)	$ (33)
Less than 12 months, Number of securities in a continuous loss position | Securities	817	231
12 months or more, Fair value	$ 466	$ 1,201
12 months or more, Gross unrealized losses	$ (62)	$ (43)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	83	174
Fair value	$ 6,302	$ 2,840
Gross unrealized losses	$ (394)	$ (76)	[1]
Number of securities in a continuous loss position | Securities	900	405
Fixed maturity securities | U.S. corporate | Utilities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 485	$ 55
Less than 12 months, Gross unrealized losses	$ (25)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	74	10
12 months or more, Fair value	$ 14	$ 164
12 months or more, Gross unrealized losses	$ (1)	$ (5)
12 months or more, Number of securities in a continuous loss position | Securities	7	23
Fair value	$ 499	$ 219
Gross unrealized losses	$ (26)	$ (5)
Number of securities in a continuous loss position | Securities	81	33
Fixed maturity securities | U.S. corporate | Energy
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 1,162	$ 404
Less than 12 months, Gross unrealized losses	$ (134)	$ (16)
Less than 12 months, Number of securities in a continuous loss position | Securities	163	56
12 months or more, Fair value	$ 131	$ 96
12 months or more, Gross unrealized losses	$ (28)	$ (5)
12 months or more, Number of securities in a continuous loss position | Securities	22	15
Fair value	$ 1,293	$ 500
Gross unrealized losses	$ (162)	$ (21)
Number of securities in a continuous loss position | Securities	185	71
Fixed maturity securities | U.S. corporate | Finance and insurance
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 1,142	$ 399
Less than 12 months, Gross unrealized losses	$ (35)	$ (3)
Less than 12 months, Number of securities in a continuous loss position | Securities	160	56
12 months or more, Fair value	$ 94	$ 257
12 months or more, Gross unrealized losses	$ (8)	$ (10)
12 months or more, Number of securities in a continuous loss position | Securities	15	35
Fair value	$ 1,236	$ 656
Gross unrealized losses	$ (43)	$ (13)
Number of securities in a continuous loss position | Securities	175	91
Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 836	$ 160
Less than 12 months, Gross unrealized losses	$ (26)	$ (3)
Less than 12 months, Number of securities in a continuous loss position | Securities	107	20
12 months or more, Fair value	$ 51	$ 182
12 months or more, Gross unrealized losses	$ (4)	$ (5)
12 months or more, Number of securities in a continuous loss position | Securities	10	32
Fair value	$ 887	$ 342
Gross unrealized losses	$ (30)	$ (8)
Number of securities in a continuous loss position | Securities	117	52
Fixed maturity securities | U.S. corporate | Technology and communications
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 658	$ 181
Less than 12 months, Gross unrealized losses	$ (36)	$ (3)
Less than 12 months, Number of securities in a continuous loss position | Securities	95	27
12 months or more, Fair value	$ 23	$ 97
12 months or more, Gross unrealized losses	$ (2)	$ (1)
12 months or more, Number of securities in a continuous loss position | Securities	5	15
Fair value	$ 681	$ 278
Gross unrealized losses	$ (38)	$ (4)
Number of securities in a continuous loss position | Securities	100	42
Fixed maturity securities | U.S. corporate | Industrial
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 476	$ 151
Less than 12 months, Gross unrealized losses	$ (33)	$ (4)
Less than 12 months, Number of securities in a continuous loss position | Securities	64	21
12 months or more, Fair value	$ 44	$ 80
12 months or more, Gross unrealized losses	$ (11)	$ (4)
12 months or more, Number of securities in a continuous loss position | Securities	9	11
Fair value	$ 520	$ 231
Gross unrealized losses	$ (44)	$ (8)
Number of securities in a continuous loss position | Securities	73	32
Fixed maturity securities | U.S. corporate | Capital goods
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 293	$ 85
Less than 12 months, Gross unrealized losses	$ (10)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	48	13
12 months or more, Fair value	$ 26	$ 122
12 months or more, Gross unrealized losses	$ (2)	$ (5)
12 months or more, Number of securities in a continuous loss position | Securities	4	18
Fair value	$ 319	$ 207
Gross unrealized losses	$ (12)	$ (5)
Number of securities in a continuous loss position | Securities	52	31
Fixed maturity securities | U.S. corporate | Consumer-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 427	$ 132
Less than 12 months, Gross unrealized losses	$ (18)	$ (2)
Less than 12 months, Number of securities in a continuous loss position | Securities	60	17
12 months or more, Fair value	$ 63	$ 139
12 months or more, Gross unrealized losses	$ (4)	$ (6)
12 months or more, Number of securities in a continuous loss position | Securities	10	18
Fair value	$ 490	$ 271
Gross unrealized losses	$ (22)	$ (8)
Number of securities in a continuous loss position | Securities	70	35
Fixed maturity securities | U.S. corporate | Transportation
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 273	$ 52
Less than 12 months, Gross unrealized losses	$ (10)	$ (2)
Less than 12 months, Number of securities in a continuous loss position | Securities	38	9
12 months or more, Fair value	$ 20	$ 57
12 months or more, Gross unrealized losses	$ (2)	$ (2)
12 months or more, Number of securities in a continuous loss position | Securities	1	6
Fair value	$ 293	$ 109
Gross unrealized losses	$ (12)	$ (4)
Number of securities in a continuous loss position | Securities	39	15
Fixed maturity securities | U.S. corporate | Other
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 84	$ 20
Less than 12 months, Gross unrealized losses	$ (5)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	8	2
12 months or more, Fair value	$ 0	$ 7
12 months or more, Gross unrealized losses	$ 0	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0	1
Fair value	$ 84	$ 27
Gross unrealized losses	$ (5)	$ 0
Number of securities in a continuous loss position | Securities	8	3
Fixed maturity securities | Non-U.S. corporate
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 3,016	$ 1,456
Less than 12 months, Gross unrealized losses	$ (170)	$ (67)
Less than 12 months, Number of securities in a continuous loss position | Securities	400	199
12 months or more, Fair value	$ 486	$ 504
12 months or more, Gross unrealized losses	$ (117)	$ (28)	[1]
12 months or more, Number of securities in a continuous loss position | Securities	87	67
Fair value	$ 3,502	$ 1,960
Gross unrealized losses	$ (287)	$ (95)	[1]
Number of securities in a continuous loss position | Securities	487	266
Fixed maturity securities | Non-U.S. corporate | Utilities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 130	$ 79
Less than 12 months, Gross unrealized losses	$ (6)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	20	13
12 months or more, Fair value	$ 32	$ 43
12 months or more, Gross unrealized losses	$ (3)	$ (2)
12 months or more, Number of securities in a continuous loss position | Securities	6	5
Fair value	$ 162	$ 122
Gross unrealized losses	$ (9)	$ (2)
Number of securities in a continuous loss position | Securities	26	18
Fixed maturity securities | Non-U.S. corporate | Energy
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 589	$ 442
Less than 12 months, Gross unrealized losses	$ (48)	$ (33)
Less than 12 months, Number of securities in a continuous loss position | Securities	71	57
12 months or more, Fair value	$ 127	$ 58
12 months or more, Gross unrealized losses	$ (30)	$ (5)
12 months or more, Number of securities in a continuous loss position | Securities	20	13
Fair value	$ 716	$ 500
Gross unrealized losses	$ (78)	$ (38)
Number of securities in a continuous loss position | Securities	91	70
Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 478	$ 237
Less than 12 months, Gross unrealized losses	$ (7)	$ (2)
Less than 12 months, Number of securities in a continuous loss position | Securities	77	32
12 months or more, Fair value	$ 30	$ 29
12 months or more, Gross unrealized losses	$ (1)	$ (1)
12 months or more, Number of securities in a continuous loss position | Securities	8	6
Fair value	$ 508	$ 266
Gross unrealized losses	$ (8)	$ (3)
Number of securities in a continuous loss position | Securities	85	38
Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 261	$ 134
Less than 12 months, Gross unrealized losses	$ (14)	$ (6)
Less than 12 months, Number of securities in a continuous loss position | Securities	27	10
12 months or more, Fair value	$ 37	$ 83
12 months or more, Gross unrealized losses	$ (4)	$ (3)
12 months or more, Number of securities in a continuous loss position | Securities	4	9
Fair value	$ 298	$ 217
Gross unrealized losses	$ (18)	$ (9)
Number of securities in a continuous loss position | Securities	31	19
Fixed maturity securities | Non-U.S. corporate | Technology and communications
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 324	$ 77
Less than 12 months, Gross unrealized losses	$ (15)	$ (2)
Less than 12 months, Number of securities in a continuous loss position | Securities	37	13
12 months or more, Fair value	$ 33	$ 81
12 months or more, Gross unrealized losses	$ (11)	$ (2)
12 months or more, Number of securities in a continuous loss position | Securities	9	8
Fair value	$ 357	$ 158
Gross unrealized losses	$ (26)	$ (4)
Number of securities in a continuous loss position | Securities	46	21
Fixed maturity securities | Non-U.S. corporate | Industrial
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 495	$ 214
Less than 12 months, Gross unrealized losses	$ (54)	$ (9)
Less than 12 months, Number of securities in a continuous loss position | Securities	67	30
12 months or more, Fair value	$ 110	$ 116
12 months or more, Gross unrealized losses	$ (42)	$ (9)
12 months or more, Number of securities in a continuous loss position | Securities	18	15
Fair value	$ 605	$ 330
Gross unrealized losses	$ (96)	$ (18)
Number of securities in a continuous loss position | Securities	85	45
Fixed maturity securities | Non-U.S. corporate | Capital goods
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 154	$ 63
Less than 12 months, Gross unrealized losses	$ (8)	$ (2)
Less than 12 months, Number of securities in a continuous loss position | Securities	22	7
12 months or more, Fair value	$ 41	$ 38
12 months or more, Gross unrealized losses	$ (9)	$ (3)
12 months or more, Number of securities in a continuous loss position | Securities	9	4
Fair value	$ 195	$ 101
Gross unrealized losses	$ (17)	$ (5)
Number of securities in a continuous loss position | Securities	31	11
Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 155	$ 8
Less than 12 months, Gross unrealized losses	$ (4)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	20	1
12 months or more, Fair value	$ 0	$ 0
12 months or more, Gross unrealized losses	$ 0	$ 0
12 months or more, Number of securities in a continuous loss position | Securities	0	0
Fair value	$ 155	$ 8
Gross unrealized losses	$ (4)	$ 0
Number of securities in a continuous loss position | Securities	20	1
Fixed maturity securities | Non-U.S. corporate | Transportation
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 147	$ 30
Less than 12 months, Gross unrealized losses	$ (6)	$ 0
Less than 12 months, Number of securities in a continuous loss position | Securities	17	6
12 months or more, Fair value	$ 0	$ 14
12 months or more, Gross unrealized losses	$ 0	$ (1)
12 months or more, Number of securities in a continuous loss position | Securities	0	1
Fair value	$ 147	$ 44
Gross unrealized losses	$ (6)	$ (1)
Number of securities in a continuous loss position | Securities	17	7
Fixed maturity securities | Non-U.S. corporate | Other
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 283	$ 172
Less than 12 months, Gross unrealized losses	$ (8)	$ (13)
Less than 12 months, Number of securities in a continuous loss position | Securities	42	30
12 months or more, Fair value	$ 76	$ 42
12 months or more, Gross unrealized losses	$ (17)	$ (2)
12 months or more, Number of securities in a continuous loss position | Securities	13	6
Fair value	$ 359	$ 214
Gross unrealized losses	$ (25)	$ (15)
Number of securities in a continuous loss position | Securities	55	36
Fixed maturity securities | Corporate Debt Securities
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
Less than 12 months, Fair value	$ 8,852	$ 3,095
Less than 12 months, Gross unrealized losses	$ (502)	$ (100)
Less than 12 months, Number of securities in a continuous loss position | Securities	1,217	430
12 months or more, Fair value	$ 952	$ 1,705
12 months or more, Gross unrealized losses	$ (179)	$ (71)
12 months or more, Number of securities in a continuous loss position | Securities	170	241
Fair value	$ 9,804	$ 4,800
Gross unrealized losses	$ (681)	$ (171)
Number of securities in a continuous loss position | Securities	1,387	671
[1]	Amounts included $1 million of unrealized losses on other-than-temporarily impaired securities.

Gross Unrealized Losses and F73

Gross Unrealized Losses and Fair Value of Investment Securities (Parenthetical) (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Gross unrealized losses	$ 239	$ 172	[1]
Gross unrealized losses	851	289	[1]
Other-than-temporary impairments
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Gross unrealized losses		1
Gross unrealized losses		1
Below investment grade
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Gross unrealized losses	104	27	[1],[2]
Gross unrealized losses	$ 192	69	[1],[2]
Below investment grade | Other-than-temporary impairments
Available for Sale Securities Continuous Unrealized Loss Position [Line Items]
12 months or more, Gross unrealized losses		$ 1
[1]	Amounts included $1 million of unrealized losses on other-than-temporarily impaired securities.
[2]	Amounts that have been in a continuous unrealized loss position for 12 months or more included $1 million of unrealized losses on other-than-temporarily impaired securities.

Scheduled Maturity Distribution

Scheduled Maturity Distribution of Fixed Maturity Securities (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Amortized cost or cost
Due one year or less	$ 1,729
Due after one year through five years	9,814
Due after five years through ten years	11,772
Due after ten years	21,249
Subtotal	44,564
Amortized cost or cost, fixed maturity securities	55,161	$ 55,656
Fair value
Due one year or less	1,744
Due after one year through five years	10,192
Due after five years through ten years	11,917
Due after ten years	23,403
Subtotal	47,256
Fair value, fixed maturity securities	58,197	$ 61,077
Residential mortgage-backed
Amortized cost or cost
Fixed maturity securities	4,777
Fair value
Fixed maturity securities	5,101
Commercial mortgage-backed
Amortized cost or cost
Fixed maturity securities	2,492
Fair value
Fixed maturity securities	2,559
Other asset-backed
Amortized cost or cost
Fixed maturity securities	3,328
Fair value
Fixed maturity securities	$ 3,281

Distribution Across Property Ty

Distribution Across Property Type and Geographic Region for Commercial Mortgage Loans (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 6,187	$ 6,123
Unamortized balance of loan origination fees and costs	$ (2)	$ (1)
% of total	100.00%	100.00%
Allowance for losses	$ (15)	$ (22)
Total	6,170	6,100
Commercial Mortgage Loan
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	6,187	6,123
Unamortized balance of loan origination fees and costs	$ (2)	$ (1)
% of total	100.00%	100.00%
Allowance for losses	$ (15)	$ (22)
Total	6,170	6,100
South Atlantic | Commercial Mortgage Loan
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 1,574	$ 1,673
% of total	25.00%	27.00%
Pacific | Commercial Mortgage Loan
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 1,581	$ 1,636
% of total	26.00%	27.00%
Middle Atlantic | Commercial Mortgage Loan
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 890	$ 826
% of total	14.00%	14.00%
Mountain | Commercial Mortgage Loan
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 585	$ 536
% of total	10.00%	9.00%
West North Central | Commercial Mortgage Loan
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 416	$ 382
% of total	7.00%	6.00%
East North Central | Commercial Mortgage Loan
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 386	$ 397
% of total	6.00%	7.00%
West South Central | Commercial Mortgage Loan
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 294	$ 268
% of total	5.00%	4.00%
New England | Commercial Mortgage Loan
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 268	$ 264
% of total	4.00%	4.00%
East South Central | Commercial Mortgage Loan
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 193	$ 141
% of total	3.00%	2.00%
Retail
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 2,355	$ 2,150
% of total	38.00%	35.00%
Office
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 1,516	$ 1,643
% of total	24.00%	27.00%
Industrial
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 1,562	$ 1,597
% of total	25.00%	26.00%
Apartments
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 465	$ 494
% of total	8.00%	8.00%
Mixed use/other
Distribution of Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 289	$ 239
% of total	5.00%	4.00%

Aging of Past Due Commercial Mo

Aging of Past Due Commercial Mortgage Loans by Property Type (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 6,187	$ 6,123
% of total	100.00%	100.00%
Retail
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 2,355	$ 2,150
% of total	38.00%	35.00%
Office
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 1,516	$ 1,643
% of total	24.00%	27.00%
Industrial
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 1,562	$ 1,597
% of total	25.00%	26.00%
Apartments
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 465	$ 494
% of total	8.00%	8.00%
Mixed use/other
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 289	$ 239
% of total	5.00%	4.00%
31-60 days past due
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 6	$ 0
% of total	0.00%	0.00%
31-60 days past due | Retail
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 0	$ 0
31-60 days past due | Office
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	6	0
31-60 days past due | Industrial
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	0
31-60 days past due | Apartments
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	0
31-60 days past due | Mixed use/other
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	0
61-90 days past due
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 0	$ 0
% of total	0.00%	0.00%
61-90 days past due | Retail
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 0	$ 0
61-90 days past due | Office
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	0
61-90 days past due | Industrial
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	0
61-90 days past due | Apartments
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	0
61-90 days past due | Mixed use/other
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	0
Greater than 90 days past due
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 5	$ 8
% of total	0.00%	0.00%
Greater than 90 days past due | Retail
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 0	$ 0
Greater than 90 days past due | Office
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	5	6
Greater than 90 days past due | Industrial
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	2
Greater than 90 days past due | Apartments
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	0
Greater than 90 days past due | Mixed use/other
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	0
Total past due
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 11	$ 8
% of total	0.00%	0.00%
Total past due | Retail
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 0	$ 0
Total past due | Office
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	11	6
Total past due | Industrial
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	2
Total past due | Apartments
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	0
Total past due | Mixed use/other
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	0	0
Current
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 6,176	$ 6,115
% of total	100.00%	100.00%
Current | Retail
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 2,355	$ 2,150
Current | Office
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	1,505	1,637
Current | Industrial
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	1,562	1,595
Current | Apartments
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	465	494
Current | Mixed use/other
Aging of Past Due Commercial Mortgage Loans [Line Items]
Commercial mortgage loans, recorded investment	$ 289	$ 239

Allowance for Credit Losses and

Allowance for Credit Losses and Recorded Investment in Commercial Mortgage Loans (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Financing Receivable, Allowance for Credit Losses [Line Items]
Beginning balance	$ 22
Ending balance	15	$ 22
Ending balance	6,187	6,123
Allowance for Credit Losses
Financing Receivable, Allowance for Credit Losses [Line Items]
Beginning balance	22	33	$ 42
Charge-offs	(4)	(1)	(2)
Recoveries	0	0	0
Provision	(3)	(10)	(7)
Ending balance	15	22	33
Ending allowance for individually impaired loans	0	0	0
Ending allowance for loans not individually impaired that were evaluated collectively for impairment	15	22	33
Commercial Mortgage Loans Recorded Investment
Financing Receivable, Allowance for Credit Losses [Line Items]
Ending balance	6,187	6,123	5,932
Ending balance of individually impaired loans	19	15	2
Ending balance of loans not individually impaired that were evaluated collectively for impairment	$ 6,168	$ 6,108	$ 5,930

Loan-to-Value of Commercial Mor

Loan-to-Value of Commercial Mortgage Loans by Property Type (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2015USD ($)		Dec. 31, 2014USD ($)
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 6,187		$ 6,123
% of total	100.00%		100.00%
Weighted-average debt service coverage ratio	1.79		1.78
Retail
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 2,355		$ 2,150
% of total	38.00%		35.00%
Office
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 1,516		$ 1,643
% of total	24.00%		27.00%
Industrial
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 1,562		$ 1,597
% of total	25.00%		26.00%
Apartments
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 465		$ 494
% of total	8.00%		8.00%
Mixed use/other
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 289		$ 239
% of total	5.00%		4.00%
Greater than 100%
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 38	[1]	$ 77	[2]
% of total	1.00%	[1]	1.00%	[2]
Weighted-average debt service coverage ratio	0.55	[1]	0.72	[2]
Greater than 100% | Retail
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 14	[1]	$ 18	[2]
Greater than 100% | Office
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	19	[1]	36	[2]
Greater than 100% | Industrial
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	5	[1]	23	[2]
Greater than 100% | Apartments
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0	[1]	0	[2]
Greater than 100% | Mixed use/other
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0	[1]	0	[2]
0% - 50%
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 2,099		$ 1,761
% of total	34.00%		29.00%
Weighted-average debt service coverage ratio	2.13		2.27
0% - 50% | Retail
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 846		$ 671
0% - 50% | Office
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	493		383
0% - 50% | Industrial
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	515		451
0% - 50% | Apartments
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	196		211
0% - 50% | Mixed use/other
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	49		45
51% - 60%
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 1,405		$ 1,101
% of total	23.00%		18.00%
Weighted-average debt service coverage ratio	1.82		1.75
51% - 60% | Retail
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 465		$ 419
51% - 60% | Office
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	341		278
51% - 60% | Industrial
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	478		285
51% - 60% | Apartments
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	66		76
51% - 60% | Mixed use/other
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	55		43
61% - 75%
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 2,370		$ 2,871
% of total	38.00%		47.00%
Weighted-average debt service coverage ratio	1.57		1.61
61% - 75% | Retail
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 924		$ 967
61% - 75% | Office
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	580		782
61% - 75% | Industrial
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	499		778
61% - 75% | Apartments
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	182		199
61% - 75% | Mixed use/other
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	185		145
76% - 100%
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 275		$ 313
% of total	4.00%		5.00%
Weighted-average debt service coverage ratio	1.12		1.02
76% - 100% | Retail
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 106		$ 75
76% - 100% | Office
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	83		164
76% - 100% | Industrial
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	65		60
76% - 100% | Apartments
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	21		8
76% - 100% | Mixed use/other
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 0		$ 6
[1]	Included $38 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 123%.
[2]	Included $15 million of impaired loans, $6 million of loans past due and not individually impaired and $56 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 120%.

Loan-to-Value of Commercial M79

Loan-to-Value of Commercial Mortgage Loans by Property Type (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015		Dec. 31, 2014
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 6,187		$ 6,123
Greater than 100%
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 38	[1]	$ 77	[2]
Greater than 100% | Weighted Average Loan-To-Value
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Weighted-average loan-to-value	123.00%		120.00%
Impaired Loans | Greater than 100%
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment			$ 15
Loans Past Due and Not Individually Impaired | Greater than 100%
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment			6
Loans in Good Standing | Greater than 100%
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 38		$ 56
[1]	Included $38 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 123%.
[2]	Included $15 million of impaired loans, $6 million of loans past due and not individually impaired and $56 million of loans in good standing, where borrowers continued to make timely payments, with a total weighted-average loan-to-value of 120%.

Debt Service Coverage Ratio for

Debt Service Coverage Ratio for Fixed Rate Commercial Mortgage Loans by Property Type (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 6,187	$ 6,123
% of total	100.00%	100.00%
Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 6,180	$ 6,114
% of total	100.00%	100.00%
Weighted-average loan-to-value	56.00%	59.00%
Retail
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 2,355	$ 2,150
% of total	38.00%	35.00%
Retail | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 2,355	$ 2,150
Office
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 1,516	$ 1,643
% of total	24.00%	27.00%
Office | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 1,509	$ 1,636
Industrial
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 1,562	$ 1,597
% of total	25.00%	26.00%
Industrial | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 1,562	$ 1,595
Apartments
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 465	$ 494
% of total	8.00%	8.00%
Apartments | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 465	$ 494
Mixed use/other
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 289	$ 239
% of total	5.00%	4.00%
Mixed use/other | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 289	$ 239
Less than 1.00 | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 255	$ 364
% of total	4.00%	6.00%
Weighted-average loan-to-value	74.00%	77.00%
Less than 1.00 | Retail | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 70	$ 80
Less than 1.00 | Office | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	85	119
Less than 1.00 | Industrial | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	94	158
Less than 1.00 | Apartments | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	6	1
Less than 1.00 | Mixed use/other | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	0	6
1.00 - 1.25 | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 626	$ 545
% of total	10.00%	9.00%
Weighted-average loan-to-value	64.00%	64.00%
1.00 - 1.25 | Retail | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 232	$ 253
1.00 - 1.25 | Office | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	114	101
1.00 - 1.25 | Industrial | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	181	142
1.00 - 1.25 | Apartments | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	41	48
1.00 - 1.25 | Mixed use/other | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	58	1
1.26 - 1.50 | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 1,154	$ 1,166
% of total	19.00%	19.00%
Weighted-average loan-to-value	58.00%	64.00%
1.26 - 1.50 | Retail | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 466	$ 524
1.26 - 1.50 | Office | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	265	247
1.26 - 1.50 | Industrial | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	208	246
1.26 - 1.50 | Apartments | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	74	88
1.26 - 1.50 | Mixed use/other | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	141	61
1.51 - 2.00 | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 2,647	$ 2,677
% of total	43.00%	44.00%
Weighted-average loan-to-value	58.00%	59.00%
1.51 - 2.00 | Retail | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 1,017	$ 870
1.51 - 2.00 | Office | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	699	780
1.51 - 2.00 | Industrial | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	672	706
1.51 - 2.00 | Apartments | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	199	186
1.51 - 2.00 | Mixed use/other | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	60	135
Greater than 2.00 | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 1,498	$ 1,362
% of total	24.00%	22.00%
Weighted-average loan-to-value	43.00%	45.00%
Greater than 2.00 | Retail | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 570	$ 423
Greater than 2.00 | Office | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	346	389
Greater than 2.00 | Industrial | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	407	343
Greater than 2.00 | Apartments | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	145	171
Greater than 2.00 | Mixed use/other | Fixed Rate Commercial Mortgage Loans
Commercial Mortgage Loans by Credit Quality Indicator [Line Items]
Commercial mortgage loans, recorded investment	$ 30	$ 36

Schedule of Positions in Deriva

Schedule of Positions in Derivative Instruments (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Derivative [Line Items]
Derivative assets, fair value		$ 1,129	$ 1,145
Derivative liabilities, fair value		1,063	884
Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		359	310
Other invested assets
Derivative [Line Items]
Derivative assets, fair value		1,112	1,132
GMWB embedded derivatives | Reinsurance recoverable
Derivative [Line Items]
Derivative assets, fair value	[1]	17	13
Designated As Hedging Instrument
Derivative [Line Items]
Derivative assets, fair value		637	645
Derivative liabilities, fair value		70	69
Designated As Hedging Instrument | Cash Flow Hedges
Derivative [Line Items]
Derivative assets, fair value		637	645
Derivative liabilities, fair value		70	69
Designated As Hedging Instrument | Cash Flow Hedges | Interest rate swaps | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		37	27
Designated As Hedging Instrument | Cash Flow Hedges | Interest rate swaps | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		629	639
Designated As Hedging Instrument | Cash Flow Hedges | Inflation indexed swaps | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		33	42
Designated As Hedging Instrument | Cash Flow Hedges | Inflation indexed swaps | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		0	0
Designated As Hedging Instrument | Cash Flow Hedges | Foreign currency swaps | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	0
Designated As Hedging Instrument | Cash Flow Hedges | Foreign currency swaps | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		8	6
Derivatives not designated as hedges
Derivative [Line Items]
Derivative assets, fair value		492	500
Derivative liabilities, fair value		993	815
Derivatives not designated as hedges | Interest rate swaps | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		183	177
Derivatives not designated as hedges | Interest rate swaps | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		425	452
Derivatives not designated as hedges | Foreign currency swaps | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		27	7
Derivatives not designated as hedges | Foreign currency swaps | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		0	0
Derivatives not designated as hedges | Interest rate swaps related to securitization entities | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value	[2]	30	26
Derivatives not designated as hedges | Interest rate swaps related to securitization entities | Restricted other invested assets
Derivative [Line Items]
Derivative assets, fair value	[2]	0	0
Derivatives not designated as hedges | Credit default swaps | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	0
Derivatives not designated as hedges | Credit default swaps | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		1	4
Derivatives not designated as hedges | Credit default swaps related to securitization entities | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value	[2]	14	17
Derivatives not designated as hedges | Credit default swaps related to securitization entities | Restricted other invested assets
Derivative [Line Items]
Derivative assets, fair value	[2]	0	0
Derivatives not designated as hedges | Equity index options | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	0
Derivatives not designated as hedges | Equity index options | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		30	17
Derivatives not designated as hedges | Financial futures | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		0	0
Derivatives not designated as hedges | Financial futures | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		0	0
Derivatives not designated as hedges | Equity return swaps | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		1	1
Derivatives not designated as hedges | Equity return swaps | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		2	0
Derivatives not designated as hedges | Other foreign currency contracts | Other liabilities
Derivative [Line Items]
Derivative liabilities, fair value		34	13
Derivatives not designated as hedges | Other foreign currency contracts | Other invested assets
Derivative [Line Items]
Derivative assets, fair value		17	14
Derivatives not designated as hedges | GMWB embedded derivatives | Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value	[1],[3]	352	291
Derivatives not designated as hedges | GMWB embedded derivatives | Reinsurance recoverable
Derivative [Line Items]
Derivative assets, fair value	[1],[3]	17	13
Derivatives not designated as hedges | Fixed index annuity embedded derivatives | Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value	[4]	342	276
Derivatives not designated as hedges | Fixed index annuity embedded derivatives | Other assets
Derivative [Line Items]
Derivative assets, fair value	[4]	0	0
Derivatives not designated as hedges | Indexed universal life embedded derivatives | Policyholder account balances
Derivative [Line Items]
Derivative liabilities, fair value	[5]	10	7
Derivatives not designated as hedges | Indexed universal life embedded derivatives | Reinsurance recoverable
Derivative [Line Items]
Derivative assets, fair value	[5]	$ 0	$ 0
[1]	Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.
[2]	See note 17 for additional information related to consolidated securitization entities.
[3]	Represents the embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.
[4]	Represents the embedded derivatives associated with our fixed index annuity liabilities.
[5]	Represents the embedded derivatives associated with our indexed universal life liabilities.

Activity Associated with Deriva

Activity Associated with Derivative Instruments (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2015USD ($)Policies
Derivative [Line Items]
Notional amount, beginning balance	$ 21,386
Additions	13,368
Maturities/ terminations	(13,116)
Notional amount, ending balance	21,638
Derivatives Designated As Hedges
Derivative [Line Items]
Notional amount, beginning balance	12,567
Additions	13
Maturities/ terminations	(760)
Notional amount, ending balance	11,820
Derivatives Designated As Hedges | Cash Flow Hedges
Derivative [Line Items]
Notional amount, beginning balance	12,567
Additions	13
Maturities/ terminations	(760)
Notional amount, ending balance	11,820
Derivatives Designated As Hedges | Cash Flow Hedges | Interest rate swaps
Derivative [Line Items]
Notional amount, beginning balance	11,961
Additions	0
Maturities/ terminations	(747)
Notional amount, ending balance	11,214
Derivatives Designated As Hedges | Cash Flow Hedges | Inflation indexed swaps
Derivative [Line Items]
Notional amount, beginning balance	571
Additions	13
Maturities/ terminations	(13)
Notional amount, ending balance	571
Derivatives Designated As Hedges | Cash Flow Hedges | Foreign currency swaps
Derivative [Line Items]
Notional amount, beginning balance	35
Additions	0
Maturities/ terminations	0
Notional amount, ending balance	35
Derivatives not designated as hedges
Derivative [Line Items]
Notional amount, beginning balance	8,819
Additions	13,355
Maturities/ terminations	(12,356)
Notional amount, ending balance	9,818
Derivatives not designated as hedges | Interest rate swaps
Derivative [Line Items]
Notional amount, beginning balance	5,074
Additions	2,100
Maturities/ terminations	(2,242)
Notional amount, ending balance	4,932
Derivatives not designated as hedges | Foreign currency swaps
Derivative [Line Items]
Notional amount, beginning balance	104
Additions	58
Maturities/ terminations	0
Notional amount, ending balance	162
Derivatives not designated as hedges | Interest rate swaps related to securitization entities
Derivative [Line Items]
Notional amount, beginning balance	77	[1]
Additions	0	[1]
Maturities/ terminations	(10)	[1]
Notional amount, ending balance	67	[1]
Derivatives not designated as hedges | Credit default swaps
Derivative [Line Items]
Notional amount, beginning balance	394
Additions	0
Maturities/ terminations	(250)
Notional amount, ending balance	144
Derivatives not designated as hedges | Credit default swaps related to securitization entities
Derivative [Line Items]
Notional amount, beginning balance	312	[1]
Additions	0	[1]
Maturities/ terminations	0	[1]
Notional amount, ending balance	312	[1]
Derivatives not designated as hedges | Equity index options
Derivative [Line Items]
Notional amount, beginning balance	994
Additions	1,455
Maturities/ terminations	(1,369)
Notional amount, ending balance	1,080
Derivatives not designated as hedges | Financial futures
Derivative [Line Items]
Notional amount, beginning balance	1,331
Additions	5,700
Maturities/ terminations	(5,700)
Notional amount, ending balance	1,331
Derivatives not designated as hedges | Equity return swaps
Derivative [Line Items]
Notional amount, beginning balance	108
Additions	386
Maturities/ terminations	(360)
Notional amount, ending balance	134
Derivatives not designated as hedges | Other foreign currency contracts
Derivative [Line Items]
Notional amount, beginning balance	425
Additions	2,516
Maturities/ terminations	(1,285)
Notional amount, ending balance	1,656
Derivatives not designated as hedges | Forward bond purchase commitments
Derivative [Line Items]
Notional amount, beginning balance	0
Additions	1,140
Maturities/ terminations	(1,140)
Notional amount, ending balance	$ 0
Derivatives not designated as hedges | GMWB embedded derivatives
Derivative [Line Items]
Notional amount, beginning balance | Policies	39,015
Additions | Policies	0
Maturities/ terminations | Policies	(2,869)
Notional amount, ending balance | Policies	36,146
Derivatives not designated as hedges | Fixed index annuity embedded derivatives
Derivative [Line Items]
Notional amount, beginning balance | Policies	13,901
Additions | Policies	3,939
Maturities/ terminations | Policies	(358)
Notional amount, ending balance | Policies	17,482
Derivatives not designated as hedges | Indexed universal life embedded derivatives
Derivative [Line Items]
Notional amount, beginning balance | Policies	421
Additions | Policies	595
Maturities/ terminations | Policies	(34)
Notional amount, ending balance | Policies	982
[1]	See note 17 for additional information related to consolidated securitization entities.

Schedule of Pre-Tax Income (Los

Schedule of Pre-Tax Income (Loss) Effects of Cash Flow Hedges (Detail) - Cash Flow Hedges - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015		Dec. 31, 2014		Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	$ 79		$ 1,215		$ (866)
Gain (loss) reclassified into net income (loss) from OCI	118		57		45
Gain (loss) recognized in net income (loss)	0	[1]	15	[2]	(14)	[2]
Interest Rate Swaps Hedging Assets | Net Investment Income
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	78		1,229		(892)
Gain (loss) reclassified into net income (loss) from OCI	85		63		47
Interest Rate Swaps Hedging Assets | Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI			0		0
Gain (loss) reclassified into net income (loss) from OCI			2		1
Gain (loss) recognized in net income (loss)	0	[1]	15	[2]	(14)	[2]
Interest Rate Swaps Hedging Liabilities | Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in net income (loss)	0	[1]	0	[2]	0	[2]
Interest Rate Swaps Hedging Liabilities | Interest Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	(10)		(69)		42
Gain (loss) reclassified into net income (loss) from OCI	0		1		2
Inflation indexed swaps | Net Investment Income
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	9		17		45
Gain (loss) reclassified into net income (loss) from OCI	0		(9)		(5)
Inflation indexed swaps | Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in net income (loss)	0	[1]	0	[2]	0	[2]
Foreign currency swaps | Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in net income (loss)	0	[1]	0	[2]	0	[2]
Foreign currency swaps | Interest Expense
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	2		4		(1)
Gain (loss) reclassified into net income (loss) from OCI	0		0		0
Forward bond purchase commitments | Net Investment Income
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	0		34		(60)
Gain (loss) reclassified into net income (loss) from OCI	1		0		0
Forward bond purchase commitments | Net Investment Gains (Losses)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Gain (loss) recognized in OCI	0
Gain (loss) reclassified into net income (loss) from OCI	32
Gain (loss) recognized in net income (loss)	$ 0	[1]	$ 0	[2]	$ 0	[2]
[1]	Represents ineffective portion of cash flow hedges as there were no amounts excluded from the measurement of effectiveness.
[2]	Represents ineffective portion of cash flow hedges, as there were no amounts excluded from the measurement of effectiveness.

Reconciliation of Current Perio

Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedges (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Derivative Instruments [Abstract]
Derivatives qualifying as effective accounting hedges, beginning of period	[1]	$ 2,070	$ 1,319	$ 1,909
Current period increases (decreases) in fair value, net of deferred taxes	[1]	50	788	(561)
Reclassification to net (income) loss, net of deferred taxes	[1]	(75)	(37)	(29)
Derivatives qualifying as effective accounting hedges, end of period	[1]	$ 2,045	$ 2,070	$ 1,319
[1]	See note 5 for additional information.

Reconciliation of Current Per85

Reconciliation of Current Period Changes, Net of Applicable Income Taxes, for Derivatives Qualifying as Hedges (Parenthetical) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Current period increases (decreases) in fair value, deferred taxes	$ (29)	$ (427)	$ 305
Reclassification to net (income) loss, deferred taxes	$ 43	$ 20	$ 16

Derivative Instruments - Additi

Derivative Instruments - Additional Information (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Derivative [Line Items]
Derivatives designated as cash flow hedges gain (loss), amount expected to be reclassified to future net income (loss), net of tax	[1]	$ 2,045	$ 2,070	$ 1,319	$ 1,909
Year by which all forecasted transactions associated with qualifying cash flow hedges are expected to occur		2,047
Derivatives designated as cash flow hedges gain (loss), amount expected to be reclassified to net income (loss) in the next 12 months, net of tax		$ 70
Derivative liabilities | Subject to enforceable master netting arrangement
Derivative [Line Items]
Amount required for disbursement to counterparties if the downgrade provisions had been triggered	[2]	0	2
Derivative assets | Subject to enforceable master netting arrangement
Derivative [Line Items]
Amount to claim from counterparties if the downgrade provisions had been triggered	[3]	$ 265	$ 47
[1]	See note 5 for additional information.
[2]	Included $6 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2015 and 2014.
[3]	Included $24 million and $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2015 and 2014, respectively.

Schedule of Pre-Tax Income (L87

Schedule of Pre-Tax Income (Loss) Effects of Fair Value Hedges and Related Hedged Items (Detail) - Fair value hedges $ in Millions	12 Months Ended
	Dec. 31, 2013USD ($)
Derivative [Line Items]
Gain (loss) recognized in net income (loss)	$ (42)
Hedged item, gain (loss) recognized in net income (loss)	42
Other impacts to net income (loss)	13
Interest Rate Swaps Hedging Liabilities | Interest credited
Derivative [Line Items]
Other impacts to net income (loss)	13
Interest Rate Swaps Hedging Liabilities | Net Investment Gains (Losses)
Derivative [Line Items]
Gain (loss) recognized in net income (loss)	(11)
Hedged item, gain (loss) recognized in net income (loss)	11
Foreign currency swaps | Interest credited
Derivative [Line Items]
Other impacts to net income (loss)	0
Foreign currency swaps | Net Investment Gains (Losses)
Derivative [Line Items]
Gain (loss) recognized in net income (loss)	(31)
Hedged item, gain (loss) recognized in net income (loss)	$ 31

Schedule of Pre-Tax Gain (Loss)

Schedule of Pre-Tax Gain (Loss) Recognized in Net Income (Loss) for Effects of Derivatives not Designated as Hedges (Detail) - Derivatives not designated as hedges - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		$ (105)	$ (110)	$ 50
Interest rate swaps | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		(11)	1	(7)
Interest rate swaps related to securitization entities | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)	[1]	(4)	(9)	9
Credit default swaps | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		1	1	14
Credit default swaps related to securitization entities | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)	[1]	7	19	77
Equity index options | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		(25)	(31)	(43)
Financial futures | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		(34)	90	(232)
Equity return swaps | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		(3)	5	(33)
Other foreign currency contracts | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		10	(4)	6
Foreign currency swaps | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		(22)	(7)	0
Forward bond purchase commitments | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		2	0	0
GMWB embedded derivatives | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		(25)	(147)	277
Fixed index annuity embedded derivatives | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		(7)	(27)	(18)
Indexed universal life embedded derivatives | Net Investment Gains (Losses)
Derivative [Line Items]
Pre-tax gain (loss) recognized in net income (loss)		$ 6	$ (1)	$ 0
[1]	See note 17 for additional information related to consolidated securitization entities.

Additional Information about De

Additional Information about Derivative Assets and Liabilities Subject to Enforceable Master Netting Arrangement (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Derivative [Line Items]
Gross amounts recognized, derivatives assets		$ 1,129	$ 1,145
Gross amounts recognized, derivatives liabilities		1,063	884
Subject to enforceable master netting arrangement
Derivative [Line Items]
Collateral received		(642)	(884)
Over collateralization, derivatives assets		(171)	(4)
Gross amounts recognized, net derivatives		815	884
Gross amounts offset in the balance sheet, net derivatives		0	0
Net amounts presented in the balance sheet, net derivatives		815	884
Gross amounts not offset in the balance sheet, financial instruments, net derivatives	[1]	0	0
Collateral pledged		263	49
Net amount		265	45
Subject to enforceable master netting arrangement | Derivative assets
Derivative [Line Items]
Gross amounts recognized, derivatives assets	[2]	1,135	1,157
Gross amounts offset in the balance sheet, derivatives assets	[2]	0	0
Net amounts presented in the balance sheet, derivatives assets	[2]	1,135	1,157
Gross amounts not offset in the balance sheet, financial instruments, derivatives assets	[1],[2]	(231)	(227)
Collateral received	[2]	(642)	(884)
Over collateralization, derivatives assets	[2]	3	1
Net amount, derivatives assets	[2]	265	47
Subject to enforceable master netting arrangement | Derivative liabilities
Derivative [Line Items]
Gross amounts recognized, derivatives liabilities	[3]	320	273
Gross amounts offset in the balance sheet, derivatives liabilities	[3]	0	0
Net amounts presented in the balance sheet, derivatives liabilities	[3]	320	273
Gross amounts not offset in the balance sheet, financial instruments, derivative liabilities	[1],[3]	(231)	(227)
Collateral pledged	[3]	(263)	(49)
Over collateralization, derivatives liabilities	[3]	174	5
Net amount, derivatives liabilities	[3]	$ 0	$ 2
[1]	Amounts represent derivative assets and/or liabilities that are presented gross within the balance sheet but are held with the same counterparty where we have a master netting arrangement. This adjustment results in presenting the net asset and net liability position for each counterparty.
[2]	Included $24 million and $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2015 and 2014, respectively.
[3]	Included $6 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2015 and 2014.

Additional Information about 90

Additional Information about Derivative Assets and Liabilities Subject to Enforceable Master Netting Arrangement (Parenthetical) (Detail) - Subject to enforceable master netting arrangement - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Derivative liabilities
Derivative [Line Items]
Net amounts presented in the balance sheet, accruals on derivative liabilities	[1]	$ 320	$ 273
Derivative liabilities | Other liabilities
Derivative [Line Items]
Net amounts presented in the balance sheet, accruals on derivative liabilities		6	6
Derivative assets
Derivative [Line Items]
Net amounts presented in the balance sheet, accruals on derivative assets	[2]	1,135	1,157
Derivative assets | Other assets
Derivative [Line Items]
Net amounts presented in the balance sheet, accruals on derivative assets		$ 24	$ 25
[1]	Included $6 million of accruals on derivatives classified as other liabilities and does not include amounts related to embedded derivatives and derivatives related to securitization entities as of December 31, 2015 and 2014.
[2]	Included $24 million and $25 million of accruals on derivatives classified as other assets and does not include amounts related to embedded derivatives as of December 31, 2015 and 2014, respectively.

Derivative Instruments Schedule

Derivative Instruments Schedule of Credit Default Swaps where we Sell Protection on Single Name Reference Entities and Fair Values (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Derivative [Line Items]
Notional value	$ 21,638	$ 21,386
Credit default swaps | Single Name Reference Entities
Derivative [Line Items]
Notional value	39	39
Assets	0	1
Liabilities	0	0
Credit default swaps | Single Name Reference Entities | Investment grade | Matures Less Than One Year
Derivative [Line Items]
Notional value	0	0
Assets	0	0
Liabilities	0	0
Credit default swaps | Single Name Reference Entities | Investment grade | Matures After One Year Through Five Years
Derivative [Line Items]
Notional value	39	39
Assets	0	1
Liabilities	$ 0	$ 0

Schedule of Credit Default Swap

Schedule of Credit Default Swaps where we Sell Protection on Credit Default Swap Index Tranches and Fair Values (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Derivative [Line Items]
Notional value		$ 21,638	$ 21,386
Credit default swaps | Original Index Tranche Attachment/Detachment Point And Maturity | Index Tranches
Derivative [Line Items]
Notional value		100	350
Assets		1	3
Liabilities		0	0
Credit default swaps | Original Index Tranche Attachment/Detachment Point And Maturity | Index Tranches | Matures Less Than One Year | 9% - 12%
Derivative [Line Items]
Notional value	[1]	0	250
Assets	[1]	0	2
Liabilities	[1]	0	0
Credit default swaps | Original Index Tranche Attachment/Detachment Point And Maturity | Index Tranches | Matures Less Than One Year | 7% - 15%
Derivative [Line Items]
Notional value	[2]	100	0
Assets	[2]	1	0
Liabilities	[2]	0	0
Credit default swaps | Original Index Tranche Attachment/Detachment Point And Maturity | Index Tranches | Matures After One Year Through Five Years | 7% - 15%
Derivative [Line Items]
Notional value	[1]	0	100
Assets	[1]	0	1
Liabilities	[1]	0	0
Credit default swaps | Securitization Entities | Index Tranches
Derivative [Line Items]
Notional value		312	312
Assets		0	0
Liabilities		14	17
Credit default swaps | Securitization Entities | Index Tranches | Portion Backing Third-Party Borrowings Maturing 2017
Derivative [Line Items]
Notional value	[3]	12	12
Assets	[3]	0	0
Liabilities	[3]	2	0
Credit default swaps | Securitization Entities | Index Tranches | Portion Backing Interest Maturing 2017
Derivative [Line Items]
Notional value	[4]	300	300
Assets	[4]	0	0
Liabilities	[4]	12	17
Total Credit Default Swaps on Index Tranches
Derivative [Line Items]
Notional value		412	662
Assets		1	3
Liabilities		$ 14	$ 17
[1]	The current attachment/detachment as of December 31, 2015 and 2014 was 9% - 12%.
[2]	The current attachment/detachment as of December 31, 2015 and 2014 was 7% - 15%.
[3]	Original notional value was $39 million.
[4]	Original notional value was $300 million.

Schedule of Credit Default Sw93

Schedule of Credit Default Swaps where we Sell Protection on Credit Default Swap Index Tranches and Fair Values (Parenthetical) (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Derivative [Line Items]
Notional value		$ 21,638	$ 21,386
Index Tranches | Original Index Tranche Attachment/Detachment Point And Maturity | Credit default swaps
Derivative [Line Items]
Notional value		$ 100	$ 350
Index Tranches | Original Index Tranche Attachment/Detachment Point And Maturity | Credit default swaps | 7% - 15%
Derivative [Line Items]
Current attachment percentage		7.00%	7.00%
Current detachment percentage		15.00%	15.00%
Index Tranches | Original Index Tranche Attachment/Detachment Point And Maturity | Matures Less Than One Year | Credit default swaps | 9% - 12%
Derivative [Line Items]
Current attachment percentage		9.00%	9.00%
Current detachment percentage		12.00%	12.00%
Notional value	[1]	$ 0	$ 250
Index Tranches | Original Index Tranche Attachment/Detachment Point And Maturity | Matures Less Than One Year | Credit default swaps | 7% - 15%
Derivative [Line Items]
Notional value	[2]	100	0
Index Tranches | Securitization Entities | Credit default swaps
Derivative [Line Items]
Notional value		312	312
Index Tranches | Securitization Entities | Portion Backing Third-Party Borrowings Maturing 2017 | Credit default swaps
Derivative [Line Items]
Notional value	[3]	12	12
Index Tranches | Securitization Entities | Portion Backing Third-Party Borrowings Maturing 2017 | Credit default swaps | Original Amount
Derivative [Line Items]
Notional value		39
Index Tranches | Securitization Entities | Portion Backing Interest Maturing 2017 | Credit default swaps
Derivative [Line Items]
Notional value	[4]	300	$ 300
Index Tranches | Securitization Entities | Portion Backing Interest Maturing 2017 | Credit default swaps | Original Amount
Derivative [Line Items]
Notional value		$ 300
[1]	The current attachment/detachment as of December 31, 2015 and 2014 was 9% - 12%.
[2]	The current attachment/detachment as of December 31, 2015 and 2014 was 7% - 15%.
[3]	Original notional value was $39 million.
[4]	Original notional value was $300 million.

Activity Impacting Deferred Acq

Activity Impacting Deferred Acquisition Costs (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Deferred Policy Acquisition Costs [Line Items]
Unamortized beginning balance	$ 5,200	$ 5,214	$ 5,220
Impact of foreign currency translation	(23)	(15)	(16)
Costs deferred	295	385	365
Amortization, net of interest accretion	(448)	(384)	(355)
Impairment	(455)	0	0
Unamortized ending balance	4,569	5,200	5,214
Accumulated effect of net unrealized investment (gains) losses	(171)	(348)	(176)
Ending balance	$ 4,398	$ 4,852	$ 5,038

Deferred Acquisition Costs - Ad

Deferred Acquisition Costs - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Deferred Policy Acquisition Costs [Line Items]
Increase in DAC amortization expense		$ 448	$ 384	$ 355
DAC impairment related to life block transaction		455	$ 0	$ 0
Unlocking
Deferred Policy Acquisition Costs [Line Items]
Increase in DAC amortization expense	$ 109
Life Block Transaction | Loss Recognition Testing | Term Life Insurance
Deferred Policy Acquisition Costs [Line Items]
DAC impairment related to life block transaction		$ 455

Intangible Assets (Detail)

Intangible Assets (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	$ 3,083	$ 2,900
Accumulated amortization	(2,740)	(2,651)
Present Value Of Future Profits
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	2,084	1,995
Accumulated amortization	(1,941)	(1,917)
Capitalized Software
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	665	641
Accumulated amortization	(571)	(532)
Deferred Sales Inducements To Contractholders
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	268	209
Accumulated amortization	(178)	(153)
Other Intangible Assets
Finite-Lived Intangible Assets [Line Items]
Gross carrying amount	66	55
Accumulated amortization	$ (50)	$ (49)

Intangible Assets - Additional

Intangible Assets - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Amortization expense related to PVFP, capitalized software and other intangible assets			$ 64	$ 70	$ 109
Amortization expense related to deferred sales inducements			25	30	24
Increase to PVFP amortization expense			$ 38	$ 31	$ 66
Present Value Of Future Profits | Unlocking
Finite-Lived Intangible Assets [Line Items]
Increase to PVFP amortization expense	$ 14
Long-term Care Insurance | Loss Recognition Testing | Acquired Block
Finite-Lived Intangible Assets [Line Items]
Increase to PVFP amortization expense		$ 6

Activity in Present Value of Fu

Activity in Present Value of Future Profits (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Finite-Lived Intangible Assets [Line Items]
Unamortized balance as of January 1	$ 229	$ 246	$ 297
Interest accreted at 6.45%, 5.89% and 5.52%	14	14	15
Amortization	(38)	(31)	(66)
Unamortized balance as of December 31	205	229	246
Accumulated effect of net unrealized investment (gains) losses	(62)	(151)	(85)
Balance as of December 31	$ 143	$ 78	$ 161

Activity in Present Value of 99

Activity in Present Value of Future Profits (Parenthetical) (Detail)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Interest accreted percentage	6.45%	5.89%	5.52%

Percentage of PVFP Balance Net

Percentage of PVFP Balance Net of Interest Accretion, before Effect of Unrealized Investment Gains or Losses, Estimated to be Amortized Over Next Five years (Detail)	12 Months Ended
	Dec. 31, 2015
Finite-Lived Intangible Assets [Line Items]
2,016	15.10%
2,017	13.70%
2,018	11.70%
2,019	10.00%
2,020	8.70%

Intangible Assets - Goodwill -

Intangible Assets - Goodwill - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 16		$ 14	$ 16
Goodwill impairment			0	849	$ 0
Life Insurance
Finite-Lived Intangible Assets [Line Items]
Goodwill		$ 145
Goodwill impairment	145	350		495
Long-term Care Insurance
Finite-Lived Intangible Assets [Line Items]
Goodwill		154
Goodwill impairment	154	$ 200		354
U.S. Life Insurance
Finite-Lived Intangible Assets [Line Items]
Goodwill impairment	299			849
Canada Mortgage Insurance
Finite-Lived Intangible Assets [Line Items]
Goodwill	10		8	10
Australia Mortgage Insurance
Finite-Lived Intangible Assets [Line Items]
Goodwill	$ 6		$ 6	$ 6

Reinsurance - Additional Inform

Reinsurance - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Maximum amount of individual ordinary life insurance normally retained by us on any one individual life policy	$ 5
Reinsurance recoverable	$ 17,245	$ 17,291
Minimum amount of risk-based capital General Electric Capital Corporation agreed to maintain	150.00%
Reinsurance recoveries recognized as a reduction of benefits and other changes in reserves	$ 2,771	2,846	$ 2,641
U.S. Life Insurance Subsidiaries | Fixed maturity securities
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Assets pledged as collateral	8,324	8,737
U.S. Life Insurance Subsidiaries | Commercial Mortgage Loan
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Assets pledged as collateral	347	544
International Mortgage Insurance Subsidiaries | Other invested assets
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Assets pledged as collateral		33
Union Fidelity Life Insurance Company | Ceded Credit Risk
Reinsurance Premiums for Insurance Companies, by Product Segment [Line Items]
Reinsurance recoverable	$ 14,363	$ 14,494

Net Domestic Life Insurance In-

Net Domestic Life Insurance In-Force (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Reinsurance [Abstract]
Direct life insurance in-force		$ 686,446	$ 701,797	$ 708,271
Amounts assumed from other companies		899	935	1,070
Amounts ceded to other companies	[1]	(411,340)	(393,244)	(313,593)
Net life insurance in-force		$ 276,005	$ 309,488	$ 395,748
Percentage of amount assumed to net		0.00%	0.00%	0.00%
[1]	Includes amounts accounted for under the deposit method.

Effects of Reinsurance on Premi

Effects of Reinsurance on Premiums Written and Earned (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Reinsurance [Abstract]
Direct, Written	$ 5,548	$ 5,651	$ 5,354
Assumed, Written	386	397	367
Ceded, Written	(1,140)	(1,135)	(1,141)
Net premiums, Written	4,794	4,913	4,580
Direct, Earned	5,322	5,416	5,261
Assumed, Earned	403	413	386
Ceded, Earned	(1,146)	(1,129)	(1,131)
Net premiums, Earned	$ 4,579	$ 4,700	$ 4,516
Percentage of amount assumed to net	9.00%	9.00%	9.00%
Life insurance
Reinsurance [Abstract]
Direct, Written	$ 1,030	$ 1,131	$ 1,088
Assumed, Written	34	34	3
Ceded, Written	(372)	(332)	(340)
Direct, Earned	1,030	1,131	1,088
Assumed, Earned	34	34	3
Ceded, Earned	(372)	(332)	(340)
Accident and Health Insurance Product Line
Reinsurance [Abstract]
Direct, Written	2,764	2,706	2,584
Assumed, Written	342	343	345
Ceded, Written	(682)	(708)	(709)
Direct, Earned	2,778	2,697	2,565
Assumed, Earned	347	348	350
Ceded, Earned	(688)	(706)	(700)
Mortgage insurance
Reinsurance [Abstract]
Direct, Written	1,754	1,814	1,682
Assumed, Written	10	20	19
Ceded, Written	(86)	(95)	(92)
Direct, Earned	1,514	1,588	1,608
Assumed, Earned	22	31	33
Ceded, Earned	$ (86)	$ (91)	$ (91)

Recorded Liabilities and Major

Recorded Liabilities and Major Assumptions Underlying Future Policy Benefits (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014
Liability for Future Policy Benefit, by Product Segment [Line Items]
Future policy benefits		$ 36,475	$ 35,915
Long Term Care Insurance Contracts
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for long-term care insurance contracts, Interest rate assumption, Low end	[1]	3.50%	3.50%
Liability for long-term care insurance contracts, Interest rate assumption, High end	[1]	7.50%	7.50%
Future policy benefits	[1]	$ 20,563	$ 19,310
Structured Settlements with Life Contingencies
Liability for Future Policy Benefit, by Product Segment [Line Items]
Structured settlements with life contingencies, Interest rate assumption, Lower limit	[2]	1.50%	1.50%
Structured settlements with life contingencies, Interest rate assumption, Upper limit	[2]	8.00%	8.00%
Future policy benefits	[2]	$ 8,991	$ 9,133
Annuity Contracts with Life Contingencies
Liability for Future Policy Benefit, by Product Segment [Line Items]
Liability for policyholder contract deposits, Interest rate, annuities, Low end	[2]	1.50%	1.50%
Liability for policyholder contract deposits, Interest rate, annuities, High end	[2]	8.00%	8.00%
Future policy benefits	[2]	$ 4,010	$ 4,470
Traditional Life Insurance Contracts
Liability for Future Policy Benefit, by Product Segment [Line Items]
Traditional life insurance contracts, Interest rate assumption, Lower limit	[3]	3.00%	3.00%
Traditional life insurance contracts, Interest rate assumption, Upper limit	[3]	7.50%	7.50%
Future policy benefits	[3]	$ 2,638	$ 2,733
Supplementary Contracts with Life Contingencies
Liability for Future Policy Benefit, by Product Segment [Line Items]
Supplementary contracts with life contingencies, Interest rate, Low end	[2]	1.50%	1.50%
Supplementary contracts with life contingencies, Interest rate, High end	[2]	8.00%	8.00%
Future policy benefits	[2]	$ 269	$ 265
Accident and Health Insurance Contracts
Liability for Future Policy Benefit, by Product Segment [Line Items]
Accident and health insurance contracts, Interest rate, Low end	[4]	3.50%	3.50%
Accident and health insurance contracts, Interest rate, High end	[4]	7.00%	7.00%
Future policy benefits	[4]	$ 4	$ 4
[1]	The 1983 Individual Annuitant Mortality Table or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality Table or 1994 Group Annuitant Mortality Table and company experience.
[2]	Assumptions for limited-payment contracts come from either the U.S. Population Table, 1983 Group Annuitant Mortality Table, 1983 Individual Annuitant Mortality Table, Annuity 2000 Mortality Table or 2012 Individual Annuity Reserving Table.
[3]	Principally modifications based on company experience of the Society of Actuaries 1965-70 or 1975-80 Select and Ultimate Tables, 1941, 1958, 1980 and 2001 Commissioner's Standard Ordinary Tables, 1980 Commissioner's Extended Term table and (IA) Standard Table 1996 (modified).
[4]	The 1958 and 1980 Commissioner's Standard Ordinary Tables, or 2000 U.S. Annuity Table, or 1983 Group Annuitant Mortality.

Insurance Reserves - Additional

Insurance Reserves - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended
	Dec. 31, 2014	Dec. 31, 2015
Insurance Reserves [Line Items]
Future policy benefit reserves	$ 35,915	$ 36,475
Policyholder account balances	26,032	26,209
Long-term Care Insurance | Loss Recognition Testing | Acquired Block
Insurance Reserves [Line Items]
Present value of future profits balance written off	6
Increase in reserves	710
Long-term Care Insurance | Profits Followed By Losses [Member]
Insurance Reserves [Line Items]
Future policy benefit reserves		13
Long-term care insurance future policy benefit reserves present value of expected losses		500
Federal Home Loan Bank
Insurance Reserves [Line Items]
Federal Home Loan Bank common stock held	33	30
Amount of funding agreements issued to the Federal Home Loan Bank	199	105
Letters of credit related to the Federal Home Loan Bank	583	583
Pledged assets for Federal Home Loan Bank at fair value	854	742
Variable Annuity | Nontraditional Long-Duration Contracts
Insurance Reserves [Line Items]
Nontraditional long-duration contracts liability	7,108	6,170
Guaranteed Minimum Death Benefit | Nontraditional Long-Duration Contracts | Annuity contracts
Insurance Reserves [Line Items]
Nontraditional long-duration contracts liability	55	72
Guaranteed Minimum Withdrawal And Guaranteed Annuitization Benefit Contracts
Insurance Reserves [Line Items]
Guaranteed annuitization benefit contracts	$ 532	745
Unlocking
Insurance Reserves [Line Items]
Policyholder account balances		$ 175

Recorded Liabilities for Policy

Recorded Liabilities for Policyholder Account Balances (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Insurance Reserves [Line Items]
Policyholder account balances	$ 26,209	$ 26,032
Investment contracts
Insurance Reserves [Line Items]
Policyholder account balances	17,258	17,486
Investment contracts | Annuity contracts
Insurance Reserves [Line Items]
Policyholder account balances	14,376	14,406
Investment contracts | GICs, funding agreements and FABNs
Insurance Reserves [Line Items]
Policyholder account balances	410	493
Investment contracts | Structured settlements without life contingencies
Insurance Reserves [Line Items]
Policyholder account balances	1,694	1,828
Investment contracts | Supplementary contracts without life contingencies
Insurance Reserves [Line Items]
Policyholder account balances	762	742
Investment contracts | Other
Insurance Reserves [Line Items]
Policyholder account balances	16	17
Universal life insurance contracts
Insurance Reserves [Line Items]
Policyholder account balances	$ 8,951	$ 8,546

Information about Variable Annu

Information about Variable Annuity Products Death and Living Benefit Guarantees (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Guaranteed minimum standard death benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 2,512	$ 2,877
Net amount at risk	$ 5	$ 5
Average attained age of contractholders	73 years	72 years
Guaranteed minimum enhanced death benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 2,866	$ 3,443
Net amount at risk	$ 188	$ 119
Average attained age of contractholders	73 years	73 years
Guaranteed minimum living benefit
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 3,111	$ 3,675
Guaranteed annuitization benefits
Net Amount at Risk by Product and Guarantee [Line Items]
Death benefits account value	$ 1,181	$ 1,362

Account Balances of Variable An

Account Balances of Variable Annuity Contract with Death or Living Benefit Guarantees Invested in Separate Account Investment Options (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	$ 5,352	$ 6,290
Balanced funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	3,304	3,848
Equity funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	1,387	1,639
Bond funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	576	707
Money market funds
Schedule of Fair Value of Separate Accounts by Major Category of Investment [Line Items]
Separate account investment	$ 85	$ 96

Liability for Policy and Con110

Liability for Policy and Contract Claims (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims	$ 8,095	$ 7,881
Long-term Care Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims	6,749	6,216	$ 4,999	$ 4,655
U.S. Mortgage Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims	849	1,180	$ 1,482	$ 2,009
Life Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims	202	197
Australia Mortgage Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims	165	152
Canada Mortgage Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims	87	91
Fixed Annuities
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims	18	21
Runoff
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims	18	15
Other Countries Mortgage Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Total liability for policy and contract claims	$ 7	$ 9

Changes in Liability for Policy

Changes in Liability for Policy and Contract Claims (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Beginning balance	$ 7,881
Ending balance	8,095	$ 7,881
Long-term Care Insurance
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Beginning balance	6,216	4,999	$ 4,655
Less reinsurance recoverables	(1,926)	(1,707)	(1,574)
Net beginning balance	4,290	3,292	3,081
Current year	1,655	1,474	1,323
Prior years	39	726	3
Total incurred	1,694	2,200	1,326
Current year	(151)	(134)	(131)
Prior years	(1,371)	(1,263)	(1,160)
Total paid	(1,522)	(1,397)	(1,291)
Interest on liability for policy and contract claims	232	195	176
Net ending balance	4,694	4,290	3,292
Add reinsurance recoverables	2,055	1,926	1,707
Ending balance	6,749	6,216	4,999
U.S. Mortgage Insurance
Liability for Unpaid Claims and Claims Adjustment Expense [Roll Forward]
Beginning balance	1,180	1,482	2,009
Less reinsurance recoverables	(24)	(44)	(80)
Net beginning balance	1,156	1,438	1,929
Current year	236	328	476
Prior years	(14)	29	(63)
Total incurred	222	357	413
Current year	(13)	(21)	(45)
Prior years	(521)	(618)	(859)
Total paid	(534)	(639)	(904)
Net ending balance	844	1,156	1,438
Add reinsurance recoverables	5	24	44
Ending balance	$ 849	$ 1,180	$ 1,482

Liability for Policy and Con112

Liability for Policy and Contract Claims - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Long-term Care Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Incurred related to insured events of prior year			$ 39	$ 726	$ 3
Increase in reinsurance recoverable	$ 1,926		2,055	1,926	1,707	$ 1,574
Long-term Care Insurance | Changes in Assumptions and Methodologies
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase (Decrease) in claim reserves		$ 604
Increase in reinsurance recoverable		73
Long-term Care Insurance | Reserve Correction | Unfavorable Correction
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase (Decrease) in claim reserves		$ 61
Long-term Care Insurance | Correction to Claims Reserve
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase/decrease in reserves	67
Increase (Decrease) in claim reserves	81
Long-term Care Insurance | Revised Interest Rate Assumption
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase (Decrease) in claim reserves	21
Long-term Care Insurance | Refinement of Claim Termination Rate Assumptions
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase/decrease in reserves	43
Increase (Decrease) in claim reserves	(49)
Increase in reinsurance recoverable	17			17
Long-term Care Insurance | Net favorable corrections and adjustments
Liability for Claims and Claims Adjustment Expense [Line Items]
Increase/decrease in reserves			(25)
U.S. Mortgage Insurance
Liability for Claims and Claims Adjustment Expense [Line Items]
Incurred related to insured events of prior year			(14)	29	(63)
Increase (Decrease) in claim reserves				53
Increase in reinsurance recoverable	$ 24		$ 5	$ 24	$ 44	$ 80

Employee Benefit Plans - Additi

Employee Benefit Plans - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2009
Savings Plan
Defined Benefit Plan Disclosure [Line Items]
Costs associated with plan	$ 17	$ 16	$ 17
Maximum contribution to employees savings plans, revised plan	6.00%
Defined contribution plan required years of service to vest for employees hired on or after January 1, 2011	2 years
Deposits recorded by our life insurance subsidiaries	$ 1	1
Retiree Health and Life Insurance Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Liability related to benefit plan	78	90
Change in other comprehensive income, increase (reduction)	$ 13	(10)
Age for retirees receiving policy coverage	65 years
Number of years before retirement eligibility at which retiree medical benefits are available to employees				10 years
Pension and Retiree Health and Life Insurance Benefit Plans
Defined Benefit Plan Disclosure [Line Items]
Costs associated with plan	$ 25	21	$ 22
Defined Contribution Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Percentage funding of plan by Genworth	100.00%
Defined contribution pension plan required years of service to vest	3 years
Liability related to benefit plan	$ 13	13
Defined Benefit Pension Plans
Defined Benefit Plan Disclosure [Line Items]
Liability related to benefit plan	78	71
Change in other comprehensive income, increase (reduction)	30	$ (34)
Defined Benefit Pension Plans | United Kingdom | Lifestyle Protection Insurance | Discontinued Operations, Disposed of by Sale [Member]
Defined Benefit Plan Disclosure [Line Items]
Change in other comprehensive income, increase (reduction)	15
Pension benefit assets	17
Accrued to buyout pension plan and funded annuity contract amount	69
Amount paid on a group annuity contract	58
Pension settlement costs	$ 101

Borrowings and Other Financi114

Borrowings and Other Financings - Additional Information (Detail) CAD in Millions, AUD in Millions	Apr. 01, 2013USD ($)	Jan. 31, 2016USD ($)	Jul. 31, 2015USD ($)	May. 31, 2014USD ($)	Apr. 30, 2014CAD	Dec. 31, 2013USD ($)	Aug. 31, 2013USD ($)	Jun. 30, 2013USD ($)	Sep. 30, 2015USD ($)	Jun. 30, 2014CAD	Dec. 31, 2015USD ($)	Dec. 31, 2015AUD	Dec. 31, 2014USD ($)	May. 31, 2014USD ($)	Dec. 31, 2013USD ($)	Jul. 31, 2015AUD	Sep. 30, 2013USD ($)
Debt Instrument [Line Items]
Amount outstanding, credit facility											$ 0		$ 0
Priority Indebtness											7.50%	7.50%
Customary events of default, cross-defaults with other material indebtedness, minimum											$ 100,000,000
Interest paid											424,000,000		437,000,000		$ 453,000,000
Repurchase agreements, fair value of securities pledged											231,000,000		592,000,000
Repurchase agreements, fair value of repurchase obligation											229,000,000		553,000,000
Securities lending activity, obligation to return collateral											$ 347,000,000		$ 299,000,000
Risks associated with repurchase agreements and securities lending programs											Our repurchase agreement and securities lending programs expose us to liquidity risk if we did not have enough cash or collateral readily available to return to the counterparty when required to do so under the agreements. We manage this risk by regularly monitoring our available sources of cash and collateral to ensure we can meet short-term liquidity demands under normal and stressed scenarios. We are also exposed to credit risk in the event of default of our counterparties or changes in collateral values. This risk is significantly reduced because our programs require over collateralization and collateral exposures are trued up on a daily basis. We manage this risk by using multiple counterparties and ensuring that changes in required collateral are monitored and adjusted daily. We also monitor the creditworthiness, including credit ratings, of our counterparties on a regular basis.	Our repurchase agreement and securities lending programs expose us to liquidity risk if we did not have enough cash or collateral readily available to return to the counterparty when required to do so under the agreements. We manage this risk by regularly monitoring our available sources of cash and collateral to ensure we can meet short-term liquidity demands under normal and stressed scenarios. We are also exposed to credit risk in the event of default of our counterparties or changes in collateral values. This risk is significantly reduced because our programs require over collateralization and collateral exposures are trued up on a daily basis. We manage this risk by using multiple counterparties and ensuring that changes in required collateral are monitored and adjusted daily. We also monitor the creditworthiness, including credit ratings, of our counterparties on a regular basis.
Non-Recourse Funding Obligations
Debt Instrument [Line Items]
Non-recourse funding obligations weighted-average interest rate											1.73%		1.51%
Floating Rate Subordinated Notes Due 2033 | Non-Recourse Funding Obligations
Debt Instrument [Line Items]
Debt instrument, maturity year											2,033	2,033	2,033		2,033
Repayment of secured debt											$ 30,000,000		$ 26,000,000		$ 28,000,000
Floating Rate Subordinated Notes Due in 2035 | Non-Recourse Funding Obligations
Debt Instrument [Line Items]
Debt instrument, maturity year											2,035	2,035	2,035
Repayment of secured debt											$ 31,000,000		$ 16,000,000
Genworth Holdings
Debt Instrument [Line Items]
Aggregate principal amount of notes repurchased									$ 50,000,000
Pre-tax gain (loss) on repurchase of senior notes									$ 1,000,000
Genworth Holdings | Fixed Rate Senior Notes
Debt Instrument [Line Items]
Debt instrument, redemption description											We have the option to redeem all or a portion of each series of senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread.	We have the option to redeem all or a portion of each series of senior notes at any time with notice to the noteholders at a price equal to the greater of 100% of principal or the sum of the present value of the remaining scheduled payments of principal and interest discounted at the then-current treasury rate plus an applicable spread.
Genworth Holdings | Fixed Rate Senior Notes | Minimum
Debt Instrument [Line Items]
Interest rate											4.80%
Senior notes redemption option											100.00%	100.00%
Genworth Holdings | Fixed Rate Senior Notes | Maximum
Debt Instrument [Line Items]
Interest rate											8.625%
Genworth Holdings | 5.75% Senior Notes, Due 2014
Debt Instrument [Line Items]
Interest rate													5.75%
Redemption of Long-term borrowings													$ 485,000,000
Debt instrument, maturity year															2,014
Aggregate principal amount of notes repurchased						$ 15,000,000									$ 15,000,000
Debt instrument, maturity month and year													2014-06
Genworth Holdings | 4.80% Senior Notes, Due 2024
Debt Instrument [Line Items]
Interest rate						4.80%					4.80%		4.80%		4.80%
Debt instrument, maturity year						2,024					2,024	2,024	2,024
Issued notes, aggregate principal amount						$ 400,000,000									$ 400,000,000
Issued senior notes, net proceeds						397,000,000
Genworth Holdings | 4.90% Senior Notes, Due 2023
Debt Instrument [Line Items]
Interest rate							4.90%				4.90%		4.90%
Debt instrument, maturity year							2,023				2,023	2,023	2,023
Issued notes, aggregate principal amount							$ 400,000,000
Issued senior notes, net proceeds							$ 396,000,000
Genworth Holdings | 4.95% Senior Notes, Due 2015
Debt Instrument [Line Items]
Interest rate							4.95%
Pre-tax make-whole expense on redemption of senior notes							$ 30,000,000
Debt instrument, maturity year								2,015
Aggregate principal amount of notes repurchased								$ 4,000,000
Early redemption of senior notes							$ 346,000,000
Genworth Holdings | Junior Notes due Two Thousand and Sixty Six
Debt Instrument [Line Items]
Interest rate											6.15%
Debt instrument, maturity month and year											2066-11	2066-11
Issued notes, aggregate principal amount											$ 598,000,000
Quarterly interest rate after November 15, 2016											LIBOR plus 2.0025%	LIBOR plus 2.0025%
Scheduled redemption date											Nov. 15, 2036	Nov. 15, 2036
Redemption date, subject to terms											Nov. 15, 2016	Nov. 15, 2016
Right to defer the payment of interest on the 2066 Notes during period, years											10 years	10 years
Genworth Holdings | 8.625% Senior Notes, Due 2016
Debt Instrument [Line Items]
Interest rate											8.625%		8.625%
Debt instrument, maturity year											2,016	2,016	2,016
Genworth Mortgage Insurance Corporation (GMICO)
Debt Instrument [Line Items]
Capital contributions	$ 100,000,000			$ 300,000,000		100,000,000								$ 300,000,000
U.S. Mortgage Insurance
Debt Instrument [Line Items]
Capital contributions						$ 300,000,000
Genworth MI Canada Inc. | 4.24% Senior Notes, Due 2024
Debt Instrument [Line Items]
Interest rate					4.24%						4.24%
Debt instrument, maturity year					2,024						2,024	2,024
Issued notes, aggregate principal amount | CAD					CAD 160
Genworth MI Canada Inc. | 4.59% senior notes due December 2015
Debt Instrument [Line Items]
Interest rate										4.59%
Early redemption of senior notes | CAD										CAD 150
Early redemption fee | CAD										7
Interest paid | CAD										CAD 2
Genworth MI Canada Inc. | 5.68% Senior Notes, Due 2020
Debt Instrument [Line Items]
Interest rate											5.68%		5.68%
Debt instrument, maturity year											2,020	2,020	2,020
Genworth Financial Mortgage Insurance Pty Limited | Floating Rate Debt 1
Debt Instrument [Line Items]
Debt instrument, maturity year											2,021	2,021
Subordinated floating rate notes, margin											4.75%	4.75%
Genworth Financial Mortgage Insurance Pty Limited | Floating Rate Debt 2
Debt Instrument [Line Items]
Debt instrument, maturity year											2,025	2,025
Subordinated floating rate notes, margin											3.50%	3.50%
Genworth Financial Mortgage Insurance Pty Limited | Floating Rate Junior Notes, Due 2025
Debt Instrument [Line Items]
Debt instrument, maturity year			2,025								2,025	2,025	2,025
Issued notes, aggregate principal amount | AUD																AUD 200
Early redemption fee			$ 2,000,000
Subordinated floating rate notes, margin			3.50%
Outstanding debt redeemed | AUD												AUD 90
Subsequent Event | Genworth Holdings | 8.625% Senior Notes, Due 2016
Debt Instrument [Line Items]
Interest rate		8.625%
Redemption of Long-term borrowings		$ 298,000,000
Pre-tax make-whole expense on redemption of senior notes		$ 23,000,000
Debt instrument, maturity year		2,016
United States
Debt Instrument [Line Items]
Cash and government securities collateral, minimum amount of the fair value of the applicable securities loaned											102.00%
Securities lending activity, fair value of securities loaned											$ 334,000,000		$ 288,000,000
Securities lending activity, fair value of collateral held											347,000,000		289,000,000
Securities lending activity, obligation to return collateral											$ 347,000,000		299,000,000
Canada
Debt Instrument [Line Items]
Cash and government securities collateral, minimum amount of the fair value of the applicable securities loaned											105.00%
Securities lending activity, fair value of securities loaned											$ 340,000,000		$ 371,000,000
Debt Covenant
Debt Instrument [Line Items]
Financial covenants, maximum capitalization ratio											0.35	0.35
Financial covenants, consolidated net worth											$ 8,900,000,000
Financial covenants, consolidated net income											50.00%	50.00%
Credit facility covenant for regulatory proceedings											30 days	30 days
Short-term borrowings | Revolving Credit Facility Maturing September 2016
Debt Instrument [Line Items]
Facility, maximum borrowing capacity																	$ 300,000,000
Line of credit facility, expiration date											Sep. 26, 2016	Sep. 26, 2016
Letter of Credit | Revolving Credit Facility Maturing September 2016
Debt Instrument [Line Items]
Facility, maximum borrowing capacity																	$ 100,000,000

Borrowings and Other Financi115

Borrowings and Other Financings - Long Term Borrowings (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Deferred borrowing charges	$ (15)	$ (15)
Total	4,570	4,612
Genworth Holdings
Debt Instrument [Line Items]
Long-term borrowings	4,100	4,151
Deferred borrowing charges	(21)	(24)
Total	4,079	4,127
Genworth Holdings | 8.625% Senior Notes, Due 2016
Debt Instrument [Line Items]
Long-term borrowings	298	300
Genworth Holdings | 6.52% Senior Notes, Due 2018
Debt Instrument [Line Items]
Long-term borrowings	598	600
Genworth Holdings | 7.70% Senior Notes, Due 2020
Debt Instrument [Line Items]
Long-term borrowings	397	400
Genworth Holdings | 7.20% Senior Notes, Due 2021
Debt Instrument [Line Items]
Long-term borrowings	389	399
Genworth Holdings | 7.625% Senior Notes, Due 2021
Debt Instrument [Line Items]
Long-term borrowings	724	758
Genworth Holdings | 4.90% Senior Notes, Due 2023
Debt Instrument [Line Items]
Long-term borrowings	399	399
Genworth Holdings | 4.80% Senior Notes, Due 2024
Debt Instrument [Line Items]
Long-term borrowings	400	400
Genworth Holdings | 6.50% Senior Notes, Due 2034
Debt Instrument [Line Items]
Long-term borrowings	297	297
Genworth Holdings | 6.15% Fixed-to-Floating Rate Junior Subordinated Notes, Due 2066
Debt Instrument [Line Items]
Long-term borrowings	598	598
Genworth MI Canada Inc.
Debt Instrument [Line Items]
Long-term borrowings	315	374
Deferred borrowing charges	(2)	(2)
Total	313	372
Genworth MI Canada Inc. | 5.68% Senior Notes, Due 2020
Debt Instrument [Line Items]
Long-term borrowings	199	236
Genworth MI Canada Inc. | 4.24% Senior Notes, due 2024
Debt Instrument [Line Items]
Long-term borrowings	116	138
Genworth Financial Mortgage Insurance Pty Limited
Debt Instrument [Line Items]
Long-term borrowings	182	114
Deferred borrowing charges	(4)	(1)
Total	178	113
Genworth Financial Mortgage Insurance Pty Limited | Floating Rate Junior Notes, Due 2021
Debt Instrument [Line Items]
Long-term borrowings	36	114
Genworth Financial Mortgage Insurance Pty Limited | Floating Rate Junior Notes, Due 2025
Debt Instrument [Line Items]
Long-term borrowings	$ 146	$ 0

Borrowings and Other Financi116

Borrowings and Other Financings - Long Term Borrowings (Parenthetical) (Detail)	1 Months Ended			3 Months Ended	12 Months Ended
	Jul. 31, 2015	Dec. 31, 2013	Aug. 31, 2013	Sep. 30, 2015	Dec. 31, 2015	Dec. 31, 2014
8.625% Senior Notes, Due 2016 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate					8.625%	8.625%
Debt instrument, maturity year					2,016	2,016
6.52% Senior Notes, Due 2018 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate					6.52%	6.52%
Debt instrument, maturity year					2,018	2,018
7.70% Senior Notes, Due 2020 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate					7.70%	7.70%
Debt instrument, maturity year					2,020	2,020
7.20% Senior Notes, Due 2021 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate					7.20%	7.20%
Debt instrument, maturity year					2,021	2,021
7.625% Senior Notes, Due 2021 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate					7.625%	7.625%
Debt instrument, maturity year					2,021	2,021
4.90% Senior Notes, Due 2023 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate			4.90%		4.90%	4.90%
Debt instrument, maturity year			2,023		2,023	2,023
4.80% Senior Notes, Due 2024 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate		4.80%			4.80%	4.80%
Debt instrument, maturity year		2,024			2,024	2,024
6.50% Senior Notes, Due 2034 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate					6.50%	6.50%
Debt instrument, maturity year					2,034	2,034
6.15% Fixed-to-Floating Rate Junior Subordinated Notes, Due 2066 | Genworth Holdings
Debt Instrument [Line Items]
Interest rate					6.15%	6.15%
Debt instrument, maturity year					2,066	2,066
5.68% Senior Notes, Due 2020 | Genworth MI Canada Inc.
Debt Instrument [Line Items]
Interest rate					5.68%	5.68%
Debt instrument, maturity year					2,020	2,020
4.24% Senior Notes, due 2024 | Genworth MI Canada Inc.
Debt Instrument [Line Items]
Interest rate					4.24%	4.24%
Debt instrument, maturity year					2,024	2,024
Floating Rate Junior Notes, Due 2021 | Genworth Financial Mortgage Insurance Pty Limited
Debt Instrument [Line Items]
Debt instrument, maturity year				2,021	2,021	2,021
Floating Rate Junior Notes, Due 2025 | Genworth Financial Mortgage Insurance Pty Limited
Debt Instrument [Line Items]
Debt instrument, maturity year	2,025				2,025	2,025

Schedule of Non-recourse Fundin

Schedule of Non-recourse Funding Obligations of Special Purpose Consolidated Captive Insurance Subsidiaries (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Nonrecourse Funding Obligations [Line Items]
Subtotal		$ 1,935	$ 1,996
Deferred borrowing charges		(15)	(15)
Non-recourse funding obligations		1,920	1,981
River Lake Insurance Company (a), Due 2033
Nonrecourse Funding Obligations [Line Items]
Subtotal	[1]	570	570
River Lake Insurance Company (b), Due 2033
Nonrecourse Funding Obligations [Line Items]
Subtotal	[2]	405	435
River Lake Insurance Company II (a), Due 2035
Nonrecourse Funding Obligations [Line Items]
Subtotal	[1]	192	192
River Lake Insurance Company II (b), Due 2035
Nonrecourse Funding Obligations [Line Items]
Subtotal	[2]	453	484
Rivermont Life Insurance Company I (a), due 2050
Nonrecourse Funding Obligations [Line Items]
Subtotal	[1]	$ 315	$ 315
[1]	Accrual of interest based on one-month LIBOR that resets every 28 days plus a fixed margin.
[2]	Accrual of interest based on one-month LIBOR that resets on a specified date each month plus a contractual margin

Schedule of Non-recourse Fun118

Schedule of Non-recourse Funding Obligations of Special Purpose Consolidated Captive Insurance Subsidiaries (Parenthetical) (Detail)		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014
Nonrecourse Funding Obligations [Line Items]
Interest rate reset period, number of days		28 days	28 days
River Lake Insurance Company (a), Due 2033
Nonrecourse Funding Obligations [Line Items]
Debt instrument, maturity year	[1]	2,033	2,033
River Lake Insurance Company (b), Due 2033
Nonrecourse Funding Obligations [Line Items]
Debt instrument, maturity year	[2]	2,033	2,033
River Lake Insurance Company II (a), Due 2035
Nonrecourse Funding Obligations [Line Items]
Debt instrument, maturity year	[1]	2,035	2,035
River Lake Insurance Company II (b), Due 2035
Nonrecourse Funding Obligations [Line Items]
Debt instrument, maturity year	[2]	2,035	2,035
Rivermont Life Insurance Company I (a), due 2050
Nonrecourse Funding Obligations [Line Items]
Debt instrument, maturity year	[1]	2,050	2,050
[1]	Accrual of interest based on one-month LIBOR that resets every 28 days plus a fixed margin.
[2]	Accrual of interest based on one-month LIBOR that resets on a specified date each month plus a contractual margin

Principal Amounts of Long Term

Principal Amounts of Long Term Debt Including Senior Notes and Non-recourse Funding by Maturity (Detail) $ in Millions	Dec. 31, 2015USD ($)
Principal Amounts Of Long Term Debt Including Senior Notes And Non Recourse Funding By Maturity [Line Items]
2,016	$ 298
2,017	0
2,018	598
2,019	0
2020 and thereafter	5,636
Total	$ 6,532

Principal Amounts of Long Te120

Principal Amounts of Long Term Debt Including Senior Notes and Non-recourse Funding by Maturity (Parenthetical) (Detail) $ in Billions	12 Months Ended
	Dec. 31, 2015USD ($)
Repayments Requiring Regulatory Approval
Principal Amounts Of Long Term Debt Including Senior Notes And Non Recourse Funding By Maturity [Line Items]
Repayment of secured debt	$ 1.9

Remaining Contractual Maturity

Remaining Contractual Maturity of Agreements (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	$ 229	$ 553
Securities lending	347	299
Total repurchase agreements and securities lending	576	852
U.S. government, agencies and government-sponsored enterprises
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	229	553
Equity Securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	5	2
Fixed maturity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	342	297
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	18	36
Fixed maturity securities | Non-U.S. government
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	39	32
Fixed maturity securities | U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	95	66
Fixed maturity securities | Non-U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	190	163
Overnight and continuous
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	347	299
Total repurchase agreements and securities lending	347	299
Overnight and continuous | U.S. government, agencies and government-sponsored enterprises
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	0	0
Overnight and continuous | Equity Securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	5	2
Overnight and continuous | Fixed maturity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	342	297
Overnight and continuous | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	18	36
Overnight and continuous | Fixed maturity securities | Non-U.S. government
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	39	32
Overnight and continuous | Fixed maturity securities | U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	95	66
Overnight and continuous | Fixed maturity securities | Non-U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	190	163
Up to 30 days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Total repurchase agreements and securities lending	58	129
Up to 30 days | U.S. government, agencies and government-sponsored enterprises
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	58	129
Up to 30 days | Equity Securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Up to 30 days | Fixed maturity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Up to 30 days | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Up to 30 days | Fixed maturity securities | Non-U.S. government
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Up to 30 days | Fixed maturity securities | U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Up to 30 days | Fixed maturity securities | Non-U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
31 - 90 days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Total repurchase agreements and securities lending	25	123
31 - 90 days | U.S. government, agencies and government-sponsored enterprises
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	25	123
31 - 90 days | Equity Securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
31 - 90 days | Fixed maturity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
31 - 90 days | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
31 - 90 days | Fixed maturity securities | Non-U.S. government
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
31 - 90 days | Fixed maturity securities | U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
31 - 90 days | Fixed maturity securities | Non-U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Greater than 90 days
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Total repurchase agreements and securities lending	146	301
Greater than 90 days | U.S. government, agencies and government-sponsored enterprises
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Repurchase agreements	146	301
Greater than 90 days | Equity Securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Greater than 90 days | Fixed maturity securities
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Greater than 90 days | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Greater than 90 days | Fixed maturity securities | Non-U.S. government
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Greater than 90 days | Fixed maturity securities | U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	0	0
Greater than 90 days | Fixed maturity securities | Non-U.S. corporate
Transfer of Certain Financial Assets Accounted for as Secured Borrowings [Line Items]
Securities lending	$ 0	$ 0

Components of Income (Loss) bef

Components of Income (Loss) before Income Taxes (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Abstract]
Domestic	$ (468)	$ (2,022)	$ 283
Foreign	453	723	710
Income (loss) from continuing operations before income taxes	$ (15)	$ (1,299)	$ 993

Components of Income Tax (Benef

Components of Income Tax (Benefit) Expense (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Abstract]
Current federal income taxes	$ 1	$ (3)	$ (12)
Deferred federal income taxes	(199)	(305)	137
Total federal income taxes	(198)	(308)	125
Current state income taxes	0	4	(1)
Deferred state income taxes	4	(4)	(9)
Total state income taxes	4	0	(10)
Current foreign income taxes	186	246	426
Deferred foreign income taxes	(1)	(32)	(228)
Total foreign income taxes	185	214	198
Total provision (benefit) for income taxes	$ (9)	$ (94)	$ 313

Income Taxes - Additional Infor

Income Taxes - Additional Information (Detail) - USD ($) $ in Millions	3 Months Ended	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Income Tax Examination [Line Items]
Current income tax payable	$ 35	$ 10	$ 35
Tax Impact From Potential Business Portfolio Changes	205	0	205	$ 0
Valuation allowances	296	353	296
NOL carryforwards		4,972
Foreign tax credit carryforwards	666	$ 787	666
Net operating loss carryforwards, expiration date/(year)		2,021
Foreign tax credit carryforwards, expiration year		2,019
Net U.S. deferred tax asset		$ 131
Deferred tax assets related to net operating loss and foreign tax credit carryforwards		2,514
Unremitted foreign income that is considered permanently reinvested on which U.S. deferred income tax are not provided		1,712
International businesses cash and short-term investments related to the unremitted earnings of foreign operations		178
Unrecognized tax benefits	49	28	49	41	$ 55
Unrecognized tax benefits, amount that if recognized would affect the effective rate on continuing operations		21
Unrecognized tax benefits, interest and penalties (expense)		1	3	1
Unrecognized tax benefits, accrued interest and penalties	0	0	0
Unrecognized tax benefits, amount that is reasonably possible that it will be recognized in 2015		11
Section 338 Election
Income Tax Examination [Line Items]
Remaining deferred tax assets related to Section 338 election deduction	599	$ 599	599
Tax matters agreement obligation related to Section 338 election, period of repayment, years		8 years
Maximum deferred tax assets related to Section 338 election deduction		$ 640
Percentage of tax savings associated with Section 338 deductions		80.00%
U.S. Jurisdiction
Income Tax Examination [Line Items]
Net U.S. deferred tax asset		$ 137
Additional paid-in capital
Income Tax Examination [Line Items]
Adjustment to deferred tax liability for unsupported balance			6	17
Australia Mortgage Insurance
Income Tax Examination [Line Items]
Tax Impact From Potential Business Portfolio Changes	174		174
Lifestyle Protection Insurance
Income Tax Examination [Line Items]
Tax Impact From Potential Business Portfolio Changes			31
Tax Matters Agreement
Income Tax Examination [Line Items]
Interest expense related to tax matters agreement		$ 11	$ 13	$ 15
Accretion rate for tax matters agreement		5.72%	5.72%	5.72%
Liability for estimated present value of tax payments to former parent	$ 216	$ 188	$ 216

Reconciliation of Federal Statu

Reconciliation of Federal Statutory Tax Rate to Effective Income Tax Rate (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Tax Examination [Line Items]
Pre-tax income (loss)	$ (15)	$ (1,299)	$ 993
Statutory U.S. federal income tax rate	(5)	(455)	348
State income tax, net of federal income tax effect	2	0	(2)
Benefit on tax favored investments	(14)	(19)	(18)
Effect of foreign operations	(20)	(66)	(66)
Net impact of repatriating foreign earnings	0	205	0
Interest on uncertain tax positions	0	(2)	(1)
Non-deductible expenses	(3)	4	2
Non-deductible goodwill	0	245	0
Valuation allowance	25	(6)	16
Stock-based compensation	5	4	25
Other, net	1	(4)	9
Total provision (benefit) for income taxes	$ (9)	$ (94)	$ 313
Statutory U.S. federal income tax rate	35.00%	35.00%	35.00%
State income tax, net of federal income tax effect	(18.00%)	0.00%	(0.20%)
Benefit on tax favored investments	93.30%	1.40%	(1.80%)
Effect of foreign operations	129.20%	5.10%	(6.60%)
Net impact of repatriating foreign earnings	0.00%	(15.80%)	0.00%
Interest on uncertain tax positions	0.00%	0.10%	(0.10%)
Non-deductible expenses	22.00%	(0.30%)	0.20%
Non-deductible goodwill	0.00%	(18.80%)	0.00%
Valuation allowance	(165.00%)	0.50%	1.60%
Stock-based compensation	(31.70%)	(0.30%)	2.50%
Other, net	(6.80%)	0.30%	0.90%
Effective rate	58.00%	7.20%	31.50%

Components of Net Deferred Inco

Components of Net Deferred Income Tax Liability (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Income Taxes [Abstract]
Foreign tax credit carryforwards	$ 787	$ 666
Accrued commission and general expenses	199	203
State income taxes	302	275
Net operating loss carryforwards	1,727	1,797
Other	51	21
Gross deferred income tax assets	3,066	2,962
Valuation allowance	(353)	(296)
Total deferred income tax assets	2,713	2,666
Investments	29	86
Net unrealized gains on investment securities	639	1,260
Net unrealized gains on derivatives	218	222
Insurance reserves	751	491
DAC	863	1,115
PVFP and other intangibles	20	3
Investment in foreign subsidiaries	10	310
Other	52	37
Total deferred income tax liabilities	2,582	3,524
Net deferred income tax asset	131
Net deferred income tax (liability)	$ (24)	$ (858)

Reconciliation of Unrecognized

Reconciliation of Unrecognized Tax Benefits (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Taxes [Abstract]
Balance as of January 1	$ 49	$ 41	$ 55
Gross additions, current period	5	7	3
Gross reductions, current period	0	(3)	0
Gross additions, prior years	0	17	4
Gross reductions, prior years	(26)	(13)	(21)
Balance as of December 31	$ 28	$ 49	$ 41

Supplemental Cash Flow Infor128

Supplemental Cash Flow Information - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Supplemental Cash Flow Information [Abstract]
Net cash paid for taxes	$ 153	$ 645	$ 125
Cash paid for interest	$ 424	$ 437	$ 453

Stock-Based Compensation - Addi

Stock-Based Compensation - Additional Information (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Share Based Employee Compensation [Line Items]
Stock-based compensation expense	$ 16,000,000	$ 28,000,000	$ 39,000,000
Granted, shares subject to option	0	0	0
Unrecognized stock-based compensation expense	$ 29,000,000	$ 35,000,000
Unrecognized stock-based compensation expense, expected weighted-average period of recognition (years)	2 years	2 years
Amounts received from option exercises	$ 1,000,000	$ 20,000,000
Tax benefit realized from the exercise of share based awards	4,000,000	11,000,000
Genworth Canada
Share Based Employee Compensation [Line Items]
Stock-based compensation expense	(3,000,000)	6,000,000	$ 11,000,000
Unrecognized stock-based compensation expense	2,000,000	3,000,000	$ 3,000,000
Genworth Australia
Share Based Employee Compensation [Line Items]
Stock-based compensation expense	2,000,000	2,000,000
Unrecognized stock-based compensation expense	$ 4,000,000	$ 5,000,000
Vested restricted share rights	0	0
Stock Appreciation Rights
Share Based Employee Compensation [Line Items]
Granted stock options, exercise price range, lower limit	$ 4.96	$ 14.30
Granted stock options, exercise price range, upper limit	7.99	17.89
Granted stock options, fair value	$ 3.43	$ 3.05
Vested restricted share rights	59,000	1,353,000
Stock Appreciation Rights Cap Price
Share Based Employee Compensation [Line Items]
Maximum share value at exercise of SARs	$ 75
Employee Stock Option and Stock Appreciation Rights
Share Based Employee Compensation [Line Items]
Granted stock options, exercise term (years)	10 years
Stock Appreciation Rights (SARs)
Share Based Employee Compensation [Line Items]
Average vesting period	3 years	4 years	4 years
Restricted Stock Units
Share Based Employee Compensation [Line Items]
Granted stock options, exercise price range, lower limit	$ 4.96	$ 9.19
Granted stock options, exercise price range, upper limit	$ 7.99	$ 17.89
Average vesting period	4 years	4 years
Granted stock options, fair value	$ 7.50	$ 15
Vested restricted share rights	1,390,000	938,000
Stock Retention Awards
Share Based Employee Compensation [Line Items]
Average vesting period	2 years
Granted stock options, fair value	$ 1
Cash granted	$ 10,000,000
Forfeited amount due to employees leaving company	$ 1,000,000
Performance Stock Units ("PSUs")
Share Based Employee Compensation [Line Items]
Average vesting period	3 years	3 years
Granted stock options, fair value	$ 7.75	$ 7.75
Performance Stock Units ("PSUs") | Maximum
Share Based Employee Compensation [Line Items]
Granted stock options, fair value		17.89
Performance Stock Units ("PSUs") | Minimum
Share Based Employee Compensation [Line Items]
Granted stock options, fair value		$ 15.23
Omnibus Incentive Plan
Share Based Employee Compensation [Line Items]
Equity awards, amount of shares authorized to grant				16,000,000	25,000,000
Stock-based compensation expense	$ 17,000,000	$ 20,000,000	$ 28,000,000

Stock Option and SAR Weighted-A

Stock Option and SAR Weighted-Average Grant-Date Fair Value Information and Related Valuation Assumptions (Detail) - $ / shares shares in Thousands		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options and SARs, granted		0	0	0
Black-Scholes Model
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (years)		6 years	6 years	5 years 10 months 24 days
Expected volatility		66.00%	100.20%	100.70%
Expected dividend yield		0.00%	0.50%	0.50%
Risk-free interest rate		1.90%	1.90%	1.10%
Black-Scholes Model | Stock Compensation Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options and SARs, granted		1,378	2,960	3,404
Fair value per options and SARs		$ 3.43	$ 3.05	$ 2.53
Black-Scholes Model | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum share value at exercise of SARs		$ 75	$ 75	$ 75
Monte-Carlo Simulation
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	[1]			102.50%
Expected dividend yield	[1]			0.50%
Risk-free interest rate	[1]			1.10%
Monte-Carlo Simulation | Stock Compensation Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options and SARs, granted	[1]			1,200
Fair value per options and SARs	[1]			$ 5.88
Monte-Carlo Simulation | Stock Appreciation Rights (SARs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum share value at exercise of SARs	[1]			$ 75
[1]	For purposes of determining the fair value of 1.2 million shares of performance-accelerated SARs that were issued in January 2013, we used a Monte-Carlo Simulation technique. Monte-Carlo Simulation is a method used to simulate future stock price movements in order to determine the fair value due to unique vesting and exercising provisions. The performance-accelerated SARs have a derived service period of one year on average and have a grant price of $7.90. The performance-accelerated SARs vest on the third anniversary of the grant date but are subject to earlier vesting on or after the one year anniversary of the grant date based on the closing price of our Class A Common Stock exceeding certain specified amounts ($12.00, $16.00 and $20.00, respectively) for 45 consecutive trading days. Based on the closing price of our Class A Common Stock, the first tranche at $12.00 vested in January 2014 and the second tranche at $16.00 vested in June 2014.

Stock Option and SAR Weighte131

Stock Option and SAR Weighted-Average Grant-Date Fair Value Information and Related Valuation Assumptions (Parenthetical) (Detail) - $ / shares shares in Millions	1 Months Ended			12 Months Ended
	Jun. 30, 2014	Jan. 31, 2014	Jan. 31, 2013	Dec. 31, 2014
Share Price One
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance-accelerated SARs subject to earlier vesting on or after one year anniversary of the grant date based on the closing price of our Class A Common Stock				$ 12
Vesting based on closing stock price		$ 12
Share Price Two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance-accelerated SARs subject to earlier vesting on or after one year anniversary of the grant date based on the closing price of our Class A Common Stock				16
Vesting based on closing stock price	$ 16
Share Price Three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Performance-accelerated SARs subject to earlier vesting on or after one year anniversary of the grant date based on the closing price of our Class A Common Stock				$ 20
Early Vesting in One Third Increments
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of consecutive trading days exceeding certain specified amounts				45 days
Performance Accelerated Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Omnibus Incentive Plan, shares issued			1.2
Options grant-date fair value			$ 7.90

Rollforward of Share-Based Comp

Rollforward of Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding (Detail) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Stock-Based Compensation [Abstract]
Beginning balance, shares subject to option	2,504	4,310
Granted, shares subject to option	0	0	0
Exercised, shares subject to option	(47)	(921)
Expired and forfeited, shares subject to option	(317)	(885)
Ending balance, shares subject to option	2,140	2,504	4,310
Beginning balance, weighted-average exercise price	$ 12.86	$ 13.17
Exercisable as of December 31, shares subject to option	2,140
Granted, weighted-average exercise price	$ 0	0
Exercised, weighted-average exercise price	4.39	8.10
Expired and forfeited, weighted-average exercise price	17.62	19.32
Ending balance, weighted-average exercise price	12.34	$ 12.86	$ 13.17
Exercisable as of December 31, weighted-average exercise price	$ 12.34

Information about Stock Options

Information about Stock Options Outstanding (Detail) shares in Thousands	12 Months Ended
	Dec. 31, 2015$ / sharesshares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Outstanding, shares | shares	2,140
Outstanding, average exercise price	$ 12.34
Exercise Price Range, $ 2.00 - $ 2.46
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower limit	2	[1]
Exercise price range, upper limit	$ 2.46	[1]
Outstanding, shares | shares	362	[1]
Outstanding, average life (years)	3 years 15 days	[1],[2]
Outstanding, average exercise price	$ 2.43	[1]
Exercise Price Range, $ 7.36 - $ 7.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower limit	7.36
Exercise price range, upper limit	$ 7.80
Outstanding, shares | shares	433
Outstanding, average life (years)	1 year 9 months 7 days	[2]
Outstanding, average exercise price	$ 7.79
Exercise Price Range, $ 9.10 - $ 14.18
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower limit	9.10
Exercise price range, upper limit	$ 14.18
Outstanding, shares | shares	1,119
Outstanding, average life (years)	9 years 11 months 12 days	[2]
Outstanding, average exercise price	$ 14.14
Exercise Price Range, $14.92 - $22.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower limit	14.92
Exercise price range, upper limit	$ 22.80
Outstanding, shares | shares	100
Outstanding, average life (years)	2 years 3 months 29 days	[2]
Outstanding, average exercise price	$ 21.80
Exercise Price Range, $30.52 - $34.13
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Exercise price range, lower limit	30.52
Exercise price range, upper limit	$ 34.13
Outstanding, shares | shares	126
Outstanding, average life (years)	11 months 27 days	[2]
Outstanding, average exercise price	$ 32.86
[1]	These shares have an aggregate intrinsic value of $1 million each for total options outstanding and exercisable.
[2]	Average contractual life remaining in years.

Information about Stock Opti134

Information about Stock Options Outstanding (Parenthetical) (Detail) - Exercise Price Range, $ 2.00 - $ 2.46 $ in Millions	Dec. 31, 2015USD ($)
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Aggregate intrinsic value, total options outstanding	$ 1
Aggregate intrinsic value, exercisable options	$ 1

Stock Option Activity and Other

Stock Option Activity and Other Equity-Based Awards (Detail) - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning balance, shares subject to option	2,504	4,310
Exercised, shares subject to option	(47)	(921)
Terminated, shares subject to option	(317)	(885)
Ending balance, shares subject to option	2,140	2,504
Deferred Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	634	579
Granted, number of awards	256	113
Exercised, number of awards	(10)	(58)
Terminated, number of awards	0	0
Balance as of December 31, number of awards	880	634
Balance as of January 1, weighted-average grant date fair value	$ 9.96	$ 9.43
Granted, weighted-average grant date fair value	3.90	12.98
Exercised, weighted-average grant date fair value	2.14	6.65
Terminated, weighted-average grant date fair value	0	0
Balance as of December 31, weighted-average grant date fair value	$ 8.18	$ 9.96
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	2,913	2,887
Granted, number of awards	2,087	1,226
Exercised, number of awards	(1,390)	(938)
Terminated, number of awards	(355)	(262)
Balance as of December 31, number of awards	3,255	2,913
Balance as of January 1, weighted-average grant date fair value	$ 12.09	$ 10.21
Granted, weighted-average grant date fair value	7.50	15
Exercised, weighted-average grant date fair value	11.60	10.06
Terminated, weighted-average grant date fair value	10.10	12.16
Balance as of December 31, weighted-average grant date fair value	$ 9.22	$ 12.09
Performance Stock Units ("PSUs")
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	304	0
Granted, number of awards	535	343
Exercised, number of awards	0	0
Terminated, number of awards	(129)	(39)
Balance as of December 31, number of awards	710	304
Balance as of January 1, weighted-average grant date fair value	$ 15.32	$ 0
Granted, weighted-average grant date fair value	7.75	15.31
Exercised, weighted-average grant date fair value	0	0
Terminated, weighted-average grant date fair value	9.72	15.23
Balance as of December 31, weighted-average grant date fair value	$ 10.63	$ 15.32
Stock Appreciation Rights
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	12,067	12,365
Granted, number of awards	1,378	2,960
Exercised, number of awards	(59)	(1,353)
Terminated, number of awards	(1,238)	(1,905)
Balance as of December 31, number of awards	12,148	12,067
Balance as of January 1, weighted-average grant date fair value	$ 3.62	$ 4
Granted, weighted-average grant date fair value	3.43	3.05
Exercised, weighted-average grant date fair value	1.28	3.88
Terminated, weighted-average grant date fair value	4.05	5.23
Balance as of December 31, weighted-average grant date fair value	$ 3.56	$ 3.62
Genworth Canada
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Beginning balance, shares subject to option	1,002	987
Granted, shares subject to option	53	114
Exercised, shares subject to option	(88)	(93)
Terminated, shares subject to option	(12)	(6)
Ending balance, shares subject to option	955	1,002
Genworth Canada | Restricted Stock Units and Performance Stock Unit Awards
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	203	177
Granted, number of awards	78	93
Exercised, number of awards	(60)	(67)
Terminated, number of awards	(27)	0
Balance as of December 31, number of awards	194	203
Genworth Canada | Deferred Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	54	45
Granted, number of awards	14	9
Exercised, number of awards	(14)	0
Terminated, number of awards	0	0
Balance as of December 31, number of awards	54	54
Genworth Canada | Executive Deferred Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	21	20
Granted, number of awards	10	1
Exercised, number of awards	0	0
Terminated, number of awards	0	0
Balance as of December 31, number of awards	31	21
Genworth Australia
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercised, number of awards	0	0
Genworth Australia | Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Balance as of January 1, number of awards	2,803	0
Granted, number of awards	147	2,846
Exercised, number of awards	(40)	(5)
Terminated, number of awards	(145)	(38)
Balance as of December 31, number of awards	2,765	2,803

Fair Value Financial Instrument

Fair Value Financial Instruments Not Required to Be Carried at Fair Value (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		$ 6,170	$ 6,100
Restricted commercial mortgage loans		161	201
Other invested assets		2,309	2,208
Long-term borrowings		4,570	4,612
Non-recourse funding obligations		1,920	1,981
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		0	0
Restricted commercial mortgage loans	[1]	0	0
Other invested assets		0	0
Long-term borrowings	[2]	0	0
Non-recourse funding obligations	[2]	0	0
Borrowings related to securitization entities	[1]	0	0
Investment contracts		0	0
Commitments to fund limited partnerships		0	0
Ordinary course of business lending commitments		0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		0	0
Restricted commercial mortgage loans	[1]	0	0
Other invested assets		197	238
Long-term borrowings	[2]	3,343	4,155
Non-recourse funding obligations	[2]	0	0
Borrowings related to securitization entities	[1]	104	146
Investment contracts		5	7
Commitments to fund limited partnerships		0	0
Ordinary course of business lending commitments		0	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		6,476	6,573
Restricted commercial mortgage loans	[1]	179	228
Other invested assets		82	85
Long-term borrowings	[2]	175	118
Non-recourse funding obligations	[2]	1,401	1,423
Borrowings related to securitization entities	[1]	0	0
Investment contracts		17,905	18,005
Commitments to fund limited partnerships		0	0
Ordinary course of business lending commitments		0	0
Notional amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans	[3]	0	0
Restricted commercial mortgage loans	[1],[3]	0	0
Other invested assets	[3]	0	0
Long-term borrowings	[2],[3]	0	0
Non-recourse funding obligations	[2],[3]	0	0
Borrowings related to securitization entities	[1],[3]	0	0
Investment contracts	[3]	0	0
Commitments to fund limited partnerships		131	53
Ordinary course of business lending commitments		40	155
Carrying value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		6,170	6,100
Restricted commercial mortgage loans	[1]	161	201
Other invested assets		273	311
Long-term borrowings	[2]	4,570	4,612
Non-recourse funding obligations	[2]	1,920	1,981
Borrowings related to securitization entities	[1]	98	134
Investment contracts		17,258	17,486
Commitments to fund limited partnerships		0	0
Ordinary course of business lending commitments		0	0
Fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Commercial mortgage loans		6,476	6,573
Restricted commercial mortgage loans	[1]	179	228
Other invested assets		279	323
Long-term borrowings	[2]	3,518	4,273
Non-recourse funding obligations	[2]	1,401	1,423
Borrowings related to securitization entities	[1]	104	146
Investment contracts		17,910	18,012
Commitments to fund limited partnerships		0	0
Ordinary course of business lending commitments		$ 0	$ 0
[1]	See note 17 for additional information related to consolidated securitization entities.
[2]	See note 12 for additional information related to borrowings.
[3]	These financial instruments do not have notional amounts.

Summary of Significant Inputs U

Summary of Significant Inputs Used by Third-Party Pricing Services for Certain Fair Value Measurements of Fixed Maturity Securities that Classified as Level 2 (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 58,197	$ 61,077
Fixed maturity securities
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	58,197	61,077
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	6,203	6,000
Fixed maturity securities | State and Political Subdivisions
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,438	2,222
Fixed maturity securities | Non-U.S. government
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,015	1,902
Fixed maturity securities | U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	24,401	25,223
Fixed maturity securities | Non-U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	12,199	14,095
Fixed maturity securities | Residential mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	5,101	5,228
Fixed maturity securities | Commercial mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,559	2,702
Fixed maturity securities | Other asset-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	3,281	3,705
Level 2 | Fixed maturity securities
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	53,017	55,323
Level 2 | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	6,200	5,996
Level 2 | Fixed maturity securities | State and Political Subdivisions
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,403	2,192
Level 2 | Fixed maturity securities | Non-U.S. government
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,015	1,895
Level 2 | Fixed maturity securities | U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	22,072	22,804
Level 2 | Fixed maturity securities | Non-U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	10,654	12,291
Level 2 | Fixed maturity securities | Residential mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	4,985	5,163
Level 2 | Fixed maturity securities | Commercial mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,549	2,697
Level 2 | Fixed maturity securities | Other asset-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	2,139	$ 2,285
Level 2 | Third-Party Pricing Services | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 6,200
Primary methodologies	Price quotes from trading desk, broker feeds
Significant inputs	Bid side prices, trade prices, Option Adjusted Spread (“OAS”) to swap curve, Bond Market Association (“BMA”) OAS, Treasury Curve, Agency Bullet Curve, maturity to issuer spread
Level 2 | Third-Party Pricing Services | Fixed maturity securities | State and Political Subdivisions
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 2,403
Primary methodologies	Multi-dimensional attribute-based modeling systems, third-party pricing vendors
Significant inputs	Trade prices, material event notices, Municipal Market Data benchmark yields, broker quotes
Level 2 | Third-Party Pricing Services | Fixed maturity securities | Non-U.S. government
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 1,996
Primary methodologies	Matrix pricing, spread priced to benchmark curves, price quotes from market makers
Significant inputs	Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources
Level 2 | Third-Party Pricing Services | Fixed maturity securities | U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 21,505
Primary methodologies	Multi-dimensional attribute-based modeling systems, broker quotes, price quotes from market makers, internal models, OAS-based models
Significant inputs	Bid side prices to Treasury Curve, Issuer Curve, which includes sector, quality, duration, OAS percentage and change for spread matrix, trade prices, comparative transactions, Trade Reporting and Compliance Engine ("TRACE") reports
Level 2 | Third-Party Pricing Services | Fixed maturity securities | Non-U.S. corporate
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 10,364
Primary methodologies	Multi-dimensional attribute-based modeling systems, OAS-based models, price quotes from market makers
Significant inputs	Benchmark yields, trade prices, broker quotes, comparative transactions, issuer spreads, bid-offer spread, market research publications, third-party pricing sources
Level 2 | Third-Party Pricing Services | Fixed maturity securities | Residential mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 4,985
Primary methodologies	OAS-based models, To Be Announced pricing models, single factor binomial models, internally priced
Significant inputs	Prepayment and default assumptions, aggregation of bonds with similar characteristics, including collateral type, vintage, tranche type, weighted-average life, weighted-average loan age, issuer program and delinquency ratio, pay up and pay down factors, TRACE reports
Level 2 | Third-Party Pricing Services | Fixed maturity securities | Commercial mortgage-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 2,549
Primary methodologies	Multi-dimensional attribute-based modeling systems, pricing matrix, spread matrix priced to swap curves, Trepp commercial mortgage-backed securities analytics model
Significant inputs	Credit risk, interest rate risk, prepayment speeds, new issue data, collateral performance, origination year, tranche type, original credit ratings, weighted-average life, cash flows, spreads derived from broker quotes, bid side prices, spreads to daily updated swaps curves
Level 2 | Third-Party Pricing Services | Fixed maturity securities | Other asset-backed
Fair value measurements Significant unobservable inputs [Line Items]
Available-for-sale debt securities	$ 2,139
Primary methodologies	Multi-dimensional attribute-based modeling systems, spread matrix priced to swap curves, price quotes from market makers, internal models
Significant inputs	Spreads to daily updated swaps curves, spreads derived from trade prices and broker quotes, bid side prices, new issue data, collateral performance, analysis of prepayment speeds, cash flows, collateral loss analytics, historical issue analysis, trade data from market makers, TRACE reports

Fair Value of Financial Inst138

Fair Value of Financial Instruments - Additional Information (Detail) $ in Millions	12 Months Ended
	Dec. 31, 2015USD ($)	Dec. 31, 2014USD ($)
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	$ 58,197	$ 61,077
Period end valuation	0
GMWB non-performance risk impact	$ 79	74
Fixed maturity securities
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	58,197	61,077
Fixed maturity securities | Non-U.S. government
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	2,015	1,902
Fixed maturity securities | U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	24,401	25,223
Fixed maturity securities | Non-U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	12,199	14,095
Level 1 | Fixed maturity securities
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	0	0
Level 1 | Fixed maturity securities | Non-U.S. government
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	0	0
Level 1 | Fixed maturity securities | U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	0	0
Level 1 | Internal models | Fixed maturity securities | Non-U.S. government
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	19
Level 1 | Internal models | Fixed maturity securities | U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	567
Level 1 | Internal models | Fixed maturity securities | Non-U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	290
Level 3 | Fixed maturity securities
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	5,180	5,754
Level 3 | Fixed maturity securities | Non-U.S. government
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	0	7
Level 3 | Fixed maturity securities | U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	2,329	2,419
Level 3 | Fixed maturity securities | Non-U.S. corporate
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	1,545	$ 1,804
Level 3 | Internal models | Fixed maturity securities
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	3,534
Level 3 | Broker Quotes | Fixed maturity securities
Fair Value of Financial Instruments [Line Items]
Available-for-sale debt securities	$ 1,646

Assets by Class of Instrument t

Assets by Class of Instrument that are Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		$ 58,197	$ 61,077
Available-for-sale equity securities		310	275
Derivative assets, fair value		1,129	1,145
Total other invested assets		2,309	2,208
Restricted other invested assets related to securitization entities	[1]	413	411
Separate account assets		7,883	9,208
Total assets		68,726	72,646
Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading securities		447	241
Derivative assets, fair value		1,112	1,132
Securities lending collateral		347	289
Reinsurance recoverable | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[2]	17	13
Interest rate swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		1,054	1,091
Foreign currency swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		8	6
Credit default swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		1	4
Equity index options | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		30	17
Other foreign currency contracts | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		17	14
Equity return swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		2
Fair value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total other invested assets		279	323
Fair value | Other Invested Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total other invested assets		1,906	1,662
Fixed maturity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		58,197	61,077
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		6,203	6,000
Fixed maturity securities | State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,438	2,222
Fixed maturity securities | Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,015	1,902
Fixed maturity securities | U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		24,401	25,223
Fixed maturity securities | U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,693	3,864
Fixed maturity securities | U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,501	2,742
Fixed maturity securities | U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		5,632	5,646
Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		4,096	4,013
Fixed maturity securities | U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,193	2,325
Fixed maturity securities | U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,173	1,287
Fixed maturity securities | U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,950	2,006
Fixed maturity securities | U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,675	1,900
Fixed maturity securities | U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,086	1,039
Fixed maturity securities | U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		402	401
Fixed maturity securities | Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		12,199	14,095
Fixed maturity securities | Non-U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		843	903
Fixed maturity securities | Non-U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,686	2,036
Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,473	2,957
Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		752	796
Fixed maturity securities | Non-U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		988	1,053
Fixed maturity securities | Non-U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		986	1,213
Fixed maturity securities | Non-U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		604	618
Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		526	534
Fixed maturity securities | Non-U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		605	590
Fixed maturity securities | Non-U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,736	3,395
Fixed maturity securities | Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		5,101	5,228
Fixed maturity securities | Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,559	2,702
Fixed maturity securities | Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,281	3,705
Equity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale equity securities		310	275
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total other invested assets		0	0
Restricted other invested assets related to securitization entities	[1]	0	0
Separate account assets		7,883	9,208
Total assets		8,153	9,445
Level 1 | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading securities		0	0
Derivative assets, fair value		0	0
Securities lending collateral		0	0
Level 1 | Reinsurance recoverable | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[2]	0	0
Level 1 | Interest rate swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 1 | Foreign currency swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 1 | Credit default swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 1 | Equity index options | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 1 | Other foreign currency contracts | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 1 | Equity return swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0
Level 1 | Fair value | Other Invested Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total other invested assets		0	0
Level 1 | Fixed maturity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Non-U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Fixed maturity securities | Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	0
Level 1 | Equity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale equity securities		270	237
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total other invested assets		197	238
Restricted other invested assets related to securitization entities	[1]	181	181
Separate account assets		0	0
Total assets		55,072	57,150
Level 2 | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading securities		447	241
Derivative assets, fair value		1,078	1,112
Securities lending collateral		347	289
Level 2 | Reinsurance recoverable | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[2]	0	0
Level 2 | Interest rate swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		1,054	1,091
Level 2 | Foreign currency swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		8	6
Level 2 | Credit default swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	1
Level 2 | Equity index options | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 2 | Other foreign currency contracts | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		14	14
Level 2 | Equity return swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		2
Level 2 | Fair value | Other Invested Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total other invested assets		1,872	1,642
Level 2 | Fixed maturity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		53,017	55,323
Level 2 | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		6,200	5,996
Level 2 | Fixed maturity securities | State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,403	2,192
Level 2 | Fixed maturity securities | Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,015	1,895
Level 2 | Fixed maturity securities | U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		22,072	22,804
Level 2 | Fixed maturity securities | U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,244	3,420
Level 2 | Fixed maturity securities | U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,248	2,457
Level 2 | Fixed maturity securities | U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		4,917	5,030
Level 2 | Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3,987	3,873
Level 2 | Fixed maturity securities | U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,158	2,280
Level 2 | Fixed maturity securities | U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,112	1,251
Level 2 | Fixed maturity securities | U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,770	1,840
Level 2 | Fixed maturity securities | U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,436	1,537
Level 2 | Fixed maturity securities | U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		980	886
Level 2 | Fixed maturity securities | U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		220	230
Level 2 | Fixed maturity securities | Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		10,654	12,291
Level 2 | Fixed maturity securities | Non-U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		556	575
Level 2 | Fixed maturity securities | Non-U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,434	1,712
Level 2 | Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,282	2,736
Level 2 | Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		583	599
Level 2 | Fixed maturity securities | Non-U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		926	1,011
Level 2 | Fixed maturity securities | Non-U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		902	1,082
Level 2 | Fixed maturity securities | Non-U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		391	381
Level 2 | Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		455	445
Level 2 | Fixed maturity securities | Non-U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		461	436
Level 2 | Fixed maturity securities | Non-U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,664	3,314
Level 2 | Fixed maturity securities | Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		4,985	5,163
Level 2 | Fixed maturity securities | Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,549	2,697
Level 2 | Fixed maturity securities | Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,139	2,285
Level 2 | Equity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale equity securities		2	4
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total other invested assets		82	85
Restricted other invested assets related to securitization entities	[1]	232	230
Separate account assets		0	0
Total assets		5,501	6,051
Level 3 | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Trading securities		0	0
Derivative assets, fair value		34	20
Securities lending collateral		0	0
Level 3 | Reinsurance recoverable | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value	[2]	17	13
Level 3 | Interest rate swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 3 | Foreign currency swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0	0
Level 3 | Credit default swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		1	3
Level 3 | Equity index options | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		30	17
Level 3 | Other foreign currency contracts | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		3	0
Level 3 | Equity return swaps | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative assets, fair value		0
Level 3 | Fair value | Other Invested Assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total other invested assets		34	20
Level 3 | Fixed maturity securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		5,180	5,754
Level 3 | Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		3	4
Level 3 | Fixed maturity securities | State and Political Subdivisions
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		35	30
Level 3 | Fixed maturity securities | Non-U.S. government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		0	7
Level 3 | Fixed maturity securities | U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		2,329	2,419
Level 3 | Fixed maturity securities | U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		449	444
Level 3 | Fixed maturity securities | U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		253	285
Level 3 | Fixed maturity securities | U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		715	616
Level 3 | Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		109	140
Level 3 | Fixed maturity securities | U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		35	45
Level 3 | Fixed maturity securities | U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		61	36
Level 3 | Fixed maturity securities | U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		180	166
Level 3 | Fixed maturity securities | U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		239	363
Level 3 | Fixed maturity securities | U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		106	153
Level 3 | Fixed maturity securities | U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		182	171
Level 3 | Fixed maturity securities | Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,545	1,804
Level 3 | Fixed maturity securities | Non-U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		287	328
Level 3 | Fixed maturity securities | Non-U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		252	324
Level 3 | Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		191	221
Level 3 | Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		169	197
Level 3 | Fixed maturity securities | Non-U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		62	42
Level 3 | Fixed maturity securities | Non-U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		84	131
Level 3 | Fixed maturity securities | Non-U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		213	237
Level 3 | Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		71	89
Level 3 | Fixed maturity securities | Non-U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		144	154
Level 3 | Fixed maturity securities | Non-U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		72	81
Level 3 | Fixed maturity securities | Residential mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		116	65
Level 3 | Fixed maturity securities | Commercial mortgage-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		10	5
Level 3 | Fixed maturity securities | Other asset-backed
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale debt securities		1,142	1,420
Level 3 | Equity Securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale equity securities		$ 38	$ 34
[1]	See note 17 for additional information related to consolidated securitization entities.
[2]	Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.

Assets Measured at Fair Value o

Assets Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015		Dec. 31, 2014		Dec. 31, 2013
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		$ 6,051		$ 5,870		$ 6,143
Total realized and unrealized gains (losses), Included in net income (loss)		10		34		(29)
Total realized and unrealized gains (losses), Included in OCI		(127)		58		(22)
Purchases		662		846		563
Sales		(236)		(261)		(304)
Issuances		3		3		3
Settlements		(683)		(679)		(773)
Transfer into Level 3		415	[1]	672	[2]	560	[2]
Transfer out of Level 3		(594)	[1]	(492)	[2]	(271)	[2]
Ending balance		5,501		6,051		5,870
Total gains (losses) included in net income (loss) attributable to assets still held		24		16		(34)
Other assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	[3]			0		9
Total realized and unrealized gains (losses), Included in net income (loss)	[3]					0
Total realized and unrealized gains (losses), Included in OCI	[3]					0
Purchases	[3]					0
Sales	[3]					0
Issuances	[3]					0
Settlements	[3]					(9)
Transfer into Level 3	[2],[3]					0
Transfer out of Level 3	[2],[3]					0
Ending balance	[3]					0
Total gains (losses) included in net income (loss) attributable to assets still held	[3]					0
Restricted other invested assets related to securitization entities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	[4]	230		211		194
Total realized and unrealized gains (losses), Included in net income (loss)	[4]	2		19		(1)
Total realized and unrealized gains (losses), Included in OCI	[4]	0		0		0
Purchases	[4]	0		0		19
Sales	[4]	0		0		0
Issuances	[4]	0		0		0
Settlements	[4]	0		0		(20)
Transfer into Level 3	[4]	0	[1]	0	[2]	19	[2]
Transfer out of Level 3	[4]	0	[1]	0	[2]	0	[2]
Ending balance	[4]	232		230		211
Total gains (losses) included in net income (loss) attributable to assets still held	[4]	2		18		(1)
Reinsurance recoverable
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	[5]	13		(1)		10
Total realized and unrealized gains (losses), Included in net income (loss)	[5]	1		11		(14)
Total realized and unrealized gains (losses), Included in OCI	[5]	0		0		0
Purchases	[5]	0		0		0
Sales	[5]	0		0		0
Issuances	[5]	3		3		3
Settlements	[5]	0		0		0
Transfer into Level 3	[5]	0	[1]	0	[2]	0	[2]
Transfer out of Level 3	[5]	0	[1]	0	[2]	0	[2]
Ending balance	[5]	17		13		(1)
Total gains (losses) included in net income (loss) attributable to assets still held	[5]	1		11		(14)
Fixed maturity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		5,754		5,523		5,721
Total realized and unrealized gains (losses), Included in net income (loss)		33		37		10
Total realized and unrealized gains (losses), Included in OCI		(127)		58		(22)
Purchases		618		809		500
Sales		(230)		(222)		(240)
Issuances		0		0		0
Settlements		(680)		(669)		(716)
Transfer into Level 3		406	[1]	672	[2]	541	[2]
Transfer out of Level 3		(594)	[1]	(454)	[2]	(271)	[2]
Ending balance		5,180		5,754		5,523
Total gains (losses) included in net income (loss) attributable to assets still held		24		15		15
Fixed maturity securities | U.S. government, agencies and government-sponsored enterprises
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		4		5		9
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		0
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		0		0		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(1)		(1)		(4)
Transfer into Level 3		0	[1]	0	[2]	0	[2]
Transfer out of Level 3		0	[1]	0	[2]	0	[2]
Ending balance		3		4		5
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | State and Political Subdivisions
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		30		27		25
Total realized and unrealized gains (losses), Included in net income (loss)		3		2		2
Total realized and unrealized gains (losses), Included in OCI		7		(4)		0
Purchases		5		5		0
Sales		0		0		0
Issuances		0		0		0
Settlements		0		0		0
Transfer into Level 3		0	[1]	0	[2]	0	[2]
Transfer out of Level 3		(10)	[1]	0	[2]	0	[2]
Ending balance		35		30		27
Total gains (losses) included in net income (loss) attributable to assets still held		3		2		2
Fixed maturity securities | Non-U.S. government
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		7		23		9
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(1)		0		1
Purchases		0		2		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(1)		(2)		(2)
Transfer into Level 3		0	[1]	0	[2]	16	[2]
Transfer out of Level 3		(5)	[1]	(16)	[2]	(1)	[2]
Ending balance		0		7		23
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | U.S. corporate
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		2,419		2,373		2,676
Total realized and unrealized gains (losses), Included in net income (loss)		24		26		15
Total realized and unrealized gains (losses), Included in OCI		(84)		58		(15)
Purchases		294		206		180
Sales		(16)		(60)		(150)
Issuances		0		0		0
Settlements		(191)		(251)		(348)
Transfer into Level 3		137	[1]	301	[2]	185	[2]
Transfer out of Level 3		(254)	[1]	(234)	[2]	(170)	[2]
Ending balance		2,329		2,419		2,373
Total gains (losses) included in net income (loss) attributable to assets still held		19		10		11
Fixed maturity securities | U.S. corporate | Utilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		444		420		414
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(14)		11		15
Purchases		67		12		6
Sales		0		0		(15)
Issuances		0		0		0
Settlements		(16)		(5)		(20)
Transfer into Level 3		10	[1]	58	[2]	57	[2]
Transfer out of Level 3		(42)	[1]	(52)	[2]	(37)	[2]
Ending balance		449		444		420
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | U.S. corporate | Energy
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		285		281		240
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(13)		0		12
Purchases		4		40		42
Sales		(4)		0		(10)
Issuances		0		0		0
Settlements		(11)		(4)		(25)
Transfer into Level 3		0	[1]	27	[2]	26	[2]
Transfer out of Level 3		(8)	[1]	(59)	[2]	(4)	[2]
Ending balance		253		285		281
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | U.S. corporate | Finance and insurance
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		616		433		453
Total realized and unrealized gains (losses), Included in net income (loss)		16		14		13
Total realized and unrealized gains (losses), Included in OCI		(28)		23		(3)
Purchases		90		39		33
Sales		0		(1)		(11)
Issuances		0		0		0
Settlements		(33)		(10)		(9)
Transfer into Level 3		97	[1]	155	[2]	21	[2]
Transfer out of Level 3		(43)	[1]	(37)	[2]	(64)	[2]
Ending balance		715		616		433
Total gains (losses) included in net income (loss) attributable to assets still held		14		3		12
Fixed maturity securities | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		140		224		243
Total realized and unrealized gains (losses), Included in net income (loss)		2		2		(4)
Total realized and unrealized gains (losses), Included in OCI		(3)		2		12
Purchases		29		0		42
Sales		(9)		(38)		(13)
Issuances		0		0		0
Settlements		(40)		(60)		(64)
Transfer into Level 3		0	[1]	10	[2]	8	[2]
Transfer out of Level 3		(10)	[1]	0	[2]	0	[2]
Ending balance		109		140		224
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		(6)
Fixed maturity securities | U.S. corporate | Technology and communications
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		45		60		73
Total realized and unrealized gains (losses), Included in net income (loss)		3		3		2
Total realized and unrealized gains (losses), Included in OCI		(2)		5		(6)
Purchases		0		0		6
Sales		0		(20)		(6)
Issuances		0		0		0
Settlements		0		(13)		(1)
Transfer into Level 3		0	[1]	10	[2]	3	[2]
Transfer out of Level 3		(11)	[1]	0	[2]	(11)	[2]
Ending balance		35		45		60
Total gains (losses) included in net income (loss) attributable to assets still held		3		3		2
Fixed maturity securities | U.S. corporate | Industrial
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		36		24		29
Total realized and unrealized gains (losses), Included in net income (loss)		0		2		0
Total realized and unrealized gains (losses), Included in OCI		(3)		1		1
Purchases		28		27		0
Sales		0		0		0
Issuances		0		0		0
Settlements		0		(15)		(6)
Transfer into Level 3		0	[1]	0	[2]	0	[2]
Transfer out of Level 3		0	[1]	(3)	[2]	0	[2]
Ending balance		61		36		24
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | U.S. corporate | Capital goods
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		166		139		169
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		1
Total realized and unrealized gains (losses), Included in OCI		(6)		3		4
Purchases		30		8		15
Sales		(3)		0		(35)
Issuances		0		0		0
Settlements		(1)		0		(14)
Transfer into Level 3		0	[1]	31	[2]	0	[2]
Transfer out of Level 3		(6)	[1]	(15)	[2]	(1)	[2]
Ending balance		180		166		139
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		1
Fixed maturity securities | U.S. corporate | Consumer-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		363		386		496
Total realized and unrealized gains (losses), Included in net income (loss)		1		1		1
Total realized and unrealized gains (losses), Included in OCI		(8)		1		8
Purchases		39		62		27
Sales		0		(1)		(46)
Issuances		0		0		0
Settlements		(52)		(86)		(107)
Transfer into Level 3		11	[1]	0	[2]	35	[2]
Transfer out of Level 3		(115)	[1]	0	[2]	(28)	[2]
Ending balance		239		363		386
Total gains (losses) included in net income (loss) attributable to assets still held		0		1		0
Fixed maturity securities | U.S. corporate | Transportation
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		153		196		205
Total realized and unrealized gains (losses), Included in net income (loss)		1		2		1
Total realized and unrealized gains (losses), Included in OCI		(5)		4		0
Purchases		7		10		9
Sales		0		0		0
Issuances		0		0		0
Settlements		(31)		(11)		(36)
Transfer into Level 3		0	[1]	0	[2]	18	[2]
Transfer out of Level 3		(19)	[1]	(48)	[2]	(1)	[2]
Ending balance		106		153		196
Total gains (losses) included in net income (loss) attributable to assets still held		1		2		1
Fixed maturity securities | U.S. corporate | Other
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		171		210		354
Total realized and unrealized gains (losses), Included in net income (loss)		1		2		1
Total realized and unrealized gains (losses), Included in OCI		(2)		8		(58)
Purchases		0		8		0
Sales		0		0		(14)
Issuances		0		0		0
Settlements		(7)		(47)		(66)
Transfer into Level 3		19	[1]	10	[2]	17	[2]
Transfer out of Level 3		0	[1]	(20)	[2]	(24)	[2]
Ending balance		182		171		210
Total gains (losses) included in net income (loss) attributable to assets still held		1		1		1
Fixed maturity securities | Non-U.S. corporate
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		1,804		1,819		1,960
Total realized and unrealized gains (losses), Included in net income (loss)		4		4		3
Total realized and unrealized gains (losses), Included in OCI		(49)		8		(24)
Purchases		100		282		120
Sales		(24)		(124)		(33)
Issuances		0		0		0
Settlements		(208)		(223)		(214)
Transfer into Level 3		16	[1]	107	[2]	69	[2]
Transfer out of Level 3		(98)	[1]	(69)	[2]	(62)	[2]
Ending balance		1,545		1,804		1,819
Total gains (losses) included in net income (loss) attributable to assets still held		2		2		2
Fixed maturity securities | Non-U.S. corporate | Utilities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		328		260		242
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(4)		6		8
Purchases		18		54		10
Sales		0		0		0
Issuances		0		0		0
Settlements		(46)		(14)		0
Transfer into Level 3		0	[1]	22	[2]	0	[2]
Transfer out of Level 3		(9)	[1]	0	[2]	0	[2]
Ending balance		287		328		260
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | Non-U.S. corporate | Energy
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		324		320		286
Total realized and unrealized gains (losses), Included in net income (loss)		(1)		0		1
Total realized and unrealized gains (losses), Included in OCI		(21)		(14)		7
Purchases		15		55		7
Sales		(24)		0		(14)
Issuances		0		0		0
Settlements		(41)		(48)		(17)
Transfer into Level 3		0	[1]	20	[2]	50	[2]
Transfer out of Level 3		0	[1]	(9)	[2]	0	[2]
Ending balance		252		324		320
Total gains (losses) included in net income (loss) attributable to assets still held		(1)		0		0
Fixed maturity securities | Non-U.S. corporate | Finance and insurance
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		221		181		245
Total realized and unrealized gains (losses), Included in net income (loss)		5		3		2
Total realized and unrealized gains (losses), Included in OCI		(6)		32		(16)
Purchases		21		71		21
Sales		0		(42)		(19)
Issuances		0		0		0
Settlements		(26)		(8)		(9)
Transfer into Level 3		0	[1]	21	[2]	18	[2]
Transfer out of Level 3		(24)	[1]	(37)	[2]	(61)	[2]
Ending balance		191		221		181
Total gains (losses) included in net income (loss) attributable to assets still held		3		2		2
Fixed maturity securities | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		197		212		194
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(1)		(4)		(1)
Purchases		15		35		42
Sales		0		0		0
Issuances		0		0		0
Settlements		(41)		(46)		(23)
Transfer into Level 3		0	[1]	0	[2]	0	[2]
Transfer out of Level 3		(1)	[1]	0	[2]	0	[2]
Ending balance		169		197		212
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | Non-U.S. corporate | Technology and communications
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		42		58		69
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(4)		(1)		1
Purchases		24		20		0
Sales		0		(35)		0
Issuances		0		0		0
Settlements		0		0		(12)
Transfer into Level 3		0	[1]	0	[2]	0	[2]
Transfer out of Level 3		0	[1]	0	[2]	0	[2]
Ending balance		62		42		58
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | Non-U.S. corporate | Industrial
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		131		151		207
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(4)		2		1
Purchases		7		0		21
Sales		0		(12)		0
Issuances		0		0		0
Settlements		(18)		0		(77)
Transfer into Level 3		1	[1]	0	[2]	0	[2]
Transfer out of Level 3		(33)	[1]	(10)	[2]	(1)	[2]
Ending balance		84		131		151
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | Non-U.S. corporate | Capital goods
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		237		299		329
Total realized and unrealized gains (losses), Included in net income (loss)		0		1		0
Total realized and unrealized gains (losses), Included in OCI		(7)		(3)		11
Purchases		0		30		4
Sales		0		(35)		0
Issuances		0		0		0
Settlements		(17)		(52)		(45)
Transfer into Level 3		0	[1]	10	[2]	0	[2]
Transfer out of Level 3		0	[1]	(13)	[2]	0	[2]
Ending balance		213		237		299
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		89		96		106
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(2)		0		4
Purchases		0		6		15
Sales		0		0		0
Issuances		0		0		0
Settlements		0		(13)		(30)
Transfer into Level 3		15	[1]	0	[2]	1	[2]
Transfer out of Level 3		(31)	[1]	0	[2]	0	[2]
Ending balance		71		89		96
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | Non-U.S. corporate | Transportation
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		154		153		147
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		0
Total realized and unrealized gains (losses), Included in OCI		(2)		1		7
Purchases		0		11		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(8)		(25)		(1)
Transfer into Level 3		0	[1]	14	[2]	0	[2]
Transfer out of Level 3		0	[1]	0	[2]	0	[2]
Ending balance		144		154		153
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | Non-U.S. corporate | Other
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		81		89		135
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		0
Total realized and unrealized gains (losses), Included in OCI		2		(11)		(46)
Purchases		0		0		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(11)		(17)		0
Transfer into Level 3		0	[1]	20	[2]	0	[2]
Transfer out of Level 3		0	[1]	0	[2]	0	[2]
Ending balance		72		81		89
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | Residential mortgage-backed
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		65		104		143
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		(9)
Total realized and unrealized gains (losses), Included in OCI		(1)		(3)		7
Purchases		58		16		0
Sales		0		(23)		(8)
Issuances		0		0		0
Settlements		(10)		(9)		(27)
Transfer into Level 3		76	[1]	13	[2]	14	[2]
Transfer out of Level 3		(72)	[1]	(33)	[2]	(16)	[2]
Ending balance		116		65		104
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Fixed maturity securities | Commercial mortgage-backed
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		5		6		35
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		(5)
Total realized and unrealized gains (losses), Included in OCI		(1)		2		(1)
Purchases		9		0		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(2)		(2)		(32)
Transfer into Level 3		13	[1]	7	[2]	11	[2]
Transfer out of Level 3		(14)	[1]	(8)	[2]	(2)	[2]
Ending balance		10		5		6
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		(4)
Fixed maturity securities | Other asset-backed
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		1,420		1,166		864
Total realized and unrealized gains (losses), Included in net income (loss)		2		5		4
Total realized and unrealized gains (losses), Included in OCI		2		(3)		10
Purchases		152		298		200
Sales		(190)		(15)		(49)
Issuances		0		0		0
Settlements		(267)		(181)		(89)
Transfer into Level 3		164	[1]	244	[2]	246	[2]
Transfer out of Level 3		(141)	[1]	(94)	[2]	(20)	[2]
Ending balance		1,142		1,420		1,166
Total gains (losses) included in net income (loss) attributable to assets still held		0		1		4
Equity Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		34		78		99
Total realized and unrealized gains (losses), Included in net income (loss)		0		0		2
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		1		1		1
Sales		(6)		(38)		(24)
Issuances		0		0		0
Settlements		0		0		0
Transfer into Level 3		9	[1]	0	[2]	0	[2]
Transfer out of Level 3		0	[1]	(7)	[2]	0	[2]
Ending balance		38		34		78
Total gains (losses) included in net income (loss) attributable to assets still held		0		0		0
Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		20		59		110
Total realized and unrealized gains (losses), Included in net income (loss)		(26)		(33)		(26)
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		43		36		43
Sales		0		(1)		(40)
Issuances		0		0		0
Settlements		(3)		(10)		(28)
Transfer into Level 3		0	[1]	0	[2]	0	[2]
Transfer out of Level 3		0	[1]	(31)	[2]	0	[2]
Ending balance		34		20		59
Total gains (losses) included in net income (loss) attributable to assets still held		(3)		(28)		(34)
Other invested assets | Derivative assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		20		25		34
Total realized and unrealized gains (losses), Included in net income (loss)		(26)		(33)		(33)
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		43		36		43
Sales		0		(1)		0
Issuances		0		0		0
Settlements		(3)		(7)		(19)
Transfer into Level 3		0	[1]	0	[2]	0	[2]
Transfer out of Level 3		0	[1]	0	[2]	0	[2]
Ending balance		34		20		25
Total gains (losses) included in net income (loss) attributable to assets still held		(3)		(28)		(36)
Other invested assets | Trading Securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		0		34		76
Total realized and unrealized gains (losses), Included in net income (loss)				0		7
Total realized and unrealized gains (losses), Included in OCI				0		0
Purchases				0		0
Sales				0		(40)
Issuances				0		0
Settlements				(3)		(9)
Transfer into Level 3	[2]			0		0
Transfer out of Level 3	[2]			(31)		0
Ending balance				0		34
Total gains (losses) included in net income (loss) attributable to assets still held				0		2
Other invested assets | Credit default swaps | Derivative assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		3		10		7
Total realized and unrealized gains (losses), Included in net income (loss)		1		0		12
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		0		0		0
Sales		0		0		0
Issuances		0		0		0
Settlements		(3)		(7)		(9)
Transfer into Level 3		0	[1]	0	[2]	0	[2]
Transfer out of Level 3		0	[1]	0	[2]	0	[2]
Ending balance		1		3		10
Total gains (losses) included in net income (loss) attributable to assets still held		1		0		6
Other invested assets | Equity index options | Derivative assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		17		12		25
Total realized and unrealized gains (losses), Included in net income (loss)		(25)		(31)		(43)
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		38		36		39
Sales		0		0		0
Issuances		0		0		0
Settlements		0		0		(9)
Transfer into Level 3		0	[1]	0	[2]	0	[2]
Transfer out of Level 3		0	[1]	0	[2]	0	[2]
Ending balance		30		17		12
Total gains (losses) included in net income (loss) attributable to assets still held		(3)		(28)		(40)
Other invested assets | Other foreign currency contracts | Derivative assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		0		3		0
Total realized and unrealized gains (losses), Included in net income (loss)		(2)		(2)		(1)
Total realized and unrealized gains (losses), Included in OCI		0		0		0
Purchases		5		0		4
Sales		0		(1)		0
Issuances		0		0		0
Settlements		0		0		0
Transfer into Level 3		0	[1]	0	[2]	0	[2]
Transfer out of Level 3		0	[1]	0	[2]	0	[2]
Ending balance		3		0		3
Total gains (losses) included in net income (loss) attributable to assets still held		$ (1)		0		(1)
Other invested assets | Interest rate swaps | Derivative assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance				$ 0		2
Total realized and unrealized gains (losses), Included in net income (loss)						(1)
Total realized and unrealized gains (losses), Included in OCI						0
Purchases						0
Sales						0
Issuances						0
Settlements						(1)
Transfer into Level 3	[2]					0
Transfer out of Level 3	[2]					0
Ending balance						0
Total gains (losses) included in net income (loss) attributable to assets still held						$ (1)
[1]	The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads, as well as changes in the industry sectors assigned to specific securities.
[2]	The transfers into and out of Level 3 for fixed maturity securities were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value, such as external ratings or credit spreads.
[3]	Represents contingent receivables associated with recent business dispositions.
[4]	See note 17 for additional information related to consolidated securitization entities.
[5]	Represents embedded derivatives associated with the reinsured portion of our GMWB liabilities.

Gains and Losses Included in Ne

Gains and Losses Included in Net Income (Loss) from Assets and Liabilities Recorded at Fair Value (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Fair value of financial instruments [Abstract]
Total realized and unrealized gains (losses) included in net income (loss), assets	$ 10	$ 34	$ (29)
Total gains (losses) included in net income (loss) attributable to assets still held, assets	24	16	(34)
Total realized and unrealized (gains) losses included in net (income) loss, liabilities	16	177	(339)
Total (gains) losses included in net (income) loss attributable to liabilities still held, liabilities	48	178	(337)
Net Investment Income
Fair value of financial instruments [Abstract]
Total realized and unrealized gains (losses) included in net income (loss), assets	42	44	36
Total gains (losses) included in net income (loss) attributable to assets still held, assets	33	19	35
Total realized and unrealized (gains) losses included in net (income) loss, liabilities	0	0	0
Total (gains) losses included in net (income) loss attributable to liabilities still held, liabilities	0	0	0
Net Investment Gains (Losses)
Fair value of financial instruments [Abstract]
Total realized and unrealized gains (losses) included in net income (loss), assets	(32)	(10)	(65)
Total gains (losses) included in net income (loss) attributable to assets still held, assets	(9)	(3)	(69)
Total realized and unrealized (gains) losses included in net (income) loss, liabilities	16	177	(339)
Total (gains) losses included in net (income) loss attributable to liabilities still held, liabilities	$ 48	$ 178	$ (337)

Liabilities by Class of Instrum

Liabilities by Class of Instrument that are Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		$ 1,063	$ 884
Borrowings related to securitization entities	[1]	81	85
Total liabilities		1,144	969
Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		704	574
Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[2]	352	291
Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		342	276
Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		10	7
Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		359	310
Other liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		220	204
Other liabilities | Interest rate swaps related to securitization entities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	30	26
Other liabilities | Inflation indexed swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		33	42
Other liabilities | Foreign currency swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		27	7
Other liabilities | Credit default swaps related to securitization entities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	14	17
Other liabilities | Equity return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		1	1
Other liabilities | Other foreign currency contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		34	13
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Borrowings related to securitization entities	[1]	0	0
Total liabilities		0	0
Level 1 | Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 1 | Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[2]	0	0
Level 1 | Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 1 | Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 1 | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 1 | Other liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 1 | Other liabilities | Interest rate swaps related to securitization entities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	0	0
Level 1 | Other liabilities | Inflation indexed swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 1 | Other liabilities | Foreign currency swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 1 | Other liabilities | Credit default swaps related to securitization entities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	0	0
Level 1 | Other liabilities | Equity return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 1 | Other liabilities | Other foreign currency contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Borrowings related to securitization entities	[1]	0	0
Total liabilities		345	293
Level 2 | Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 2 | Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[2]	0	0
Level 2 | Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 2 | Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 2 | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		345	293
Level 2 | Other liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		220	204
Level 2 | Other liabilities | Interest rate swaps related to securitization entities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	30	26
Level 2 | Other liabilities | Inflation indexed swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		33	42
Level 2 | Other liabilities | Foreign currency swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		27	7
Level 2 | Other liabilities | Credit default swaps related to securitization entities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	0	0
Level 2 | Other liabilities | Equity return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		1	1
Level 2 | Other liabilities | Other foreign currency contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		34	13
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Borrowings related to securitization entities	[1]	81	85
Total liabilities		799	676
Level 3 | Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		704	574
Level 3 | Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[2]	352	291
Level 3 | Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		342	276
Level 3 | Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		10	7
Level 3 | Other liabilities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		14	17
Level 3 | Other liabilities | Interest rate swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 3 | Other liabilities | Interest rate swaps related to securitization entities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	0	0
Level 3 | Other liabilities | Inflation indexed swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 3 | Other liabilities | Foreign currency swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 3 | Other liabilities | Credit default swaps related to securitization entities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value	[1]	14	17
Level 3 | Other liabilities | Equity return swaps
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		0	0
Level 3 | Other liabilities | Other foreign currency contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative liabilities, fair value		$ 0	$ 0
[1]	See note 17 for additional information related to consolidated securitization entities.
[2]	Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.

Liabilities Measured at Fair Va

Liabilities Measured at Fair Value on Recurring Basis and Utilized Significant Unobservable (Level 3) Inputs to Determine Fair Value (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		$ 676	$ 347	$ 544
Total realized and unrealized (gains) losses included in net (income) loss		16	177	(339)
Total realized and unrealized (gains) losses included in OCI		0	0	0
Purchases		4	4	8
Sales		0	(2)	0
Issuances		109	152	135
Settlements		(6)	(2)	(1)
Transfer into Level 3		0	0	0
Transfer out of Level 3		0	0	0
Ending balance		799	676	347
Total (gains) losses included in net (income) loss attributable to liabilities still held		48	178	(337)
Derivative liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		17	33	105
Total realized and unrealized (gains) losses included in net (income) loss		(7)	(18)	(79)
Total realized and unrealized (gains) losses included in OCI		0	0	0
Purchases		4	4	8
Sales		0	(2)	0
Issuances		0	0	0
Settlements		0	0	(1)
Transfer into Level 3		0	0	0
Transfer out of Level 3		0	0	0
Ending balance		14	17	33
Total (gains) losses included in net (income) loss attributable to liabilities still held		21	(19)	(79)
Policyholder account balances
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		574	239	377
Total realized and unrealized (gains) losses included in net (income) loss		27	186	(273)
Total realized and unrealized (gains) losses included in OCI		0	0	0
Purchases		0	0	0
Sales		0	0	0
Issuances		109	151	135
Settlements		(6)	(2)	0
Transfer into Level 3		0	0	0
Transfer out of Level 3		0	0	0
Ending balance		704	574	239
Total (gains) losses included in net (income) loss attributable to liabilities still held		31	188	(271)
Policyholder account balances | GMWB embedded derivatives
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	[1]	291	96	350
Total realized and unrealized (gains) losses included in net (income) loss	[1]	26	158	(291)
Total realized and unrealized (gains) losses included in OCI	[1]	0	0	0
Purchases	[1]	0	0	0
Sales	[1]	0	0	0
Issuances	[1]	35	37	37
Settlements	[1]	0	0	0
Transfer into Level 3	[1]	0	0	0
Transfer out of Level 3	[1]	0	0	0
Ending balance	[1]	352	291	96
Total (gains) losses included in net (income) loss attributable to liabilities still held	[1]	30	160	(289)
Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		276	143	27
Total realized and unrealized (gains) losses included in net (income) loss		7	27	18
Total realized and unrealized (gains) losses included in OCI		0	0	0
Purchases		0	0	0
Sales		0	0	0
Issuances		65	108	98
Settlements		(6)	(2)	0
Transfer into Level 3		0	0	0
Transfer out of Level 3		0	0	0
Ending balance		342	276	143
Total (gains) losses included in net (income) loss attributable to liabilities still held		7	27	18
Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		7	0
Total realized and unrealized (gains) losses included in net (income) loss		(6)	1
Total realized and unrealized (gains) losses included in OCI		0	0
Purchases		0	0
Sales		0	0
Issuances		9	6
Settlements		0	0
Transfer into Level 3		0	0
Transfer out of Level 3		0	0
Ending balance		10	7	0
Total (gains) losses included in net (income) loss attributable to liabilities still held		(6)	1
Credit default swaps related to securitization entities | Derivative liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	[2]	17	32	104
Total realized and unrealized (gains) losses included in net (income) loss	[2]	(7)	(19)	(77)
Total realized and unrealized (gains) losses included in OCI	[2]	0	0	0
Purchases	[2]	4	4	5
Sales	[2]	0	0	0
Issuances	[2]	0	0	0
Settlements	[2]	0	0	0
Transfer into Level 3	[2]	0	0	0
Transfer out of Level 3	[2]	0	0	0
Ending balance	[2]	14	17	32
Total (gains) losses included in net (income) loss attributable to liabilities still held	[2]	21	(19)	(77)
Borrowings related to securitization entities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance	[2]	85	75	62
Total realized and unrealized (gains) losses included in net (income) loss	[2]	(4)	9	13
Total realized and unrealized (gains) losses included in OCI	[2]	0	0	0
Purchases	[2]	0	0	0
Sales	[2]	0	0	0
Issuances	[2]	0	1	0
Settlements	[2]	0	0	0
Transfer into Level 3	[2]	0	0	0
Transfer out of Level 3	[2]	0	0	0
Ending balance	[2]	81	85	75
Total (gains) losses included in net (income) loss attributable to liabilities still held	[2]	(4)	9	13
Other foreign currency contracts | Derivative liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance		$ 0	1	0
Total realized and unrealized (gains) losses included in net (income) loss			1	(2)
Total realized and unrealized (gains) losses included in OCI			0	0
Purchases			0	3
Sales			(2)	0
Issuances			0	0
Settlements			0	0
Transfer into Level 3			0	0
Transfer out of Level 3			0	0
Ending balance			0	1
Total (gains) losses included in net (income) loss attributable to liabilities still held			0	(2)
Credit default swaps | Derivative liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance			0	1
Total realized and unrealized (gains) losses included in net (income) loss				(1)
Total realized and unrealized (gains) losses included in OCI				0
Purchases				0
Sales				0
Issuances				0
Settlements				0
Transfer into Level 3				0
Transfer out of Level 3				0
Ending balance				0
Total (gains) losses included in net (income) loss attributable to liabilities still held				(1)
Equity index options | Derivative liabilities
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Beginning balance			$ 0	0
Total realized and unrealized (gains) losses included in net (income) loss				1
Total realized and unrealized (gains) losses included in OCI				0
Purchases				0
Sales				0
Issuances				0
Settlements				(1)
Transfer into Level 3				0
Transfer out of Level 3				0
Ending balance				0
Total (gains) losses included in net (income) loss attributable to liabilities still held				$ 1
[1]	Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.
[2]	See note 17 for additional information related to consolidated securitization entities.

Summary of Significant Unobserv

Summary of Significant Unobservable Inputs Used for Fair Value Measurements Classified As Level 3 (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fixed maturity securities available-for-sale, at fair value		$ 58,197	$ 61,077
Derivative liabilities, fair value		1,063	884
Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value		704	574
Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value	[1]	352	291
Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value		342	276
Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value		10	7
Level 3 | Policyholder account balances
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Derivative liabilities, fair value		$ 704	574
Level 3 | Policyholder account balances | GMWB embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique	[1]	Stochastic cash flow model
Derivative liabilities, fair value	[1]	$ 352	291
Fair value, withdrawal utilization rate, lower limit	[1]	0.00%
Fair value, withdrawal utilization rate, upper limit	[1]	98.00%
Fair value, lapse rate, lower limit	[1]	0.00%
Fair value, lapse rate, upper limit	[1]	15.00%
Fair value input, credit spreads, lower limit	[1]	0.40%
Fair value input, credit spreads, upper limit	[1]	0.85%
Fair value input, equity index volatility, lower limit	[1]	17.00%
Fair value input, equity index volatility, upper limit	[1]	24.00%
Fair value, withdrawal utilization rate, weighted-average		66.00%
Fair value, lapse rate, weighted-average		6.00%
Fair value input, credit spreads, weighted-average	[1]	0.70%
Fair value input, equity index volatility, weighted-average	[1]	21.00%
Level 3 | Policyholder account balances | Fixed index annuity embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Option budget method
Derivative liabilities, fair value		$ 342	276
Fair value, expected future interest credited, lower limit		0.00%
Fair value, expected future interest credited, upper limit		3.00%
Fair value, expected future interest credited, weighted-average		2.00%
Level 3 | Policyholder account balances | Indexed universal life embedded derivatives
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Option budget method
Derivative liabilities, fair value		$ 10	$ 7
Fair value, expected future interest credited, lower limit		3.00%
Fair value, expected future interest credited, upper limit		10.00%
Fair value, expected future interest credited, weighted-average		6.00%
Other invested assets | Level 3 | Equity index options
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Discounted cash flows
Derivative assets, fair value		$ 30
Fair value input, equity index volatility, lower limit		0.00%
Fair value input, equity index volatility, upper limit		23.00%
Fair value input, equity index volatility, weighted-average		17.00%
Other invested assets | Level 3 | Other foreign currency contracts
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Fair value input, interest rate volatility, lower limit		24.00%
Valuation technique		Discounted cash flows
Fair value input, interest rate volatility, upper limit		25.00%
Derivative liabilities, fair value		$ 3
Fair value input, foreign exchange volatility, lower limit		9.00%
Fair value input, foreign exchange volatility, upper limit		13.00%
Fair value input, interest rate volatility, weighted-average		25.00%
Fair value input, foreign exchange volatility, weighted-average		12.00%
Other invested assets | Level 3 | Credit default swaps
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique	[2]	Discounted cash flows
Derivative assets, fair value	[2]	$ 1
Fair value input, credit spreads	[2]	0.05%
Internal Models | Level 3 | U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 2,050
Fair value input, credit spreads, lower limit		0.66%
Fair value input, credit spreads, upper limit		6.44%
Fair value input, credit spreads, weighted-average		2.25%
Internal Models | Level 3 | U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 425
Fair value input, credit spreads, lower limit		1.00%
Fair value input, credit spreads, upper limit		3.46%
Fair value input, credit spreads, weighted-average		1.77%
Internal Models | Level 3 | U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 141
Fair value input, credit spreads, lower limit		1.24%
Fair value input, credit spreads, upper limit		3.65%
Fair value input, credit spreads, weighted-average		2.08%
Internal Models | Level 3 | U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 598
Fair value input, credit spreads, lower limit		0.96%
Fair value input, credit spreads, upper limit		6.44%
Fair value input, credit spreads, weighted-average		2.52%
Internal Models | Level 3 | U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 109
Fair value input, credit spreads, lower limit		1.50%
Fair value input, credit spreads, upper limit		4.95%
Fair value input, credit spreads, weighted-average		2.80%
Internal Models | Level 3 | U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 61
Fair value input, credit spreads, lower limit		2.52%
Fair value input, credit spreads, upper limit		3.54%
Fair value input, credit spreads, weighted-average		3.05%
Internal Models | Level 3 | U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 180
Fair value input, credit spreads, lower limit		0.94%
Fair value input, credit spreads, upper limit		5.16%
Fair value input, credit spreads, weighted-average		2.26%
Internal Models | Level 3 | U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 239
Fair value input, credit spreads, lower limit		0.94%
Fair value input, credit spreads, upper limit		3.50%
Fair value input, credit spreads, weighted-average		2.30%
Internal Models | Level 3 | U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 95
Fair value input, credit spreads, lower limit		0.66%
Fair value input, credit spreads, upper limit		3.35%
Fair value input, credit spreads, weighted-average		2.23%
Internal Models | Level 3 | U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 167
Fair value input, credit spreads, lower limit		0.82%
Fair value input, credit spreads, upper limit		4.95%
Fair value input, credit spreads, weighted-average		1.54%
Internal Models | Level 3 | U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 35
Fair value input, credit spreads		4.03%
Internal Models | Level 3 | Non-U.S. corporate
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 1,418
Fair value input, credit spreads, lower limit		0.94%
Fair value input, credit spreads, upper limit		7.14%
Fair value input, credit spreads, weighted-average		2.22%
Internal Models | Level 3 | Non-U.S. corporate | Utilities
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 287
Fair value input, credit spreads, lower limit		1.12%
Fair value input, credit spreads, upper limit		2.12%
Fair value input, credit spreads, weighted-average		1.57%
Internal Models | Level 3 | Non-U.S. corporate | Energy
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 213
Fair value input, credit spreads, lower limit		1.46%
Fair value input, credit spreads, upper limit		5.52%
Fair value input, credit spreads, weighted-average		2.65%
Internal Models | Level 3 | Non-U.S. corporate | Finance and insurance
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 181
Fair value input, credit spreads, lower limit		1.25%
Fair value input, credit spreads, upper limit		2.30%
Fair value input, credit spreads, weighted-average		1.47%
Internal Models | Level 3 | Non-U.S. corporate | Consumer-non-cyclical
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 155
Fair value input, credit spreads, lower limit		0.94%
Fair value input, credit spreads, upper limit		3.32%
Fair value input, credit spreads, weighted-average		2.13%
Internal Models | Level 3 | Non-U.S. corporate | Industrial
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 70
Fair value input, credit spreads, lower limit		1.50%
Fair value input, credit spreads, upper limit		2.80%
Fair value input, credit spreads, weighted-average		2.53%
Internal Models | Level 3 | Non-U.S. corporate | Capital goods
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 180
Fair value input, credit spreads, lower limit		1.50%
Fair value input, credit spreads, upper limit		4.40%
Fair value input, credit spreads, weighted-average		2.59%
Internal Models | Level 3 | Non-U.S. corporate | Consumer-cyclical
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 71
Fair value input, credit spreads, lower limit		1.09%
Fair value input, credit spreads, upper limit		3.54%
Fair value input, credit spreads, weighted-average		2.36%
Internal Models | Level 3 | Non-U.S. corporate | Transportation
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 144
Fair value input, credit spreads, lower limit		1.20%
Fair value input, credit spreads, upper limit		3.54%
Fair value input, credit spreads, weighted-average		1.97%
Internal Models | Level 3 | Non-U.S. corporate | Other
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 55
Fair value input, credit spreads, lower limit		3.54%
Fair value input, credit spreads, upper limit		7.14%
Fair value input, credit spreads, weighted-average		4.64%
Internal Models | Level 3 | Non-U.S. corporate | Technology and communications
Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Valuation technique		Internal models
Fixed maturity securities available-for-sale, at fair value		$ 62
Fair value input, credit spreads, lower limit		1.79%
Fair value input, credit spreads, upper limit		5.52%
Fair value input, credit spreads, weighted-average		3.12%
[1]	Represents embedded derivatives associated with our GMWB liabilities, excluding the impact of reinsurance.
[2]	Unobservable input valuation based on the current market credit default swap premium.

Schedule of Securitized Assets

Schedule of Securitized Assets (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Variable Interest Entity [Line Items]
Total assets	$ 106,431	$ 111,316
Securitized assets not required to be consolidated
Variable Interest Entity [Line Items]
Total assets	136	142
Securitized assets required to be consolidated
Variable Interest Entity [Line Items]
Total assets	267	300
Total securitized assets
Variable Interest Entity [Line Items]
Total assets	403	442
Other assets | Securitized assets not required to be consolidated
Variable Interest Entity [Line Items]
Total assets	$ 136	$ 142

Assets and Liabilities Recorded

Assets and Liabilities Recorded for Consolidated Securitization Entities (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Variable Interest Entity [Line Items]
Restricted commercial mortgage loans	$ 161	$ 201
Total restricted other invested assets	413	411
Total investments	69,128	71,773
Cash and cash equivalents	5,965	4,645	$ 3,657
Accrued investment income	653	660
Other assets	520	479
Derivative liabilities	1,063	884
Borrowings related to securitization entities	179	219
Securitization entities
Variable Interest Entity [Line Items]
Restricted commercial mortgage loans	161	201
Trading securities	413	411
Total restricted other invested assets	413	411
Total investments	574	612
Cash and cash equivalents	1	1
Accrued investment income	1	1
Other assets	5	0
Total assets	581	614
Derivative liabilities	44	43
Other liabilities	2	2
Total other liabilities	46	45
Borrowings related to securitization entities	179	219
Total liabilities	$ 225	$ 264

Activity Presented in Consolida

Activity Presented in Consolidated Statement of Income Related to Consolidated Securitization Entities (Detail) - USD ($) $ in Millions		3 Months Ended																12 Months Ended
		Dec. 31, 2015		Sep. 30, 2015		Jun. 30, 2015		Mar. 31, 2015		Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Variable Interest Entity [Line Items]
Net investment income																		$ 3,138	$ 3,142	$ 3,155
Derivatives	[1]																	(76)	(103)	(49)
Total net investment gains (losses)	[2]																	5	16	69
Total revenues		$ 2,156	[3]	$ 2,100	[3]	$ 2,157	[3]	$ 2,135	[3]	$ 2,229		$ 2,190		$ 2,194		$ 2,116		8,548	8,729	8,625
Interest expense																		419	433	450
Income before income taxes																		(15)	(1,299)	993
Provision for income taxes																		(9)	(94)	313
Net income		$ (240)	[4],[5]	$ (238)	[4],[5]	$ (139)	[4],[5]	$ 204	[4],[5]	$ (708)	[6]	$ (787)	[6]	$ 228	[6]	$ 219	[6]	(413)	(1,048)	714
Securitization entities
Variable Interest Entity [Line Items]
Restricted commercial mortgage loans																		14	14	23
Restricted other invested assets																		5	5	4
Net investment income																		19	19	27
Trading securities																		(2)	15	(4)
Derivatives																		3	10	86
Borrowings related to securitization entities recorded at fair value																		4	(9)	(13)
Total net investment gains (losses)																		5	16	69
Total revenues																		24	35	96
Interest expense																		9	10	16
Total expenses																		9	10	16
Income before income taxes																		15	25	80
Provision for income taxes																		5	9	27
Net income																		$ 10	$ 16	$ 53
[1]	See note 5 for additional information on the impact of derivative instruments included in net investment gains (losses).
[2]	See note 17 for additional information related to consolidated securitization entities.
[3]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $12 million of higher revenue, which included $5 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements.
[4]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[5]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.
[6]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.

Borrowings Related to Securitiz

Borrowings Related to Securitization Entities (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014
Variable Interest Entity [Line Items]
Principal amount		$ 110	$ 146
Borrowings related to securitization entities		179	219
GFCM LLC, due 2035, 5.2541%
Variable Interest Entity [Line Items]
Principal amount		0	21
Borrowings related to securitization entities		0	21
GFCM LLC, due 2035, 5.7426%
Variable Interest Entity [Line Items]
Principal amount		98	113
Borrowings related to securitization entities		98	113
Marvel Finance 2007-4 LLC, due 2017
Variable Interest Entity [Line Items]
Principal amount	[1],[2]	12	12
Borrowings related to securitization entities	[1],[2]	$ 10	$ 12
Genworth Special Purpose Five, LLC, due 2040
Variable Interest Entity [Line Items]
Principal amount	[1],[2],[3]
Borrowings related to securitization entities	[1],[2]	$ 71	$ 73
[1]	Accrual of interest based on three-month LIBOR that resets every three months plus a fixed margin.
[2]	Carrying value represents fair value as a result of electing fair value option for these liabilities.
[3]	Principal amount not applicable. Notional balance was $118 million and $115 million as of December 31, 2015 and 2014, respectively.

Borrowings Related to Securi149

Borrowings Related to Securitization Entities (Parenthetical) (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014
Genworth Special Purpose Five, LLC, due 2040
Variable Interest Entity [Line Items]
Notional balance	$ 118	$ 115

Insurance Subsidiary Financi150

Insurance Subsidiary Financial Information and Regulatory Matters - Additional Information (Detail) $ in Millions	Apr. 01, 2013USD ($)	Dec. 31, 2015USD ($)	May. 31, 2014USD ($)	Dec. 31, 2013USD ($)	Dec. 31, 2015USD ($)State	Dec. 31, 2014USD ($)	May. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Statutory Accounting Practices [Line Items]
Amount of dividend our subsidiaries could pay in 2015 without obtaining regulatory approval		$ 140			$ 140
Dividends received from insurance subsidiaries					0	$ 0		$ 0
Additional statutory reserves		$ 150			$ 150	70
Statutory contingency reserve, annual additions, percentage of earned premiums, minimum		50.00%			50.00%
Minimum loss ratio requirement to hold statutory contingency reserve		35.00%			35.00%
Period of time when statutory contingency reserve has to be held, in years					10 years
Statutory contingency reserve		$ 500			$ 500	193
Guarantees provided to third parties
Statutory Accounting Practices [Line Items]
Maximum potential amount of future obligation		25			$ 25	28
U.S. Mortgage Insurance subsidiaries
Statutory Accounting Practices [Line Items]
Maximum risk-to-capital ratio					25
Number of states with risk-to-capital requirements | State					15
Genworth Mortgage Insurance Corporation (GMICO)/PMIERs Capital Credit/2009 To 2015 Book Years
Statutory Accounting Practices [Line Items]
Capital credit from reinsurance transaction		535
Genworth Mortgage Insurance Corporation (GMICO)/PMIERs Capital Credit
Statutory Accounting Practices [Line Items]
Intercompany sale of affiliated preferred securities		200
Universal life insurance contracts | Virginia and Delaware
Statutory Accounting Practices [Line Items]
Additional statutory reserves		$ 198			$ 198
U.S. domiciled life insurance subsidiaries
Statutory Accounting Practices [Line Items]
Impact of permitted practices on combined statutory capital and surplus					$ 120	$ 365
Consolidated RBC ratio		393.00%			393.00%	435.00%
Insurance Subsidiary | NEW YORK
Statutory Accounting Practices [Line Items]
Additional statutory reserves		$ 89			$ 89	$ 39
Insurance Subsidiary | NEW YORK | To be recorded over the next three years
Statutory Accounting Practices [Line Items]
Additional statutory reserves		267			267
Domestic subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory capital and surplus		4,270			4,270	4,352
Combined statutory net income (loss)					(319)	(262)		342
Domestic subsidiaries | Captive life reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory capital and surplus		671			671	1,057
Combined statutory net income (loss)					(276)	(281)		(102)
International insurance subsidiaries
Statutory Accounting Practices [Line Items]
Dividends received from insurance subsidiaries					640	630		317
Combined statutory capital and surplus		5,249			5,249	5,773
Combined statutory net income (loss)					412	(66)		573
Statutory capital and surplus required		$ 1,673			1,673	1,642
Increase (decrease) in statutory capital					205	205
Domestic insurance subsidiaries
Statutory Accounting Practices [Line Items]
Dividends received from insurance subsidiaries					41	108		418
Domestic insurance subsidiaries | Extraordinary Dividend
Statutory Accounting Practices [Line Items]
Dividends received from insurance subsidiaries					$ 0	$ 0		$ 0
Genworth Mortgage Insurance Corporation (GMICO)
Statutory Accounting Practices [Line Items]
Capital contribution	$ 100		$ 300	$ 100			$ 300
Genworth Mortgage Insurance Corporation (GMICO) | U.S. Mortgage Insurance subsidiaries
Statutory Accounting Practices [Line Items]
Risk-to-capital ratio		16.4			16.4	14.3
Genworth Financial's Subsidiaries
Statutory Accounting Practices [Line Items]
Restricted net assets		$ 12,700			$ 12,700
Genworth Holdings' Subsidiaries
Statutory Accounting Practices [Line Items]
Restricted net assets		12,800			12,800
Rivermont Insurance Company I
Statutory Accounting Practices [Line Items]
Maximum potential amount of future obligation		15			15
Limited Guarantee Provided to a subsidiary accounted for as a derivative		$ 4			$ 4	$ 5
Brookfield Life and Annuity Insurance Company Limited ("BLAIC") | Long-term Care Insurance
Statutory Accounting Practices [Line Items]
Percent of in-force long-term care insurance business, reinsured					50.00%
Genworth Financial International Holdings, LLC ("GFIH") | Australian Mortgage Insurance Subsidiaries
Statutory Accounting Practices [Line Items]
Ownership percentage		52.00%			52.00%
Genworth Financial International Holdings, LLC ("GFIH") | Canadian Mortgage Insurance Subsidiaries
Statutory Accounting Practices [Line Items]
Ownership percentage		40.60%			40.60%
Genworth Holdings
Statutory Accounting Practices [Line Items]
Maximum potential amount of future obligation		$ 2,000			$ 2,000

Schedule of Statutory Accountin

Schedule of Statutory Accounting Practices (Detail) - Domestic subsidiaries - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	$ (319)	$ (262)	$ 342
Combined statutory capital and surplus	4,270	4,352
Life insurance subsidiaries, excluding captive life reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	(330)	(179)	359
Combined statutory capital and surplus	2,548	2,560
Mortgage insurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	287	198	85
Combined statutory capital and surplus	1,722	1,792
Combined statutory net income (loss), excluding captive reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	(43)	19	444
Captive life reinsurance subsidiaries
Statutory Accounting Practices [Line Items]
Combined statutory net income (loss)	(276)	(281)	$ (102)
Combined statutory capital and surplus	$ 671	$ 1,057

Segment Information - Additiona

Segment Information - Additional Information (Detail) $ in Millions	1 Months Ended	3 Months Ended					12 Months Ended
	Jun. 30, 2013USD ($)	Sep. 30, 2015USD ($)	Dec. 31, 2014USD ($)	Jun. 30, 2014USD ($)	Sep. 30, 2013USD ($)	Jun. 30, 2013USD ($)	Dec. 31, 2015USD ($)Segment	Dec. 31, 2014USD ($)	Dec. 31, 2013USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | Segment							5
Expenses related to restructuring, net						$ 10	$ 5	$ 0	$ 10
Goodwill impairment, net							0	791	0
Gains (losses) from sale of businesses, net							(141)	0	0
Gains (losses) on early extinguishment of debt, net							(2)	(2)	(20)
Gains (losses) from life block transactions, net							(296)	0	0
Tax Impact From Potential Business Portfolio Changes			$ 205				$ 0	$ 205	$ 0
Assumed tax rate on adjustments to net operating income								35.00%
Life Block Transaction | Term Life Insurance
Segment Reporting Information [Line Items]
Gains (losses) from life block transactions, net		$ (296)
Genworth Financial Mortgage Insurance Pty Limited | Floating Rate Junior Notes, Due 2021
Segment Reporting Information [Line Items]
Gains (losses) on early extinguishment of debt, net		$ (1)
Debt instrument, maturity year		2,021					2,021	2,021
Genworth Holdings
Segment Reporting Information [Line Items]
Gains (losses) on early extinguishment of debt, net		$ (1)
Aggregate principal amount of notes repurchased		$ 50
Genworth Holdings | 4.95% Senior Notes, Due 2015
Segment Reporting Information [Line Items]
Gains (losses) on early extinguishment of debt, net					$ (20)
Debt instrument, maturity year	2,015
Aggregate principal amount of notes repurchased	$ 4					$ 4
Genworth Canada | 4.59% senior notes due December 2015
Segment Reporting Information [Line Items]
Gains (losses) on early extinguishment of debt, net				$ (2)
Debt instrument, maturity year				2,015
Legal Entities
Segment Reporting Information [Line Items]
Tax Impact From Potential Business Portfolio Changes			31
Long-term Care Insurance
Segment Reporting Information [Line Items]
Goodwill impairment, net								$ 296
Life Insurance
Segment Reporting Information [Line Items]
Goodwill impairment, net								495
Australia Mortgage Insurance
Segment Reporting Information [Line Items]
Tax Impact From Potential Business Portfolio Changes			$ 174					$ 174

Summary of Segments and Corpora

Summary of Segments and Corporate and Other Activities (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2015		Sep. 30, 2015		Jun. 30, 2015		Mar. 31, 2015		Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Premiums																	$ 4,579	$ 4,700	$ 4,516
Net investment income																	3,138	3,142	3,155
Net investment gains (losses)																	(75)	(22)	(64)
Policy fees and other income																	906	909	1,018
Total revenues	$ 2,156	[1]	$ 2,100	[1]	$ 2,157	[1]	$ 2,135	[1]	$ 2,229		$ 2,190		$ 2,194		$ 2,116		8,548	8,729	8,625
Benefits and other changes in policy reserves																	5,149	6,418	4,737
Interest credited																	720	737	738
Acquisition and operating expenses, net of deferrals																	1,309	1,138	1,244
Amortization of deferred acquisition costs and intangibles																	966	453	463
Goodwill impairment																	0	849	0
Interest expense																	419	433	450
Total benefits and expenses	2,359	[2]	2,451	[2]	1,912	[2]	1,841	[2]	3,153	[3]	3,170	[3]	1,886	[3]	1,819	[3]	8,563	10,028	7,632
Income (loss) from continuing operations before income taxes																	(15)	(1,299)	993
Provision (benefit) for income taxes																	(9)	(94)	313
Income (loss) from continuing operations	(167)	[4]	(217)	[4]	175	[4]	203	[4]	(846)	[5]	(793)	[5]	224	[5]	210	[5]	(6)	(1,205)	680
Income (loss) from discontinued operations, net of taxes	(73)	[6]	(21)	[6]	(314)	[6]	1	[6]	138		6		4		9		(407)	157	34
Net income (loss)	(240)	[4],[6]	(238)	[4],[6]	(139)	[4],[6]	204	[4],[6]	(708)	[5]	(787)	[5]	228	[5]	219	[5]	(413)	(1,048)	714
Less: net income attributable to noncontrolling interests	52		46		54		50		52		57		52		35		202	196	154
Net income (loss) available to Genworth Financial, Inc.'s common stockholders	(292)		$ (284)		$ (193)		$ 154		(760)	[5]	$ (844)	[5]	$ 176	[5]	$ 184	[5]	(615)	(1,244)	560
Total assets	106,431								111,316								106,431	111,316
Segment, Continuing Operations
Segment Reporting Information [Line Items]
Total assets	106,304								109,173								106,304	109,173
Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	127								2,143								127	2,143
U.S. Mortgage Insurance
Segment Reporting Information [Line Items]
Total assets	2,899								2,324								2,899	2,324
U.S. Mortgage Insurance | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	602	578	554
Net investment income																	58	59	60
Net investment gains (losses)																	1	0	0
Policy fees and other income																	4	2	2
Total revenues																	665	639	616
Benefits and other changes in policy reserves																	222	357	412
Interest credited																	0	0	0
Acquisition and operating expenses, net of deferrals																	155	140	144
Amortization of deferred acquisition costs and intangibles																	10	7	6
Goodwill impairment																		0
Interest expense																	0	0	0
Total benefits and expenses																	387	504	562
Income (loss) from continuing operations before income taxes																	278	135	54
Provision (benefit) for income taxes																	99	44	17
Income (loss) from continuing operations																	179	91	37
Income (loss) from discontinued operations, net of taxes																	0	0	0
Net income (loss)																	179	91	37
Less: net income attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	179	91	37
Total assets	2,899								2,324								2,899	2,324
U.S. Mortgage Insurance | Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	0								0								0	0
Canada Mortgage Insurance
Segment Reporting Information [Line Items]
Total assets	4,520								4,920								4,520	4,920
Canada Mortgage Insurance | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	466	515	560
Net investment income																	130	155	170
Net investment gains (losses)																	(32)	(2)	31
Policy fees and other income																	0	1	(1)
Total revenues																	564	669	760
Benefits and other changes in policy reserves																	96	102	139
Interest credited																	0	0	0
Acquisition and operating expenses, net of deferrals																	66	90	93
Amortization of deferred acquisition costs and intangibles																	36	38	37
Goodwill impairment																		0
Interest expense																	18	21	22
Total benefits and expenses																	216	251	291
Income (loss) from continuing operations before income taxes																	348	418	469
Provision (benefit) for income taxes																	90	111	133
Income (loss) from continuing operations																	258	307	336
Income (loss) from discontinued operations, net of taxes																	0	0	0
Net income (loss)																	258	307	336
Less: net income attributable to noncontrolling interests																	118	140	154
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	140	167	182
Total assets	4,520								4,920								4,520	4,920
Canada Mortgage Insurance | Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	0								0								0	0
Australia Mortgage Insurance
Segment Reporting Information [Line Items]
Total assets	2,987								3,494								2,987	3,494
Australia Mortgage Insurance | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	357	406	398
Net investment income																	114	144	159
Net investment gains (losses)																	6	3	(2)
Policy fees and other income																	(3)	(16)	0
Total revenues																	474	537	555
Benefits and other changes in policy reserves																	81	78	134
Interest credited																	0	0	0
Acquisition and operating expenses, net of deferrals																	98	97	110
Amortization of deferred acquisition costs and intangibles																	18	21	22
Goodwill impairment																		0
Interest expense																	10	10	11
Total benefits and expenses																	207	206	277
Income (loss) from continuing operations before income taxes																	267	331	278
Provision (benefit) for income taxes																	80	248	51
Income (loss) from continuing operations																	187	83	227
Income (loss) from discontinued operations, net of taxes																	0	0	0
Net income (loss)																	187	83	227
Less: net income attributable to noncontrolling interests																	84	56	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	103	27	227
Total assets	2,987								3,494								2,987	3,494
Australia Mortgage Insurance | Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	0								0								0	0
U.S. Life Insurance
Segment Reporting Information [Line Items]
Goodwill impairment									299									849
Total assets	79,530								82,891								79,530	82,891
U.S. Life Insurance | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	3,128	3,169	2,957
Net investment income																	2,701	2,665	2,621
Net investment gains (losses)																	(10)	41	(3)
Policy fees and other income																	726	712	755
Total revenues																	6,545	6,587	6,330
Benefits and other changes in policy reserves																	4,692	5,820	3,975
Interest credited																	596	618	619
Acquisition and operating expenses, net of deferrals																	684	658	658
Amortization of deferred acquisition costs and intangibles																	872	345	384
Goodwill impairment																		849
Interest expense																	92	87	97
Total benefits and expenses																	6,936	8,377	5,733
Income (loss) from continuing operations before income taxes																	(391)	(1,790)	597
Provision (benefit) for income taxes																	(138)	(385)	213
Income (loss) from continuing operations																	(253)	(1,405)	384
Income (loss) from discontinued operations, net of taxes																	0	0	0
Net income (loss)																	(253)	(1,405)	384
Less: net income attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	(253)	(1,405)	384
Total assets	79,530								82,891								79,530	82,891
U.S. Life Insurance | Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	0								0								0	0
Runoff
Segment Reporting Information [Line Items]
Total assets	12,115								12,971								12,115	12,971
Runoff | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	1	3	5
Net investment income																	138	129	139
Net investment gains (losses)																	(69)	(66)	(58)
Policy fees and other income																	189	209	216
Total revenues																	259	275	302
Benefits and other changes in policy reserves																	44	37	32
Interest credited																	124	119	119
Acquisition and operating expenses, net of deferrals																	76	84	81
Amortization of deferred acquisition costs and intangibles																	29	39	6
Goodwill impairment																		0
Interest expense																	1	1	2
Total benefits and expenses																	274	280	240
Income (loss) from continuing operations before income taxes																	(15)	(5)	62
Provision (benefit) for income taxes																	(10)	(19)	13
Income (loss) from continuing operations																	(5)	14	49
Income (loss) from discontinued operations, net of taxes																	0	0	0
Net income (loss)																	(5)	14	49
Less: net income attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	(5)	14	49
Total assets	12,115								12,971								12,115	12,971
Runoff | Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	0								0								0	0
Corporate and Other
Segment Reporting Information [Line Items]
Total assets	4,380								4,716								4,380	4,716
Corporate and Other | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Premiums																	25	29	42
Net investment income																	(3)	(10)	6
Net investment gains (losses)																	29	2	(32)
Policy fees and other income																	(10)	1	46
Total revenues																	41	22	62
Benefits and other changes in policy reserves																	14	24	45
Interest credited																	0	0	0
Acquisition and operating expenses, net of deferrals																	230	69	158
Amortization of deferred acquisition costs and intangibles																	1	3	8
Goodwill impairment																		0
Interest expense																	298	314	318
Total benefits and expenses																	543	410	529
Income (loss) from continuing operations before income taxes																	(502)	(388)	(467)
Provision (benefit) for income taxes																	(130)	(93)	(114)
Income (loss) from continuing operations																	(372)	(295)	(353)
Income (loss) from discontinued operations, net of taxes																	(407)	157	34
Net income (loss)																	(779)	(138)	(319)
Less: net income attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	(779)	(138)	$ (319)
Total assets	4,253								2,573								4,253	2,573
Corporate and Other | Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	$ 127								$ 2,143								$ 127	$ 2,143
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $12 million of higher revenue, which included $5 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements.
[2]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $310 million of charges, which included $60 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements. We also recorded an expected loss of $140 million related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[3]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates.
[4]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[5]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.
[6]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.

Summary of Revenues for Segment

Summary of Revenues for Segments and Corporate and Other Activities (Detail) - USD ($) $ in Millions	3 Months Ended												12 Months Ended
	Dec. 31, 2015	[1]	Sep. 30, 2015	[1]	Jun. 30, 2015	[1]	Mar. 31, 2015	[1]	Dec. 31, 2014	Sep. 30, 2014	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Revenues	$ 2,156		$ 2,100		$ 2,157		$ 2,135		$ 2,229	$ 2,190	$ 2,194	$ 2,116	$ 8,548	$ 8,729	$ 8,625
Segment, Continuing Operations | U.S. Mortgage Insurance
Segment Reporting Information [Line Items]
Revenues													665	639	616
Segment, Continuing Operations | Canada Mortgage Insurance
Segment Reporting Information [Line Items]
Revenues													564	669	760
Segment, Continuing Operations | Australia Mortgage Insurance
Segment Reporting Information [Line Items]
Revenues													474	537	555
Segment, Continuing Operations | Long-term Care Insurance
Segment Reporting Information [Line Items]
Revenues													3,752	3,523	3,316
Segment, Continuing Operations | Life Insurance
Segment Reporting Information [Line Items]
Revenues													1,902	1,981	1,982
Segment, Continuing Operations | Fixed Annuities
Segment Reporting Information [Line Items]
Revenues													891	1,083	1,032
Segment, Continuing Operations | U.S. Life Insurance
Segment Reporting Information [Line Items]
Revenues													6,545	6,587	6,330
Segment, Continuing Operations | Runoff
Segment Reporting Information [Line Items]
Revenues													259	275	302
Segment, Continuing Operations | Corporate and Other
Segment Reporting Information [Line Items]
Revenues													$ 41	$ 22	$ 62
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $12 million of higher revenue, which included $5 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements.

Summary of Net Operating Income

Summary of Net Operating Income (Loss) for Segments and Corporate and Other Activities (Detail) - USD ($) $ in Millions	3 Months Ended																	12 Months Ended
	Dec. 31, 2015		Sep. 30, 2015		Jun. 30, 2015		Mar. 31, 2015		Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Jun. 30, 2013	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Net operating income (loss)																		$ 255	$ (398)	$ 585
Net investment gains (losses), net																		(19)	(5)	(29)
Goodwill impairment, net																		0	(791)	0
Gains (losses) from sale of businesses, net																		(141)	0	0
Gains (losses) on early extinguishment of debt, net																		(2)	(2)	(20)
Gains (losses) from life block transactions, net																		(296)	0	0
Expenses related to restructuring, net																	$ (10)	(5)	0	(10)
Tax impact from potential business portfolio changes									$ (205)									0	(205)	0
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders																		(208)	(1,401)	526
Net income attributable to noncontrolling interests	$ 52		$ 46		$ 54		$ 50		52		$ 57		$ 52		$ 35			202	196	154
Income (loss) from continuing operations	(167)	[1]	(217)	[1]	175	[1]	203	[1]	(846)	[2]	(793)	[2]	224	[2]	210	[2]		(6)	(1,205)	680
Income (loss) from discontinued operations, net of taxes	(73)	[3]	(21)	[3]	(314)	[3]	1	[3]	138		6		4		9			(407)	157	34
Net income (loss)	(240)	[1],[3]	(238)	[1],[3]	(139)	[1],[3]	204	[1],[3]	(708)	[2]	(787)	[2]	228	[2]	219	[2]		(413)	(1,048)	714
Less: net income attributable to noncontrolling interests	52		46		54		50		52		57		52		35			202	196	154
Net income (loss) available to Genworth Financial, Inc.'s common stockholders	$ (292)		$ (284)		$ (193)		$ 154		(760)	[2]	$ (844)	[2]	$ 176	[2]	$ 184	[2]		(615)	(1,244)	560
Australia Mortgage Insurance
Segment Reporting Information [Line Items]
Tax impact from potential business portfolio changes									(174)										(174)
Long-term Care Insurance
Segment Reporting Information [Line Items]
Goodwill impairment, net																			(296)
Life Insurance
Segment Reporting Information [Line Items]
Goodwill impairment, net																			(495)
U.S. Life Insurance
Segment Reporting Information [Line Items]
Goodwill impairment, net									$ (274)
Segment, Continuing Operations | U.S. Mortgage Insurance
Segment Reporting Information [Line Items]
Net operating income (loss)																		179	91	37
Net income attributable to noncontrolling interests																		0	0	0
Income (loss) from continuing operations																		179	91	37
Income (loss) from discontinued operations, net of taxes																		0	0	0
Net income (loss)																		179	91	37
Less: net income attributable to noncontrolling interests																		0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																		179	91	37
Segment, Continuing Operations | Canada Mortgage Insurance
Segment Reporting Information [Line Items]
Net operating income (loss)																		152	170	170
Net income attributable to noncontrolling interests																		118	140	154
Income (loss) from continuing operations																		258	307	336
Income (loss) from discontinued operations, net of taxes																		0	0	0
Net income (loss)																		258	307	336
Less: net income attributable to noncontrolling interests																		118	140	154
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																		140	167	182
Segment, Continuing Operations | Australia Mortgage Insurance
Segment Reporting Information [Line Items]
Net operating income (loss)																		102	200	228
Net income attributable to noncontrolling interests																		84	56	0
Income (loss) from continuing operations																		187	83	227
Income (loss) from discontinued operations, net of taxes																		0	0	0
Net income (loss)																		187	83	227
Less: net income attributable to noncontrolling interests																		84	56	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																		103	27	227
Segment, Continuing Operations | Long-term Care Insurance
Segment Reporting Information [Line Items]
Net operating income (loss)																		29	(815)	129
Segment, Continuing Operations | Life Insurance
Segment Reporting Information [Line Items]
Net operating income (loss)																		(80)	74	173
Segment, Continuing Operations | Fixed Annuities
Segment Reporting Information [Line Items]
Net operating income (loss)																		94	100	92
Segment, Continuing Operations | U.S. Life Insurance
Segment Reporting Information [Line Items]
Net operating income (loss)																		43	(641)	394
Net income attributable to noncontrolling interests																		0	0	0
Income (loss) from continuing operations																		(253)	(1,405)	384
Income (loss) from discontinued operations, net of taxes																		0	0	0
Net income (loss)																		(253)	(1,405)	384
Less: net income attributable to noncontrolling interests																		0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																		(253)	(1,405)	384
Segment, Continuing Operations | Runoff
Segment Reporting Information [Line Items]
Net operating income (loss)																		27	48	66
Net income attributable to noncontrolling interests																		0	0	0
Income (loss) from continuing operations																		(5)	14	49
Income (loss) from discontinued operations, net of taxes																		0	0	0
Net income (loss)																		(5)	14	49
Less: net income attributable to noncontrolling interests																		0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																		(5)	14	49
Segment, Continuing Operations | Corporate and Other
Segment Reporting Information [Line Items]
Net operating income (loss)																		(248)	(266)	(310)
Net income attributable to noncontrolling interests																		0	0	0
Income (loss) from continuing operations																		(372)	(295)	(353)
Income (loss) from discontinued operations, net of taxes																		(407)	157	34
Net income (loss)																		(779)	(138)	(319)
Less: net income attributable to noncontrolling interests																		0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																		$ (779)	$ (138)	$ (319)
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[2]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.
[3]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.

Schedule of Revenue, Net Income

Schedule of Revenue, Net Income and Assets by Geographic Location (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2015		Sep. 30, 2015		Jun. 30, 2015		Mar. 31, 2015		Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Segment Reporting Information [Line Items]
Total revenues	$ 2,156	[1]	$ 2,100	[1]	$ 2,157	[1]	$ 2,135	[1]	$ 2,229		$ 2,190		$ 2,194		$ 2,116		$ 8,548	$ 8,729	$ 8,625
Income (loss) from continuing operations	(167)	[2]	(217)	[2]	175	[2]	203	[2]	(846)	[3]	(793)	[3]	224	[3]	210	[3]	(6)	(1,205)	680
Net income (loss)	(240)	[2],[4]	$ (238)	[2],[4]	$ (139)	[2],[4]	$ 204	[2],[4]	(708)	[3]	$ (787)	[3]	$ 228	[3]	$ 219	[3]	(413)	(1,048)	714
Total assets	106,431								111,316								106,431	111,316
Segment, Continuing Operations
Segment Reporting Information [Line Items]
Total assets	106,304								109,173								106,304	109,173
Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	127								2,143								127	2,143
United States
Segment Reporting Information [Line Items]
Total revenues																	7,483	7,487	7,259
Income (loss) from continuing operations																	(430)	(1,570)	153
Net income (loss)																	(430)	(1,570)	141
Total assets	98,738								100,690								98,738	100,690
United States | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Total assets	98,738								100,690								98,738	100,690
United States | Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	0								0								0	0
Canada
Segment Reporting Information [Line Items]
Total revenues																	564	669	760
Income (loss) from continuing operations																	258	307	336
Net income (loss)																	258	307	336
Total assets	4,520								4,920								4,520	4,920
Canada | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Total assets	4,520								4,920								4,520	4,920
Canada | Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	0								0								0	0
Australia
Segment Reporting Information [Line Items]
Total revenues																	474	537	555
Income (loss) from continuing operations																	187	83	227
Net income (loss)																	187	83	227
Total assets	2,987								3,494								2,987	3,494
Australia | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Total assets	2,987								3,494								2,987	3,494
Australia | Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	0								0								0	0
Other Countries
Segment Reporting Information [Line Items]
Total revenues																	27	36	51
Income (loss) from continuing operations																	(21)	(25)	(36)
Net income (loss)																	(428)	132	$ 10
Total assets	186								2,212								186	2,212
Other Countries | Segment, Continuing Operations
Segment Reporting Information [Line Items]
Total assets	59								69								59	69
Other Countries | Segment, Discontinued Operations
Segment Reporting Information [Line Items]
Total assets	$ 127								$ 2,143								$ 127	$ 2,143
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $12 million of higher revenue, which included $5 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements.
[2]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[3]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.
[4]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.

Quarterly Results of Operati157

Quarterly Results of Operations (Detail) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2015		Sep. 30, 2015		Jun. 30, 2015		Mar. 31, 2015		Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2015		Dec. 31, 2014		Dec. 31, 2013
Quarterly Results Of Operations [Abstract]
Total revenues	$ 2,156	[1]	$ 2,100	[1]	$ 2,157	[1]	$ 2,135	[1]	$ 2,229		$ 2,190		$ 2,194		$ 2,116		$ 8,548		$ 8,729		$ 8,625
Total benefits and expenses	2,359	[2]	2,451	[2]	1,912	[2]	1,841	[2]	3,153	[3]	3,170	[3]	1,886	[3]	1,819	[3]	8,563		10,028		7,632
Income (loss) from continuing operations	(167)	[4]	(217)	[4]	175	[4]	203	[4]	(846)	[5]	(793)	[5]	224	[5]	210	[5]	(6)		(1,205)		680
Income (loss) from discontinued operations, net of taxes	(73)	[6]	(21)	[6]	(314)	[6]	1	[6]	138		6		4		9		(407)		157		34
Net income (loss)	(240)	[4],[6]	(238)	[4],[6]	(139)	[4],[6]	204	[4],[6]	(708)	[5]	(787)	[5]	228	[5]	219	[5]	(413)		(1,048)		714
Net income attributable to noncontrolling interests	52		46		54		50		52		57		52		35		202		196		154
Net income (loss) available to Genworth Financial, Inc.'s common stockholders	$ (292)		$ (284)		$ (193)		$ 154		$ (760)	[5]	$ (844)	[5]	$ 176	[5]	$ 184	[5]	$ (615)		$ (1,244)		$ 560
Income (loss) from continuing operations available to Genworth Financial, Inc.'s common stockholders per common share:
Basic	$ (0.44)		$ (0.53)		$ 0.24		$ 0.31		$ (1.81)		$ (1.71)		$ 0.35		$ 0.35		$ (0.42)		$ (2.82)		$ 1.07
Diluted	(0.44)		(0.53)		0.24		0.31		(1.81)		(1.71)		0.34		0.35		(0.42)		(2.82)		1.05
Net income (loss) available to Genworth Financial, Inc.'s common stockholders per common share:
Basic	(0.59)		(0.57)		(0.39)		0.31		(1.53)		(1.70)		0.35		0.37		(1.24)		(2.51)		1.13
Diluted	$ (0.59)		$ (0.57)		$ (0.39)		$ 0.31		$ (1.53)		$ (1.70)		$ 0.35		$ 0.37		$ (1.24)		$ (2.51)		$ 1.12
Weighted-average common shares outstanding:
Basic	497.6		497.4		497.4		497		496.7		496.6		496.6		495.8		497.4		496.4		493.6
Diluted	497.6	[7]	497.4	[7]	499.3	[7]	498.9	[7]	496.7	[8]	496.6	[8]	503.6	[8]	502.7	[8]	497.4	[9]	496.4	[9]	498.7	[9]
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $12 million of higher revenue, which included $5 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements.
[2]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $310 million of charges, which included $60 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements. We also recorded an expected loss of $140 million related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[3]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates.
[4]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[5]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.
[6]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.
[7]	Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2015 and December 31, 2015, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2015 and December 31, 2015, as the inclusion of shares for stock options, RSUs and SARs of 1.3 million and 1.4 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2015 and December 31, 2015, dilutive potential weighted-average common shares outstanding would have been 498.7 and 499.0 million, respectively.
[8]	Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2014 and December 31, 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the three months ended September 30, 2014 and December 31, 2014, as the inclusion of shares for stock options, RSUs and SARs of 5.4 million and 3.2 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the three months ended September 30, 2014 and December 31, 2014, dilutive potential weighted-average common shares outstanding would have been 502.0 million and 499.9 million, respectively.
[9]	Under applicable accounting guidance, companies in a loss position are required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the years ended December 31, 2015 and 2014, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share for the years ended December 31, 2015 and 2014, as the inclusion of shares for stock options, restricted stock units ("RSUs") and stock appreciation rights ("SARs") of 1.6 million and 5.6 million, respectively, would have been antidilutive to the calculation. If we had not incurred a loss from continuing operations available to Genworth Financial, Inc.'s common stockholders and net loss available to Genworth Financial, Inc.'s common stockholders for the years ended December 31, 2015 and 2014, dilutive potential weighted-average common shares outstanding would have been 499.0 million and 502.0 million, respectively.

Quarterly Results of Operati158

Quarterly Results of Operations (Parenthetical) (Detail) - USD ($) shares in Millions, $ in Millions	3 Months Ended				12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Dec. 31, 2014	Sep. 30, 2014	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Quarterly Financial Information [Line Items]
Gains (losses) from sale of businesses, net					$ (141)	$ 0	$ 0
Weighted-average diluted common shares outstanding, antidilutive securities (stock options, RSUs and SARs)	1.4	1.3	3.2	5.4	1.6	5.6
Weighted-average number of diluted shares if not in a loss position	499	498.7	499.9	502	499	502
Goodwill impairment					$ 0	$ 849	0
Goodwill impairment, net					0	791	0
Tax impact from business portfolio changes			$ 205		0	205	$ 0
Long-term Care Insurance
Quarterly Financial Information [Line Items]
Additional expenses			735
Goodwill impairment			154	$ 200		354
Additional expenses, net of taxes			478
Goodwill impairment, net						296
Long-term Care Insurance | Correction to Claims Reserve
Quarterly Financial Information [Line Items]
Adjustment made to the claim reserves, net of reinsurance			67
Adjustment made to the claim reserves, net of reinsurance and taxes			44
Long-term Care Insurance | Refinement of Claim Termination Rate Assumptions
Quarterly Financial Information [Line Items]
Adjustment made to the claim reserves, net of reinsurance			43
Adjustment made to the claim reserves, net of reinsurance and taxes			28
U.S. Life Insurance
Quarterly Financial Information [Line Items]
Goodwill impairment			299			849
Goodwill impairment, net			274
U.S. Life Insurance | Unlocking
Quarterly Financial Information [Line Items]
Revenue related to unlocking	$ 12
Charges	310
Charges, net of taxes	194
U.S. Life Insurance | Reinsurance Correction | Unlocking
Quarterly Financial Information [Line Items]
Revenue related to unlocking	5
Charges	60
Charges, net of taxes	36
Life Insurance
Quarterly Financial Information [Line Items]
Goodwill impairment			145	$ 350		495
Goodwill impairment, net						495
Life Insurance | Reserve Correction
Quarterly Financial Information [Line Items]
Correction to reserves on a reinsurance transaction			49
Correction to reserves on a reinsurance transaction, net of taxes			32
Australia Mortgage Insurance
Quarterly Financial Information [Line Items]
Tax impact from business portfolio changes			174			$ 174
Lifestyle Protection Insurance
Quarterly Financial Information [Line Items]
Gains (losses) from sale of businesses, net	(63)
Tax impact from business portfolio changes			$ 31
European Mortgage Insurance Business
Quarterly Financial Information [Line Items]
Gains (losses) from sale of businesses	(140)
Gains (losses) from sale of businesses, net	$ (134)				$ (141)

Commitments and Contingencies -

Commitments and Contingencies - Additional Information (Detail) - USD ($)	1 Months Ended
	Jun. 30, 2015	Dec. 31, 2015	Sep. 30, 2014
Commitments and Contingencies Disclosure [Line Items]
Self insured retention		$ 25,000,000
Commitment to fund limited partnership investments		131,000,000
Commitment to fund U.S. commercial mortgage loan investments		17,000,000
Commitment to fund private placement investments		23,000,000
Rivermont Insurance Company I
Commitments and Contingencies Disclosure [Line Items]
One time commitment fee		2,000,000
Maximum potential amount of future obligation		$ 15,000,000
Minnesota Department of Commerce
Commitments and Contingencies Disclosure [Line Items]
Civil penalty payable	$ (90,000)
Agreement period to not enter into any new and existing captive reinsurance transactions after the date of the consent order	10 years
U.S. Mortgage Insurance
Commitments and Contingencies Disclosure [Line Items]
Legal accrual			$ 53,000,000

Component of Changes In Accumul

Component of Changes In Accumulated Other Comprehensive Income (Loss), Net of Taxes (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items]
Net unrealized investment gains (losses), beginning of period	[1]	$ 2,453	$ 926	$ 2,638
Net unrealized investment gains (losses), OCI before reclassifications	[1]	(1,218)	1,595	(1,772)
Net unrealized investment gains (losses), amounts reclassified from (to) OCI	[1]	5	(12)	21
Net unrealized investment gains (losses), current period OCI	[1]	(1,213)	1,583	(1,751)
Net unrealized investment gains (losses), before noncontrolling interest	[1]	1,240	2,509	887
Less: Net unrealized investment gains (losses), change in OCI attributable to noncontrolling interests	[1]	(14)	56	(39)
Net unrealized investment gains (losses), end of period	[1]	1,254	2,453	926
Derivatives qualifying as effective accounting hedges, beginning of period	[2]	2,070	1,319	1,909
Derivatives qualifying as hedges, OCI before reclassifications	[2]	50	788	(561)
Derivatives qualifying as hedges, amounts reclassified from (to) OCI	[2]	(75)	(37)	(29)
Derivatives qualifying as hedges, current period OCI	[2]	(25)	751	(590)
Derivatives qualifying as hedges, before noncontrolling interests	[2]	2,045	2,070	1,319
Less: Derivatives qualifying as hedges, change in OCI attributable to noncontrolling interests	[2]	0	0	0
Derivatives qualifying as effective accounting hedges, end of period	[2]	2,045	2,070	1,319
Foreign currency translation and other adjustments, beginning balances		(77)	297	655
Foreign currency translation and other adjustments, OCI before reclassifications		(530)	(537)	(442)
Foreign currency translation and other adjustments, amounts reclassified from (to) OCI		0	0	0
Foreign currency translation and other adjustments, current period OCI		(530)	(537)	(442)
Foreign currency translation and other adjustments, before noncontrolling interests		(607)	(240)	213
Less: Foreign currency translation and other adjustments, change in OCI attributable to noncontrolling interests		(318)	(163)	(84)
Foreign currency translation and other adjustments, ending balances		(289)	(77)	297
Accumulated other comprehensive income (loss), beginning balances		4,446	2,542	5,202
OCI before reclassifications		(1,698)	1,846	(2,775)
Amounts reclassified from (to) OCI		(70)	(49)	(8)
Total other comprehensive income (loss)		(1,768)	1,797	(2,783)
Accumulated other comprehensive income (loss), before noncontrolling interests		2,678	4,339	2,419
Less: change in OCI attributable to noncontrolling interests		(332)	(107)	(123)
Accumulated other comprehensive income (loss), ending balances		$ 3,010	$ 4,446	$ 2,542
[1]	Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information.
[2]	See note 5 for additional information.

Changes In Accumulated Other161

Changes In Accumulated Other Comprehensive Income (Loss) - Additional Information (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items]
Unrecognized postretirement benefit obligation, current period OCI	$ 5	$ 37	$ 6
Unrecognized postretirement benefit obligation, current period OCI, tax	3	14	1
Foreign currency translation and other adjustments, current period OCI, tax	$ (63)	$ (10)	$ 39

Reclassifications In (Out) of A

Reclassifications In (Out) of Accumulated Other Comprehensive Income (Loss), Net of Taxes (Detail) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items]
Net unrealized investment gains (losses), amounts reclassified from (to) OCI, provision for income taxes		$ (2)	$ 7	$ (12)
Net unrealized investment gains (losses), amounts reclassified from (to) OCI	[1]	5	(12)	21
Derivatives qualifying as hedges, amounts reclassified from (to) OCI	[2]	(75)	(37)	(29)
Provision for income taxes
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items]
Net unrealized investment gains (losses), amounts reclassified from (to) OCI, provision for income taxes		(2)	7	(12)
Derivatives qualifying as hedges, amounts reclassified from (to) OCI		43	20	16
Interest Rate Swaps Hedging Assets | Net Investment Gains (Losses)
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items]
Derivatives qualifying as hedges, amounts reclassified from (to) OCI		0	(2)	(1)
Interest Rate Swaps Hedging Assets | Net Investment Income
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items]
Derivatives qualifying as hedges, amounts reclassified from (to) OCI		(85)	(63)	(47)
Interest Rate Swaps Hedging Liabilities | Interest Expense
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items]
Derivatives qualifying as hedges, amounts reclassified from (to) OCI		0	(1)	(2)
Inflation indexed swaps | Net Investment Income
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items]
Derivatives qualifying as hedges, amounts reclassified from (to) OCI		0	9	5
Forward bond purchase commitments | Net Investment Gains (Losses)
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items]
Derivatives qualifying as hedges, amounts reclassified from (to) OCI		(32)	0	0
Forward bond purchase commitments | Net Investment Income
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items]
Derivatives qualifying as hedges, amounts reclassified from (to) OCI		(1)	0	0
Unrealized gains (losses) on investment | Net Investment Gains (Losses)
Accumulated Other Comprehensive Income Loss Net Of Tax [Line Items]
Net unrealized investment gains (losses), amounts reclassified from (to) OCI, before tax	[3]	$ 7	$ (19)	$ 33
[1]	Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information.
[2]	See note 5 for additional information.
[3]	Amounts exclude adjustments to DAC, PVFP, sales inducements and benefit reserves.

Noncontrolling Interests - Addi

Noncontrolling Interests - Additional Information (Detail) AUD / shares in Units, CAD in Millions, AUD in Millions, $ in Millions	Oct. 30, 2015USD ($)shares	Oct. 30, 2015AUDshares	May. 15, 2015USD ($)	May. 11, 2015AUD / sharesshares	May. 15, 2014AUD / sharesshares	Dec. 31, 2015CADshares	Dec. 31, 2015USD ($)shares	Dec. 31, 2014CADshares	Dec. 31, 2014USD ($)shares	Dec. 31, 2013CADshares	Dec. 31, 2013USD ($)shares	May. 21, 2014	Jul. 31, 2009
Noncontrolling Interest [Line Items]
Dividend paid to noncontrolling interests							$ 157		$ 75		$ 52
Proceeds from sale of subsidiary shares to noncontrolling interests							$ 226		$ 517		$ 0
Genworth Canada IPO
Noncontrolling Interest [Line Items]
Beneficial ownership percentage of ordinary shares						57.30%	57.30%						57.50%
Genworth Canada
Noncontrolling Interest [Line Items]
Beneficial ownership percentage of ordinary shares						57.30%	57.30%
Repurchase of subsidiary shares through issuer bid, number of shares | shares						1,400,000	1,400,000	1,900,000	1,900,000	3,900,000	3,900,000
Common shares repurchased, value | CAD						CAD 50		CAD 75		CAD 105
Shares authorized to be repurchased | shares						4,700,000	4,700,000	4,700,000	4,700,000	4,900,000	4,900,000
Amount received as a result of participation in Issuer Bid							$ 23		$ 38		$ 58
Dividend paid to noncontrolling interests							49		$ 69		52
Genworth Australia
Noncontrolling Interest [Line Items]
Beneficial ownership percentage of ordinary shares	52.00%	52.00%	52.00%					66.20%	66.20%			66.20%
Repurchase of subsidiary shares through issuer bid, number of shares | shares	54,600,000	54,600,000
Common shares repurchased, value | AUD		AUD 150
Amount received as a result of participation in Issuer Bid	$ 55
Dividend paid to noncontrolling interests							$ 108		$ 6
Shares sold | shares				92,300,000	220,000,000
Price per ordinary share | AUD / shares				AUD 3.08	AUD 2.65
Gross proceeds of the Offer									541
Fees and expenses in connection with the Offer									$ 27		$ 3
Proceeds from sale of subsidiary shares to noncontrolling interests			$ 226

Changes in Ownership Interests

Changes in Ownership Interests and Effect on Stockholders' Equity (Detail) - USD ($) $ in Millions	3 Months Ended												12 Months Ended
	Dec. 31, 2015	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	[1]	Sep. 30, 2014	[1]	Jun. 30, 2014	[1]	Mar. 31, 2014	[1]	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Consolidation, Less than Wholly Owned Subsidiary, Parent Ownership Interest, Effects of Changes, Net [Line Items]
Net loss available to Genworth Financial, Inc.'s common stockholders	$ (292)	$ (284)	$ (193)	$ 154	$ (760)		$ (844)		$ 176		$ 184		$ (615)	$ (1,244)	$ 560
Transfers to the noncontrolling interests:
Decrease in Genworth Financial, Inc.'s additional paid-in capital for initial sale of Genworth Australia shares to noncontrolling interests													0	(145)
Decrease in Genworth Financial, Inc.'s additional paid-in capital for additional sale of Genworth Australia shares to noncontrolling interests													(65)	0
Net transfers to noncontrolling interests													(65)	(145)
Change from net loss available to Genworth Financial, Inc.'s common stockholders and transfers to noncontrolling interests													$ (680)	$ (1,389)
[1]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.

Sale of Businesses - Additional

Sale of Businesses - Additional Information (Detail) - USD ($) $ in Millions	Dec. 01, 2015	Apr. 01, 2013	Dec. 31, 2015	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Loss on sale of discontinued operations, net of taxes				$ (141)	$ 0	$ 0
Wealth Management Business
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Net proceeds from sale of business						360
Proceeds from sale of business						412
Loss on sale of discontinued operations, net of taxes						$ (29)
European Mortgage Insurance Business
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Net proceeds from sale of business				55
Loss on sale of discontinued operations, net of taxes			$ (134)	(141)
Fair value less closing costs impairment			135	135
Loss on sale of discontinued operations,taxes				1
Discontinued operations Closing costs				5
Lifestyle Protection Insurance
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Loss on sale of discontinued operations, net of taxes			$ (63)
Lifestyle Protection Insurance | Assets Held For Sale Discontinued Operations
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Net proceeds from sale of business	$ 400
Proceeds from sale of business	$ 493
Loss on sale of discontinued operations, net of taxes				(381)
Tax Benefit from Provision for Loss on Disposal				$ 155
Reverse Mortgage Business
Income Statement, Balance Sheet and Additional Disclosures by Planned Disposal Groups [Line Items]
Proceeds from sale of business		$ 22

Assets and Liabilities Associat

Assets and Liabilities Associated with Discontinued Operations (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Assets
Fixed maturity securities available-for-sale, at fair value	$ 58,197	$ 61,077
Equity securities available-for-sale, at fair value	310	275
Other invested assets	2,309	2,208
Total investments	69,128	71,773
Cash and cash equivalents	28	273	$ 557
Accrued investment income	653	660
Deferred acquisition costs	4,398	4,852	$ 5,038
Reinsurance recoverable	17,245	17,291
Assets held for sale	127	2,143
Liabilities
Policyholder account balances	26,209	26,032
Liability for policy and contract claims	8,095	7,881
Unearned premiums	3,308	3,485
Liabilities held for sale	127	1,094
European Mortgage Insurance Business
Assets
Fair value less closing costs impairment	135
Assets Held For Sale Discontinued Operations | Lifestyle Protection Insurance
Assets
Fixed maturity securities available-for-sale, at fair value	0	1,171
Equity securities available-for-sale, at fair value	0	7
Other invested assets	0	52
Total investments	0	1,230
Cash and cash equivalents	0	202
Accrued investment income	0	21
Deferred acquisition costs	0	193
Intangible assets	0	22
Reinsurance recoverable	0	32
Other assets	0	109
Assets held for sale	0	1,809
Liabilities
Policyholder account balances	0	11
Liability for policy and contract claims	0	106
Unearned premiums	0	439
Other liabilities	0	322
Deferred tax liability	0	50
Liabilities held for sale	0	928
Asset Held For Sale | European Mortgage Insurance Business
Assets
Fixed maturity securities available-for-sale, at fair value	195	199
Other invested assets	6	36
Total investments	201	235
Cash and cash equivalents	28	71
Accrued investment income	3	4
Intangible assets	0	1
Reinsurance recoverable	21	23
Other assets	14	0
Assets held for sale	267	334
Fair value less closing costs impairment	(140)	0
Assets held for sale	127	334
Liabilities
Liability for policy and contract claims	56	56
Unearned premiums	58	62
Other liabilities	12	48
Deferred tax liability	1	0
Liabilities held for sale	$ 127	$ 166

Summary of Operating Results of

Summary of Operating Results of Discontinued Operations (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2015		Sep. 30, 2015		Jun. 30, 2015		Mar. 31, 2015		Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Premiums																	$ 4,579	$ 4,700	$ 4,516
Net investment income																	3,138	3,142	3,155
Net investment gains (losses)																	(75)	(22)	(64)
Policy fees and other income																	906	909	1,018
Benefits and expenses:
Benefits and other changes in policy reserves																	5,149	6,418	4,737
Total benefits and expenses	$ 2,359	[1]	$ 2,451	[1]	$ 1,912	[1]	$ 1,841	[1]	$ 3,153	[2]	$ 3,170	[2]	$ 1,886	[2]	$ 1,819	[2]	8,563	10,028	7,632
Income (loss) from discontinued operations, net of taxes	(73)	[3]	$ (21)	[3]	$ (314)	[3]	$ 1	[3]	$ 138		$ 6		$ 4		$ 9		(407)	157	34
Wealth Management Business
Revenues:
Policy fees and other income																			211
Total revenues																			211
Benefits and expenses:
Acquisition and operating expenses																			178
Amortization of deferred acquisition costs and intangibles																			4
Total benefits and expenses																			182
Income (loss) before income taxes and loss on sale																			29
Provision (benefit) for income taxes																			12
Income (loss) before loss on sale																			17
Loss on sale, net of taxes																			(29)
Goodwill impairment and other loss from sale, net of taxes																			(29)
Income (loss) from discontinued operations, net of taxes																			(12)
Lifestyle Protection Insurance
Benefits and expenses:
Loss on sale, net of taxes	$ (63)
Assets Held For Sale Discontinued Operations | Lifestyle Protection Insurance
Revenues:
Premiums																	627	731	632
Net investment income																	74	100	116
Net investment gains (losses)																		2	27
Policy fees and other income																		3	3
Total revenues																	701	836	778
Benefits and expenses:
Benefits and other changes in policy reserves																	182	202	158
Acquisition and operating expenses																	396	447	415
Amortization of deferred acquisition costs and intangibles																	83	118	106
Interest expense																	29	46	42
Total benefits and expenses																	690	813	721
Income (loss) before income taxes and loss on sale																	11	23	57
Provision (benefit) for income taxes																	37	(134)	11
Income (loss) before loss on sale																	(26)	157	46
Loss on sale, net of taxes																	(381)
Income (loss) from discontinued operations, net of taxes																	$ (407)	$ 157	$ 46
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $310 million of charges, which included $60 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements. We also recorded an expected loss of $140 million related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[2]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates.
[3]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.

Condensed Consolidating Balance

Condensed Consolidating Balance Sheet (Detail) - USD ($) $ in Millions	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Assets
Fixed maturity securities available-for-sale, at fair value	$ 58,197	$ 61,077
Equity securities available-for-sale, at fair value	310	275
Commercial mortgage loans	6,170	6,100
Restricted commercial mortgage loans related to securitization entities	161	201
Policy loans	1,568	1,501
Other invested assets	2,309	2,208
Restricted other invested assets related to securitization entities, at fair value	413	411
Investments in subsidiaries	0	0
Total investments	69,128	71,773
Cash and cash equivalents	5,965	4,645	$ 3,657
Accrued investment income	653	660
Deferred acquisition costs	4,398	4,852	5,038
Intangible assets and goodwill	357	265
Reinsurance recoverable	17,245	17,291
Other assets	520	479
Intercompany notes receivable	0	0
Deferred tax assets	155	0
Separate account assets	7,883	9,208
Assets held for sale	127	2,143
Total assets	106,431	111,316
Liabilities and stockholders' equity
Future policy benefits	36,475	35,915
Policyholder account balances	26,209	26,032
Liability for policy and contract claims	8,095	7,881
Unearned premiums	3,308	3,485
Other liabilities	3,004	3,234
Intercompany notes payable	0	0
Borrowings related to securitization entities	179	219
Non-recourse funding obligations	1,920	1,981
Long-term borrowings	4,570	4,612
Deferred tax liability	24	858
Separate account liabilities	7,883	9,208
Liabilities held for sale	127	1,094
Total liabilities	91,794	94,519
Equity:
Common stock	1	1
Additional paid-in capital	11,949	11,997
Accumulated other comprehensive income (loss)	3,010	4,446	2,542	$ 5,202
Retained earnings	564	1,179
Treasury stock, at cost	(2,700)	(2,700)
Total Genworth Financial, Inc.'s stockholders' equity	12,824	14,923
Noncontrolling interests	1,813	1,874
Total equity	14,637	16,797	15,620	$ 17,781
Total liabilities and equity	106,431	111,316
Parent Guarantor
Assets
Fixed maturity securities available-for-sale, at fair value	0	0
Equity securities available-for-sale, at fair value	0	0
Commercial mortgage loans	0	0
Restricted commercial mortgage loans related to securitization entities	0	0
Policy loans	0	0
Other invested assets	0	0
Restricted other invested assets related to securitization entities, at fair value	0	0
Investments in subsidiaries	12,814	14,895
Total investments	12,814	14,895
Cash and cash equivalents	0	0	0
Accrued investment income	0	0
Deferred acquisition costs	0	0
Intangible assets and goodwill	0	0
Reinsurance recoverable	0	0
Other assets	0	2
Intercompany notes receivable	0	9
Deferred tax assets	25
Separate account assets	0	0
Assets held for sale	0	0
Total assets	12,839	14,906
Liabilities and stockholders' equity
Future policy benefits	0	0
Policyholder account balances	0	0
Liability for policy and contract claims	0	0
Unearned premiums	0	0
Other liabilities	13	3
Intercompany notes payable	2	0
Borrowings related to securitization entities	0	0
Non-recourse funding obligations	0	0
Long-term borrowings	0	0
Deferred tax liability	0	(20)
Separate account liabilities	0	0
Liabilities held for sale	0	0
Total liabilities	15	(17)
Equity:
Common stock	1	1
Additional paid-in capital	11,949	11,997
Accumulated other comprehensive income (loss)	3,010	4,446
Retained earnings	564	1,179
Treasury stock, at cost	(2,700)	(2,700)
Total Genworth Financial, Inc.'s stockholders' equity	12,824	14,923
Noncontrolling interests	0	0
Total equity	12,824	14,923
Total liabilities and equity	12,839	14,906
Issuer
Assets
Fixed maturity securities available-for-sale, at fair value	150	150
Equity securities available-for-sale, at fair value	0	0
Commercial mortgage loans	0	0
Restricted commercial mortgage loans related to securitization entities	0	0
Policy loans	0	0
Other invested assets	114	14
Restricted other invested assets related to securitization entities, at fair value	0	0
Investments in subsidiaries	12,989	15,003
Total investments	13,253	15,167
Cash and cash equivalents	1,124	953	1,219
Accrued investment income	0	0
Deferred acquisition costs	0	0
Intangible assets and goodwill	0	0
Reinsurance recoverable	0	0
Other assets	199	183
Intercompany notes receivable	2	267
Deferred tax assets	1,038
Separate account assets	0	0
Assets held for sale	0	0
Total assets	15,616	16,570
Liabilities and stockholders' equity
Future policy benefits	0	0
Policyholder account balances	0	0
Liability for policy and contract claims	0	0
Unearned premiums	0	0
Other liabilities	279	251
Intercompany notes payable	658	604
Borrowings related to securitization entities	0	0
Non-recourse funding obligations	0	0
Long-term borrowings	4,078	4,127
Deferred tax liability	0	(970)
Separate account liabilities	0	0
Liabilities held for sale	0	0
Total liabilities	5,015	4,012
Equity:
Common stock	0	0
Additional paid-in capital	9,097	9,162
Accumulated other comprehensive income (loss)	3,116	4,449
Retained earnings	(1,612)	(1,053)
Treasury stock, at cost	0	0
Total Genworth Financial, Inc.'s stockholders' equity	10,601	12,558
Noncontrolling interests	0	0
Total equity	10,601	12,558
Total liabilities and equity	15,616	16,570
All Other Subsidiaries
Assets
Fixed maturity securities available-for-sale, at fair value	58,247	61,127
Equity securities available-for-sale, at fair value	310	275
Commercial mortgage loans	6,170	6,100
Restricted commercial mortgage loans related to securitization entities	161	201
Policy loans	1,568	1,501
Other invested assets	2,198	2,199
Restricted other invested assets related to securitization entities, at fair value	413	411
Investments in subsidiaries	0	0
Total investments	69,067	71,814
Cash and cash equivalents	4,841	3,692	2,438
Accrued investment income	657	664
Deferred acquisition costs	4,398	4,852
Intangible assets and goodwill	357	265
Reinsurance recoverable	17,245	17,291
Other assets	323	295
Intercompany notes receivable	458	395
Deferred tax assets	(908)
Separate account assets	7,883	9,208
Assets held for sale	127	2,143
Total assets	104,448	110,619
Liabilities and stockholders' equity
Future policy benefits	36,475	35,915
Policyholder account balances	26,209	26,032
Liability for policy and contract claims	8,095	7,881
Unearned premiums	3,308	3,485
Other liabilities	2,722	2,991
Intercompany notes payable	0	267
Borrowings related to securitization entities	179	219
Non-recourse funding obligations	1,920	1,981
Long-term borrowings	492	485
Deferred tax liability	24	1,848
Separate account liabilities	7,883	9,208
Liabilities held for sale	127	1,094
Total liabilities	87,434	91,406
Equity:
Common stock	0	0
Additional paid-in capital	17,007	17,080
Accumulated other comprehensive income (loss)	3,028	4,459
Retained earnings	(5,134)	(4,205)
Treasury stock, at cost	0	0
Total Genworth Financial, Inc.'s stockholders' equity	14,901	17,334
Noncontrolling interests	2,113	1,879
Total equity	17,014	19,213
Total liabilities and equity	104,448	110,619
Eliminations
Assets
Fixed maturity securities available-for-sale, at fair value	(200)	(200)
Equity securities available-for-sale, at fair value	0	0
Commercial mortgage loans	0	0
Restricted commercial mortgage loans related to securitization entities	0	0
Policy loans	0	0
Other invested assets	(3)	(5)
Restricted other invested assets related to securitization entities, at fair value	0	0
Investments in subsidiaries	(25,803)	(29,898)
Total investments	(26,006)	(30,103)
Cash and cash equivalents	0	0	$ 0
Accrued investment income	(4)	(4)
Deferred acquisition costs	0	0
Intangible assets and goodwill	0	0
Reinsurance recoverable	0	0
Other assets	(2)	(1)
Intercompany notes receivable	(460)	(671)
Deferred tax assets	0
Separate account assets	0	0
Assets held for sale	0	0
Total assets	(26,472)	(30,779)
Liabilities and stockholders' equity
Future policy benefits	0	0
Policyholder account balances	0	0
Liability for policy and contract claims	0	0
Unearned premiums	0	0
Other liabilities	(10)	(11)
Intercompany notes payable	(660)	(871)
Borrowings related to securitization entities	0	0
Non-recourse funding obligations	0	0
Long-term borrowings	0	0
Deferred tax liability	0	0
Separate account liabilities	0	0
Liabilities held for sale	0	0
Total liabilities	(670)	(882)
Equity:
Common stock	0	0
Additional paid-in capital	(26,104)	(26,242)
Accumulated other comprehensive income (loss)	(6,144)	(8,908)
Retained earnings	6,746	5,258
Treasury stock, at cost	0	0
Total Genworth Financial, Inc.'s stockholders' equity	(25,502)	(29,892)
Noncontrolling interests	(300)	(5)
Total equity	(25,802)	(29,897)
Total liabilities and equity	$ (26,472)	$ (30,779)

Condensed Consolidating Income

Condensed Consolidating Income Statement (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2015		Sep. 30, 2015		Jun. 30, 2015		Mar. 31, 2015		Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Premiums																	$ 4,579	$ 4,700	$ 4,516
Net investment income																	3,138	3,142	3,155
Net investment gains (losses)																	(75)	(22)	(64)
Policy fees and other income																	906	909	1,018
Total revenues	$ 2,156	[1]	$ 2,100	[1]	$ 2,157	[1]	$ 2,135	[1]	$ 2,229		$ 2,190		$ 2,194		$ 2,116		8,548	8,729	8,625
Benefits and expenses:
Benefits and other changes in policy reserves																	5,149	6,418	4,737
Interest credited																	720	737	738
Acquisition and operating expenses, net of deferrals																	1,309	1,138	1,244
Amortization of deferred acquisition costs and intangibles																	966	453	463
Goodwill impairment																	0	849	0
Interest expense																	419	433	450
Total benefits and expenses	2,359	[2]	2,451	[2]	1,912	[2]	1,841	[2]	3,153	[3]	3,170	[3]	1,886	[3]	1,819	[3]	8,563	10,028	7,632
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries																	(15)	(1,299)	993
Provision (benefit) for income taxes																	(9)	(94)	313
Equity in income (loss) of subsidiaries																	0	0	0
Income (loss) from continuing operations	(167)	[4]	(217)	[4]	175	[4]	203	[4]	(846)	[5]	(793)	[5]	224	[5]	210	[5]	(6)	(1,205)	680
Income (loss) from discontinued operations, net of taxes	(73)	[6]	(21)	[6]	(314)	[6]	1	[6]	138		6		4		9		(407)	157	34
Net income (loss)	(240)	[4],[6]	(238)	[4],[6]	(139)	[4],[6]	204	[4],[6]	(708)	[5]	(787)	[5]	228	[5]	219	[5]	(413)	(1,048)	714
Less: net income attributable to noncontrolling interests	52		46		54		50		52		57		52		35		202	196	154
Net income (loss) available to Genworth Financial, Inc.'s common stockholders	$ (292)		$ (284)		$ (193)		$ 154		$ (760)	[5]	$ (844)	[5]	$ 176	[5]	$ 184	[5]	(615)	(1,244)	560
Parent Guarantor
Revenues:
Premiums																	0	0	0
Net investment income																	(3)	(2)	(1)
Net investment gains (losses)																	0	0	0
Policy fees and other income																	0	0	0
Total revenues																	(3)	(2)	(1)
Benefits and expenses:
Benefits and other changes in policy reserves																	0	0	0
Interest credited																	0	0	0
Acquisition and operating expenses, net of deferrals																	32	21	33
Amortization of deferred acquisition costs and intangibles																	0	0	0
Goodwill impairment																		0
Interest expense																	0	0	0
Total benefits and expenses																	32	21	33
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries																	(35)	(23)	(34)
Provision (benefit) for income taxes																	(8)	(8)	13
Equity in income (loss) of subsidiaries																	(579)	(1,229)	607
Income (loss) from continuing operations																	(606)	(1,244)	560
Income (loss) from discontinued operations, net of taxes																	(9)	0	0
Net income (loss)																	(615)	(1,244)	560
Less: net income attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	(615)	(1,244)	560
Issuer
Revenues:
Premiums																	0	0	0
Net investment income																	1	0	1
Net investment gains (losses)																	43	4	6
Policy fees and other income																	(32)	(4)	0
Total revenues																	12	0	7
Benefits and expenses:
Benefits and other changes in policy reserves																	0	0	0
Interest credited																	0	0	0
Acquisition and operating expenses, net of deferrals																	2	0	32
Amortization of deferred acquisition costs and intangibles																	0	0	0
Goodwill impairment																		0
Interest expense																	307	321	322
Total benefits and expenses																	309	321	354
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries																	(297)	(321)	(347)
Provision (benefit) for income taxes																	(103)	(112)	(120)
Equity in income (loss) of subsidiaries																	(463)	(1,147)	796
Income (loss) from continuing operations																	(657)	(1,356)	569
Income (loss) from discontinued operations, net of taxes																	0	0	(29)
Net income (loss)																	(657)	(1,356)	540
Less: net income attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	(657)	(1,356)	540
All Other Subsidiaries
Revenues:
Premiums																	4,579	4,700	4,516
Net investment income																	3,154	3,159	3,170
Net investment gains (losses)																	(118)	(26)	(70)
Policy fees and other income																	940	914	1,022
Total revenues																	8,555	8,747	8,638
Benefits and expenses:
Benefits and other changes in policy reserves																	5,149	6,418	4,737
Interest credited																	720	737	738
Acquisition and operating expenses, net of deferrals																	1,275	1,117	1,179
Amortization of deferred acquisition costs and intangibles																	966	453	463
Goodwill impairment																		849
Interest expense																	128	128	147
Total benefits and expenses																	8,238	9,702	7,264
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries																	317	(955)	1,374
Provision (benefit) for income taxes																	102	30	420
Equity in income (loss) of subsidiaries																	0	0	0
Income (loss) from continuing operations																	215	(985)	954
Income (loss) from discontinued operations, net of taxes																	(398)	157	63
Net income (loss)																	(183)	(828)	1,017
Less: net income attributable to noncontrolling interests																	202	196	154
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	(385)	(1,024)	863
Eliminations
Revenues:
Premiums																	0	0	0
Net investment income																	(14)	(15)	(15)
Net investment gains (losses)																	0	0	0
Policy fees and other income																	(2)	(1)	(4)
Total revenues																	(16)	(16)	(19)
Benefits and expenses:
Benefits and other changes in policy reserves																	0	0	0
Interest credited																	0	0	0
Acquisition and operating expenses, net of deferrals																	0	0	0
Amortization of deferred acquisition costs and intangibles																	0	0	0
Goodwill impairment																		0
Interest expense																	(16)	(16)	(19)
Total benefits and expenses																	(16)	(16)	(19)
Income (loss) from continuing operations before income taxes and equity in income (loss) of subsidiaries																	0	0	0
Provision (benefit) for income taxes																	0	(4)	0
Equity in income (loss) of subsidiaries																	1,042	2,376	(1,403)
Income (loss) from continuing operations																	1,042	2,380	(1,403)
Income (loss) from discontinued operations, net of taxes																	0	0	0
Net income (loss)																	1,042	2,380	(1,403)
Less: net income attributable to noncontrolling interests																	0	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	$ 1,042	$ 2,380	$ (1,403)
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $12 million of higher revenue, which included $5 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements.
[2]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $310 million of charges, which included $60 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements. We also recorded an expected loss of $140 million related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[3]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional expenses of $735 million. During the fourth quarter of 2014, we also recorded goodwill impairments of $299 million in our U.S. Life Insurance segment. In the fourth quarter of 2014, we recorded a correction of $49 million in our life insurance business related to reserves on a reinsurance transaction. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $67 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $43 million favorable refinement of assumptions for claim termination rates.
[4]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[5]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.
[6]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.

Condensed Consolidating Stateme

Condensed Consolidating Statement of Comprehensive Income (Detail) - USD ($) $ in Millions		3 Months Ended																12 Months Ended
		Dec. 31, 2015	[1],[2]	Sep. 30, 2015	[1],[2]	Jun. 30, 2015	[1],[2]	Mar. 31, 2015	[1],[2]	Dec. 31, 2014	[3]	Sep. 30, 2014	[3]	Jun. 30, 2014	[3]	Mar. 31, 2014	[3]	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Condensed Financial Statements, Captions [Line Items]
Net income (loss)		$ (240)		$ (238)		$ (139)		$ 204		$ (708)		$ (787)		$ 228		$ 219		$ (413)	$ (1,048)	$ 714
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities not other-than-temporarily impaired																		(1,209)	1,573	(1,817)
Net unrealized gains (losses) on other-than- temporarily impaired securities																		(4)	10	66
Derivatives qualifying as hedges	[4]																	(25)	751	(590)
Foreign currency translation and other adjustments																		(530)	(537)	(442)
Total other comprehensive income (loss)																		(1,768)	1,797	(2,783)
Total comprehensive income (loss)																		(2,181)	749	(2,069)
Less: comprehensive income attributable to noncontrolling interests																		(106)	32	31
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders																		(2,075)	717	(2,100)
Parent Guarantor
Condensed Financial Statements, Captions [Line Items]
Net income (loss)																		(615)	(1,244)	560
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities not other-than-temporarily impaired																		(1,181)	1,539	(1,778)
Net unrealized gains (losses) on other-than- temporarily impaired securities																		(4)	10	66
Derivatives qualifying as hedges																		(25)	751	(590)
Foreign currency translation and other adjustments																		(250)	(339)	(358)
Total other comprehensive income (loss)																		(1,460)	1,961	(2,660)
Total comprehensive income (loss)																		(2,075)	717	(2,100)
Less: comprehensive income attributable to noncontrolling interests																		0	0	0
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders																		(2,075)	717	(2,100)
Issuer
Condensed Financial Statements, Captions [Line Items]
Net income (loss)																		(657)	(1,356)	540
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities not other-than-temporarily impaired																		(1,158)	1,510	(1,733)
Net unrealized gains (losses) on other-than- temporarily impaired securities																		(4)	11	65
Derivatives qualifying as hedges																		(24)	751	(590)
Foreign currency translation and other adjustments																		(171)	(273)	(335)
Total other comprehensive income (loss)																		(1,357)	1,999	(2,593)
Total comprehensive income (loss)																		(2,014)	643	(2,053)
Less: comprehensive income attributable to noncontrolling interests																		0	0	0
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders																		(2,014)	643	(2,053)
All Other Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net income (loss)																		(183)	(828)	1,017
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities not other-than-temporarily impaired																		(1,210)	1,573	(1,817)
Net unrealized gains (losses) on other-than- temporarily impaired securities																		(4)	10	66
Derivatives qualifying as hedges																		(19)	794	(615)
Foreign currency translation and other adjustments																		(530)	(537)	(442)
Total other comprehensive income (loss)																		(1,763)	1,840	(2,808)
Total comprehensive income (loss)																		(1,946)	1,012	(1,791)
Less: comprehensive income attributable to noncontrolling interests																		(106)	32	31
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders																		(1,840)	980	(1,822)
Eliminations
Condensed Financial Statements, Captions [Line Items]
Net income (loss)																		1,042	2,380	(1,403)
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities not other-than-temporarily impaired																		2,340	(3,049)	3,511
Net unrealized gains (losses) on other-than- temporarily impaired securities																		8	(21)	(131)
Derivatives qualifying as hedges																		43	(1,545)	1,205
Foreign currency translation and other adjustments																		421	612	693
Total other comprehensive income (loss)																		2,812	(4,003)	5,278
Total comprehensive income (loss)																		3,854	(1,623)	3,875
Less: comprehensive income attributable to noncontrolling interests																		0	0	0
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders																		$ 3,854	$ (1,623)	$ 3,875
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[2]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.
[3]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.
[4]	See note 5 for additional information.

Condensed Consolidating Stat171

Condensed Consolidating Statement of Cash Flows (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2015		Sep. 30, 2015	[2]	Jun. 30, 2015	[2]	Mar. 31, 2015		Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net income (loss)	$ (240)	[1],[2]	$ (238)	[1]	$ (139)	[1]	$ 204	[1],[2]	$ (708)	[3]	$ (787)	[3]	$ 228	[3]	$ 219	[3]	$ (413)	$ (1,048)	$ 714
Less (income) loss from discontinued operations, net of taxes	73	[2]	$ 21		$ 314		(1)	[2]	(138)		$ (6)		$ (4)		(9)		407	(157)	(34)
Adjustments to reconcile net income (loss) to net cash from operating activities:
Equity in (income) loss from subsidiaries																	0	0	0
Dividends from subsidiaries																	0	0	0
Loss on sale of subsidiaries																	141	0	0
Amortization of fixed maturity discounts and premiums and limited partnerships																	(106)	(111)	(105)
Net investment losses (gains)																	75	22	64
Charges assessed to policyholders																	(788)	(777)	(812)
Acquisition costs deferred																	(293)	(383)	(363)
Amortization of deferred acquisition costs and intangibles																	966	453	463
Goodwill impairment																	0	849	0
Deferred income taxes																	(196)	(341)	(100)
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments																	(239)	206	(59)
Stock-based compensation expense																	16	28	39
Change in certain assets and liabilities:
Accrued investment income and other assets																	(106)	(163)	(53)
Insurance reserves																	1,847	2,497	1,644
Current tax liabilities																	(15)	(196)	341
Other liabilities, policy and contract claims and other policy-related balances																	293	1,517	(361)
Cash from operating activities-held for sale																	2	42	21
Net cash from operating activities																	1,591	2,438	1,399
Cash flows from investing activities:
Fixed maturity securities																	4,541	5,198	4,891
Commercial mortgage loans																	882	765	896
Restricted commercial mortgage loans related to securitization entities																	41	32	60
Proceeds from sales of investments:
Fixed maturity and equity securities																	4,391	2,386	4,147
Purchases and originations of investments:
Fixed maturity and equity securities																	(9,750)	(9,188)	(10,458)
Commercial mortgage loans																	(956)	(967)	(873)
Other invested assets, net																	175	(35)	65
Policy loans, net																	25	12	242
Intercompany notes receivable																	0	0	0
Capital contributions to subsidiaries																	0	0	0
Proceeds from sale of a subsidiary, net of cash transferred																	273	0	365
Payments for businesses purchased, net of cash acquired																	0
Cash from investing activities-held for sale																	(26)	(39)	85
Net cash from investing activities																	(404)	(1,836)	(580)
Cash flows from financing activities:
Deposits to universal life and investment contracts																	2,257	2,993	2,999
Withdrawals from universal life and investment contracts																	(2,144)	(2,588)	(3,269)
Redemption and repurchase of non-recourse funding obligations																	(61)	(42)	(28)
Proceeds from the issuance of long-term debt																	150	144	793
Repayment and repurchase of long-term debt																	(120)	(621)	(365)
Repayment of borrowings related to securitization entities																	(36)	(32)	(108)
Proceeds from intercompany notes payable																	0	0	0
Repurchase of subsidiary shares																	(68)	(28)	(43)
Dividends paid to noncontrolling interests																	(157)	(75)	(52)
Proceeds from the sale of subsidiary shares to noncontrolling interests																	226	517	0
Dividends paid to parent																			0
Other, net																	(98)	(30)	(53)
Cash from financing activities-held for sale																	9	(33)	(23)
Net cash from financing activities																	(42)	205	(149)
Effect of exchange rate changes on cash and cash equivalents																	(70)	(103)	(109)
Net change in cash and cash equivalents																	1,075	704	561
Cash and cash equivalents at beginning of period							4,918								4,214		4,918	4,214	3,653
Cash and cash equivalents at end of period	5,993								4,918								5,993	4,918	4,214
Less cash and cash equivalents held for sale at end of period	28								273								28	273	557
Cash and cash equivalents at end of year	5,965								4,645								5,965	4,645	3,657
Parent Guarantor
Cash flows from operating activities:
Net income (loss)																	(615)	(1,244)	560
Less (income) loss from discontinued operations, net of taxes																	9	0	0
Adjustments to reconcile net income (loss) to net cash from operating activities:
Equity in (income) loss from subsidiaries																	579	1,229	(607)
Dividends from subsidiaries																	0	0	535
Loss on sale of subsidiaries																	0
Amortization of fixed maturity discounts and premiums and limited partnerships																	0	0	0
Net investment losses (gains)																	0	0	0
Charges assessed to policyholders																	0	0	0
Acquisition costs deferred																	0	0	0
Amortization of deferred acquisition costs and intangibles																	0	0	0
Goodwill impairment																		0
Deferred income taxes																	(4)	4	24
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments																	0	0	0
Stock-based compensation expense																	21	21	26
Change in certain assets and liabilities:
Accrued investment income and other assets																	3	(4)	2
Insurance reserves																	0	0	0
Current tax liabilities																	(3)	(2)	3
Other liabilities, policy and contract claims and other policy-related balances																	2	11	(4)
Cash from operating activities-held for sale																	0	0	0
Net cash from operating activities																	(8)	15	539
Cash flows from investing activities:
Fixed maturity securities																	0	0	0
Commercial mortgage loans																	0	0	0
Restricted commercial mortgage loans related to securitization entities																	0	0	0
Proceeds from sales of investments:
Fixed maturity and equity securities																	0	0	0
Purchases and originations of investments:
Fixed maturity and equity securities																	0	0	0
Commercial mortgage loans																	0	0	0
Other invested assets, net																	0	0	0
Policy loans, net																	0	0	0
Intercompany notes receivable																	9	(1)	(8)
Capital contributions to subsidiaries																	0	(12)	(531)
Proceeds from sale of a subsidiary, net of cash transferred																	0		0
Payments for businesses purchased, net of cash acquired																	0
Cash from investing activities-held for sale																	0	0	0
Net cash from investing activities																	9	(13)	(539)
Cash flows from financing activities:
Deposits to universal life and investment contracts																	0	0	0
Withdrawals from universal life and investment contracts																	0	0	0
Redemption and repurchase of non-recourse funding obligations																	0	0	0
Proceeds from the issuance of long-term debt																	0	0	0
Repayment and repurchase of long-term debt																	0	0	0
Repayment of borrowings related to securitization entities																	0	0	0
Proceeds from intercompany notes payable																	2	0	0
Repurchase of subsidiary shares																	0	0	0
Dividends paid to noncontrolling interests																	0	0	0
Proceeds from the sale of subsidiary shares to noncontrolling interests																	0	0
Dividends paid to parent																			0
Other, net																	(3)	(2)	0
Cash from financing activities-held for sale																	0	0	0
Net cash from financing activities																	(1)	(2)	0
Effect of exchange rate changes on cash and cash equivalents																	0	0	0
Net change in cash and cash equivalents																	0	0	0
Cash and cash equivalents at beginning of period							0								0		0	0	0
Cash and cash equivalents at end of period	0								0								0	0	0
Less cash and cash equivalents held for sale at end of period	0								0								0	0	0
Cash and cash equivalents at end of year	0								0								0	0	0
Issuer
Cash flows from operating activities:
Net income (loss)																	(657)	(1,356)	540
Less (income) loss from discontinued operations, net of taxes																	0	0	29
Adjustments to reconcile net income (loss) to net cash from operating activities:
Equity in (income) loss from subsidiaries																	463	1,147	(796)
Dividends from subsidiaries																	530	630	376
Loss on sale of subsidiaries																	0
Amortization of fixed maturity discounts and premiums and limited partnerships																	0	0	0
Net investment losses (gains)																	(43)	(4)	(6)
Charges assessed to policyholders																	0	0	0
Acquisition costs deferred																	0	0	0
Amortization of deferred acquisition costs and intangibles																	0	0	0
Goodwill impairment																		0
Deferred income taxes																	(65)	(146)	(138)
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments																	41	1	1
Stock-based compensation expense																	0	0	0
Change in certain assets and liabilities:
Accrued investment income and other assets																	13	(9)	67
Insurance reserves																	0	0	0
Current tax liabilities																	18	(77)	45
Other liabilities, policy and contract claims and other policy-related balances																	(38)	91	(11)
Cash from operating activities-held for sale																	0	0	0
Net cash from operating activities																	262	277	107
Cash flows from investing activities:
Fixed maturity securities																	1	150	0
Commercial mortgage loans																	0	0	0
Restricted commercial mortgage loans related to securitization entities																	0	0	0
Proceeds from sales of investments:
Fixed maturity and equity securities																	0	0	150
Purchases and originations of investments:
Fixed maturity and equity securities																	0	(150)	(150)
Commercial mortgage loans																	0	0	0
Other invested assets, net																	(100)	0	0
Policy loans, net																	0	0	0
Intercompany notes receivable																	265	(19)	(3)
Capital contributions to subsidiaries																	(25)	0	(1)
Proceeds from sale of a subsidiary, net of cash transferred																	0		425
Payments for businesses purchased, net of cash acquired																	(197)
Cash from investing activities-held for sale																	0	0	(30)
Net cash from investing activities																	(56)	(19)	391
Cash flows from financing activities:
Deposits to universal life and investment contracts																	0	0	0
Withdrawals from universal life and investment contracts																	0	0	0
Redemption and repurchase of non-recourse funding obligations																	0	0	0
Proceeds from the issuance of long-term debt																	0	0	793
Repayment and repurchase of long-term debt																	(50)	(485)	(365)
Repayment of borrowings related to securitization entities																	0	0	0
Proceeds from intercompany notes payable																	54	3	(87)
Repurchase of subsidiary shares																	0	0	0
Dividends paid to noncontrolling interests																	0	0	0
Proceeds from the sale of subsidiary shares to noncontrolling interests																	0	0
Dividends paid to parent																			(414)
Other, net																	(39)	(42)	(49)
Cash from financing activities-held for sale																	0	0	0
Net cash from financing activities																	(35)	(524)	(122)
Effect of exchange rate changes on cash and cash equivalents																	0	0	0
Net change in cash and cash equivalents																	171	(266)	376
Cash and cash equivalents at beginning of period							953								1,219		953	1,219	843
Cash and cash equivalents at end of period	1,124								953								1,124	953	1,219
Less cash and cash equivalents held for sale at end of period	0								0								0	0	0
Cash and cash equivalents at end of year	1,124								953								1,124	953	1,219
All Other Subsidiaries
Cash flows from operating activities:
Net income (loss)																	(183)	(828)	1,017
Less (income) loss from discontinued operations, net of taxes																	398	(157)	(63)
Adjustments to reconcile net income (loss) to net cash from operating activities:
Equity in (income) loss from subsidiaries																	0	0	0
Dividends from subsidiaries																	(530)	(630)	(497)
Loss on sale of subsidiaries																	141
Amortization of fixed maturity discounts and premiums and limited partnerships																	(106)	(111)	(105)
Net investment losses (gains)																	118	26	70
Charges assessed to policyholders																	(788)	(777)	(812)
Acquisition costs deferred																	(293)	(383)	(363)
Amortization of deferred acquisition costs and intangibles																	966	453	463
Goodwill impairment																		849
Deferred income taxes																	(127)	(195)	14
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments																	(280)	205	(60)
Stock-based compensation expense																	(5)	7	13
Change in certain assets and liabilities:
Accrued investment income and other assets																	(123)	(151)	(122)
Insurance reserves																	1,847	2,497	1,644
Current tax liabilities																	(30)	(117)	293
Other liabilities, policy and contract claims and other policy-related balances																	328	1,421	(346)
Cash from operating activities-held for sale																	2	42	21
Net cash from operating activities																	1,335	2,151	1,167
Cash flows from investing activities:
Fixed maturity securities																	4,540	5,048	4,891
Commercial mortgage loans																	882	765	896
Restricted commercial mortgage loans related to securitization entities																	41	32	60
Proceeds from sales of investments:
Fixed maturity and equity securities																	4,391	2,386	3,997
Purchases and originations of investments:
Fixed maturity and equity securities																	(9,750)	(9,038)	(10,308)
Commercial mortgage loans																	(956)	(967)	(873)
Other invested assets, net																	277	(40)	65
Policy loans, net																	25	12	242
Intercompany notes receivable																	(63)	(2)	95
Capital contributions to subsidiaries																	25	12	532
Proceeds from sale of a subsidiary, net of cash transferred																	273		(60)
Payments for businesses purchased, net of cash acquired																	197
Cash from investing activities-held for sale																	(26)	(39)	115
Net cash from investing activities																	(144)	(1,831)	(348)
Cash flows from financing activities:
Deposits to universal life and investment contracts																	2,257	2,993	2,999
Withdrawals from universal life and investment contracts																	(2,144)	(2,588)	(3,269)
Redemption and repurchase of non-recourse funding obligations																	(61)	(42)	(28)
Proceeds from the issuance of long-term debt																	150	144	0
Repayment and repurchase of long-term debt																	(70)	(136)	0
Repayment of borrowings related to securitization entities																	(36)	(32)	(108)
Proceeds from intercompany notes payable																	(267)	19	3
Repurchase of subsidiary shares																	(68)	(28)	(43)
Dividends paid to noncontrolling interests																	(157)	(75)	(52)
Proceeds from the sale of subsidiary shares to noncontrolling interests																	226	517
Dividends paid to parent																			0
Other, net																	(56)	14	(4)
Cash from financing activities-held for sale																	0	(33)	(23)
Net cash from financing activities																	(217)	753	(525)
Effect of exchange rate changes on cash and cash equivalents																	(70)	(103)	(109)
Net change in cash and cash equivalents																	904	970	185
Cash and cash equivalents at beginning of period							3,965								2,995		3,965	2,995	2,810
Cash and cash equivalents at end of period	4,869								3,965								4,869	3,965	2,995
Less cash and cash equivalents held for sale at end of period	28								273								28	273	557
Cash and cash equivalents at end of year	4,841								3,692								4,841	3,692	2,438
Eliminations
Cash flows from operating activities:
Net income (loss)																	1,042	2,380	(1,403)
Less (income) loss from discontinued operations, net of taxes																	0	0	0
Adjustments to reconcile net income (loss) to net cash from operating activities:
Equity in (income) loss from subsidiaries																	(1,042)	(2,376)	1,403
Dividends from subsidiaries																	0	0	(414)
Loss on sale of subsidiaries																	0
Amortization of fixed maturity discounts and premiums and limited partnerships																	0	0	0
Net investment losses (gains)																	0	0	0
Charges assessed to policyholders																	0	0	0
Acquisition costs deferred																	0	0	0
Amortization of deferred acquisition costs and intangibles																	0	0	0
Goodwill impairment																		0
Deferred income taxes																	0	(4)	0
Net increase (decrease) in trading securities, held-for-sale investments and derivative instruments																	0	0	0
Stock-based compensation expense																	0	0	0
Change in certain assets and liabilities:
Accrued investment income and other assets																	1	1	0
Insurance reserves																	0	0	0
Current tax liabilities																	0	0	0
Other liabilities, policy and contract claims and other policy-related balances																	1	(6)	0
Cash from operating activities-held for sale																	0	0	0
Net cash from operating activities																	2	(5)	(414)
Cash flows from investing activities:
Fixed maturity securities																	0	0	0
Commercial mortgage loans																	0	0	0
Restricted commercial mortgage loans related to securitization entities																	0	0	0
Proceeds from sales of investments:
Fixed maturity and equity securities																	0	0	0
Purchases and originations of investments:
Fixed maturity and equity securities																	0	0	0
Commercial mortgage loans																	0	0	0
Other invested assets, net																	(2)	5	0
Policy loans, net																	0	0	0
Intercompany notes receivable																	(211)	22	(84)
Capital contributions to subsidiaries																	0	0	0
Proceeds from sale of a subsidiary, net of cash transferred																	0		0
Payments for businesses purchased, net of cash acquired																	0
Cash from investing activities-held for sale																	0	0	0
Net cash from investing activities																	(213)	27	(84)
Cash flows from financing activities:
Deposits to universal life and investment contracts																	0	0	0
Withdrawals from universal life and investment contracts																	0	0	0
Redemption and repurchase of non-recourse funding obligations																	0	0	0
Proceeds from the issuance of long-term debt																	0	0	0
Repayment and repurchase of long-term debt																	0	0	0
Repayment of borrowings related to securitization entities																	0	0	0
Proceeds from intercompany notes payable																	211	(22)	84
Repurchase of subsidiary shares																	0	0	0
Dividends paid to noncontrolling interests																	0	0	0
Proceeds from the sale of subsidiary shares to noncontrolling interests																	0	0
Dividends paid to parent																			414
Other, net																	0	0	0
Cash from financing activities-held for sale																	0	0	0
Net cash from financing activities																	211	(22)	498
Effect of exchange rate changes on cash and cash equivalents																	0	0	0
Net change in cash and cash equivalents																	0	0	0
Cash and cash equivalents at beginning of period							$ 0								$ 0		0	0	0
Cash and cash equivalents at end of period	0								0								0	0	0
Less cash and cash equivalents held for sale at end of period	0								0								0	0	0
Cash and cash equivalents at end of year	$ 0								$ 0								$ 0	$ 0	$ 0
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[2]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.
[3]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.

Schedule I Genworth Financia172

Schedule I Genworth Financial, Inc. Summary of Investments-Other than Investments in Related Parties (Detail) $ in Millions	Dec. 31, 2015USD ($)
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	$ 65,006
Fair value	0
Carrying value	69,128
Commercial mortgage loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	6,170
Fair value	0
Carrying value	6,170
Restricted commercial mortgage loans related to securitization entities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	161
Fair value	0
Carrying value	161
Policy Loans
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	1,568
Fair value	0
Carrying value	1,568
Other invested assets
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	1,208	[1]
Fair value	0	[1]
Carrying value	2,309	[1]
Restricted other invested assets related to securitization entities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	413
Fair value	0
Carrying value	413
Fixed maturity securities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	55,161
Fair value	58,197
Carrying value	58,197
Fixed maturity securities | Bonds | U.S. government, agencies and authorities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	5,487
Fair value	6,203
Carrying value	6,203
Fixed maturity securities | Bonds | State and Political Subdivisions
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	2,287
Fair value	2,438
Carrying value	2,438
Fixed maturity securities | Bonds | Non-U.S. government
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	1,910
Fair value	2,015
Carrying value	2,015
Fixed maturity securities | Bonds | Public Utilities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	4,170
Fair value	4,536
Carrying value	4,536
Fixed maturity securities | Bonds | All Other Corporate Bonds
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	41,307
Fair value	43,005
Carrying value	43,005
Equity Securities
Summary of Investments, Other than Investments in Related Parties, Reportable Data [Line Items]
Amortized cost or cost	325
Fair value	310
Carrying value	$ 310
[1]	The amount shown in the consolidated balance sheet for other invested assets differs from amortized cost or cost presented, as other invested assets include certain assets with a carrying amount that differs from amortized cost or cost.

Schedule II Genworth Financi173

Schedule II Genworth Financial, Inc. (Parent Company Only) (Balance Sheets) (Detail) - USD ($) $ in Millions		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Assets
Investments in subsidiaries		$ 0	$ 0
Deferred tax asset		2,713	2,666
Other assets		520	479
Intercompany notes receivable		0	0
Total assets		106,431	111,316
Liabilities:
Other liabilities		3,004	3,234
Total liabilities		$ 91,794	$ 94,519
Commitments and contingencies
Stockholders' equity:
Common stock		$ 1	$ 1
Additional paid-in capital		11,949	11,997
Net unrealized investment gains (losses):
Net unrealized gains (losses) on securities not other-than-temporarily impaired		1,236	2,431
Net unrealized gains (losses) on other-than-temporarily impaired securities		18	22
Net unrealized investment gains (losses)	[1]	1,254	2,453	$ 926	$ 2,638
Derivatives qualifying as hedges	[2]	2,045	2,070	1,319	1,909
Foreign currency translation and other adjustments		(289)	(77)	297	655
Total accumulated other comprehensive income (loss)		3,010	4,446	2,542	$ 5,202
Retained earnings		564	1,179
Treasury stock, at cost		(2,700)	(2,700)
Total Genworth Financial, Inc.'s stockholders' equity		12,824	14,923
Total liabilities and equity		106,431	111,316
Parent Company
Assets
Investments in subsidiaries		12,814	14,895
Deferred tax asset		25	20
Other assets		0	2
Intercompany notes receivable		0	9
Total assets		12,839	14,926
Liabilities:
Other liabilities		13	3
Intercompany notes payable		2	0	$ 0
Total liabilities		$ 15	$ 3
Commitments and contingencies
Stockholders' equity:
Common stock		$ 1	$ 1
Additional paid-in capital		11,949	11,997
Net unrealized investment gains (losses):
Net unrealized gains (losses) on securities not other-than-temporarily impaired		1,236	2,431
Net unrealized gains (losses) on other-than-temporarily impaired securities		18	22
Net unrealized investment gains (losses)		1,254	2,453
Derivatives qualifying as hedges		2,045	2,070
Foreign currency translation and other adjustments		(289)	(77)
Total accumulated other comprehensive income (loss)		3,010	4,446
Retained earnings		564	1,179
Treasury stock, at cost		(2,700)	(2,700)
Total Genworth Financial, Inc.'s stockholders' equity		12,824	14,923
Total liabilities and equity		$ 12,839	$ 14,926
[1]	Net of adjustments to DAC, PVFP, sales inducements and benefit reserves. See note 4 for additional information.
[2]	See note 5 for additional information.

Schedule II Genworth Financi174

Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Income) (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2015		Sep. 30, 2015		Jun. 30, 2015		Mar. 31, 2015		Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Revenues:
Net investment income																	$ 3,138	$ 3,142	$ 3,155
Total revenues	$ 2,156	[1]	$ 2,100	[1]	$ 2,157	[1]	$ 2,135	[1]	$ 2,229		$ 2,190		$ 2,194		$ 2,116		8,548	8,729	8,625
Expenses:
Acquisition and operating expenses, net of deferrals																	1,309	1,138	1,244
Loss before income taxes and equity in income (loss) of subsidiaries																	(15)	(1,299)	993
Provision (benefit) from income taxes																	(9)	(94)	313
Equity in income (loss) of subsidiaries																	0	0	0
Loss from discontinued operations, net of taxes	(73)	[2]	(21)	[2]	(314)	[2]	1	[2]	138		6		4		9		(407)	157	34
Net income (loss) available to Genworth Financial, Inc.'s common stockholders	$ (292)		$ (284)		$ (193)		$ 154		$ (760)	[3]	$ (844)	[3]	$ 176	[3]	$ 184	[3]	(615)	(1,244)	560
Parent Company
Revenues:
Net investment income																	(3)	(2)	(1)
Total revenues																	(3)	(2)	(1)
Expenses:
Acquisition and operating expenses, net of deferrals																	32	21	33
Total expenses																	32	21	33
Loss before income taxes and equity in income (loss) of subsidiaries																	(35)	(23)	(34)
Provision (benefit) from income taxes																	(8)	(8)	13
Equity in income (loss) of subsidiaries																	(579)	(1,229)	607
Loss from discontinued operations, net of taxes																	(9)	0	0
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	$ (615)	$ (1,244)	$ 560
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $12 million of higher revenue, which included $5 million of corrections related to reinsurance inputs, in our universal and term universal life insurance products. The updated assumptions reflected changes to persistency, long-term interest rates, mortality and other refinements.
[2]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.
[3]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.

Schedule II Genworth Financi175

Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Comprehensive Income) (Detail) - USD ($) $ in Millions		3 Months Ended																12 Months Ended
		Dec. 31, 2015	[1],[2]	Sep. 30, 2015	[1],[2]	Jun. 30, 2015	[1],[2]	Mar. 31, 2015	[1],[2]	Dec. 31, 2014	[3]	Sep. 30, 2014	[3]	Jun. 30, 2014	[3]	Mar. 31, 2014	[3]	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Condensed Financial Statements, Captions [Line Items]
Net income (loss) available to Genworth Financial, Inc.'s common stockholders		$ (240)		$ (238)		$ (139)		$ 204		$ (708)		$ (787)		$ 228		$ 219		$ (413)	$ (1,048)	$ 714
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities not other-than-temporarily impaired																		(1,209)	1,573	(1,817)
Net unrealized gains (losses) on other-than-temporarily impaired securities																		(4)	10	66
Derivatives qualifying as hedges	[4]																	(25)	751	(590)
Foreign currency translation and other adjustments																		(530)	(537)	(442)
Total other comprehensive income (loss)																		(1,768)	1,797	(2,783)
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders																		(2,075)	717	(2,100)
Parent Company
Condensed Financial Statements, Captions [Line Items]
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																		(615)	(1,244)	560
Other comprehensive income (loss), net of taxes:
Net unrealized gains (losses) on securities not other-than-temporarily impaired																		(1,181)	1,539	(1,778)
Net unrealized gains (losses) on other-than-temporarily impaired securities																		(4)	10	66
Derivatives qualifying as hedges																		(25)	751	(590)
Foreign currency translation and other adjustments																		(250)	(339)	(358)
Total other comprehensive income (loss)																		(1,460)	1,961	(2,660)
Total comprehensive income (loss) available to Genworth Financial, Inc.'s common stockholders																		$ (2,075)	$ 717	$ (2,100)
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[2]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.
[3]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.
[4]	See note 5 for additional information.

Schedule II Genworth Financi176

Schedule II Genworth Financial, Inc. (Parent Company Only) (Statements of Cash Flows) (Detail) - USD ($) $ in Millions	3 Months Ended																12 Months Ended
	Dec. 31, 2015		Sep. 30, 2015	[2]	Jun. 30, 2015	[2]	Mar. 31, 2015		Dec. 31, 2014		Sep. 30, 2014		Jun. 30, 2014		Mar. 31, 2014		Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities:
Net income (loss) available to Genworth Financial, Inc.'s common stockholders	$ (240)	[1],[2]	$ (238)	[1]	$ (139)	[1]	$ 204	[1],[2]	$ (708)	[3]	$ (787)	[3]	$ 228	[3]	$ 219	[3]	$ (413)	$ (1,048)	$ 714
Less loss from discontinued operations, net of taxes	73	[2]	$ 21		$ 314		(1)	[2]	(138)		$ (6)		$ (4)		(9)		407	(157)	(34)
Adjustments to reconcile net income (loss) available to Genworth Financial, Inc.'s common stockholders to net cash from operating activities:
Equity in (income) loss from subsidiaries																	0	0	0
Dividends from subsidiaries																	0	0	0
Deferred income taxes																	(196)	(341)	(100)
Stock-based compensation expense																	16	28	39
Change in certain assets and liabilities:
Accrued investment income and other assets																	(106)	(163)	(53)
Current tax liabilities																	(15)	(196)	341
Other liabilities and other policy-related balances																	293	1,517	(361)
Net cash from operating activities																	1,591	2,438	1,399
Cash flows from investing activities:
Intercompany notes receivable																	0	0	0
Capital contribution paid to subsidiaries																	0	0	0
Net cash from investing activities																	(404)	(1,836)	(580)
Cash flows from financing activities:
Other, net																	(98)	(30)	(53)
Net cash from financing activities																	(42)	205	(149)
Effect of exchange rate changes on cash and cash equivalents																	(70)	(103)	(109)
Cash and cash equivalents at beginning of year							4,645								3,657		4,645	3,657
Cash and cash equivalents at end of year	5,965								4,645								5,965	4,645	3,657
Parent Company
Cash flows from operating activities:
Net income (loss) available to Genworth Financial, Inc.'s common stockholders																	(615)	(1,244)	560
Less loss from discontinued operations, net of taxes																	9	0	0
Adjustments to reconcile net income (loss) available to Genworth Financial, Inc.'s common stockholders to net cash from operating activities:
Equity in (income) loss from subsidiaries																	579	1,229	(607)
Dividends from subsidiaries																	0	0	535
Deferred income taxes																	(4)	4	24
Stock-based compensation expense																	21	21	26
Change in certain assets and liabilities:
Accrued investment income and other assets																	3	(4)	2
Current tax liabilities																	(3)	(2)	3
Other liabilities and other policy-related balances																	2	11	(4)
Net cash from operating activities																	(8)	15	539
Cash flows from investing activities:
Intercompany notes receivable																	9	(1)	(8)
Capital contribution paid to subsidiaries																	0	(12)	(531)
Net cash from investing activities																	9	(13)	(539)
Cash flows from financing activities:
Other, net																	(3)	(2)	0
Intercompany notes payable	2								0								2	0	0
Net cash from financing activities																	(1)	(2)	0
Effect of exchange rate changes on cash and cash equivalents																	0	0	0
Cash and cash equivalents at beginning of year							$ 0								$ 0		0	0	0
Cash and cash equivalents at end of year	$ 0								$ 0								$ 0	$ 0	$ 0
[1]	We completed our annual review of assumptions in the fourth quarter of 2015, which primarily resulted in $194 million, net of taxes, of charges, which included $36 million, net of taxes, of corrections related to reinsurance inputs, in our universal and term universal life insurance products. We also recorded an expected loss of $134 million, net of taxes, related to the planned sale of our mortgage insurance business in Europe in the fourth quarter of 2015.
[2]	We completed the sale of our lifestyle protection insurance business on December 1, 2015 and recorded an additional loss of $63 million, net of taxes, in the fourth quarter of 2015. The additional loss in the fourth quarter of 2015 was primarily related to the write off of currency translation adjustments on a holding company that was not part of the sale but related to our lifestyle protection insurance business that was substantially liquidated after the completion of the sale.
[3]	During the fourth quarter of 2014, we completed our annual loss recognition testing of our long-term care insurance business which resulted in additional charges of $478 million, net of taxes. During the fourth quarter of 2014, we also recorded goodwill impairments of $274 million, net of taxes, in our U.S. Life Insurance segment. There was $205 million net tax impact in the fourth quarter of 2014 from potential business portfolio changes. We recognized a tax charge of $174 million in the fourth quarter of 2014 associated with our Australian mortgage insurance business as we can no longer assert our intent to permanently reinvest earnings in that business. In addition, in connection with our plans to sell our lifestyle protection insurance business, we made a change to the permanent reinvestment assertion of one of its legal entities recognizing tax expense of $31 million in the fourth quarter of 2014. We recorded a correction of $32 million, net of taxes, in our life insurance business related to reserves on a reinsurance transaction in the fourth quarter of 2014. Our long-term care insurance claim reserves also increased in the fourth quarter of 2014 as a result of a $44 million unfavorable correction related to claims in course of settlement arising in connection with the implementation of our updated assumptions and methodologies as part of our comprehensive claims review completed in the third quarter of 2014, partially offset by a $28 million favorable refinement of assumptions for claim termination rates.

Schedule II Genworth Financi177

Schedule II Genworth Financial, Inc. (Parent Company Only) - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions	Apr. 01, 2013	May. 31, 2014	Dec. 31, 2013	Dec. 31, 2015	Dec. 31, 2014	May. 31, 2014	Dec. 31, 2013
Condensed Financial Statements, Captions [Line Items]
Class A common stock, par value				$ 0.001	$ 0.001
Genworth Holdings
Condensed Financial Statements, Captions [Line Items]
Class A common stock, par value	$ 0.001
Percentage of subsidiary equity ownership	100.00%
Genworth Financial
Condensed Financial Statements, Captions [Line Items]
Class A common stock, par value	$ 0.001
Genworth Mortgage Holdings, LLC
Condensed Financial Statements, Captions [Line Items]
Percentage of subsidiary common shares distributed as a dividend	84.60%
Percentage of subsidiary equity ownership	15.40%
Genworth Mortgage Holdings, Inc.
Condensed Financial Statements, Captions [Line Items]
Percentage of subsidiary common shares distributed as a dividend	100.00%
Genworth Holdings/U.S. Mortgage Insurance Business
Condensed Financial Statements, Captions [Line Items]
Percentage of subsidiary equity ownership	100.00%
Genworth Mortgage Insurance Corporation (GMICO)
Condensed Financial Statements, Captions [Line Items]
Capital contributions	$ 100	$ 300	$ 100			$ 300
Parent Company
Condensed Financial Statements, Captions [Line Items]
Deferred tax assets related to tax elections				$ 25	$ 20
Current income tax receivable				0	3
Net cash received for taxes				$ 1	$ 23		$ 5

Schedule III Genworth Financ178

Schedule III Genworth Financial, Inc. Supplemental Insurance Information (Schedule of Supplemental Insurance Information) (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	$ 4,398	$ 4,852
Future Policy Benefits	36,475	35,915
Policyholder Account Balances	26,209	26,032
Liability for Policy and Contract Claims	8,095	7,881
Unearned Premiums	3,308	3,485
Premium Revenue	4,579	4,700	$ 4,516
Net Investment Income	3,138	3,142	3,155
Interest Credited and Benefits and Other Changes in Policy Reserves	5,869	7,155	5,475
Amortization of Deferred Acquisition Costs	902	383	354
Other Operating Expenses	1,792	2,490	1,803
Premiums Written	4,794	4,913	4,580
U.S. Mortgage Insurance
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	22	16
Future Policy Benefits	0	0
Policyholder Account Balances	0	0
Liability for Policy and Contract Claims	849	1,180
Unearned Premiums	258	178
Premium Revenue	602	578	554
Net Investment Income	58	59	60
Interest Credited and Benefits and Other Changes in Policy Reserves	222	357	412
Amortization of Deferred Acquisition Costs	7	5	4
Other Operating Expenses	158	142	146
Premiums Written	682	628	567
Canada Mortgage Insurance
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	108	112
Future Policy Benefits	0	0
Policyholder Account Balances	0	0
Liability for Policy and Contract Claims	87	91
Unearned Premiums	1,460	1,548
Premium Revenue	466	515	560
Net Investment Income	130	155	170
Interest Credited and Benefits and Other Changes in Policy Reserves	96	102	139
Amortization of Deferred Acquisition Costs	35	35	31
Other Operating Expenses	85	114	121
Premiums Written	641	583	499
Australia Mortgage Insurance
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	35	41
Future Policy Benefits	0	0
Policyholder Account Balances	0	0
Liability for Policy and Contract Claims	165	152
Unearned Premiums	963	1,112
Premium Revenue	357	406	398
Net Investment Income	114	144	159
Interest Credited and Benefits and Other Changes in Policy Reserves	81	78	134
Amortization of Deferred Acquisition Costs	16	15	17
Other Operating Expenses	110	113	126
Premiums Written	328	509	519
U.S. Life Insurance
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	3,963	4,390
Future Policy Benefits	36,471	35,911
Policyholder Account Balances	23,009	22,874
Liability for Policy and Contract Claims	6,969	6,434
Unearned Premiums	621	639
Premium Revenue	3,128	3,169	2,957
Net Investment Income	2,701	2,665	2,621
Interest Credited and Benefits and Other Changes in Policy Reserves	5,288	6,438	4,594
Amortization of Deferred Acquisition Costs	816	291	298
Other Operating Expenses	832	1,648	841
Premiums Written	3,115	3,172	2,963
Runoff
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	270	293
Future Policy Benefits	4	4
Policyholder Account Balances	3,200	3,158
Liability for Policy and Contract Claims	18	15
Unearned Premiums	6	7
Premium Revenue	1	3	5
Net Investment Income	138	129	139
Interest Credited and Benefits and Other Changes in Policy Reserves	168	156	151
Amortization of Deferred Acquisition Costs	28	37	4
Other Operating Expenses	78	87	85
Premiums Written	1	2	4
Corporate and Other
Supplementary Insurance Information, by Segment [Line Items]
Deferred Acquisition Costs	0	0
Future Policy Benefits	0	0
Policyholder Account Balances	0	0
Liability for Policy and Contract Claims	7	9
Unearned Premiums	0	1
Premium Revenue	25	29	42
Net Investment Income	(3)	(10)	6
Interest Credited and Benefits and Other Changes in Policy Reserves	14	24	45
Amortization of Deferred Acquisition Costs	0	0	0
Other Operating Expenses	529	386	484
Premiums Written	$ 27	$ 19	$ 28